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Abstract 
 
Patient activation covers the skills, abilities and behaviour that contribute to how able 
and willing someone is to take an active role in managing their health. Patient 
activation is currently often assessed using the Patient Activation Measure (PAM). 
While there is growing interest in patient activation, there has been limited research 
about it within inflammatory arthritis (IA). Consequently, three studies were 
conducted to address these knowledge gaps and better understand patient activation. 
The findings of these studies were synthesised into a framework reporting factors 
related to patient activation within inflammatory arthritis that may be amenable to 
intervention.  
  
A systematic literature review reported that interventions targeting patient activation 
in long-term conditions can be effective but that no specific format or style of 
delivery was more effective than others. 
  
Qualitative interviews conducted at two timepoints explored how patients who were 
skilled at managing their health considered patient activation to incorporate many of 
the ways that they already self-managed. This included knowing what techniques 
(both pharmacological and non-pharmacological) suited them and reduced the impact 
of their symptoms, and when and how to seek appropriate help, including navigating 
the National Health Service (NHS). They identified that the PAM did not always 
reflect the fluctuating nature of their conditions.  
  
A survey study administered at two time points reported associations with 
PAM scores and a range of clinical, demographic and psychosocial variables 
across a sample of rheumatology patients in England. Regression analysis confirmed 
that  self-efficacy, health literacy, illness beliefs and health locus of control significantly 
contributed to variance in PAM scores.  
 
Longitudinal, mixed-methods data indicate that patient activation is more than the 
items listed in the PAM. It incorporates several factors including health literacy, illness 
beliefs, self-efficacy and health locus of control underneath a broader umbrella of 
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skills and abilities. Training healthcare professionals about the nature of patient 
activation in rheumatology may contribute to conversations being more 
collaborative and equip them with the skills to effectively support patient activation.  
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Chapter 1: Introduction to the thesis 
This thesis addresses patient activation and its relevance to patients managing 
inflammatory arthritis (IA). The thesis reports three studies related to patient 
activation. Firstly, a systematic review of the literature regarding patient activation 
interventions in randomised controlled trials, delivered to participants with long-term 
physical health conditions. Secondly, a qualitative interview study at two time points 
investigating patient perceptions of patient activation. Finally, a survey of people living 
with IA in the UK, administered at two timepoints, to identify their levels of patient 
activation and the association of patient activation with a range of clinical, 
demographic and psychosocial variables. These findings are synthesised into a 
framework describing aspects of patient activation that may be amenable to 
intervention. 
This chapter introduces the thesis, briefly describes inflammatory arthritis and its 
management and some of the aspects of self-management. The chapter provides the 
rationale, structure, aims and objectives of the thesis. Lastly, the chapter introduces 
the researcher and the patient research partner. 
 
1.1 Inflammatory arthritis 
IA is an umbrella term that describes several long-term conditions including 
rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS) and 
systemic lupus erythematosus (SLE) (Versus Arthritis, 2019). Symptoms often include 
pain, fatigue, stiffness and psychosocial issues such as disturbed sleep and 
psychological distress (Gettings, 2010; Hill, 2006). These conditions can impact 
people in a range of physical and psychosocial ways to a varying degree and commonly 
require significant life adaptations. The consequences of IA often include reduced 
mobility and unpredictable fluctuations or “flares” in disease activity and symptoms 
(Homer, 2005). IA can be associated with lower life expectancy and increased rates 
of disability (Gonzalez et al., 2007). 
 
Diagnosing IA depends on the precise condition and involves classification against 
specific criteria. For RA, the criteria are the American College of Rheumatology 
(ACR)/European League Against Rheumatism (EULAR) classification criteria (Aletaha 
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et al., 2010). For PsA, diagnosis is confirmed using the Classification Criteria for 
Psoriatic Arthritis (Helliwell and Taylor, 2005). AS is diagnosed using the New York 
Criteria (van der Linden, Vaulkenburg and Cats, 1984) and SLE diagnoses are 
confirmed using the European League Against Rheumatism/American College of 
Rheumatology Classification Criteria for Systemic Lupus Erythematosus (Aringer et 
al., 2019). Diagnosis is generally conducted or confirmed by a rheumatologist. IA is 
managed in secondary care with specialist rheumatology teams. These often focus on 
managing the physical symptoms and reducing disease activity and underlying disease 
damage (Gettings, 2010; National Audit Office, 2009). Additional psychosocial 
support to help individuals self-manage their condition is increasingly being offered in 
specialist services, however, access to this type of support is often inconsistent across 
the country (House of Commons Committee of Public Accounts, 2010). 
 
1.2 Methods of managing inflammatory arthritis 
There is currently not a cure for IA. However, there are pharmacological and non-
pharmacological treatments available to manage the symptoms and reduce the impact 
of disease on patients (National Institute for Health and Clinical Excellence Guideline, 
2009). This includes aiming to reduce pain, increase mobility and physical function, 
and to support people to live well and cope with their long-term condition. Multiple 
good practice recommendations for care and patient education propose that people 
receive personalised one-to-one care to effectively manage their condition (Zangi et 
al., 2015; Kennedy et al., 2005). Patients should also receive care with a 
multidisciplinary approach in order to manage their IA and this secondary care is 
generally delivered in rheumatology departments. This can include support from 
occupational therapy, physiotherapy, podiatry and specialist nurse care as well as 
maintaining links and monitoring from primary care.  
 
1.2.1 Pharmacological treatment for IA 
Pharmacological treatment for IA commonly includes non-steroidal anti-inflammatory 
drugs (NSAIDs) for pain relief based on patients’ requirements and to complement 
prescribed treatment regimens (Crofford, 2013). Disease modifying anti-rheumatic 
drugs (DMARDs) are commonly used as an initial response to IA symptoms (NICE, 
2009). They are often used in conjunction with corticosteroids taken either orally or 
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injected directly into joints to target them specifically (NICE, 2009). Biological 
therapies are a specific type of DMARD that aim to reduce tumour-necrosing factors 
that contribute to inflammation (Arthritis Care, 2017). They are used when other 
DMARDs are not effective. Recently biosimilar medications (i.e. a biological 
medication developed once the patent on the original biologics expires) have been 
introduced and many patients have swapped to biosimilar medications to cost-save 
for the NHS (Manova et al., 2018). 
 
1.2.2 Non-pharmacological support for IA 
Non-pharmacological support for IA includes the wider multi-disciplinary team, and 
often pertains to broad psychosocial challenges to support people to live well with 
IA (Luqmani et al., 2006; Luqmani et al., 2009). These approaches aim to improve 
outcomes related to disability and function, mobility and overall quality of life (NICE, 
2009). Nurse-led care is common within rheumatology and includes providing 
education and psychosocial interventions as well as monitoring biomarkers and 
physical health outcomes (Ndosi et al., 2011). While people living with IA often 
experience elevated levels of psychological distress (Gettings, 2010), there are rarely 
resources provided for psychologists to be based in specialist rheumatology 
departments. A large proportion of non-pharmacological support to help people to 
live well with inflammatory arthritis includes self-management support and/or patient 
education. This will be discussed in more detail in chapter 2. Patients thus need to be 
sufficiently activated in order to engage in managing the complexities of their IA. 
 
1.2.3 Thesis aim 
To develop a framework to describe factors that may be amenable to intervention in 
patient activation in the context of inflammatory arthritis. 
 
1.2.4 Thesis objectives 
• To identify the evidence surrounding patient activation interventions in long-
term physical health conditions. 
• To understand how skilled self-managers with IA conceptualise patient 
activation. 
• To understand how skilled self-managers at different levels of activation 
perceive and enact patient activation over time. 
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• To explore longitudinal changes to patient activation (measured using the 
PAM), and its associations with related constructs in patients with IA. 
• To develop a framework to describe patient activation in patients with IA.  
• To identify factors that influence patient activation and may be amenable to 
intervention. 
 
1.3  Researcher perspective 
1.3.1 Researcher experience 
The researcher has experience working with people with a range of long-term 
conditions to support them to self-manage. Some of this was with people with 
rheumatic conditions but initially the researcher had only a limited amount of 
knowledge and experience within rheumatology. This has increased following 
exposure to literature, relevant conferences, observing clinical staff and meeting 
patients. Working closely with a patient research partner (PRP) has brought 
additional context to the researcher’s understanding of life with rheumatic 
conditions. The researcher’s perspective is also formed by life with a long-term health 
condition and the challenges this poses.  
 
1.3.2 Statement of epistemological position 
Research is informed by the perspectives held by researchers on what we can know 
(ontology) and how we can know it (epistemology) (Braun & Clarke, 2013). Clarifying 
one’s position explicitly is a research strength as it provides context for the 
researcher’s position and how it shaped the research (Meyrick, 2006). 
 
The researcher takes a pragmatic approach to this research. Researchers who are 
pragmatists understand truth and reality to be whatever is appropriate for the study 
needs and research questions (Dures et al., 2011). This approach does not reject 
epistemologies as a whole, instead it suggests that considering appropriate methods 
to generate useful data is more valuable than limiting oneself to a single 
methodological viewpoint (Morgan, 2007). Research exists and is conducted in social 
contexts but there is no commitment to a single perception of reality, allowing 
perceptions of reality to be singular or multiple dependent on the needs of the study 
(Cresswell, 2003; Creswell and Clarke, 2011). Research exists and is conducted in 
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social contexts but there is no commitment to a single perception of reality, allowing 
perceptions of reality to be singular or multiple dependent on the needs of the study 
(Cresswell, 2003; Creswell and Clarke, 2011). This is a third option compared to the 
realist approach to research (representing a single, knowable and accessible reality) 
typically captured using quantitative research or a more relativist model of reality 
(where multiple realities exist dependent on context, interpretation and position) 
typically used in qualitative studies (Clarke and Braun, 2013). 
 
Mixed-methods research is often pragmatic as this position is helpful for the flexibility 
required to approach ‘real world’ research questions with appropriate methods 
(Johnson and Onwuegbuzie, 2004). This allows the research question to be more of 
a consideration than the lens through which the phenomena are studied (Hanson et 
al., 2005). It is not that epistemologies are denied consideration in pragmatic research, 
rather the priority and intention remain focussed on developing useful knowledge 
appropriate to the needs of the research. Given that the studies included in the thesis 
include both qualitative and quantitative research methods, the research questions 
for these studies could not be fully answered with a realist or relativist epistemology 
alone. 
 
Consequently, the mixed-methods approach throughout the thesis suits the 
pragmatic position held by the researcher. The studies and thesis benefitted from 
designs that valued flexibility, practicality and consideration for the impact of the 
research (Dures et al., 2011). 
 
1.4 A note on language throughout the thesis 
It has been acknowledged that referring to people with IA as “patients” places their 
condition at the forefront of their identity when discussing them. Instead, the 
accepted way to refer to them is as “people with IA”.  The term patients will be used 
throughout this thesis for the purpose of clarity and brevity. This will help to 
distinguish between people with rheumatic conditions and the wider population. 
However, the researcher is aware of the issues with this terminology. The use of the 
word “patient” does not reflect a lack of concern for recognising people’s holistic 
identities, of which their diagnoses are just one part. 
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1.5 Patient involvement in research 
The research design, data collection and analysis has been supported by the work of 
a patient research partner (PRP). The PRP provided input about living with a 
rheumatic condition and considered research with reference to this. Evidence 
demonstrates that patient and public involvement in health research contributes to 
studies meeting recruitment targets, and that it also strengthens the findings (Ennis 
and Wykes, 2013; Ocloo and Matthews, 2016). Patient involvement specifically in 
rheumatology has identified substantial barriers to living well with rheumatic 
conditions that were under-represented in research (Hewlett et al., 2006). Therefore, 
there is a clear benefit to including patients in research. It was anticipated that, over 
the course of the PhD, working with a PRP who had experiential knowledge of the 
topic would result in more specific feedback and contributions to the project. 
 
During the PhD, the PRP attended supervisory team meetings, contributed to the 
planning of studies and reviewed the findings and analysis. He was involved in the 
dissemination of the findings of the studies about patient activation in inflammatory 
arthritis. Members of the supervisory team and the researcher provided any 
necessary training and contextual information to support the PRP to carry out his 
role, and his involvement in specific studies is noted in the pertinent chapters. 
 
1.6 Thesis structure 
To achieve the aims and objectives set out above, this thesis is structured into ten 
chapters. The next two chapters are background chapters reviewing the literature 
and contextual frame in which the research is set. Five chapters are dedicated to the 
methods and findings of three studies investigating patient activation in long-term 
conditions, specifically inflammatory arthritis. Study one is a systematic review of the 
existing research on the effectiveness of interventions targeting patient activation in 
long-term conditions, and has a single chapter dedicated to it. Studies two and three 
are longitudinal studies and combine the data analysed at each time point into a single 
results chapter for each study. The thesis ends with two chapters that discuss the 
findings and contributions to knowledge as well as the proposal of a framework to 
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describe patient activation in inflammatory arthritis, with recommendations for 
further research and implications for practice as a result of this development. 
  
 
Chapter 2: Approaches to health and 
healthcare 
The first section of this chapter reviews how health and healthcare have been conceptualised 
previously. This will be followed by a summary of a range of models of both health and 
healthcare that are relevant to the concept of patient activation that is investigated in the 
next chapter. 
 
The way that health and healthcare have been understood has evolved over time. There has 
been a shift away from a paternalistic approach that viewed people as passive recipients of 
care targeting only the biomedical challenges. Instead, research has led healthcare to take 
a more holistic approach that sees people as involved in managing their own health in 
collaboration with healthcare professionals.  The changes of status and responsibilities for 
patients are most evident for people with long-term conditions.  
 
2.1 The biomedical model 
The conceptualisation of illness has previously focused on the biomedical model, 
which understood experiences of illnesses as being caused by disease or physical 
dysfunction. This model placed disease as the singular cause of illness with all 
experiences of illness and symptoms having an underlying pathophysiology (Wade 
and Halligan, 2004). The model’s aim was a return to health, defining this as the 
“absence of disease”. If the cause of disease was removed, then a person would be 
healthy and no longer experience symptoms related to that cause. This approach was 
applied universally and did not account for whether ill health was acute (short-lived) 
or chronic (long-term). 
 
The biomedical model had an assumption of dualism, in which the body and 
consciousness are separate entities (Albery and Munafo, 2007). Therefore, treating 
physical health challenges did not require consideration of the mind. The psyche was 
presumed to be independent from the experience of physical health. It was expected 
that compliance with medical routines would lead directly to a positive outcome 
regardless of other factors that could contribute to ill health (Engel, 1977). The use 
of the term “compliance” here reflects some of the developments in terminology 
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over this time, particularly related to patients and their uptake of prescribed 
regimens. This implies that patients are expected to comply with the 
recommendations provided to them. There are similar implications with the term 
“adherence”, suggesting that a patient will continue to follow the instructions of a 
healthcare professional providing that they have been informed of the details, 
justification and guidance (Treharne et al., 2006). A shift in terminology towards 
referring to “concordance” or “collaboration” has begun. This reflects agreement 
and communication between patients and healthcare professionals and the value of 
patients being involved in determining the direction of care (Treharne et al., 2006). 
 
The biomedical model of health had consequences for healthcare systems and care 
delivery. These consequences included healthcare being a very paternalistic practice 
as the focus of consultations revolved around identifying the underlying disease; this 
relied on the biological expertise of healthcare professionals. They were viewed as 
the experts and providers of information, with little opportunity for patients to 
contribute to the decision-making process. Both patients and healthcare professionals 
expected healthcare professionals to lead consultations and be responsible for 
informing patients of both the diagnostic process and any treatments required (Engel, 
1980). This approach did not empower patients to feel involved and engaged in their 
own care and was not collaborative in any way. 
 
2.1.1 Criticisms of the biomedical model 
The biomedical model has since been heavily criticised for its reductionist 
conceptualisation of illness and for the limitations in accounting for the wide variety 
of experiences of illness (Wade and Halligan, 2004). There was a clear need to 
consider other factors (both intrinsic and extrinsic to patients) that contributed to 
health. This model also assumed that healthcare encounters focused on acute 
conditions that had the potential to return to health. In comparison, long-term 
conditions that did not always lead to a cure needed a different understanding. The 
lack of consideration of the contributions of social, psychological or behavioural 
factors to the experience of illness positioned patients in a passive role, or a “victim 
of circumstance” (Wade and Halligan, 2004). This denied them the opportunity to 
contribute to the management of their condition. This model of understanding illness 
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may have been more appropriate in circumstances when someone was acutely ill but 
was less helpful in capturing peoples’ experiences in living with long-term conditions 
or unexplained illnesses. Wade and Halligan (2004) also described a need for a model 
that accounted for personal context and that recognised the role that patients and 
their free will played in the management and outcomes of their health. 
 
2.2 Moving toward patient-centred care: the 
biopsychosocial model 
Due to these criticisms, the biopsychosocial model sought to describe the experience 
of illness differently, encompassing social and psychological factors which can 
contribute to the presentation of an illness (Engel, 1977). The assumption was that 
these many factors would interact with each other and contribute to the dynamic 
and complex experience of health. This more holistic approach to health is 
considered more flexible and comprehensive (Albery and Munafo, 2007). However, 
since this model’s development, suggestions have been made that it is not possible to 
know all the factors that contribute to the presentation of an illness and these may 
be even broader than biopsychosocial aspects (Borrell-Carrio, Suchman and Epstein, 
2004). Another potential criticism of this model is that there is no guarantee that a 
healthcare professional working to this approach will (or should) give equal 
consideration to all three aspects (bio-, psycho-, and social) of health (Benning, 2015). 
 
The biopsychosocial model was initially described with relation to psychiatric 
conditions, but has since been applied to physical health conditions (Engel, 1980). 
While the biological aspect often continued to take precedence, Richter (1999) 
recommended that healthcare professionals consider that the psychosocial difficulties 
people experience remain as important as biomedical factors in someone’s health 
care. This emphasised the responsibility of healthcare professionals in engaging 
patients to co-operate in behaviour change to improve their condition. This implies 
a continuing primarily passive role for patients (Engel, 1980). 
 
2.3 The Chronic Care Model 
The Chronic Care model (CCM) (Wagner, 1998) retained a biopsychosocial focus 
and is a model of healthcare and the context of care delivery. The CCM proposed 
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that healthcare systems are often designed to provide acute care and that long-term 
conditions are often managed sub-optimally. A large proportion of healthcare remains 
focused on supporting people with long-term conditions and NHS England has 
estimated that 70% of budgets for acute services were used by people with long-term 
conditions (NHS England Care Quality Commission, Health Education England and 
Public Health England, 2014). Given that the resources required to help people 
manage long-term conditions is so great, the CCM initially proposed that outcomes 
would substantially improve if clinical systems were adapted to best suit these 
patients and their needs (Wagner, Austin and Von Korff, 1996). Therefore, the 
chronic care model described how three separate, interrelated “galaxies” were 
important for providing care (Wagner, 1998): 
● the community, with the resources available to it; 
● the healthcare system; 
● the provider organisations. 
 
Between these three galaxies, Wagner (1998) reported six aspects of healthcare that 
were deemed essential to providing effective care for long-term conditions: 
● Community links and resources. 
● Healthcare organisations with strong support for self-management and 
prioritising the care of long-term conditions (Bodenheimer, Wagner and 
Grumbach, 2002). 
● Self-management support that reflected the role of patients in solving 
problems related to their health and having the practical tools they require to 
care for themselves (Bodenheimer, Wagner and Grumbach, 2002). 
● A delivery system design that included a separation between acute and long-
term care services and staff who were ready to support people to self-manage 
(Bodenheimer, Wagner and Grumbach, 2002). This focus on wider systemic 
improvements was particularly embraced as part of the Co-Creating Health 
project (Wallace et al., 2012) which will be discussed in more detail in section 
2.1.6. 
● Decision support that was prompt, clear and pitched at a level to avoid 
overwhelming individuals. 
● Clinical information systems that provide feedback to patients and healthcare 
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professionals on outcomes, reminders and contribute to decision-making in a 
collaborative way (Bodenheimer, Wagner and Grumbach, 2002). 
 
The CCM aimed to be integral to the way that care is delivered to people with long-
term conditions. There is evidence for improved care following interventions based 
on this model, in terms of improved biomedical outcomes (Coleman et al., 2009). A 
crucial dimension of the CCM was self-management support (Glasgow et al., 2005a). 
 
2.4 Self-management 
The shift to increase the responsibility of willing patients increased awareness of self-
management. Self-management can be considered from two perspectives. The first is 
that it is a series of skills, tools and approaches someone can use to manage their 
health (Bodenheimer and McGregor, 2005). The second understands self-
management to be the process of shifting the dynamics of the patient-healthcare 
professional relationship to be one of equals where they make decisions together and 
bring different skills and expertise to the partnership (De Silva, 2011; Bodenheimer 
and McGregor, 2005. 
 
Self-management focuses on the patient as someone actively involved in their own 
care (Bandura, 1997). It includes the activities that people do for themselves to 
maintain their health and wellbeing. This incorporates meeting their emotional and 
social requirements and preventing further problems related to their health 
(Department of Health, 2005). Self-management is a major focus in healthcare policy 
and in the development of care pathways for long-term conditions (Ong, Jinks and 
Morden, 2011). A key concept related to self-management is self-efficacy, which will 
be discussed in detail in section 2.7.2. Self-efficacy is defined as:  
 
“People's beliefs about their capabilities to produce designated levels of performance that 
exercise influence over events that affect their lives.” (Bandura, 1994). 
 
Healthcare services slowly began to move towards people becoming more actively 
involved in their care.  The Nursing and Midwifery Code of Practice noted that 
healthcare professionals have a duty to “recognise and respect the contribution that 
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people can make to their own health and wellbeing” and “encourage and empower people 
to share decisions about their treatment and care” (Nursing and Midwifery Council, 2018, 
section 2). The move towards personalised care intended for all strands of healthcare 
to provide support for people to manage their health (Hibbard and Gilburt 2014). 
This support reflected the conceptualisation of self-management to include the new 
style of collaborative relationship between patients and healthcare professionals 
working as equals (De Silva, 2011). There was an expectation that patients would 
take increased responsibility for managing their condition within and outside of 
consultations (Barlow et al., 2002). Self-management offered the opportunity for 
healthcare professionals to work more holistically on aspects of health beyond 
medical management, and to consider behaviours, social roles and the emotional 
impact of a long-term condition (Lorig and Holman, 2003). 
 
The growing acceptance of the biopsychosocial model gave people with long-term 
conditions a role as experts in living with their diagnosis. Healthcare policy and 
providers expected people to develop skills to manage their health and become more 
involved in making decisions about their condition (Hibbard et al., 2004), to the point 
that the NHS Constitution (NHS England, 2015) provided a list of responsibilities for 
patients as well as their rights. By the beginning of the 21st century, self-management 
interventions were designed to support people to self-manage using a biopsychosocial 
understanding of ill health.  
 
2.5 Flagship self-management-based interventions 
The initial steps towards a more person-centred approach to managing care for long-
term conditions advanced substantially with the introduction of self-management 
programmes. These often sat outside of usual service provision,  not part of routine 
healthcare but an add-on (Lorig and Holman, 2003). These interventions were often 
multi-week, group-based and sought to increase self-efficacy. This was typically 
achieved through group members watching peers achieve their goals and increasing 
their confidence in self-management. In this way, the peers modelled positive self-
management behaviours to other group members. This would increase other group 
members’ belief that they too could hold greater control over their health (Barlow 
et al., 2002; Abraham and Gardner, 2009). 
31 
 
 
Some of the seminal early self-management programmes were the Chronic Disease 
Self-Management Programme (CDSMP) and the Arthritis Self-Management 
Programme (ASMP). These were developed and conducted in Stanford by Kate Lorig 
and her colleagues in the late 1990s (Lorig et al., 2001) and largely recruited people 
with arthritis in the first few trials (Vadiee, 2012). They focused on providing 
information around topics such as sleep, relaxation, noticing and managing cognitions 
around health, dealing with emotion and problem-solving strategies. The groups 
allowed the opportunity for discussions aimed at group members learning from one 
another and validating their concerns and challenges as legitimate (Lorig et al., 2001). 
The overall aim was to give group members the skills and confidence to manage their 
conditions and lead them towards improved  problem-solving and decision-making 
to make best use of resources to collaborate with healthcare professionals and 
change health-related behaviours (Grover and Joshi, 2015). These interventions were 
revolutionary because of their focus on building self-efficacy with a view to promoting 
behaviour change. This was an alternative to focusing on providing information and 
assuming participants would make changes as a result. The link between participants’ 
knowledge of what they should do and the behaviour they subsequently carried out 
was strengthened with the increase in self-efficacy. 
 
There is evidence to suggest that as well as contributing to improved outcomes 
following participation in self-management programmes (Lorig, Ritter and Plant, 
2005), increased self-efficacy contributes to people feeling more in control over their 
health (Dures et al., 2016a). This is in line with Bandura’s model of self-efficacy 
(Bandura, 2004; Griffiths et al., 2005), where group members modelled helpful 
changes to their peers to bring about the anticipated increases in self-efficacy as an 
outcome of the programme. 
 
Participants who completed the CDSMP and ASMP programmes have reported a 
substantial increase in their knowledge about their condition, both through the group 
itself and after feeling empowered to seek out additional information about their 
condition (Wilson, Kendall and Brooks, 2007). What is important to note is that the 
evidence suggested that CDSMPs did not contribute towards significant changes in 
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physical symptoms and levels of disability, but rather left people feeling less distressed 
and more confident about coping with their condition (Lorig et al., 2001). 
 
Common limitations of group-based interventions apply when critiquing the CDSMP 
and ASMP (i.e., confidentiality issues between group members and the risk of 
primarily recruiting those who are already very engaged). Additionally, the lack of 
impact on physical symptoms was viewed as a limitation by Lawn and Schoo (2010) 
in their review of approaches to self-management. They also recognised that this 
method did not have an impact on the actions and approach of healthcare 
professionals. A greater cultural shift towards collaborative self-management was 
required as an encounter with an unsupportive healthcare professional had the 
potential to contribute to setbacks in someone’s self-management abilities and 
confidence, with poor self-management support reducing the effectiveness of 
interventions. 
 
The outcome of these initial programmes led to self-management based interventions 
of this type becoming widespread. This included interventions in a variety of contexts, 
both generic and condition-specific (Lawn and Schoo, 2010). These interventions 
typically involved a psychoeducational focus with a structure inspired by Kate Lorig’s 
CDSMPs. 
 
One such intervention was the Expert Patient Programme (EPP), which was 
developed in the UK in partnership with the Department of Health during 2002. It 
was taken up on a substantial scale, with 98% of primary care organisations 
participating (Vadiee, 2012). The intention of this initiative was to introduce this form 
of self-management intervention into the NHS to understand how acceptable and 
successful it was within a UK context (Kennedy, Rogers and Gately, 2005). This 
entailed patient tutors, with a range of health conditions, leading 6-week standardised 
programmes for their peers based on improving self-management skills. These skills 
included managing medical consultations with preparation, and practical solutions to 
set priorities for discussions, communicating about their conditions and goal setting 
(planning small changes for the week ahead that adhered to specific guidelines to 
make them more likely to be achievable) (Wilson, 2008). The focus was not to 
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improve the symptoms of patients’ conditions but rather to improve life with the 
condition. These patient tutors were volunteers who had undergone a criminal 
record check and been interviewed to ensure suitability for the opportunity. They 
received four days of training in how to deliver the course, the ethos of the 
programme and how to facilitate groups, and were required to commit to 
contributing to two programmes each year. The rationale behind this was that group 
participants were more likely to learn from someone like themselves who could 
become a role model to group members (Wilson, 2008). 
 
Like the CDSMPs, the EPP provided the opportunity to practise problem solving, 
action planning and relaxation strategies such as breathing and imagery exercises with 
the group. Information was provided as part of the programme. However, group 
members reported that this information was often either not sufficiently thorough 
or to a level of detail that was beyond what participants felt they needed (Wilson, 
Kendall and Brooks, 2007). This implies a challenge of presenting a level of detail and 
complexity that was appropriate for a group of varying abilities. 
 
While the lay-led aspect of the EPP and their personal stories were valuable features 
of the programme (Barlow, Bancroft and Turner, 2005), feedback provided by 
participants suggested that having a healthcare professional present for parts of the 
intervention would offer the opportunity for knowledge provision (Turner et al., 
2015). However, General Practitioners demonstrated limited engagement with the 
EPP (Barlow, Bancroft and Turner, 2005; Blakeman et al., 2006). These issues may 
have limited discussion if group participants wanted to discuss something of risk or 
requiring complex condition-based knowledge that went beyond the skills of the lay 
tutor or the rigid, pre-planned programme manual (Wilson, 2008).  
 
Like the findings of the CDSMP, the EPP demonstrated significant improvements in 
self-efficacy, participation in activities and social roles and psychological wellbeing. 
Similarly to the CDSMP, there were no significant improvements at follow-up in pain, 
energy levels or usage of health services (Wilson, 2008). The EPP began to bring the 
issue of generic versus condition-specific interventions into the consciousness of the 
UK healthcare system. Overall, there has been mixed opinion on whether condition-
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specific, rather than generic, approaches to self-management support are better. 
Feedback from the EPP suggested that participants found it beneficial to discuss 
condition-specific information and the shared understanding that came from having 
similar experiences with their conditions (Ngooi and Packer, 2017). This indicates 
that while generic programmes have benefits, condition-specific forms of support can 
be one way of reducing the challenges involved in pitching the level of educational 
detail appropriately. This information can be more focused for the relevant condition 
(De Silva, 2011). Rogers et al. (2005) conducted a national evaluation of the EPP and 
identified that many participants would prefer condition-specific self-management 
support to obtain their preferred level of detail in the education sections. Course 
materials for specific long-term conditions would also benefit the delivery of the EPP 
(Vadiee, 2012). 
 
Recruiting participants from secondary care for the EPP proved to be challenging. 
The evaluation report suggested that work was needed to encourage healthcare 
professionals to engage with the lay-led philosophy and approach to care, as well as 
to engage NHS trusts to implement such programmes (Kennedy, Rogers and Gately, 
2005). It was apparent that systemic change was required, as well as training 
healthcare professionals to effectively work with expert patients and work 
collaboratively to improve care for people with long-term conditions in the NHS. 
Critical analysis also suggested that the EPP contributed towards the reinforcement 
of healthcare professionals’ power as it centred around patients being encouraged by 
healthcare professionals to join the programme instead of attending through 
proactive self-referral (Wilson, 2001). This could have been for several reasons. The 
EPP being based in a hospital setting may have contributed to healthcare professionals 
inadvertently being gatekeepers as patients may not have felt able to attend freely 
compared to if the programmes had been based in the community. Alternatively, 
patients who required additional self-management support may have benefitted from 
the encouragement of healthcare professionals to attend.  
 
Based on the clear need for wider cultural change to support self-management, the 
Co-Creating Health (CCH) project (Wallace et al., 2012) was developed. This was 
based on the Chronic Care model (Wagner, 1998) and piloted similarly structured, 
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condition-specific self-management programmes across multiple sites in the UK in 
four different long-term conditions. The focus of the study was on incorporating self-
management support into routine care pathways through several means. The first 
was the standardised group programme based on the CDSMP delivered with a 
healthcare professional and a patient partner working in collaboration. This pairing 
was reported to be challenging in some circumstances, particularly around finding 
time for the professionals and lay tutors to prepare for the group sessions, as well as 
managing the lay tutors’ own health during this time (Wallace et al., 2012). There 
were benefits to this pairing though, as group participants were generally positive 
about the combination of professional knowledge and the authentic lived experience 
of the lay tutors (Ahmad, Wallace and Turner, 2009). However, there was no clear 
instruction on how to formalise arrangements between the two tutors to determine 
the responsibility split and to support the lay tutors in these group interventions. This 
meant there was a great deal of diversity in the support and levels of responsibility 
held by the lay tutors, particularly around the organisation and administration of the 
course (Wallace et al., 2012). 
 
The group programmes were delivered in conjunction with two other strands of the 
project. The second of these was a training scheme to support healthcare 
professionals in supporting people to self-manage during their routine clinical contact. 
Supporting patients to self-manage was deemed to be the responsibility of a range of 
healthcare professionals. This included GPs, nurses, medics and allied health 
professionals. The third strand of the project were service development projects 
focusing on sustainable implementation of co-produced self-management support 
(Wallace et al., 2012). The intention was for these three arms combined to bring 
about a cultural shift in the way that self-management was approached in the NHS. 
This could move healthcare professionals towards including self-management support 
more often in their daily practice  (Wallace et al., 2012). In this the CCH project 
moved beyond the focus of the EPP to increase peoples’ knowledge and ability to 
manage their health, and to a programme designed to bring about changes to the 
wider healthcare system. 
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From the self-management programme arm of CCH, participants at the beginning of 
the interventions were often passive in managing their health. The end evaluations 
demonstrated substantial improvements in how able and willing group members 
generally were to self-manage (Wallace et al., 2012). The training aimed at healthcare 
professionals to encourage them to collaborate with patients was well received and 
demonstrated small changes in the techniques used in clinical settings to support self-
management, however the study authors recognised that the small sample sizes 
limited the generalisability of the findings. 
 
CCH continued the growing implementation of self-management support in the NHS 
and the consciousness of NHS staff. However, this study demonstrated the need for 
self-management support that was longer term and more embedded into the mind-
set of healthcare professionals and within services to bring about systemic change 
(Wallace et al., 2012). Implementing this more embedded self-management support 
would go beyond offering this type of intervention as an “add-on”, to supporting 
patients to follow up on their goals, bringing about changes to behaviour and 
supporting patients to act as a collaborative partner in their care (Wallace et al., 
2012). 
 
2.6 Self-management in the NHS  
2.6.1 Current environment for self-management in the NHS 
Focus on self-management and empowering patients continued to grow following 
CCH, and this was a major focus of the NHS Five Year Forward View document 
(NHS England Care Quality Commission, 2014). Systems such as personal health 
budgets and self-management support coaches were established and departments 
continued to make room for empowered people to be able to manage their own 
conditions, take the lead in planning their care and accessing structured education, 
specialist advice and emotional support when required (Hibbard and Gilburt, 2014).  
 
As the number of people living with long-term conditions continued to rise (Roberts 
et al., 2016), this remained one of the largest challenges for healthcare systems. There 
was an increase in focus on managing long-term conditions in individuals, identifying 
people who may be struggling to self-manage, and individualising care (Roberts et al., 
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2016). Self-management interventions formed an integral part of care and took a 
variety of forms, including a combination of professional and lay person led self-
management courses such as the CCH, EPP and CDSMP. There was also a growth in 
telephone and internet-based support and the beginnings of integration of informal 
opportunities for self-management support as part of routine care (Hibbard and 
Gilburt, 2014). 
 
Healthcare professionals are expected to create a suitable environment for 
empowering people to self-manage. This has begun to be incorporated into routine 
practice in the current healthcare climate, strengthened by research evidence 
indicating the benefits of healthcare professional behaviours for self-management. For 
example, there are recognised relationships between empowering behaviours from 
nursing staff for inpatients and one’s ability to self-manage post-discharge (Jerofke, 
Weiss and Yakusheva, 2014). Evidence suggests that the knowledge and skills that 
healthcare professionals have in order to support self-management and engage in 
collaborative care vary, and healthcare professionals have struggled to identify their 
learning needs (Do et al., 2015; Hooft et al., 2015). 
 
Focussing interventions on specific populations or based on demographic factors has 
offered the opportunity to increase support for people who may not have engaged 
with other services or who may be more vulnerable to risks following poorly 
managed conditions, or for whom a more generic approach would not be 
appropriate. Examples of this included working with patients with low health literacy 
(see section 2.2.4), severe mental health problems, or with older people with knee 
pain (Rademakers and Heijmans, 2018; Goldberg et al., 2013; Ganji et al., 2018). The 
integration of self-management into stepped care models has led to services beginning 
to implement tailored self-management at a variety of levels (Korpershoek et al., 
2016). Stepped care refers to the approach to healthcare where all patients have 
access to interventions that are low intensity or targeted at those functioning best, 
and those with greater need or with higher risks are offered more intense support 
(Von Korff et al., 2015). 
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The influence of patients’ wider networks and communities is becoming increasingly 
relevant as a consideration to the NHS. However, this is still growing as a perspective 
and currently much self-management support does not take the wider context and 
environment into consideration (Rogers et al., 2011). The consideration of 
communities and networks can help to support individuals to participate in 
meaningful activities that promote positive self-management behaviour and increased 
wellbeing. Social prescribing has begun to do this by referring patients to services 
designed to improve their health and wellbeing without directly meeting biomedical 
needs (Tierney et al., 2020). This was intended to build social networks that increase 
cohesion and camaraderie with networks that may not occur naturally but require 
nurturing and developing. This linking was taken a step further by the GENIE 
intervention that intended to move beyond the concept of actively self-managing 
patients to active and engaged networks (Band et al., 2019). This work built on the 
idea that social isolation was a factor in poor health outcomes and developed the 
Generating Engagement in Network Involvement (GENIE) study. This developed a 
questionnaire to map participants’ social network, guide them to select activities they 
have an interest in to develop their wellbeing, and use a local database to match 
participants up to these activities (Rogers, 2018). These types of support reflect the 
expansion of how self-management is reflected in the NHS and how commissioners 
have implemented systems to focus on the wider social determinants of self-
management support. 
 
Research has moved towards a greater understanding of the evidence base and 
concepts underlying self-management. This has led to further study into concepts 
such as patient engagement, self-efficacy and patient activation in detail. These will be 
discussed in the latter half of this chapter and in the next chapter. 
 
 
2.6.2 Criticisms of self-management based approaches 
Self-management based interventions are still subject to criticisms about whether 
those who would benefit most from support are neglected (Wilson, Kendall and 
Brooks, 2007). There is a risk that these approaches and the research studies that 
contribute to their development, tend to attract people who are likely to already be 
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engaged with their health and able to manage to some degree, or believe in the 
benefits of managing their own health (Hochhalter et al., 2010).  
 
Self-management based interventions like the EPP have been accused of continuing 
to perpetuate the model of medical dominance because people may feel coerced into, 
or expected to accept, receiving such an intervention to manage their health, or when 
it is expected as a responsibility rather than making an informed, empowered choice 
(Gilbert, 2005). The growth of self-management support has also been met with 
criticism for placing the blame for poor health management with individuals for their 
failure to effectively make behavioural changes, instead of tackling wider systemic 
factors that contribute to people being passive or unable to make health-related 
behaviour change (Wilson, Kendall and Brooks, 2007). This perspective does not 
consider the other forms of systemic and structural inequalities and factors that 
contribute to someone’s health. Some of these inequalities include the deprivation of 
local authority governments and the impact this has on healthcare provision and life 
expectancy (Public Health England, 2017). Other factors such as housing, transport, 
work availability and recreation facilities also impact on health in ways that go beyond 
an individual’s ability to self-manage their health (Buck and Gregory, 2018; British 
Academy, 2014). Consequently, self-management placing blame on individuals for not 
effectively managing their health does not consider the other contributors to health 
and the role that policy makers play in peoples’ health. The behaviour and attitude of 
health professionals also has the potential to be a barrier to self-management, instead 
perpetuating power imbalances and disempowering patients. 
 
2.7 Models and theories underlying self-management 
principles  
The preceding section described the emergence of self-management in healthcare. 
As self-managing a health condition requires patients to make behavioural and 
cognitive changes, this section will examine the relevant underpinning cognitive and 
behaviour-change theories. This will provide both a sense of the background research 
that contributed to an understanding of patient activation and the additional detail 
for concepts that are captured in studies later in this thesis. 
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2.7.1 Social Cognitive Theory  
Social Cognitive Theory has been prominent in research related to person-centred 
care and self-management. This theory posits that people can learn by observing 
others modelling helpful behaviours (Bandura, 2004).  Modelling behaviours have been 
reported as part of the benefit of group self-management interventions as they offer 
group members access to behaviour that they may not yet be confident enough to 
attempt themselves and to view the intended behaviour being reinforced (Bandura, 
2004). The benefits of peer modelling are particularly relevant for patients as it 
provides personal comparison for managing conditions that healthcare professionals 
are not able to offer because of their different perspective. For this reason, patients 
can learn better from these groups compared to one-to-one contacts with health 
professionals. 
 
2.7.2 Self-efficacy 
Self-efficacy is one of the “core determinants” of social cognitive theory (Bandura, 
2004, p.143). It is defined as:  
 
“… an individual’s belief in their capacity to successfully learn and perform a specific 
behaviour. A strong sense of self-efficacy leads to a feeling of control, and willingness to take 
on and persist with new and difficult tasks. When applied to health, this theory suggests that 
patients are empowered and motivated to manage their health problems when they feel 
confident in their ability to achieve this goal” (Coulter and Ellins, 2006, p.89) 
  
Self-efficacy refers to an individual’s belief that they are able to carry out behaviours 
related to managing their health (Bandura, 2004). Self-efficacy is a vital component of 
how people learn to self-manage and is often targeted during self-management 
interventions: research has demonstrated that self-efficacy can be increased through 
intervention (Wallace et al., 2012; Hewlett et al., 2011). Increased self-efficacy is 
associated with learning from vicarious experiences (Rosenstock, Strecher and 
Becker, 1988). 
 
Self-efficacy has an impact on how people consider making health-related behaviour 
change, how well they are able to return to maintaining health-related behaviours 
after a setback and how likely it is that someone will continue to maintain behaviours 
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longer term (Dures and Hewlett, 2012). However, self-efficacy doesn’t necessarily 
mean that someone is going to take steps to change their behaviour, although it does 
consider that someone’s personal expectations are major determinants of behaviour 
change (Gwynn et al., 2016). People may not carry out behaviours that they feel 
confident they could achieve for a variety of reasons as other determinants also 
contribute to behaviours (Bandura, 1998). For example, external factors such as 
climate, finances or access to facilities may prevent people who have high self-efficacy 
to exercise from doing so. 
 
2.7.3 Health Locus of Control 
The concept of Health Locus of Control (HLOC) found its origin in Rotter’s social 
learning theory (Rotter, 1954) and relates to whether people believe that outcomes 
occur as a result of actions that they can take charge of (internal locus of control), 
or because of factors that are outside of their control (external locus of control). 
Wallston et al. (1976) developed the concept more specifically to consider how much 
someone feels they are responsible for their health. This resulted in the creation of 
the HLOC Scale, based on the hypothesis that a person with an internal HLOC would 
be more likely to take steps to improve their situation. Research that initially tested 
this concept suggested that people with an internal HLOC participated in more 
preventative health behaviours, sought further information more often and had 
increased knowledge about their health (Wallston and Wallston, 1978). 
 
The Multidimensional HLOC scale was developed with people diagnosed with 
rheumatoid arthritis (Wallston, 2005) and is one of the most common methods of 
capturing health locus of control. This measure separated HLOC into internal (one’s 
health being impacted by the actions of the self) and external (separated into two 
categories: chance, and the actions of powerful others). A factor that Norman and 
Conner (1996) proposed to have contributed to the mixed results evident in early 
HLOC studies was how much people valued their health. They proposed that if 
people did not value their health then they would be less likely to follow the 
anticipated health-behaviour patterns. Wallston (1989) began to move towards the 
integration of HLOC into a wider theory of health behaviour, inspired by social 
learning theory. This included a consideration of locus of control, health value and 
self-efficacy as a moderator. 
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2.7.4 Health literacy 
“Health literacy represents the cognitive and social skills which determine the motivation 
and ability of individuals to gain access to, understand and use information in ways which 
promote and maintain good health” (Nutbeam, 1998, p357). 
 
Health literacy is often conceptualised to include a variety of skills, including being 
able to comprehend and evaluate health related information to make decisions 
related to one’s health (Buchbinder et al., 2011). Other skills covered under this 
umbrella term include the ability to discern reliable sources of health-related 
information and navigate health services to obtain the support needed to manage 
one’s health (Diviani et al., 2015). Paasche-Orlow and Wolf (2007) note that the 
context in which health literacy is measured with abilities and complexity of health-
related tasks can vary enormously between and within people and health conditions. 
Health literacy has so far been understood as a skills-based construct and can be a 
gateway to positive increases in other health-related outcomes such as improved 
physical health and lower rates of anxiety and depression (Smith et al., 2013). This 
includes patient activation (Goodworth et al., 2016a), which will be discussed in detail 
in the next chapter. 
 
Health literacy can be a clinical risk or a personal asset, depending on how else people 
manage and perceive their health (Nutbeam, 2008). Someone with high self-efficacy 
and low health literacy may feel confident and able to manage problems independently 
of healthcare professionals. However, with low health literacy they may lack the 
ability to recognise warning signs indicative of health problems that require 
intervention and the ability to identify a clear path to intervention when these 
problems necessitate doing so. Low health literacy can have a profound impact on 
how people make use of their health care services. People may experience feelings 
of discomfort, disempowerment, shame and distrust because of not being able to fully 
understand information in clinics and may decrease attendance as a result (Paasche-
Orlow and Wolf, 2007). 
 
Health literacy is categorised into functional, interactive and critical forms (Nutbeam, 
McGill and Premkumar, 2017). 
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• Functional health literacy refers to the basic ability to gather information 
related to one’s health and successfully apply it to prescribed activities. 
• Communicative health literacy describes the ability to establish meaning from 
a variety of sources and types of information in order to apply it to managing 
health. This includes the ability to apply information to circumstances that 
have changed, or to make decisions after considering information.  
• Critical health literacy is the ability to manage health based on the analysis of 
health-related information. Low critical health literacy may be a barrier to 
people seeking information from healthcare professionals or managing a long-
term condition effectively.  
 
Low health literacy is widespread and screening exercises have estimated that 
between 43% and 61% of adults in England would be unable to comprehend and use 
health information they have been provided in its entirety (Rowlands et al., 2015). As 
a result, health literacy can profoundly affect someone’s ability to self-manage and 
take active responsibility for their own health. Low health literacy could be a barrier 
to people engaging with patient activation interventions (Sola, Couturier and Voyer, 
2015). 
 
2.7.5 Stages of Change model 
This model is commonly applied to health-behaviour change, but was developed to 
describe the stages through which people may move when considering changes to 
addiction-related behaviour (Prochaska and DiClemente, 1982). The stages were: 
● Precontemplation: Where people are unaware of the change they may make 
and aren’t able to consider behaviour change. 
● Contemplation: Where people are aware of the problems currently lying 
ahead of them and the changes required to resolve the problem. 
● Preparation: Where people have made the decision to change their behaviour 
but have not yet taken steps towards changing their behaviour. 
● Action: When people are testing out the behaviour change to understand the 
effects and how to manage the challenges and setbacks associated with the 
behaviour change. 
● Maintenance: Maintaining behaviour change despite obstacles, life events and 
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potential setbacks  (Prochaska and DiClemente, 1986). 
 
The model was designed for people to move in an upward spiral towards behaviour 
change and to account for people relapsing in behaviour during maintenance, with 
the opportunity to move towards action and maintenance again. Accounting for 
change not always being linear was also considered so this model can be viewed in a 
non-linear way and with people returning to earlier stages (Ogden, 2012).  
 
2.8 Criticisms of models of health and healthcare 
A consideration of models in health psychology is that they have been constructed 
with the intention to understand encounters with health and healthcare via 
experiences (Kernick, 2006). However, in some ways this could contribute to 
reductionist conceptualisations of health that the introduction of the biopsychosocial 
model intended to avoid (Crossley, 2000). The models may not consider the range 
of experience in people’s realities and the wider systemic and contextual factors. Like 
the self-management programmes critiqued for the responsibility given to patients, 
these models also place responsibility for the psychological impact of their health 
with individuals (Murray & Chamberlain, 1999). However, these models have 
contributed towards research and clinical practice to improve quality of life, design 
interventions and improve health-related outcomes. 
 
2.9 Chapter Summary 
This chapter has demonstrated the complexities of self-management and long-term 
conditions. Models of health and healthcare have been used in several ways to better 
understand how people can self-manage long-term conditions. This has included 
explaining the nature of health conditions and ways to approach behaviour change to 
improve patients’ health. Additionally, models have informed the design of 
interventions and ways to understand and capture outcomes related to health. In 
order to effectively self-manage a health condition, including being able to initiate and 
continue behavioural and cognitive activities to self-manage, patients require a sense 
of responsibility for managing their own health. Patient activation refers to one’s 
ability and willingness to take responsibility for their own health and encompasses 
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many types of self-management behaviours and skills. Patient activation and its 
relevance to wider literature will be discussed in the next chapter. 
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Chapter 3: Patient Activation 
The previous chapter introduced self-management and raised the issue that a patient needs 
to be engaged to effectively self-manage their condition. This chapter introduces patient 
activation and how it is distinct from similar concepts, looks at how it is captured and 
examines the literature on how it is conceptualised and understood. 
 
3.1 Defining patient activation 
3.1.1 Definitions and description 
Patient activation is defined as the knowledge and skills that someone has in order to 
take responsibility for managing their own health as well as how likely it is that they 
will do so (Hibbard and Greene, 2013; Hibbard et al., 2015). Patient activation has 
been described as a broad, multi-dimensional self-management self-concept (Hibbard 
and Mahoney, 2010). Patient activation is considered to incorporate associated 
concepts such as self-management behaviours (e.g. how closely patients follow 
medication routines), health literacy and self-efficacy (Hibbard et al., 2004; Do et al., 
2015).  
 
Where patient activation is high, patients are confident and proactive in managing 
their health, seeking information when required to make decisions about their health, 
and carrying out positive health-related behaviours. Alternatively, when patient 
activation is low, people are passive, unable or unwilling to take responsibility for 
managing their health, and very dependent on healthcare professionals for 
information and direction.  
 
Higher levels of activation are associated with fewer emergency admissions, fewer 
days as an inpatient, and lower healthcare costs (Hibbard et al., 2015). On an 
individual level, increased activation is associated with better outcomes overall 
(McCusker et al., 2016). Therefore, there is value in understanding patient activation 
to benefit both a resource-scarce NHS and individual patients. The NHS Five Year 
Forward View places people managing their own conditions at the core of NHS 
intentions and goals for the near future and consequently, the concept of patient 
activation has become prominent within the UK (Chew et al., 2017; NHS England 
Care Quality Commission, 2014). 
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3.1.2 How does activation differ from engagement, enablement and 
empowerment?  
Given the rising interest in patient activation and significant increase in publications 
related to the concept in the last five years, there is variation in how patient activation 
is defined and conceptualised. Some researchers consider patient activation as a way 
of capturing other constructs (Solomon, Wagner and Goes, 2012; Foot et al., 2014). 
Hibbard and Greene (2013) consider patient activation to be an aspect of patient 
engagement and as something that contributes towards the intention of being 
activated. 
 
Whilst the term patient activation is often used interchangeably with patient 
engagement, empowerment or enablement (Graffigna, Barello and Bonanomi, 2017; 
Higgins, Larson and Schnall, 2016), another school of thought considers the four 
terms to be independent concepts in their own rights. To manage the challenges of 
semantics and overlapping concepts, definitions of each of these terms will be 
provided for the purpose of this thesis. This will include references to how each of 
these constructs overlap with the current definition of patient activation. 
• As introduced in section 3.1.1, patient activation is the knowledge and skills 
that someone has in order to take responsibility for managing their own 
health as well as how likely it is that they will do so (Hibbard and Greene, 
2013; Hibbard et al., 2015). Patient activation is broad and includes additional 
skills like the acquisition and use of health-related information, practical skills 
pertaining to how people manage their health, and determination to become 
or remain empowered to manage their health. 
• Patient enablement is how well patients can comprehend and cope with their 
health (Hudon et al., 2011). Patient enablement is often captured immediately 
after a consultation in order to understand how well positioned the person is 
to act based on the content and effectiveness of the interaction from the 
patient’s perspective. Patient enablement has been considered a transitional 
construct that contributes towards increased self-efficacy. 
• Patient empowerment occurs when people believe that they have an active 
role in their own care and move towards contributing to health-related 
decision making (Alegría et al., 2008). This construct and definition are very 
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closely related to patient activation but are distinct within this thesis because 
patient activation is a broader construct that incorporates other skills. 
Instead, patient empowerment focuses on the belief that they have a role and 
does not incorporate the actions people take. While patient empowerment 
has been researched, reviewed and captured with reference to patient 
activation, it has also been investigated separately. The Health Empowerment 
Model (Schulz and Nakamoto, 2013) inferred that health literacy and 
empowerment were distinct but closely related, and the combination of high 
health literacy and empowerment contributes to an effective self-manager. 
The authors considered the impact of low health literacy, which could lead to 
either a patient requiring high support or a self-manager who was potentially 
at risk as they had little understanding/knowledge. Alternatively, someone 
with high health literacy who is not empowered may be unnecessarily reliant 
on healthcare professionals for support. 
• Patient engagement is defined as the steps people take to make the best use 
of the healthcare provision that they are able to access (Gruman et al., 2010). 
This could be considered part of the skills and behaviours contained within 
patient activation. Sometimes patient activation has been viewed as how 
engaged a patient is and the two terms have been used interchangeably (Do 
et al., 2015). The Patient Engagement Model (Graffigna, Barello and Bonanomi, 
2017) proposes that engagement is a mechanism towards improving patient 
activation, along with positive emotions and a good relationship between 
patient and healthcare professional. However, this model was developed 
without formally confirming the mediating effect of these various factors, 
which limits its credibility. The homogenous sample also limits generalisability. 
Patient engagement has also been used interchangeably with patient 
activation, although the two concepts are different (Toscos et al., 2019). 
 
The conceptual overlap between these constructs and patient activation can lead to 
confusion. Therefore, the definitions of these constructs above will be used for the 
duration of this thesis for clarity. Table 3.1 summarises the conceptual differences 
between these concepts. 
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Table 3.1: Conceptual differences between patient activation, enablement, 
engagement and empowerment  
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Belief in the role one has in 
shaping the outcomes of 
one’s health 
Y  Y Y 
Determination to remain 
involved in managing one’s 
health 
Y    
Skills in acquiring 
information 
Y    
Ability to make effective use 
of healthcare provision 
Y   Y 
Ability to comprehend 
health-related information 
Y Y   
Ability to practically cope 
with one’s health 
Y Y   
 
3.2  Measuring patient activation 
3.2.1 Hibbard PAM development and validation 
The Patient Activation Measure (PAM) (Hibbard et al., 2004) is often considered to 
be the beginning of patient activation gaining traction as a concept. Consequently, it 
is not possible to discuss patient activation without referring to the PAM. Upon the 
publication of the PAM, Hibbard et al. (2004) highlighted the importance of patients’ 
belief in their role and responsibility in managing their health. The development of 
the PAM also offered the potential value of stratifying people into activation levels in 
order to design and target appropriate interventions to support them to self-manage.  
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The development of Patient Reported Outcome Measures (PROMs) requires testing 
the validity of these PROMs to ensure that they measure what they intend to. There 
are multiple types of validity and each are important to ensure the quality of a 
measure. Types of validity include: 
• Content validity reports how well a PROM captures suitable content related 
to the construct it intends to measure (Frost et al., 2007). Content validity is 
incorporated in the development of PROMs by collecting qualitative data from 
participants have experience that is relevant to the construct that the PROM 
intends to capture. This includes using data from these participants to 
determine items that are appropriate for the PROM.  
• Construct validity refers to how well the PROM relates to the construct it 
should capture (Frost et al., 2007). Construct validity could be tested by 
comparing the responses to items in the PROM of interest to responses to 
other PROMs that capture similar or relevant constructs. This could be to 
determine whether there is a relationship or no relationship depending on 
the relation between the constructs. 
• Face validity captures the extent to which the PROM appears to be clear 
about what construct it captures from the perspective of both patients and 
professionals (Coolican, 2013).  
• Test-retest reliability captures the stability of a PROM over time when there 
has been no meaningful change in the construct being measured from the 
patient perspective. This is calculated by having the same participants 
complete the measure multiple times in order to investigate the correlation 
between their scores on the different completion times (Coolican, 2013).   
• Criterion validity captures how well a PROM performs against a gold 
standard capturing this construct. This could be captured qualitatively, 
biomedically or using another PROM (Frost et al., 2007).  
• Sensitivity to change captures changes in PROM scores within participants 
that is anticipated when there has been a meaningful change in the construct 
being measured from the patient’s perspective (Fitzpatrick et al., 1998). 
 
 
 
51 
 
The original long-form PAM was developed through the process noted below: 
• A literature review that reached a definition of patient activation that 
identified six domains that constitute patient activation and these were 
elaborated to develop 18 domains.  
• Discussion with a panel of 21 experts in their field (although the professional 
breakdown of expertise is not provided) using consensus methods to 
contribute to the conceptual definition of patient activation by identifying 
domains of activation. This ordered the total 18 domains in rank of 
importance. These focus groups contributed to increased content validity of 
the measure. 
• Two focus groups of participants with undisclosed long-term conditions 
who were recruited from newspaper advertising for the first phases of 
development. The focus groups offered the opportunity to review and alter 
the domains as necessary. Gathering the patient perspectives on activation 
increased the measure’s content validity. 
• A total of 80 potential items were listed and refined following cognitive 
testing with 20 participants living with unspecified long-term conditions. The 
items were reduced to 75 items in the questionnaire. 
• A pilot study where 100 participants with unspecified long-term conditions 
completed the 75-item questionnaire. Rasch analysis reduced the 
questionnaire to 21 items. Removing items that did not contribute additional 
information following Rasch analysis increased the content validity of the 
PAM. This pilot study would also have contributed to increased face validity. 
• The research team conducted additional testing to confirm the rigour of the 
measure. This included establishing test-retest reliability with 30 participants 
from the pilot study a fortnight after they first completed the measure. The 
findings indicated that of the 30 participants, 28 had a score upon retesting 
that was within the 95% confidence interval of their initial test estimate. 
While it is not always possible to capture criterion validity, this was 
reviewed during the development of the PAM (Frost et al., 2007).  
• Criterion validity was determined via interviewing ten participants from the 
pilot study, split into five who had scored lowest and five who had scored 
highest. The interviews focused on how participants managed their health 
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and responded to specific challenges posed by the researchers. Independent 
judges determined from reading the transcripts whether participants were 
high or low scorers, and nobody was misclassified during this process.  
• The PAM was further refined with a sample of 486 participants formed of a 
combination of health employees and cardiology patients (Hibbard and 
Mahoney, 2010; Hibbard et al., 2004). Nearly a quarter of these did not have 
a long-term condition, but it was this stage of the process that contributed 
to the understanding of four levels of patient activation. This led to a 
restructure and the measure becoming 22 items. 
• Finally, a sample of 1,515 participants who were 45 years old and above 
were recruited to complete the PAM via telephone. The findings indicated 
similar results to that of the 100-participant pilot survey. This sample was 
randomly selected, and demographic information was not provided, 
including whether these participants had health conditions. 
• Sensitivity to change was not captured during this initial development of the 
PAM but is an important form of validity to consider. 
 
The short form 13-item PAM (Hibbard et al., 2005) was later developed following 
secondary analysis of the initial large survey that was used in the 2004 report. These 
secondary data were analysed using Rasch analysis to identify items that could be 
removed from the original PAM.  
 
The PAM categorised people into four developmental stages of activation from level 
1 (completely passive in health management) to level 4 (able to sustain active health 
management after a setback). Additional details on these stages are available in table 
3.2. These stages were proposed as developmental but not necessarily linear in both 
directions meaning that people can move to both lower and higher PAM levels 
(Hibbard et al., 2004). However, this description did not clarify whether people are 
able to skip stages as their patient activation changes. The PAM also provides patients 
with a PAM score between 0 and100 depending on their responses to the items. 
 
Participants can respond to the 13 items with “disagree strongly”, “disagree”, “agree”, 
“agree strongly” or “N/A”. The algorithm that calculates scores and levels from the 
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raw data and the cut-off points for what scores lie in which level are not publicly 
available. The 13-item PAM  (Hibbard et al., 2005) is presented in figure 3.2. 
 
Table 3.2: Description of PAM Levels 
Level Description of Level 
1 Patients are either disinterested or unable to take active 
responsibility for their health, being led by healthcare professionals 
instead. 
2 Patients have some awareness that they could take active 
responsibility for their health, but there is still much they are unable 
or unwilling to do. 
3 Patients are taking active responsibility for their condition and 
continuing to develop their skills and confidence. 
4 Patients can maintain active responsibility for their condition, despite 
fluctuations or setbacks. 
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Figure 3.2: 13-item PAM (Insignia Health, 2018): 
 
 
Below are some statements that people sometimes make when they talk about their 
health. Please indicate how much you agree or disagree with each statement as it 
applies to you personally by circling your answer. There are no right or wrong 
answers, just what is true for you. If the statement does not apply to you, circle N/A. 
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The PAM’s intended applications were to offer tailored support to patients based on 
their individual needs and evaluate the efficacy of self-management interventions or 
person-centred care (Hibbard et al., 2004). The PAM has also been used as a process 
measure, as increasing patient activation can improve peoples’ engagement with 
managing their health (Roberts et al., 2016). The consequence of this is that the PAM 
could be used as a clinical tool to design self-management support, an outcome tool 
to determine how successful the intervention was, and the process measure to 
explain the change in outcome.  
 
The PAM creators proposed that for those people living with low levels of activation, 
very small behaviour changes could have a big impact and contribute to patients 
feeling more ready to take the next step in actively managing their health (Hibbard, 
2007). The PAM has demonstrated a ceiling effect: patients with lower levels of 
activation appeared to experience the greatest change in PAM scores after an 
intervention and those at the higher end of the scale experience much less change 
(Hibbard et al., 2007). This implied that targeting interventions designed to increase 
patient activation had the most benefit when it was aimed at those who are currently 
struggling and that interventions aimed at supporting those actively managing their 
condition should be different to best accommodate their needs.  
 
One of the factors that may have contributed to this ceiling effect is a recruitment 
bias where the participants recruited are those who are engaged enough at baseline 
to participate in an intervention. Harvey et al. (2012) carried out a survey as part of 
a health promotion trial with employees with health insurance. The study reported 
that people were still able to make progress within PAM levels even at higher levels, 
which challenges the reported ceiling effect. These changes were associated with 
various health behaviours. However, the study is limited by the follow-up rate of 51%, 
meaning that much of the population didn’t provide data to gain a full picture. The 
non-responders were also described as having lower PAM scores although the full 
comparison data were not published; this is likely to have impacted on the findings 
demonstrating increased average PAM scores. People with lower PAM scores may 
also be less engaged in research related to their health and as a result maybe more 
likely to drop out of research studies. 
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The debate about how patient activation is conceptualised is ongoing. Some 
researchers followed the proposed model of four discrete stages where people are 
either “activated” in managing their condition or not, whereas others viewed PAM 
scores as potentially fluctuating points on a continuum (Linden, 2015). There has been 
debate around how patient activation behaves and changes over time. The short form 
of the PAM (Hibbard et al., 2005) was developed in line with the guidance of the 
Institute of Medicine Summit (Adams et al., 2004) with the intention that 
measurements should be able to capture information at multiple time points to 
understand people’s abilities over time. Some studies propose that PAM scores can 
be maintained, although this may have been impacted by the presence of an open 
referral to inpatient support when required as part of the study (Moljord et al., 2017). 
However, one study demonstrated a reduction in mean PAM score at a group level 
(Rijken et al., 2014). This study however had mixed results for individuals, with around 
20% increasing in PAM levels, 40% demonstrating a decreased PAM level and 40% 
remaining at the same level. There are a variety of different contextual factors that 
may have impacted on PAM scores both within and between studies. These include 
the presence of an intervention, such as in the case of Moljord et al.’s work (2017); 
how much the health condition studied was likely to fluctuate; and how consistent 
and accessible healthcare has been during the period of data collection.   
 
Ledford, Ledford & Childress (2013) sought to understand patient activation from 
the perspectives of healthcare professionals as well as patients. They compared PAM 
scores from patients with an assessment of patient activation as perceived by 
healthcare professionals that had been determined using Likert-type scales related to 
behaviour in clinic. This included patients’ actions such as asking for clarification, 
asking questions and how easily they allowed the professional to stay “on-message”. 
These two different measures of patient activation were compared to a third 
perspective. This third perspective was that of a researcher who had developed a 
taxonomy of behaviours presumed to be related to patient activation and coded the 
clinical interactions against the taxonomy. Behaviours included in the taxonomy 
included seeking information, expressing preferences, discussing third-party 
experiences, or providing precise health-related information. The intention was to 
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understand how well the patient-reported PAM data correlated with behaviours in 
this taxonomy and with the professionals’ perspective. The PAM did not correlate 
with either the researcher or healthcare professionals’ taxonomy of patient 
activation, although the two professionals’ measures correlated with one-another. 
This reflects a mismatch between healthcare professionals’ understanding of how 
patient activation may be enacted according to their experience and clinical 
judgement, compared to how the PAM captures people’s levels of patient activation. 
Given this difference, it may well be that patient activation means different things to 
different patients in varying contexts depending on their role or circumstances. This 
study was strengthened by the triangulation of multiple types of data, a comparatively 
large sample size of 19 for qualitative research, and added rigor by using multiple 
coders within the professional groups who discussed the discrepancies to reach 
consensus. 
 
There is currently limited qualitative research investigating patients’ perceptions of 
the PAM and how closely it aligns with the concept of patient activation according to 
the literature. Understanding how patients feel about patient activation, what it 
means to them, and how they are currently performing and have previously 
performed patient activation can provide insight for healthcare professionals working 
with patient populations. It would also allow them to identify those who need support 
to actively manage their own health, and ways in which they can continue to work 
collaboratively and effectively with those who are keen to be primarily responsible 
for their own health. 
 
Research into patient activation often focuses on understanding how reliable and valid 
the PAM is in varying populations and applications, as well as translating it for use in 
other languages  (Armstrong et al., 2016). Research has often taken the form of 
reviewing Patient Recorded Outcome Measures (PROMs) alongside the PAM or 
gathering data from patients to understand how effective the PAM is in certain 
circumstances (Chew et al., 2017). However, despite large uptake of the PAM across 
the UK and internationally, it is evident that there is still a lot that is unknown about 
how the measure is used in research and practice within the NHS (Roberts et al., 
2016). 
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3.2.2 Potential limitations of the PAM 
There were several limitations to the methods employed during the development of 
the PAM that are limitations of the research and of the PAM itself. Firstly, while the 
details of the development process were provided, it was not clear what expertise 
the professionals were bringing to the consensus building exercise. Additionally, the 
demographic data provided about participants in the pilot studies were very limited. 
It was unclear what long-term conditions they were living with or what their 
background was. As they provided domains that were incorporated into the measure 
and were a vital part of the development process, this contextual information would 
have been valuable to further understand the PAM and its intended applications.  
 
The participants recruited from advertisements could be assumed to be literate 
enough to read and comprehend the newspaper advertisement and engaged enough 
in health-related matters to apply for the research. This means that the PAM was 
likely developed using patients who were already had higher patient activation and 
engagement. The use of participants of 45 years and older also limits the 
generalisability of the findings of the validation study. 
 
One particular limitation of the PAM is that the model conceptualising patient 
activation was developed after the measure (Hibbard and Mahoney, 2010). This 
suggests that the measure was developed without a clear theoretical grounding of 
how patient activation changes, develops and could be captured. The development of 
the model following the PAM development has the potential to contribute towards 
a model that does not reflect the data collection for the studies related to the model, 
and instead confirms the domains captured in the pre-existing measure. Given the 
published guidelines that suggest that the theoretical framework should predate the 
development of a PROM (Patrick et al., 2007), the chronology of the development of 
the PAM and the patient activation model contravenes this.  
 
3.2.3 Use of the PAM in the NHS 
Patient activation is of growing interest to the NHS because  evidence suggests that 
people with increased levels of patient activation have lower healthcare costs and can 
self-manage more effectively (Do et al., 2015). This initial evidence was a major driving 
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force in the uptake of licences and encouragement of usage of the PAM given the 
current resource and financial strain within the NHS (British Medical Association, 
2016). This also reflects the ongoing shift from paternalistic healthcare to person-
centred care discussed in chapter two. 
 
NHS England has invested in 1.8 million PAM licences to support people to actively 
manage their health and is working towards implementing the PAM as a tool across 
47 clinical practice sites for people with long-term conditions (Armstrong et al., 
2017). The interest in patient activation was also reflected in several large collations 
of research evidence by organisations such as the Health Foundation (Armstrong et 
al., 2017) and on behalf of NHS Wales (Rix and Marrin, 2015). This provided national 
credibility for the PAM and solidified its place as the most influential approach to 
capture patient activation. 
 
Roberts et al. (2016) embarked on a series of studies to capture how the PAM was 
being used within the NHS. One of these included critiques of the PAM from people 
living with the consequences of strokes. They described it as being too broad for the 
skills that they developed as a result of their health changes. A focus on the different 
skills and knowledge that forms patient activation in different conditions implied that 
the PAM may be interpreted differently by people depending on their health 
condition. Additionally, if patients felt the PAM didn’t capture their experiences of 
managing their health condition, the validity of findings using the PAM in relevant 
studies should be considered before drawing generalisable conclusions. While this 
article discusses patient activation from a range of different perspectives and case 
studies, they often included small sample sizes which may limit the generalisability of 
findings and included convenience samples which may have been impacted by using 
the stroke nurses who recruited participants. 
 
The way that the PAM was implemented allowed it to be used in ways beyond 
ensuring that patients are receiving appropriate self-management support (Hibbard 
et al., 2004). It became a tool for triaging (Bristol Clinical Commissioning Group, no 
date) as well as becoming central in a pilot stratifying services to determine what 
support to offer to patients (Coleman and Price, 2017). The findings of this pilot 
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suggested the need for incorporating the PAM into practice within primary care and 
secondary care (Armstrong et al., 2017). The pilot also suggested that the 
implementation of the PAM across services has the potential to help people know 
and use their PAM results. Additionally, the authors suggest that services could 
develop care plans based on these measures to move towards inter-organisational, 
coherent person-centred care. 
 
An ethnographic study investigating how the PAM was accepted and implemented in 
NHS services identified that the PAM was being used but with a great deal of flexibility 
depending on the healthcare professional (Chew et al., 2017). This was often because 
patients required support from healthcare professionals to complete the measure 
and this support took the form of rephrasing items for clarity. This contributes 
towards barriers to validity, for instance, patients giving socially desirable answers 
and healthcare professionals prompting them to reconsider their responses. This co-
completion was viewed as a way of developing a shared understanding of peoples’ 
concept of and amount of patient activation within a therapeutic exercise (Chew et 
al., 2017). Depending on how patients’ responses are interpreted by healthcare 
professionals, the measure may have become more flexible over time, and concept 
of patient activation has become less precise and fixed.  This work was strengthened 
by a very large sample size (112 interviews) and across a range of sites to get some 
variety across the different contexts. The addition of 123 hours of events and clinical 
appointments and 180 documents over two years provided a rich level of detail to 
add weight to these findings. 
 
Research into patient activation has grown to incorporate a better understanding of 
the role that carers play in supporting those with long-term conditions, and how 
successfully healthcare professionals provide the kind of support required for people 
to take responsibility for their own health (NHS England, 2015a). Some of the 
literature being published around patient activation has begun to include identifying 
how to support people who might benefit from further support. This would be 
carried out through risk stratification in collaboration with primary care and clinical 
commissioning groups (CCGs) and has been proposed by Hibbard and Helen (2014).  
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3.2.4 Ways of capturing patient activation 
It is clear that the PAM is the dominant measure for capturing patient activation. 
However, there are alternatives. One of these is the Patient Assessment of Chronic 
Illness Care measure (PACIC) (Glasgow et al., 2005). This measure is intended to 
capture how closely to Wagner’s chronic care model (CCM) (Wagner 1998) people 
believe the care they have received has been. The PACIC was adapted from an 
outcome measure developed for clinicians to determine how much they included 
aspects of the CCM in their own practice. The participants recruited to validate the 
measure reported how often they experienced the types of care discussed in each of 
the 20 items, from “never” to “always”. The PACIC includes three items dedicated 
solely to the measure of patient activation and the remaining items capture skills 
related to actively managing health, e.g. problem solving or goal setting. Gibbons et 
al. (2005) suggest that the PACIC measures a single, unidimensional trait instead of 
the previously thought five separate factors, and Glasgow et al. (2005) have found 
that is correlates moderately well with PAM (r=0.43, p<0.001). 
 
The Health Literacy Questionnaire (HLQ) (Osborne et al., 2013) was developed in 
order to capture health literacy but also has a subscale related to actively managing 
one’s health. For this reason, this could act as an alternative to the PAM, but it is less 
focused on patient activation. The HLQ was developed following concept mapping, 
and the items developed were reviewed by researchers and clinical staff in four 
primary care centres in Australia. The measure was reviewed with cognitive 
interviews and then two samples calibrated the measure. The measure also went 
through several stages of validity testing to add rigor and strengthen findings of 
studies that use the HLQ. The measure was developed with 52% of the study sample 
participants having a musculoskeletal long-term condition and is focused on the 
understanding of health literacy as discussed by Nutbeam (2008). 
 
3.3  Literature on patient activation using the PAM 
Since Judith Hibbard and her colleagues introduced and refined the PAM, many 
studies have focused on developing and trialling interventions to help patients become 
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more engaged in their healthcare and to improve their outcomes (Roberts et al., 
2016).  
 
The studies investigating how to improve patient activation (as measured by the PAM) 
have focused on improving skills that demonstrate patient activation. These skills 
include question formulation within consultations or people’s contributions to 
decision making around their conditions (Hibbard and Greene, 2013). Interventions 
targeting patient activation are the topic of the systematic review in chapter 4. 
 
Identifying factors involved in increased patient activation has become a major focus 
of the literature, with the intention to better understand the relationship between 
patient activation and various clinical, demographic and psychological variables. Much 
of this work has been centred around populations with diabetes and generalisability 
to rheumatology patients may be limited (Remmers et al., 2009; Rask et al., 2009; 
Hibbard et al., 2008), although some studies have focused on other long-term health 
conditions and participants at risk of developing health conditions. 
 
There is a correlation between health literacy and patient activation levels, as 
captured using the PAM (Hibbard et al., 2008). For this reason, health literacy has 
been recommended as a gateway to increasing patient activation (Goodworth et al., 
2016). It is evident that health literacy can profoundly affect someone’s ability to self-
manage and could be a barrier to people engaging with patient activation 
interventions (Sola, Couturier and Voyer, 2015).  
 
Studies have described a relationship between self-reported health status and patient 
activation (Chen, Mortensen and Bloodworth, 2014; Rijken et al., 2014; Hibbard et 
al., 2008) in different long-term conditions. However, these studies have been 
impacted by collecting the self-report and patient activation data at different points 
(Rijken et al., 2014). The usefulness of the findings of one study might be because it 
focuses on self-rated mental health rather than physical health (Chen, Mortensen and 
Bloodworth, 2014). Goodworth et al. (2016) found that objective measures of 
function were not related to patient activation levels and instead supported the idea 
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that self-report measures of function could, therefore, be more relevant in patient 
activation.  
 
Given that self-efficacy can be a predictor of illness beliefs (Osborn, 2011), it is of 
consequence in patient activation research. Literature has repeatedly demonstrated 
self-efficacy to be associated with patient activation (Skolasky et al., 2008; Do et al., 
2015; Goodworth et al., 2016). This is attributed to people self-managing more 
effectively or feeling more confident about taking steps to change behaviours if they 
have high self-efficacy (Dixon, Hibbard and Tusler, 2009). 
 
Various demographic factors are thought to impact patient activation levels, and ones 
of particular interest include sex, age, ethnicity, and level of education. Gleason-
Comstock et al. (2016) identified that gender was a modifier for patient activation 
levels in the relationship between depression and patient activation in older adults. 
Hendriks and Rademakers (2014) also identified gender as a factor in a model of 
patient activation and found associations with other health outcomes in patients with 
diabetes. However, in a study deliberately attempting to investigate sex differences 
in patient activation, the authors did not identify a significant difference in PAM scores 
between men and women (Hendriks et al., 2016).  They recognised the limitations of 
the cross-sectional study where many other important factors were not adjusted for 
which could have impacted the findings of the research. One of these important 
factors was whether participants lived alone or with other people, which may have 
had an impact on patient activation between the sexes. These mixed findings suggest 
the need for further research to clarify these relationships, particularly in under-
researched populations. Of these, rheumatology patients are one such population. 
 
Ethnicity appears to be predictive of patient activation scores in people with mental 
health diagnoses (Eliacin et al., 2018), and this could be attributed to a perception of 
less-equitable relationships between patients and healthcare professionals in people 
with ethnic minority backgrounds (Alexander, Hearld and Mittler, 2014). Given how 
crucial the collaborative relationship is for patients to be able to actively manage their 
health (Dures et al., 2016b), an imbalance of power would likely contribute towards 
patients feeling further disempowered, disengaged and less likely to self-manage 
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effectively. Given that only 19% of healthcare professionals within the NHS in 2017 
were from ethnic minorities, this is likely also a factor in how well represented 
patients from an ethnic minority may feel (NHS Workforce Statistics, 2018). The 
relationship between ethnicity and factors that have been demonstrated to be 
associated with patient activation (such as health literacy, completed years of 
education and socioeconomic status) also require consideration (Gwynn et al., 2016; 
Hawley and Morris, 2016). While there is still no established literature associating 
inequalities in access to healthcare and patient activation, it is likely that they play a 
part and, therefore, should be a focus of further research. 
 
Age is another demographic factor of interest in patient activation studies. An inverse 
relationship between age and patient activation has been identified, suggesting that 
people are generally less able or willing to take active responsibility for their health 
as they age (Gleason et al., 2016). One explanation is that this is the result of 
additional challenges around declining mobility, cognitive function or increasing 
multimorbidity, or access to interventions limited by poor mobility, low confidence, 
or access to technology. Alternatively, it is possible that this is the result of 
generational shifts from a current generation of older people who made use of the 
NHS before collaborative care began to inform the culture of healthcare interactions. 
Older adults may have different perceptions of the role of a patient if their 
understanding of healthcare was formed primarily before the shift from biomedical 
to a biopsychosocial understanding of health had really begun. 
 
Education level has also been demonstrated to be associated with PAM scores. 
Hendriks and Rademakers (2014) identified that high education levels were 
associated with higher PAM scores in patients with type II diabetes. Findings are 
similar to the results of studies with participants with other health conditions 
(Goodworth et al., 2016; Donald et al., 2011). Rijken et al. (2014) identified in their 
national patient activation survey in the Netherlands that higher education levels 
(university level or a high vocational equivalent) increased the likelihood of an 
increase in PAM scores at follow-up. They found that this was regardless of the 
participants’ initial PAM scores and levels. This could potentially be attributed to 
people with higher education levels being more able to learn from experiences to 
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more easily actively manage their health, or they may be more competent using 
language to communicate challenges and comprehend information provided by 
healthcare professionals. It is also possible that education levels are a proxy for 
income levels, with people earning higher wages being more likely to have received 
higher levels of education and having more confidence and personal resources in 
order to access support. Therefore, this may be a factor associated with patient 
activation and related outcomes. 
  
Patient activation as captured by the PAM has been demonstrated to be associated 
with improved health outcomes such as blood pressure, specific blood results such 
as haemoglobin levels and body mass index (BMI) (Hibbard and Greene, 2013; Harvey 
et al., 2012). The studies identifying these relationships are limited by their cross-
sectional nature and there has been limited longitudinal work investigating whether 
these relationships remain stable or fluctuate over time dependent on healthcare 
interactions and resources. Their findings confirmed the initial understanding that 
some, but not all, self-care behaviours are associated with high PAM scores 
(McCusker et al., 2016; Hendriks & Rademakers, 2014). Self-care and monitoring 
behaviours have been demonstrated to be associated with PAM scores included 
regular foot checks for people with diabetes and maintaining a healthy BMI (Rask et 
al., 2009; Zimbudzi et al., 2017a; Hendriks et al., 2016). However, some of these 
findings were impacted by poor response rates to the questionnaires (Zimbudzi et 
al., 2017a; Hendriks et al., 2016) which could mean that those more likely to engage 
in these positive health behaviours are more likely to take part in research studies. 
Some health behaviours demonstrated a relationship with patient activation levels 
less consistently. For example, regular exercise was linked to increased PAM scores 
(McCusker et al., 2016; Harvey et al., 2012) but not found to be associated in a 
different study (Zimbudzi et al., 2017b). However, these investigations have focused 
on a variety of different populations, including some without diagnosed physical health 
conditions (Harvey et al., 2012). This suggests the need for research with participants 
with specific long-term conditions to determine and potentially confirm or challenge 
these relationships. Additionally, clarifying whether specific health behaviours and 
monitoring activities are related to patient activation in rheumatic conditions can help 
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identify ways in which people are likely to manage their health. This means that 
behaviours people may neglect can be identified and targeted in clinic. 
 
The association between PAM scores and healthcare costs has been consistently 
demonstrated. People with high PAM scores have been demonstrated to have lower 
healthcare costs, along with fewer emergency admissions and fewer overnight 
inpatient stays in hospital (Hibbard et al., 2004; Hibbard, Greene and Tusler, 2009; 
Remmers et al., 2009). However, there have not been data suggesting that patient 
activation scores have been associated with greater or fewer visits to primary care 
providers. Wong et al. (2011) reported that those who are more activated were 
more likely to feel like they have enough time with healthcare professionals to discuss 
their concerns and remain part of the decision-making process. This may be because 
of increased confidence to manage health conditions while being aware of when and 
how to seek help to reduce the risk of it becoming an emergency.  
 
A great deal of literature around patient activation has focused on confirming 
whether patient activation is amenable to change through intervention and how. 
Some of the approaches taken to determine how to increase patient activation will 
be discussed briefly in this section. The effectiveness of interventions targeting patient 
activation in long-term conditions will be discussed in chapter four with a systematic 
review.  
 
Attempts to increase patient activation often took place within outpatient clinical 
environments. Developing certain skills related to patient activation, such as question 
formulation, problem-solving, or health monitoring aimed to create small increases 
in confidence and changes to behaviour (Tzeng et al., 2015). Implementation research 
recognised that people living in challenging circumstances with low patient activation 
were likely to be overwhelmed by contemplating taking responsibility for their own 
health (NHS England, 2018). Therefore, the focus remained on small, sustainable 
behavioural change. One example was the introduction of a coaching session to 
increase the number of engagement and biomedical questions asked during a 
consultation (Ibe et al., 2017). The study aimed to investigate intensity of exposure 
for the most efficient increases to patient activation. The findings suggested that an 
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increase in the length of the session was associated with the patient asking more 
questions in a later consultation. 
 
The intention of encouraging people to make the best use of consultations has been 
a common aim of patient activation interventions. This has the unintended 
consequence of placing the onus on patients to be responsible for the level of 
collaboration within consultations. However, collaboration clearly must involve both 
parties and one response to this was the development of a Clinician Activation 
Measure (CS-PAM) aimed to capture how well healthcare professionals support 
people to actively manage their health (NHS England, 2015a). This measure has not 
been taken up to the same degree that the PAM has but it does begin to redress the 
balance in responsibility between both parties involved in a collaborative healthcare 
partnership. Targeting healthcare professionals for training to increase self-
management support has also contributed to responding to this imbalance. 
Eikelenboom et al. (2016) conducted a randomised control trial comparing primary 
care practices where practice nurses were tailoring self-management support to 
patients compared to control practices. They found that practices that had received 
the training intervention did not contribute to significant differences in PAM scores 
at follow-up but there was a significant difference in the number of patients having 
care plans and self-monitoring. This may suggest that the intervention did have an 
impact on people making steps to manage their health, but this was not reflected in 
their ability and willingness to do so. Alternatively, the PAM was not sufficiently 
sensitive to capture the changes in participants’ improved self-management skills 
following the intervention. 
 
Resource-based interventions have grown in popularity, particularly incorporating 
regular monitoring into a patient’s self-management. These are interventions that 
offer information or monitoring to patients in the form of electronic health records, 
internet-based applications or the provision of equipment for health monitoring i.e., 
blood pressure machines or activity trackers. Online health records or interactive 
web-based portals offering information and tailored messages have formed one 
strand of patient activation-based research. Solomon, Wagner and Goes (2012) 
declared their study to have been the first using an internet-based intervention and 
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participants with different long-term conditions targeting patient activation. They 
identified significant differences between groups in favour of the intervention after 
giving participants access to an interactive web portal with interactive information 
sessions and the ability to book appointments and organise prescriptions. 
Alternatively, provision of health monitoring equipment has formed the basis for 
interventions. These have been particularly popular in populations with long-term 
conditions such as diabetes where this monitoring is required to maintain a stable 
condition (Riippa, Linna and Rönkkö, 2014; Heinrich et al., 2012). 
 
Interventions into patient activation have focused far less on patients currently 
admitted to hospital. While studies have looked at supporting people following 
discharge from inpatient care, including one looking at the benefit of self-referral on 
patient activation for people with mental health diagnoses (Moljord et al., 2017), there 
has been limited work investigating patient activation while people are undergoing 
inpatient care. The work that has been conducted has aimed to increase inpatients’ 
ability to seek information and make decisions (Rost et al., 1991). As the study 
predates much of the post-2004 work on activation, the authors captured patient 
activation using the number of questions asked and in terms of metabolic control of 
their diabetes and the likelihood that patient activation conceptualisation has changed 
substantially during this time.  
 
More recently, research into patient activation aimed to better understand adherence 
to pharmacological interventions in long-term conditions.  Sendra-García et al. (2019) 
published preliminary analysis investigating the associations between patient 
activation and factors related to compliance and adherence in their treatment 
regimes in a rheumatology context. Participants were dichotomised into “activated” 
and “not-activated”. The studies identified that participants receiving biological 
therapies were more likely to be activated compared to those receiving DMARDs. 
However, participants on DMARD regimes were more likely to be medication 
adherent compared to those on biological therapies. While the participants 
characterised as activated were more likely to follow their prescribed regime, this 
association was not significant and suggests a complex relationship between patient 
activation and treatment management. 
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3.4  Developments in patient activation conceptualisation 
3.4.1 Hibbard & Mahoney (2010) model  
The dominant model conceptualising activation was expanded by Hibbard and 
colleagues after their development of the PAM (Hibbard and Mahoney, 2010). This 
paper elaborated the initial theory of activation involving four stages, each building 
on the other in a hierarchy (Hibbard et al., 2004) where people became more able to 
develop through the stages and engage in more complex behaviours as they became 
more activated (Hibbard et al., 2015). 
 
The authors suggested that those with high levels of negative emotion and limited 
confidence in their ability to self-manage were often low in activation (Hibbard and 
Mahoney, 2010). By making a very small behavioural change to trigger a small amount 
of individual success, however, the model suggested that confidence and activation 
had the potential to grow as people felt more in control of their health. They 
described it as a “broaden and build” theory, where the experience of positive 
emotions contributes building blocks to increased activation. However, experiencing 
repeated failures in efforts to actively manage health or change behaviours would lead 
to people being less involved and less confident in managing their health. Patient 
activation is described as a learned behaviour, but the authors do not elaborate on 
the potential external sources of learning that contribute to people becoming 
activated. 
 
The work published in the 2010 article described survey research carried out by the 
authors supporting their hypothesis that there would be a relationship between 
participants’ activation levels and the positive and negative emotions they 
experienced. This contributed to their conclusion that the PAM accounted for 21% 
of variation in positive emotions experienced by participants, and 20% of negative 
emotions. This does leave a substantial percentage of unexplained variance that is not 
accounted for by the PAM. 
 
3.4.2 Condition-specific patient activation  
Since 2010, patient activation has often been conceptualised using Hibbard’s broaden 
and build model (Shively et al., 2012; Rijken et al., 2014). However, some work has 
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begun developing more holistic models of explaining patient activation and relevant 
factors involved. These are often condition-specific to capture the intricacies that are 
relevant to the experience of certain health conditions. This builds on the assumption 
that the contextual factors that impact on living with a long-term condition differ 
based on the condition and on feedback from patients that they value condition-
specific support (Lorig, Ritter and Plant, 2005). This work would require condition-
specific theoretical groundings. Additionally, while patient activation is not condition-
specific as a concept, the self-management research demonstrated a “preference” for 
condition-specific interventions (Ngooi and Packer, 2017). 
 
One of the earliest condition-specific studies was that of Chen et al. (2014). They 
proposed a conceptual framework to describe factors relating to activated 
behaviours in people with depression. They were interested in factors related to 
healthcare setting (such as the extent of the collaborative-care relationship) and 
factors described as “neighbourhood” (incorporating demographic factors and the 
availability of healthcare resources).  Results indicated that participants’ health status, 
race and the locality they lived in (defined using census divisions) were significantly 
related to activation levels. They also identified that people using outpatient 
secondary care clinics or emergency departments generally had lower patient 
activation. While this model provided evidence for some of the demographic 
associations in patient activation, and considered the impact of wider healthcare 
factors, the authors did not measure the personal characteristics that they referred 
to in their initial conceptual framework. 
 
In comparison, Goodworth et al. (2014) investigated variables that were associated 
with patient activation in people with multiple sclerosis (MS) with a focus on 
psychosocial factors. They identified that depression, quality of life (specific to life 
with MS), and self-efficacy were correlated with patient activation. They also found 
that employment and education levels were associated with activation. While this 
study was limited by its single-site recruitment, it was wider in its investigation into 
personal and contextual factors associated with patient activation. The authors also 
proposed the value of targeting health literacy to increase patient activation scores 
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following their confirmation of the relationship between education levels and patient 
activation. 
 
Similar work has been carried out in people with Chronic Obstructive Pulmonary 
Disease (COPD) (Korpershoek et al., 2016), which demonstrated that very few of 
the participants were at higher levels of the PAM. Multiple regression demonstrated 
that anxiety, illness perception, any comorbid conditions and BMI accounted for only 
17% of the variance in PAM scores. This indicates substantial variance in patient 
activation scores yet to be explained within a COPD population. Gleason et al. (2016) 
confirmed the findings of illness perceptions contributing to patient activation in their 
study, which investigated factors related to patient activation in older people with 
functional difficulties. Education level and financial security were not significantly 
associated with patient activation, in comparison to other studies (Hendriks and 
Rademakers, 2014; Chen, Mortensen and Bloodworth, 2014). This suggests that 
varying personal and contextual factors may be relevant to increased patient 
activation in populations living with different health conditions. Blakemore et al. 
(2016) also conducted a comparable study in older adults with multiple long-term 
conditions and followed up with participants six months later. They identified that 
patient activation scores were largely stable over time, but health literacy, depression, 
retirement, and social support had significant contributions to variation in patient 
activation. However, the response rate for the study was low at 34%, and 
consequently this may have impacted upon the results. The older adults who took 
part in the study may have been more likely to be retired and well in order to have 
the time and health to take part.  
 
3.4.3 Potential for a rheumatology patient activation model 
Much research into patient activation has focused on looking at what concepts are 
related to patient activation with the intention to better understand the relationship 
between patient activation and various clinical, demographic, and psychological 
variables. Much of this work has been centred around populations with diabetes 
(Remmers et al., 2009; Rask et al., 2009; Hibbard et al., 2008), although studies have 
also focused on other long-term health conditions and participants at risk of 
developing health conditions. So far there has been limited research into 
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musculoskeletal disorders. There is benefit to understanding whether present 
findings apply to rheumatology patients. 
 
There is still limited research into the wider construct of patient activation, how it 
relates to fluctuating physical conditions, and how best to use information about 
patient activation to target the type and level of support people receive in self-
managing (Roberts et al., 2016). Understanding the factors that contribute to 
increased patient activation in people with rheumatic conditions would be beneficial 
to planning service provision. Developing an understanding of the factors that impact 
patient activation and the spread of PAM scores and levels across a rheumatology 
population would help understand what factors contribute towards patient activation 
that may be amenable to intervention.  
 
While the PAM has been used as an outcome measure, there has been limited 
longitudinal research focused on patient activation in a rheumatology context. The 
first of these was a survey study investigating what variables were associated with 
patient activation in a sample of older adults who lived with functional difficulties 
(Gleason et al., 2016). These difficulties included a range of long-term conditions. The 
study identified that patient activation was associated with self-perceived health, low 
mood, social support, and challenges with carrying out daily activities. The second of 
these is a survey study of people living in Salford in the north of England. The sample 
was formed of older adults with at least one long-term condition and identified 
relationships between PAM scores and health literacy, age, social support, quality of 
life, and whether participants were retired. These two studies did not differentiate 
between participants with and without rheumatic conditions (Gleason et al., 2016; 
Blakemore et al., 2016). Patient activation remains one of the less well understood 
concepts in self-management research overall (Roberts et al., 2016). The model 
described by Hibbard and Mahoney (2010) does not account for wider personal and 
contextual factors which may impact on patient activation, including any condition-
specific issues. A survey to understand and map patient activation scores would 
contribute to the understanding of patient activation. Combined with a detailed 
qualitative investigation about how people understand and perform patient activation, 
this can begin to fill the gaps in the understanding of patient activation. 
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Given that it appears that interventions to improve self-management are also more 
successful if they are condition-specific (Lorig, Ritter and Plant, 2005), condition-
specific research could form the foundation for developing theory-led, rheumatology-
specific interventions targeting activation in the future.  
 
3.5 Ethics considerations of patient activation 
There are some ethics-related considerations that require discussion when 
approaching patient activation. The increase in interest in patient activation within 
healthcare services (and the NHS in particular) has the opportunity to support 
patients to take on responsibility and autonomy to manage their health that allows 
them to feel more confident and in control about managing their condition. However, 
this may not always be the case and some patients may experience adverse effects as 
a consequence of this shift in responsibility. There is a risk that the initial promising 
evidence relating to higher patient activation and lower healthcare costs may lead to 
patients being pressured to take additional responsibility for their own health and to 
self-manage to a greater extent than they feel able to as it is expected as a moral 
responsibility (Gibert, DeGrazia and Danis, 2017). This may contribute to more 
people taking on responsibility they do not want or are unable to manage, or patients 
being stigmatised by healthcare professionals for not taking on this responsibility. This 
could be extended to concern that those who are actively self-managing and still 
experience flares or challenges with their health could experience shame or 
judgement from healthcare professionals for not self-managing well enough to 
anticipate and prevent this.  
 
Additionally, an important consideration when working in the field of patient 
activation and implementing self-management support is that those who choose not 
to actively self-manage and take on this responsibility will have valid reasons for doing 
so and should not face stigma or limited access to support they require. It is possible 
that asking those who are already dealing with complex and limiting life circumstances 
to take on additional self-management responsibility that they would not welcome is 
not in their best interests. The choice not to self-manage is a valid option for self-
management and is rarely captured by outcome measures such as the PAM. Similarly, 
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the term “dangerous self-manager” (Yadav et al., 2018) refers to patients with 
confidence to self-manage but limited knowledge to make use of when self-managing. 
While this approach to self-management is described in stigmatising language, it is 
also a valid choice for patients self-managing. 
 
Other ethical concerns are that when patients complete the PAM as a tool to 
determine the course of their healthcare, it is not clear what responsibility they may 
be asked to take or they may not understand that how they complete the PAM might 
have implications for their care. This is particularly relevant given the number of 
people who required support to complete the PAM in the case studies and the fact 
that 42% of adults of working age are unable to comprehend basic health information 
(Chew et al., 2017; Public Health England, 2015). With the vast number of people 
who would require this support to complete the PAM, the measure may not be as 
person-centred as it intends to be. There could be unintended consequences of 
patients ending up with inadequate support and without the self-management support 
that it is in their best interests (de Iongh, 2018) because they haven’t asked for 
support they need to complete their measure or it has been co-completed with 
healthcare professionals with different priorities. 
 
Another issue to be considered when integrating an outcome measure such as the 
PAM to stratify care is that the outcome may reduce autonomy for some patients. 
For example, those who are in the higher levels of the PAM receiving clinical care 
may be offered low-intensity resources as a form of self-management support. 
However, they may be sufficiently aware of their support needs to believe they need 
more intensive support but may not be able to access this as a consequence of their 
seemingly active self-management. The use of outcome measures in this way also asks 
patients to value their own health and does not account for fluctuations in priorities 
or recognise that health may not necessarily be a priority for patients (Gibert, 
DeGrazia and Danis, 2017). 
 
Context that is important to consider when considering how to provide self-
management support includes the range of equity in access to services, socio-
economic circumstances and other wider determinants of health. Patients with long-
term conditions across the UK are self-managing in unequal circumstances. The 
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additional facilities and resources that are available to support effective self-
management (for example, access to safe open spaces for exercise, access to healthier 
and affordable foods in shops rather than being reliant on more local shops with 
limited stock, access to personal transport for more convenient access to clubs, 
classes and additional support such as hydrotherapy, massage and physiotherapy that 
also come with additional costs) may not be available to everyone. Access to these 
resources mean that those who wish to engage in positive health behaviours will be 
able to do so more easily. Geographic inequity in healthcare contributes to health 
inequalities and how far local budgets need to stretch based on the services available 
(Rice and Smith, 2001).  
 
This is without the consideration that barriers to self-management also include a lack 
of stable access to housing, caring responsibilities or other life burdens, other life 
complexities such as job insecurity, financial concerns and fewer social resources 
(Hardman, Begg and Spelten, 2020). Not all are self-managing equally and these issues 
may make people less likely or able to engage in preventative self-care. The push 
towards patient activation and expecting people to take this additional responsibility 
may increase these health disparities and while those who are already in a position 
to self-manage effectively could benefit from the support offered, self-management 
support that includes regular attendance or work between sessions will see increased 
burden for the most vulnerable patients (Hardman, Begg and Spelten, 2020). 
 
These ethical considerations about access to support and the potential implications 
of introducing additional self-management support should be considered carefully to 
reduce the impact of health inequalities and to avoid widening the gap between those 
who have the resources to self-manage effectively and those who do not. 
 
 
3.6 Summary of thesis rationale 
• Patient activation describes how willing and able someone is to take an active 
role in managing their health (Hibbard and Greene, 2013). It is a 
multidimensional construct incorporating associated concepts such as self-
management behaviours (e.g. adherence to treatments), health literacy, and 
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self-efficacy (the belief in one’s ability to achieve a desired outcome) (Hibbard 
et al., 2004; Do et al., 2015). 
• The dominant method of capturing activation is the extensively used “Patient 
Activation Measure” (PAM) (Hibbard et al., 2004). The PAM identifies beliefs 
that people have about themselves and the responsibility they hold for 
managing their health (Hibbard and Mahoney, 2010).  This conceptualises 
activation as involving four stages, each building on the other in a hierarchy 
(Hibbard et al., 2004). As patients become more activated, they are more able 
to move through the stages and become more able to engage in more 
complex behaviours (Hibbard, 2015). While it is understood that providing 
information alone is insufficient to activate patients (Rix and Martin, 2015), 
factors that do contribute to increasing patients’ confidence and ability to 
actively manage their health are less well understood.  
• Additionally, little is known about the factors involved in patient activation in 
IA patients. As it appears that interventions to improve self-management are 
more successful if they are condition specific (Lorig, Ritter and Plant, 2005), 
condition-specific research can form the foundation for developing a theory-
led, rheumatology specific intervention targeting activation. 
• There has been limited longitudinal research focused on patient activation in 
a rheumatology context and there are gaps in the knowledge within this field. 
Patient activation skills across rheumatology populations alone are unclear, as 
well as any factors that explain variation in patient activation. 
• There is no current systematic review investigating the effectiveness of 
interventions that specifically target patient activation for long-term, 
fluctuating conditions. 
•   The aim of this thesis is to address these knowledge gaps. The following 
chapter begins with a systematic review of the literature investigating the 
effectiveness of interventions targeting patient activation. 
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Chapter 4: Systematic Literature Review 
Following the identification of a gap in the knowledge related to the effectiveness of patient 
activation interventions reported in chapter 3, this chapter reports a systematic review of 
existing evidence around the effectiveness of interventions targeting patient activation in 
people with long-term physical health conditions. This chapter is reported according to 
PRISMA guidelines (PRISMA, 2009). 
 
4.1 Background 
A description of patient activation and its current understanding was provided in the 
previous chapter. 
 
4.2 Need for review  
While there have been several reviews of the literature into patient activation in the 
UK, these have focused on documenting the evidence behind the Patient Activation 
measure (PAM), and how the PAM is being utilised in the NHS (Mukoro, 2012; 
Armstrong et al., 2016; Rix and Marrin, 2015). There has been progress with 
systematic reviews into patient empowerment, a related concept, with the measures 
used to capture it being reviewed in an attempt to understand how to target and 
support people to manage their health (Barr et al., 2015). The aim of that review 
was to identify methods of capturing a variety of concepts including patient 
activation. However, the published review deviated from the planned protocol and 
no longer included patient activation in the final synthesis (Barr et al., 2015), meaning 
that patient activation remained un-reviewed. Given that this is an ever-increasing 
field of applied health research, developing the evidence base to determine what are 
appropriate, feasible, and effective interventions is likely to be of interest to health 
providers and clinical commissioning groups (CCGs).  
 
At the time of the initial searches for this thesis there had not been a systematic 
review of the literature into interventions targeting patient activation in long-term 
physical health conditions. Therefore, a systematic review was conducted between 
October 2016 and June 2017. During the update of the review presented in this 
thesis, a newly completed doctoral thesis was identified that included a systematic 
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review investigating the effectiveness of self-management interventions in increasing 
patient activation (Alexander, 2018). However, there were some differences between 
that systematic review and the one presented in this thesis. The Alexander (2018) 
systematic review only looked at studies that used the PAM as an outcome measure. 
As there are other ways of capturing patient activation (albeit none as extensively 
used as the PAM), there was benefit in updating the review presented in this thesis, 
which included other measures of patient activation as well as the PAM. Additionally, 
given that questions about the validity of the PAM also remain (as discussed in chapter 
3), this adds benefit to reviewing the literature in further detail. 
 
There have been a range of approaches used in delivering interventions targeting 
patient activation in long-term conditions. Therefore, collating and synthesising the 
evidence around whether these interventions are effective would be beneficial. 
 
4.3 Methods 
4.3.1 Definitions 
For this review, patient activation was defined as the ability, confidence, and skills 
someone possesses to actively manage their health, as well as the belief they hold 
that their role is valuable in their healthcare (Hibbard et al., 2004). It is most 
commonly captured using the Patient Activation Measure (PAM) (Hibbard et al., 2004; 
Hibbard et al., 2005), but other outcome measures have been used, such as the 
PACIC (Glasgow et al., 2005), and  proxy measures such as participants’ knowledge 
about their condition, decision making, and self-management behaviours.  
 
The definition was deliberately broad to accommodate interventions that may target 
a wide variety of aspects of patient activation. The definition used for this review was 
also closely connected to concepts such as patient empowerment, enablement, and 
patient engagement. The overlap identified in terminology that described health 
behaviours that reflect someone being invested in managing their health and taking 
steps to be involved in the collaborative healthcare process was discussed in detail in 
section 3.1.2. The definitions discussed in this section were used for the purpose of 
the review and for reference when screening articles. When one of these concepts 
was covered in a study considered for inclusion, the definition considered by the 
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study authors was compared to the operational definition of patient activation for 
the review. A study was included if its definition for any of these concepts overlapped 
with the definition for patient activation, even if it used a measure of patient 
empowerment (as was the case in some included studies). These terms were defined 
to identify occurrences where one term has been used in a way that also meets the 
definition for patient activation for the purposes of this review.  
 
4.3.2 Objective 
This study systematically reviewed the literature to investigate effectiveness of 
interventions targeting patient activation in people with long-term physical health 
conditions compared to a control group. 
 
4.3.3 Eligibility criteria 
The full inclusion and exclusion criteria are available in appendix A. Studies were 
included if they were: 
• Randomised controlled trials (RCTs). Pragmatic randomised trials were 
included. The decision to include only RCTs risked losing feasibility or 
cohort studies by exclusion. However, this did ensure the effectiveness of 
the interventions was compared to a control group and ensured the best 
possible evidence quality. 
• Recruiting adults over 18 years old. Studies with participants under eighteen 
years of age were excluded as it is possible that children and adolescents 
respond differently to managing health conditions. The results may have 
also been biased as a result of factors such as parental support, 
responsibility and other age-related or developmental factors. 
• Not primarily investigating the management of a mental health diagnosis. 
However, studies involving participants with a primary physical health 
diagnosis and a comorbid mental health diagnosis were included. 
• Related to patient activation, captured as a primary or secondary outcome 
measure pre- and post-intervention. 
• Written in or translated into English. 
• Published in or after 2004, when Hibbard et al. (2004) published the seminal 
paper on patient activation, along with the first measure of patient 
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activation. This decision reflected the changes and growth in interest in 
patient activation since then. 
• Focussed on long-term fluctuating physical health conditions,  defined as 
those likely to physically impact the person diagnosed for a period longer 
than three months (Wagner et al., 1996), which contributed to significant 
changes in function (Perrin, Gortmaker and Walker, 1993). This allowed 
for people to have made a certain level of life adaptation to accommodate 
their condition, and to potentially have experienced some fluctuation in 
their health during this time. The definition was consulted when studies 
arose where it was unclear whether the health condition could be 
considered long-term and/or fluctuating. 
 
As the main interest was learning about how people learn to live with physical long-
term conditions, studies with participants with specifically a primary mental health 
diagnosis were excluded. However, as mentioned above, studies which recruited 
participants with physical health conditions with a comorbid diagnosis of anxiety or 
depression were included in the review. There was the risk that this may have an 
impact on how participants would learn to manage their condition, however this 
distress may occur as a result of living with the physical health condition (Gettings, 
2010). The experience of this distress may be different compared to people living 
with an initial mental health diagnosis. Another factor that contributed to this 
decision was that behaviour change interventions may be different for those with a 
primary mental health diagnosis. There are often baseline differences between people 
with mental health conditions compared to physical health conditions, and often a 
lower baseline of patient activation in those with depression compared to a physical 
health diagnosis (Chen, Mortensen and Bloodworth, 2014). Terminal illness was not 
excluded as people could be receiving palliative care for varying lengths of time. 
However, it is possible that the interventions to support people to take responsibility 
for their health would be different. 
 
4.3.4 Search strategy 
The search strategy was developed with support from a specialist subject librarian at 
the University of the West of England. 
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The search strategy was: 
(("patient activation" OR "patient engagement" OR "patient empowerment") AND 
("long term condition" OR "chronic condition" OR "chronic disease" OR "chronic 
illness" OR "long term illness")) AND intervention AND random* 
 
Searches were carried out during January 2017 and rerun in July 2019 to update the 
review. 
 
Studies were identified through a variety of means. This included searching the 
following online databases from inception to January 2017 (and later between January 
2017 and July 2019) for appropriate abstracts: PsycINFO, Medline, AMED and 
CINAHL. As patient activation is a concept that could be relevant to a variety of 
types of health professionals working with long-term physical conditions, databases 
were selected to include a variety of multi- and interdisciplinary research. Search 
alerts were set up so that any publications matching the search criteria between the 
searches and synthesising the findings were flagged to the researcher. This allowed 
them to be considered for inclusion. 
 
Additional studies were sourced by reviewing the reference lists from key 
publications and articles related to patient activation, as well as articles that were 
already included in the review.  Grey literature was reviewed, to identify research 
which may not have been fully published yet or relevant theses. This could reduce 
the risk of publication bias, as it was possible that trials which found positive changes 
were more likely to be published in journal format (Green and Higgins, 2008). Grey 
literature reviewed included theses from WorldCat dissertations, articles in Papers 
First, grey literature databases including NTIS, Open Grey, and Grey Lit Report, and 
searching for book chapters via the NLM catalogue. 
 
Finally, as a last method of identifying suitable studies for inclusion, key journals 
“Patient Education and Counselling” and “Health Education & Behaviour” were 
searched by hand from 2004 to July 2019. This reflected the requirement that studies 
needed to be published after 2004 to be considered for inclusion and offered the 
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opportunity to identify any possible papers for inclusion which may have been missed 
by prior searches. Hand searching, search alerts for recent publications matching the 
search criteria, and snowballing led to the identification of eight further studies. 
 
The Cochrane Risk of Bias tool (Higgins and Green, 2011) was selected to determine 
quality in the studies. A proportion of these studies were checked by Dr Emma Dures 
as a second reviewer. Consensus meetings were held for the duration of the review 
to discuss and determine risk of bias. In addition, a third colleague added their opinion 
on a sub-set of papers. Dr Dures’ role as a second reviewer in data extraction and 
risk of bias added rigor to strengthen the accuracy of this process. However, because 
the review also contributed towards an assignment as part of the PhD process, it was 
important to ensure the researcher retained ownership of the review. Consequently 
Dr Dures’ role was more limited than might typically be research best practice. 
Multiple reviewers determining studies’ inclusion and quality are considered best 
practice to increase the reliability (Siddaway, Wood and Hedges, 2019). Therefore, 
the limited role of the second reviewer here is a potential limitation in the study. 
Steps were taken where possible to ensure that the researcher retained ownership 
but increased reliability e.g., discussing uncertain cases with Dr Dures in order to 
reach a decision about inclusion. However, this potential limitation should be 
acknowledged.  
 
Study quality was categorised using the Cochrane guidelines (Higgins and Green, 
2011), and this was considered when synthesising the findings of the review to 
understand the impact of evidence quality on studies’ results.  
 
4.3.5 Study selection 
Study selection was carried out throughout January and February 2017 by the 
researcher and updated during July 2019 following re-running the searches. 
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Figure 4.3: PRISMA diagram with inclusion and exclusion 
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4.3.6 Data extraction 
Data extraction was carried out using the Cochrane RCT review form (Higgins and 
Green, 2011) (see appendix B). Modifications were made to extract information 
about the long-term condition studied, how patient activation was captured and 
additional details about intervention delivery. The data extraction was carried out by 
the researcher. The data extraction forms were checked by Dr Dures as a second 
reader to confirm accuracy. 
 
There was a great deal of variety in the studies available, the outcome measures used 
(including proxy measures for activation) and the forms of interventions (particularly 
in terms of duration as this ranged from the provision of resources as a one-off 
intervention to face-to-face support that spanned months. Consequently, a meta-
analysis was not possible in the analysis of the review. Instead, a narrative synthesis 
was carried out to draw together the evidence and findings of the review. 
 
4.4 Search update 
During July 2019, the database searches were replicated, along with the grey 
literature searches and journal hand searches between January 2017 and July 2019. In 
total, eight additional studies were identified for inclusion in the review.  The data 
from these were extracted independently by the researcher and are included in the 
summary tables. 
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4.5 Results 
Data extraction table 4.5 and 4.5a contain the brief descriptions of the interventions, the participants, and the findings. Given the search 
strategy, populations and interventions were so heterogeneous that a narrative synthesis was confirmed as the most appropriate strategy 
for synthesising the findings.   
 
Table 4.5: Summary of study design and long-term conditions 
Authors Study design Long-term conditions 
Lussier et al., 2016 Randomised controlled trial Hypertension diabetes or dyslipidaemia 
Wagner et al., 2012 Cluster randomised trial Hypertension 
Grønning et al., 2012 Randomised controlled trial 
Rheumatoid arthritis, psoriatic arthritis or unspecified 
polyarthritis 
Solomon, Wagner and Goes, 2012 Randomised controlled trial 
Asthma, diabetes, hypertension and other unspecified long-
term condition 
Hibbard et al., 2007 Randomised controlled trial 
Diabetes, high blood pressure, lung disease, high cholesterol, 
arthritis, heart disease 
Kvale et al., 2016 Randomised controlled trial Cancer 
Maindal et al., 2011 Cluster randomised controlled trial Dysglycaemia 
Shearer, Cisar and Greenberg, 2007 Randomised controlled trial Heart disease 
Ryvicker et al., 2013 Cluster randomised trial Hypertension 
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Eikelenboom et al., 2016 Cluster randomised trial Diabetes, asthma, COPD, cardiovascular conditions 
Wolever et al., 2010 Randomised controlled trial Diabetes 
Shively et al., 2012 Randomised controlled trial Heart failure 
Smidth et al., 2013 Cluster randomised trial COPD 
Lorig et al., 2009 Randomised controlled trial Diabetes 
Lorig et al., 2010 Randomised controlled trial Diabetes  
Jäger et al., 2017 Cluster randomised controlled trial No specified conditions noted 
Weymann, Härter and Dirmaier, 2013 Randomised controlled trial Back pain or diabetes 
Denig et al., 2014 Pragmatic randomised control trial Diabetes 
Kangovi et al., 2017 Randomised clinical trial Diabetes, obesity, hypertension 
Körner et al., 2019 Randomised controlled trial Cancer 
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Cortez et al., 2017 Cluster randomised trial Diabetes 
Dolovich et al., 2019 Pragmatic randomised controlled trial 
COPD, hypertension, osteoarthritis, diabetes, heart disease, 
cancer, stroke 
Huntink et al., 2018 Cluster randomised controlled trial Unspecific cardiovascular conditions 
Xue, 2014 Randomised controlled trial Diabetes 
Schumacher et al., 2017 Randomised controlled trial 
Cancer, angina, diabetes, congestive heart failure, arthritis, 
stroke, depression, high blood pressure, atrial fibrillation, 
COPD 
 
 
Table 4.5a: Data Extraction Table. N = number of participants, SD = standard deviation, p = significance level, r = effect 
size value 
Authors n 
Demographic 
information 
Format and 
contents of 
intervention 
Duration of 
intervention 
Activation 
Outcome 
Measure 
Findings Effect Size 
Lussier et al., 
2016 
221 
Average age (in 
years) 58.2 (SD: 
6.85) 
42% female 
72.3% had 
education beyond 
18 
Online text with 
information, with a 
subgroup attending a 
single nurse-led 
workshop 
E-learning: 
had unlimited 
access 
(intervention 
took 45-75 
mins to 
complete) 
 
Single 90-
PACIC 
Activation subscale 
was significantly 
different between 
usual care and e-
learning in favour of 
the intervention 
(p<.05) 
 
Activation was not 
significantly different 
Usual Care and 
E-learning: 
Cohen’s d= -
0.10, r = -0.05 
 
E-learning and 
workshop: 
Cohen’s d = 
0.04, r = 0.02 
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minute 
workshop 
between e-learning 
and workshop vs. 
usual care or e-
learning (p>.05) 
Usual Care and 
workshop: 
Cohen’s d = -
0.07, r = -0.03 
Wagner et 
al., 2012 
453 
Average age 54.8 
years (12.44) 
70% female 
50% white, 46% 
black, 3.7% other 
70% had education 
beyond 18 
Online access to 
clinic information, 
ability to enter and 
track blood pressure 
data. Goal setting 
and question 
answering functions 
built into this online 
access 
Ongoing 
access for up 
to 1 year 
PAM, patient 
Empowerment 
Scale, PACIC 
Not a significant 
change in PAM 
scores between 
groups (p=0.49) 
 
There was a 
significant difference 
in empowerment 
between groups 
(p=0.02) 
 
PACIC was not 
significantly different 
between groups 
(p=0.82) 
Patient 
empowerment 
raw effect size: 
1.1, p=.02 
 
 
 
Grønning et 
al., 2012 
141 
Average age 58 
(11) 
69% female, 
38% educated 
beyond 18 
Group patient 
education sessions 
provided by nurses 
with 2 one-to-one 
follow-ups 
6 weekly 
group 
sessions, 3 
hours long 
and 2 
individual 
appointments 
approximately 
45 minutes 
each 
PAM 
At 12 months, there 
was a trend towards 
higher PAM scores 
in favour of the 
intervention group, 
but the difference 
was not statistically 
significant (p=.069) 
N/A 
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Solomon, 
Wagner and 
Goes, 2012 
201 
49% of participants 
were 55-64 years 
old 
52% female, and 
62% were college 
graduates 
86% were white 
Emails with self-
delivered content 
covering evidence-
based information 
and problem-solving 
opportunities 
Weekly for 
12 weeks 
PAM 
There was a 
significant between 
group difference 
post-test in favour 
of the intervention 
group for patient 
activation (p=.04) 
F(2,55) = 6.47, P 
= .003, effect 
size r = .R436 
Hibbard et 
al., 2007 
479 
Average age of 60 
69% female 
96% white 
Group face-to-face 
intervention based 
on CDSMP 
6 weekly 
sessions 2.5 
hours long 
each 
PAM 
Activation is 
changeable and 
there were 
significant changes 
following the 
intervention 
(p<0.001) 
Insufficient 
information 
available to 
understand 
treatment effect 
Kvale et al., 
2016 
79 
100% were female 
Approximately 
80% white 
Average age 58 
Between 53% and 
60% of participants 
had college 
education 
Motivational 
interviewing session 
with health goal 
setting and barriers 
to success 
Single session PAM 
There was not a 
significant difference 
in PAM scores 
between groups at 3 
months (p=.51) 
N/A 
Maindal et 
al., 2011 
509 
Average age 62.2 
Between 66.3% 
and 68.5% of 
participants had 
vocational 
education 
46% female 
Group sessions with 
a 1:1 interview 
before and 
afterwards. This 
included information 
giving. Practical 
element included 
physical exercise and 
action planning 
2 one-to-one 
interviews 
and 8 group 
sessions over 
three months 
(18 hours of 
intervention 
in total) 
PAM 
There were no 
significant 
differences in 
patient activation 
scores between the 
groups post 
intervention (p=.18) 
  
N/A 
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Shearer, 
Cisar and 
Greenberg, 
2007 
87 
Average age 76.03 
(8.32) 
35.% female 
93% white, 
46% college 
educated 
Scripted telephone 
calls discussing 
participants’ role in 
self-management, 
discussing concerns, 
and information 
giving 
Six calls in 
total from 
nurses 
Self-
Management 
of Heart 
Failure scale 
(SMHF) 
There was a 
significant 
interaction with 
group by time for 
self-management 
behaviours at 
follow-up (p=.01) 
r = 0.29 
p > 0.05 
Ryvicker et 
al., 2013 
587 
Average age 64.2 
(10.8) 
67% female 
100% were black 
40% had lower 
than a high school 
level education 
Emails and 
monitoring 
equipment 
 
Augmented 
intervention 
provided 
information and goal 
setting 
Ongoing 
access over 
12 months 
PAM 
There was not a 
significant difference 
in PAM scores in 
the interventions 
compared to 
control in the 
multivariate models 
(p>0.05) 
N/A 
Eikelenboom 
et al., 2016 
664 
Average age 
65.4(10) 
57% female 
28.7% had self-
rated “high level” 
of education 
Personalised self-
management plan 
based on profile and 
offering access to 
varied types of 
support (internet-
based, information 
based and exercise 
groups) 
Single session PAM 
There was not a 
significant difference 
in PAM scores 
between groups at 6 
months (p=.59) 
N/A 
Wolever et 
al., 2010 
56 
Average age 
53(7.93) 
77% female 
39% white, 57% 
black, 4% other 
41% of participants 
had a college 
education 
Telephone coaching 
contact focused on 
challenges, goals and 
priorities for the 
future. Self-care was 
discussed and 
participants set goals 
Telephone 
sessions 
weekly for 8 
weeks, then 4 
fortnightly 
and a month 
break before 
the final call 
PAM  
There was a 
significant difference 
between groups in 
favour of the 
intervention in PAM 
scores (p<.001) 
Cohen’s d: 0.71 
r = 0.34 
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Shively et al., 
2012 
84 
Average age 
66.1(10.76) 
98.8% male 
77.4% white 
Average of 14.8 
years education 
Sessions with nurses 
to focus on 
increasing 
confidence and 
knowledge, 
improving skills and 
self-care behaviour. 
People set goals, 
asked questions and 
discussed barriers to 
active self-
management 
Individual 
support over 
6 months 
PAM, Self -
Care of Heart 
Failure Index 
(SMHF) 
Intervention group 
had a significant 
increase in PAM 
scores over time 
compared to the 
control group 
(p=.03) 
Group x time 
F = 3.73 
Partial n2 = 0.06 
P = 0.03 
Observed 
power = .67 
Smidth et al., 
2013 
744 
Average age 67.1 
51.1% female 
Group session 
chaired by experts 
with topics including 
self-management 
support, clinical 
information, and 
contact details for 
their doctors 
4 x 2.5-hour 
sessions 
PACIC 
There was a 
significant difference 
in activation 
between the 
intervention and 
internal control 
group (p<.05) and 
between the 
intervention group 
and the internal 
control group 
(p<.02) in favour of 
the intervention 
Intervention to 
control: 
0.12 [95% CI: 
0.00;0.25], 
(p<.05) 
 
Intervention to 
external control: 
0.14 [95% CI: 
0.03;0.25], (p = 
0.014) 
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Lorig et al., 
2009 
345 
Intervention 
group: 
Average age 67.7 
(11.9) 
62.4% female 
15.2 years of 
education 
64% white 
 
Control group: 
Average age 65.4 
(65.4) 
66.2% female 
15.7 years of 
education 
70.6% white 
 
  
Structured groups 
facilitated by peer 
leaders covering 
information and 
activities e.g. 
relaxation and goal 
setting 
6 weekly 2.5-
hour sessions 
PACIC 
Significant between 
group differences in 
changes to PAM 
scores were found 
at 6 months in 
favour of the 
intervention group 
(p=.02) 
Insufficient 
information 
available to 
understand 
treatment effect 
Lorig et al., 
2010 
761 
Average age 54.3 
73% female 
Average of 15.7 
years of education 
76% white 
Website access for 
information, threads 
and messages for 
discussion and 
activities facilitated 
online by peer lay 
leaders Exercises 
involve information, 
problem solving and 
relaxation. 
6 weeks of 
regular access 
PAM 
Significant between 
group differences in 
PAM scores were 
found at 6 months in 
favour of the 
intervention group 
(p=.02) 
r = -0.05 
p = 0.72 
Jäger et al., 
2017 
273  
Average age 
72.2(8.9) 
55.7% female 
4.8% had university 
education 
Provision posters, 
brown bags as 
prompts for 
medication and 
information tool for 
participants 
Resources 
available for 9 
months 
PAM 
There was not a 
significant difference 
in PAM scores 
between groups at 
comparing pre and 
post intervention 
scores (p=.48) 
N/A 
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attending primary 
care appointments 
Weymann, 
Härter and 
Dirmaier, 
2013 
561 
Average age 51.8 
(13.1) 
60% female 
55% had over 10 
years education 
Online information, 
with reply options to 
respond to the 
content (The 
intervention group 
was provided with 
tailored information 
according to their 
knowledge, 
circumstances and 
coping style) 
Ongoing 
access over 3 
months 
Health 
education 
impact 
questionnaire, 
preparation 
for decision 
making scale, 
health related 
knowledge 
The outcome 
measure used does 
not provide a global 
score, but the 
analysis indicated 
that there was not a 
significant main 
effect for 
intervention x time 
for any of the 
subscales with the 
exception of 
Knowledge (p=.04) 
 
Health-related 
knowledge: .53 
(p=.04) 
 
Denig et al., 
2014 
344 
Average age 61.8 
(8.5) 
44% female 
Between 38% and 
40% were 
considered to have 
“low educational 
attainment” 
Decision made 
developed for 
participant to 
understand risk of 
different heath 
conditions attached 
to an electronic 
health record: 
Participants 
reviewed treatment 
aims and options and 
were given a 
hardcopy to 
takeaway 
Single session 
Diabetes 
empowerment 
scale 
There was not a 
significant difference 
in empowerment 
around psychosocial 
management of 
diabetes between 
groups following the 
intervention (p = 
0.92). 
N/A 
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Kangovi et 
al., 2017 
302 
Approximately 
75% female 
94.7% African 
American 
Average age 56.1 
(12.6) in control 
group and 56.6 
(13.6) in 
intervention group 
Semi-structured 
interview to set 
goals, signposting 
from community 
health-worker to 
achieve goals 
6 months of 
telephone, text 
message or visits for 
support 
Finally, there was 
ongoing access to a 
weekly peer group 
for social support 
Support over 
6 months 
PAM 
There was not a 
statistically 
significant difference 
between groups in 
patient activation 
following the 
intervention. (p= 
.66) 
N/A 
Körner et 
al., 2019 
89 
Average age 54 
(SD: 12.21) 
Approximately 
77% female 
86% white 
41.9% had over 17 
years of education 
Provision of a 
workbook covering 
self-management 
skills such as 
problem solving, 
communication, 
relaxation 
techniques and 
reviewing social 
support. Participants 
worked through this 
independently and 
were not offered 
support with this. 
6 weeks 
Health 
Education 
Impact 
Questionnaire  
There was not a 
statistically 
significant difference 
between groups in 
patient 
empowerment 
following the 
intervention (p=.11), 
but there was at 
follow-up (p=.01) 
N/A 
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Cortez et al., 
2017 
238 
 
Average age 57.8 
(SD: 9.43) 
66% of control 
group and 67% of 
intervention group 
female 
34% of control 
group and 27% of 
experimental 
group educated to 
18 
Groups covering 
information 
provision, myths and 
facts and preparing 
for self-care 
Telephone calls 
individually between 
each cycle of 3 
meetings 
9 meetings of 
2 hours each 
over 11 
months 
Diabetes 
empowerment 
scale 
There was not a 
statistically 
significant difference 
between groups in 
patient activation 
following the 
intervention (p=.82) 
N/A 
Dolovich et 
al., 2019 
312 
Average age of 
intervention group 
78.1 (SD: 6.3) and 
control group 79.1 
(SD: 6.6) 
60.4% of control 
and 63.9% of 
intervention group 
female 
58.8% of 
intervention group 
and 48.7% of 
control group had 
post-18 education 
Participants were 
provided with an 
electronic health 
record where 
professionals 
contributed to a 
care plan 
Professionals 
provided ad hoc 
follow-up support 
along with use of the 
electronic health 
record 
Ongoing 
access over 6 
months 
This 
information is 
not specifically 
provided. 
There was not a 
statistically 
significant difference 
between groups in 
patient activation 
following the 
intervention 
(p=0.08) 
r = 0.17. 
Significance not 
provided. 
Huntink et 
al., 2018 
2184 
Approximately 
35% female 
Average age of 
intervention group 
72.6 (SD:9.2) and 
control group 71.6 
(SD: 9.7) 
Practice nurses 
received training in 
motivational 
interviewing to 
support patients in 
intervention 
practices 
Single session 
PACIC and 
PAM 
There were 
significant 
differences between 
groups in favour of 
the intervention for 
both PACIC and 
PAM scores at 
follow-up (P< 0.01) 
Insufficient 
information 
available to 
understand 
treatment effect 
 96 
 
Xue, 2014 221 
64.3% female 
95% white. 
Average age 62.9 
(10.8) 
59.3% had at least 
college-level 
education 
Monthly support 
groups led by a peer 
facilitator (the 
control group 
received the same 
group from a 
professional 
facilitator) 
Goal setting follow-
up calls from peer 
facilitators 
12 months PACIC 
There were not 
significant 
differences in 
PACIC score 
between the control 
and intervention 
groups following the 
intervention 
(p=0.75) 
Insufficient 
information 
available to 
understand 
treatment effect 
Schumacher 
et al., 2017 
69 
Average age 72.6 
(8.8) 
57% female 
23% white and 
77% identified as 
“non-white” 
19% had some or 
full college 
education 
Face to face visit 
from a health coach 
to identify ways their 
condition may 
worsen, to contact 
support and set 
goals 
Three telephone 
calls over the next 
month 
1 month PAM 
There was a 
statistically 
significant difference 
between groups in 
favour of the 
intervention at 
follow-up (p= 0.04) 
Insufficient 
information 
available to 
understand 
treatment effect 
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Table 4.5b: Risk of Bias Summary Table 
✓ Low risk of bias 
     High risk of bias 
-      Unclear risk of bias 
Article 
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Lussier et al., 
2016 
✓ ✓  ✓  - - 
Wagner et al., 
2012 
✓ -   ✓ - - 
Grønning et al., 
2012 
✓ ✓ ✓ ✓ ✓ - ✓ 
Solomon, 
Wagner and 
Goes, 2012 
✓ - ✓ ✓  - - 
Hibbard et al., 
2007 
- -  - ✓ - ✓ 
Kvale et al., 
2016 
- -  - ✓ -  
Maindal et al., 
2011 
✓ ✓ ✓ -  - - 
Shearer, Cisar 
and 
Greenberg, 
2007 
- - - -  -  
Ryvicker et al., 
2013 
✓ ✓ ✓ ✓  - - 
Eikelenboom et 
al., 2016 
✓ ✓  - - - - 
Wolever et al., 
2010 
✓ ✓  ✓ ✓ -  
Shively et al., 
2012 
✓ -  -  -  
Smidth et al., 
2013 
✓ -   - - - 
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Lorig et al., 
2009 
✓ -  - ✓ - - 
Lorig et al., 
2010 
✓ -  - ✓ - - 
Jäger et al., 
2017 
- -  -  - ✓ 
Weymann, 
Härter and 
Dirmaier, 2013 
 - - - - - ✓ 
Denig et al., 
2014 
✓  ✓ - - - -  
Kangovi et al., 
2017 
✓ ✓  ✓ ✓ -  
Körner et al., 
2019 
✓ ✓   ✓ -  
Cortez et al., 
2017 
- -  - - - - 
Dolovich et al., 
2019 
✓ -   ✓ - - 
Huntink et al., 
2018 
- -  - - - - 
Xue, 2014 - -  - - - ✓ 
Schumacher et 
al., 2017 
✓ ✓  ✓  - ✓ 
 
4.6 Description of included studies 
4.6.1 Participants 
Of the 25 studies, there were 9918 participants with 4722 assigned to intervention 
groups and 5196 assigned to control groups.  Ten studies had an average age in the 
6th decade of life (i.e., 50-59), nine had an average age in the 7th decade (60-69), five 
studies had an average age in the 8th decade (70-79) and one study did not specify an 
average age. In all but six studies, the majority of participants were female and the 
majority of studies had a sample that recruited mainly white people. Two studies 
(Ryvicker et al., 2013; Kangovi et al., 2017) recruited solely or almost completely 
participants who were black and one study (Schumacher et al., 2017) worked with a 
sample that self-reported that they were non-white. Education levels ranged across 
the review but most studies involved samples with at least 1/3 of participants having 
attended post-18 education. 
 
There was a range of long-term, physical health conditions that participants were 
living with across the review. Heart disease and diabetes were particularly common 
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with 6 and 13 studies recruiting participants with these conditions respectively. Four 
studies recruited participants with types of arthritis. However, two of these did not 
specify the type of arthritis and one recruited osteoarthritis. Only one study 
specifically reported recruiting patients with IA, highlighting the lack of representation 
for IA patients in patient activation interventions.  
 
4.6.2 Outcomes measured 
While 15 studies used the PAM as the measure of patient activation, six used the 
PACIC (Glasgow et al., 2005) as the outcome measure. This measure was intended 
to capture how closely to Wagner’s CCM people believed the care they have 
received had been (Glasgow et al., 2005) and included three items dedicated solely 
to patient activation. However, the remainder of the items in the measure capture 
concepts that are relevant to actively managing health, e.g. problem solving or goal 
setting. Gibbons et al. (2017) suggest that the PACIC measures a single, 
unidimensional trait instead of the previously thought five separate factors, and 
Glasgow et al. (2005) have found that this correlated moderately well with the PAM 
(r=0.43, p<0.001).  
 
The PACIC has been demonstrated to have good reliability (Gibbons et al., 2017). 
However, the validity of the subscales has been contested because of the 
aforementioned shift in conceptualisation to a single captured trait (Dattalo et al., 
2012). Lussier et al. (2016) was the only study included in the review that reported 
only the patient activation subscale. This was noted in their “other risks of bias” 
section. 
 
The Diabetes Empowerment Scale was used in two studies within the review. It is an 
eight-item measure that is intended as a measure of self-efficacy (Anderson et al., 
2000). This demonstrates how the overlap in definition between patient activation, 
empowerment, and (in these circumstances) self-efficacy has contributed to outcome 
measures being used across several different constructs. 
 
There did not appear to be a specific outcome measure that was associated with 
significant between-group differences at follow-up more than other outcome 
measures. 
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4.6.3 Control groups 
The types of control for comparison in most cases was usual care. Some studies 
included a basic intervention for the control group and an augmented version for the 
intervention group (e.g. Ryvicker et al., 2013). In one study, the two groups received 
the same intervention, but the control group received it from a professional rather 
than a peer facilitator as the study intended to identify if peer-support was effective 
(Xue, 2014). With Weymann et al. (2015), a baseline website was available, compared 
to the intervention which was tailored to individuals’ needs.  One study (Smidth et 
al., 2013) used an additional external control group to attempt to further increase 
validity. 
 
4.6.4 Interventions  
Many interventions included information provision, goal setting, and problem-solving 
barriers to active self-management. Determining priorities for change was a common 
factor in supporting participants to set goals, as well as the opportunity to report 
back on their progress towards their goals. Some interventions gave participants 
access to a portal to track information and results related to their own health to 
monitor it, and some studies also gave participants access to monitoring equipment 
such as blood pressure machines in order to be responsible for tracking their own 
health. During group interventions, discussions often focused on topics facilitated by 
a group leader and involved other activities such as relaxation exercises and goal 
setting.  
 
Interventions that were resource-based tended to be more open-ended, with 
participants determining how to make use of them. Two of these internet-based 
interventions were set up so that the control group had open access to the 
information and the intervention group were provided with tailored information 
(Weymann et al., 2015; Solomon, Wagner and Goes, 2012).  
 
Some studies also provided individual, tailored coaching to participants to allow them 
to access the support they needed in a holistic way. This included onward referrals 
to additional interventions, signposting to services and practical support such as food 
bank access (Kangovi et al., 2017; Eikelenboom et al., 2016b). Participants in these 
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studies received follow-up support, sometimes with multiple forms of support 
available (Dolovich et al., 2019).  
 
The delivery style varied enormously within studies as anticipated and has been 
demonstrated in other systematic reviews into patient empowerment (Kuijpers et al., 
2013). Overall, there did not appear to be a trend in favour of either remote or face-
to-face interventions.  
 
4.6.5 Adherence 
Most studies did not report adherence to the treatment protocol. In some 
circumstances where the intervention consisted of the provision of resources or 
information provided to participants online, it was not possible to capture adherence. 
Gronning et al., (2014) deliberately did not capture adherence. Studies that reported 
adherence to the treatment protocol had good levels of adherence (Wolever et al., 
2010; Körner et al., 2019) 
 
4.6.6 Serious adverse events 
No specific serious adverse events associated with the intervention were reported. 
One of the critical incidents reported by Dolovich et al. (2019) was not directly 
related to the intervention. It was reported that one participant had their driving 
licence revoked during the study as a consequence of their responses to a cognitive 
test. It was unclear whether the exercise that contributed to the loss of the driver’s 
licence was directly part of the study, but it was reported that the participant in 
question found this distressing. 
 
4.7 Narrative on the included studies 
Overall, there was mixed evidence for the effectiveness of patient activation 
interventions in the variety of interventions available. There was also evidence that 
changes in patient activation are maintained or improved over a follow-up period 
post-intervention. However,  few studies provided information about follow-up after 
the interventions (Lorig et al., 2009; Lorig et al., 2010; Maindal et al., 2011). This 
corroborates survey findings that patient activation scores were stable over time in 
a cohort that have not received an intervention as well as findings of a similar 
systematic review (Blakemore et al., 2016; Alexander, 2018). By this logic, any 
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increases in patient activation observed following an intervention could expect to be 
maintained similarly. 
 
While there was evidence to suggest that some interventions contributed to 
increased patient activation in comparison to the control groups, there was not a 
specific format or style of delivery that was more likely to have an effect. Additionally, 
the duration of interventions (i.e. the length of time people had access to resources, 
or the number of sessions in group or individual interventions) did not appear to 
have an impact on effectiveness. Similarly, there was not a clear pattern where group 
or one-to-one interventions were more effective.   
 
4.8 Risk of bias 
 The risk of bias for the studies is summarised in table 4.5b. Dr Dures reviewed the 
risk of bias of seven randomly selected papers from the first set of papers 
incorporated into the review.  
 
4.8.1 Random sequence generation 
Seven studies used computer generated randomisation and two used random number 
tables which contributed to low risks of bias in their studies. Seven studies did not 
provide enough information for a clear risk of bias to be determined and thus had an 
unclear risk of bias.  
 
4.8.2 Allocation concealment 
Fourteen studies did not provide information about how allocation concealment was 
arranged. In eight studies there was lower risk of bias because allocation was centrally 
done by a computer or using opaque envelopes. In some cases, there was not enough 
information reported to determine the risk of bias. 
 
4.8.3 Blinding of participants and personnel 
The nature of self-management interventions means it is often not possible to blind 
participants and personnel to allocation. Therefore, this contributed to a high risk of 
bias in many of the studies. In some circumstances, study researchers and other 
 103 
 
clinical staff were blinded to participants’ condition (Schumacher et al., 2017; Lussier 
et al., 2016). 
 
4.8.4 Blinding of outcome assessment 
Some studies arranged for outcome measure completion to be supported by 
researchers that were blinded to allocation (Wolever et al., 2010; Kangovi. et al., 
2016; Schumacher et al., 2017). Fifteen studies did not provide enough information 
to determine the risk of bias for outcome assessment and therefore this was unclear. 
 
4.8.5 Incomplete outcome data 
Many of the studies conducted their analysis using intention-to-treat analysis to 
reduce the risk of bias due to incomplete outcome data. Some studies did not specify 
if they conducted this type of analysis. Overall attrition was mixed, including one 
study where a GP withdrew from the study which removed their cluster from the 
study (Jäger et al., 2017). This range of attrition contributed to variation in overall 
risk of bias for these studies in this category.  
 
4.8.6 Selective outcome reporting  
This was impacted by the fact that few studies provided information about protocols 
in order to clarify whether all outcomes had been reported. For this reason, all 
studies had an unclear risk of bias. 
 
4.8.7 Other sources of bias 
A major risk of bias in this review was that of participants’ self-selecting. People 
already engaged and interested in actively managing their health might be more likely 
to participate in this type of research. Some studies had very small samples that may 
have been underpowered for a RCT. Some studies were potentially biased by the 
payment of participants for their time which may have contributed to the findings of 
studies being impacted. The overall moderate risk of bias in the studies limits the 
usefulness of the findings and contributes to there not being strong evidence for what 
is most effective in improving patient activation.  
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4.9 Findings of review prior to update 
The initial findings of the review identified that interventions with a structure covering 
pre-determined topics appeared to have better outcomes compared to those that 
were more open-ended and responsive based on the needs of participants at the time 
of assessment. This added weight to the collaborative nature of patient activation 
with a role for healthcare professionals to facilitate participants’ increases in 
activation. However, the inclusion of the additional studies at the time of the review 
update meant that these findings were no longer accurate. There was not a clear type 
of intervention that was more effective. 
 
4.10 Discussion 
Overall, there was evidence to suggest that patient activation is amenable to 
intervention as some of the studies included in the review demonstrated significant 
between-group differences in favour of the intervention arm. Therefore, they could 
be considered effective. Change may have occurred via increased self-efficacy given 
that techniques that increase self-efficacy were common in the interventions (e.g. 
modelling behaviour with fellow group members, building confidence through goal 
setting). Health literacy and participants’ ability to monitor their health or 
communicate their concerns were often focuses of interventions and may contribute 
to change in patient activation. However, the studies included in this review often 
had high risk of bias. This involved small sample sizes, challenges with blinding and 
self-selection of participants leading to generally engaged samples. Many of the risk 
judgements had to be categorised as “unclear”, suggesting a need for clearer 
reporting of patient activation interventions. This is particularly the case for outcome 
reporting, as protocols were not always available to compare the published studies 
with. 
 
It would be beneficial for future research to confirm how participants made use of 
online interventions, including what they accessed, how often and how long for, to 
provide context for the findings around electronic interventions. The findings of this 
review indicate that there is no overwhelming evidence for the use of any specific 
format of interventions. 
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One challenge was that patient activation was not always the primary outcome 
measure, and this may have impacted the results of the included studies, as this may 
not have always been the focus of the study. This means they weren’t specifically 
targeting patients because of their low patient activation. Given the ceiling effect 
identified with the PAM (Harvey et al., 2012) and the likelihood that people more 
engaged with their health are more likely to participate in health research it is possible 
that this will have shaped the findings of the studies. This then could contribute to 
studies appearing to be less effective compared to a broader population of NHS 
patients with a wider range of PAM scores and patient activation.  
 
It became evident during the searches that there were a variety of ways people 
conceptualised patient activation. Some studies (Shearer et al. 2007; Wagner et al., 
2012; Weymann et al., 2015) considered the concept interchangeable with patient 
empowerment, and chose to capture this using measures including the PAM. Some 
studies (Kvale et al., 2016; Shively et al., 2012) also referred to patient engagement, 
in a way that accommodated this review’s definition of patient activation. There 
would be benefit in establishing how patient activation is understood and defined by 
authors in more detail to establish consistency, potentially in the form of a concept 
review. This, along with standardising the way patient activation is captured, would 
be helpful to compare the effectiveness of interventions more easily. 
 
The Cochrane risk of bias tool focuses on reporting study design to establish the 
quality of studies (Armijo-Olivo et al., 2012). However, it became evident that some 
challenges were in the reporting of the studies and not in the design and conduct of 
the trials. Information about how well participants engaged and used the 
interventions, including attendance of face-to-face sessions, and how often they made 
use of online or hard copy resources would be of value to determine whether this 
was associated with changes to participants’ activation, as this information was 
generally not provided. Additional research into online interventions targeting patient 
activation would be useful if it had information about pages participants visited, how 
often, and how long for. This would have provided more information about the 
mechanisms and factors that may underlie the effectiveness of the intervention. 
Further intervention-focused research with larger sample sizes, recruited to be more 
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representative of the UK population, and more details about adherence would be 
beneficial to confirm these initial findings. 
 
The findings of this review have implications for practice to best support people living 
with long-term physical health conditions increase their patient activation levels. As 
no one approach is more effective than others there is scope for CCGs to offer 
patient activation interventions that are most appropriate for the needs, resource 
availability and circumstances of long-term condition patients in their area. This 
includes funds for intervention duration, availability of staff and space for face-to-face 
interventions versus telephone and remote based support and the digital literacy of 
patients in order to access internet-based support. For clinicians, it appears to be 
important that when there is information provision and goal-setting support available, 
patient activation interventions can be moderately effective and should be considered 
to support patients to actively manage their health. 
 
4.11 Limitations 
There are some limitations to the systematic review. Firstly, information was not 
always available in order to calculate effect sizes for the findings of the study and this 
made it more challenging to synthesise the findings of the review. 
 
Secondly, the protocol limited potential studies to those published or translated into 
English and, consequently, some studies may have been missed. The search strategy 
was very specific, leading to a comparatively small number of titles and abstracts to 
screen. These narrow results from the detailed search strategy may have led to the 
exclusion of studies including relevant concepts that are described in an alternative 
way, including self-management interventions which may have covered the concept 
of patient activation but not described it in this way. Only RCTs were included and, 
as a result, alternative evidence may have been missed. As this is still a relatively new 
concept, the completion and publication of an RCT in the time since the increase in 
patient activation literature means that there is a great deal of research yet to come. 
This was evident given the number of protocols that were in the literature search for 
this review and the number of additional studies that were included in the review 
when it was updated in preparation for submitting this thesis. 
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Only one researcher carried out the screening and the data extraction, however the 
risk of bias for around one third of the included studies was determined by two 
people. The screening process was carefully documented, and this was reviewed with 
the second screener, along with data extraction. 
 
 
4.12 Conclusion 
Overall, there is evidence that patient activation is amenable to intervention, but no 
specific format or delivery style is most effective. Further information about 
engagement and attendance would be helpful, especially for questions about 
activation and how involved people are in managing their health. It is also clear that 
patient activation lacks a clear definition and conceptualisation and that this makes 
establishing the evidence base more challenging, and further work is needed in this 
field. There is also a lack of work related to patient activation interventions with 
rheumatology patients and this represents a knowledge gap.
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Chapter 5: Qualitative Methods 
This chapter presents and justifies the methods for a qualitative interview study designed to 
gain insight into how rheumatology patients understand and perform patient activation. It 
covers the study design, including method of analysis. The study findings are presented in 
Chapter 6.  
 
5.1 Study aims and objectives 
The main aim of the study was to gain insight into how skilled self-managers at 
different levels of patient activation perceive and understand this construct over time.  
5.1.1 Study objectives 
The study objectives were: 
• To explore perceptions of the term, description, and concept of patient 
activation from the perspectives of IA patients that were skilled self-managers. 
• To identify individual and contextual factors that skilled self-managers with IA 
believe contribute to patient activation. 
• To explore skilled self-managers’ experiences of actively managing their IA. 
• To gather opinions from skilled self-managers with IA on the PAM as a 
method of capturing patient activation. 
• To find out how these perceptions develop over 12 months. 
• To identify potential variables for the survey study. 
 
5.2 Qualitative interviews 
5.2.1 Selecting study methods 
Qualitative research focuses on words as data and considers the way that people see, 
understand and interpret the world and the meanings they attribute to experiences 
(Braun and Clarke, 2013; Madill and Gough, 2008). Qualitative methodologies have 
become increasingly popular in recent decades, with a growing interest in qualitative 
methods to gather and analyse word-based data (Madill and Gough, 2008). 
 
In comparison to quantitative research, which seeks to remain objective and 
unbiased, qualitative research requires researchers to consider their own position, 
stance, and perspectives in order to understand what they bring to the research 
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process (Braun and Clarke, 2013). Qualitative methods were appropriate for a study 
looking to understand how people perceive patient activation because of the 
opportunity to explore the complex perspectives of participants in their own words 
(Braun and Clarke, 2013).  
 
Focus groups were considered as an alternative method of data collection for their 
flexible, responsive nature and the opportunity to consider a range of perspectives 
in a single session (Braun and Clarke, 2013). They have been a valuable method of 
data collection in relevant patient activation research, including the patient study that 
contributed to the development of the PAM (Hibbard et al., 2004). However, it was 
ultimately decided that the increased the risk of participants feeling pressured to 
provide socially desirable responses and agree with dominant voices in the group and 
this was seen as a disadvantage (Reiskin, 1989). It was anticipated that the privacy of 
a one-to-one interview would be more likely to create an environment where 
participants felt comfortable enough to voice their perspectives.  A qualitative 
questionnaire was also considered as a method of data collection, but the decision 
was taken to not pursue this. It was determined that a questionnaire study design 
would not provide the opportunity for an interactive dialogue between participants 
and the researcher and this would lead to less extensive data (Braun and Clarke, 
2013). 
 
5.2.2 Study methods 
The study was designed to be longitudinal. Participants were invited to the second 
interview 12 months after their first to understand their experiences over time. An 
interview schedule for each set of interviews (see appendices G and H) was 
developed to form the basis for the semi-structured interviews, building on the 
literature on health-related behaviours, patient perceptions of the term and definition 
of patient activation, and enablers and barriers to self-management and active 
management of health. The questions in the initial interview schedule focused on 
whether (and if so, how) people learned to take an active role in managing their 
condition and what other factors and people impacted on how easily they could do 
this. Topics that were also covered included how participants interacted with their 
rheumatology teams and how they organised support when required. This schedule 
offered the opportunity for deviations from the plan, clarifications and further 
 110 
 
exploration of points as the opportunity arose within interviews. A pilot interview 
was conducted with the PRP in order to confirm the questions were appropriate and 
the interview had the potential to flow well. 
 
Semi-structured interviews allowed the opportunity to understand beliefs that 
participants held about their health in a private space. The interview schedule 
offered a basic structure for participants to be asked the same initial set of questions. 
However, the researcher had the opportunity to react to individuals’ responses for 
the purposes of clarifying details, exploring lines of enquiry and considering new 
ideas and perspectives to view the phenomena being discussed (Barriball and Alison, 
1994). The longitudinal approach to data collection is particularly suitable for 
gathering experiential and contextual data from participants, and for following up 
with individuals’ perspectives and experiences at the second interview to clarify 
their personal accounts and how these developed (Calman, Brunton and Molassiotis, 
2013; Parkinson et al., 2016). Individual interviews also allowed flexibility for 
participants living with a long-term health condition, who may require regular breaks 
to move around, or stretch to reduce mental fatigue or physical discomfort. 
Participants had maximum autonomy over how to manage taking these breaks if 
required, as data collection was carried out on a one-to-one basis. 
 
5.3 Timeline explanation and justification 
As the research focused on how patients understood the concept of patient 
activation, it was considered whether this understanding was fixed over time. Given 
the research indicating perceptions of patient activation can differ depending on 
activation level (Dixon, Hibbard and Tusler, 2009), and patient activation levels can 
vary over time, there was an interest in whether perspectives shifted over time. The 
two interviews for each participant were spaced a year apart to allow for participants 
to have a substantial period to continue to live with their condition and to potentially 
experience health fluctuations, contact with healthcare professionals, and seasonal 
changes and therefore discuss these events at the 2nd interview. The second 
interviews also provided an opportunity for member checking with participants to 
increase the credibility of the findings from the initial analysis (Nowell et al., 2017). 
For the purpose of this study, member checking refers to discussing the overall 
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findings and categories identified within the research with participants to understand 
if they feel the analysis and categories are credible and reflect their experiences. 
  
5.4 Ethics 
Ethics approval to carry out this research was granted by the West of Scotland 4 
Research Ethics Committee (reference 17/WS/0143) following proportionate review 
and ratified by the University of the West of England as the research sponsor 
(reference HAS.17.08.007). The study took place in the Bristol Royal Infirmary at the 
University Hospitals Bristol NHS Foundation Trust (BRI) and Weston Area Health 
NHS Trust. Both recruiting sites carried out capacity and capability assessments and 
approved the research at these sites. 
 
One aspect of the research study that was focused on from an ethics standpoint was 
ensuring participants could consent to each interview individually. This meant that 
participants confirmed when consenting to the first interview that they were happy 
to be contacted about the second interview. All participants confirmed that they 
were happy for this to be the case and this offered the opportunity to opt in to each 
interview in stages. 
 
5.5 Participant identification and recruitment 
As research has demonstrated a great deal of variation in patient activation levels in 
people with long-term conditions (Hibbard et al., 2005), it was determined that 
there was a benefit to speaking with participants who have had more experience of 
managing their health to understand the factors involved that they have identified. 
One approach to screen for experienced self-managers might have involved asking 
potential participants to complete the PAM and only accepting those of confirmed 
PAM levels three and four. The risk of potentially making people feel like they were 
not of the preferred standard to participate in the research posed ethical concerns 
and pre-screening was ruled out as a technique for this study. Staff recruiting 
participants at both sites were guided to consider participants coming to clinics who 
appeared to be effective at self-management and actively taking responsibility for 
their condition. 
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Participants were eligible to take part if they were over 18 years old; diagnosed with 
a form of IA by a rheumatologist; able to provide informed consent to participate 
and able to communicate, read, and write in English. Potential participants were 
identified through their medical notes, which were accessible by their local 
rheumatology team, and provided with an information pack about the study either 
in person at a clinic appointment or by post. This research pack included a consent 
to contact form (Appendix C), an information sheet (Appendix D), and a reply-paid 
envelope (if the pack was sent through the postal service). Participants returned the 
consent to contact form to the researcher who answered any of the participant’s 
questions if required and then organised the first interview for a time of mutual 
convenience. All patients who returned the reply slips were invited to interview. 
 
The sample size was originally set at 25 participants. However, it was anticipated that 
recruitment would end when interview data were deemed to have reached saturation 
and no new codes were being identified from the transcripts (Guest, Bunce and 
Johnson, 2006). In total, 17 interviews were conducted.  
 
The use of two sites that served different communities facilitated some socio-
demographic variance within the sample. The two sites differed, with one being a 
large inner-city teaching hospital serving a large urban community (BRI) and one 
being a smaller, general hospital in a suburban area (Weston General Hospital). 
Convenience sampling was employed at both sites and participants were not 
selectively sampled based on sex, ethnicity, age, diagnosis, disease duration or 
education level.  
 
5.6 Patient research partner involvement 
In preparation for the interviews, the PRP reviewed the information sheet, consent 
forms and protocol (see appendices D, E and F) for the study to ensure the 
documentation was clear and appropriate. The researcher developed both interview 
schedules following discussion with the PRP and the first interview schedule was 
shared at a meeting with the Patient Advisory Group at the BRI for their comments 
and feedback from a range of perspectives. This group was set up for patients at this 
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department to feed back about departmental issues, care, research ideas and other 
relevant issues (Kirwan, 2015). 
 
Testing the interview schedule (see appendix G) for the first set of interviews with 
the PRP offered the researcher the opportunity to hone her technique and to ensure 
clarity and a flow of purposeful conversation. For the second set of interviews the 
interview schedule (see appendix H) was developed considering the findings from the 
first. As the interview schedule for these interviews was more flexible to account for 
individual follow-up questions, this interview schedule was not piloted with the PRP. 
The PRP also reviewed the findings of the research. 
 
5.7 Interview process 
The two face-to-face interviews for each participant took place approximately 12 
months apart and were conducted by the researcher in non-clinical rooms at either 
the BRI or Weston General Hospital. Conducting interviews within outpatient 
departments had the possibility of contributing towards power imbalance with the 
researcher being viewed as the “professional” whose opinion was prioritised. Where 
possible, measures were taken to redress the balance of power. This included 
reducing the presence of clinical equipment in the room, offering participants the 
choice of seat, moving computer equipment and keyboard off the desk where 
possible and the researcher explaining that while they are a health researcher, they 
are non-medical and independent of the patient’s direct healthcare teams. The 
researcher reassured participants that they should do whatever they felt necessary 
to maintain their comfort during the interview, including taking breaks if required. 
Participants were given opportunities to ask questions, after which they provided 
written consent. The interviews were audio recorded with participants’ consent.  
 
Initially participants completed brief questionnaires gathering demographic 
information (age, gender, education level, diagnosis and duration of disease) (see 
appendix I). This questionnaire pack provided a sense of the participants’ overall 
health to situate and described the sample with reference to their health. It captured 
participants’ abilities to carry out activities of daily living including self-care, mobilising, 
grip, and specific physical actions. This was done by having participants complete the 
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Health Assessment Questionnaire (HAQ) (Fries et al., 1980). The HAQ is a measure 
of physical function and is routinely used as a tool to understand individual levels of 
disability in rheumatology patients in clinical settings and across relevant trials 
(Hewlett, Smith and Kirwan, 2002). The HAQ has 20 items that contribute to eight 
categories of function. The categories scores range from 0 (no difficulty) to 3 (unable 
to do activities even with the use of aids). The worst score for each of the categories 
are totalled and an average calculated. The final score is then between 0 and 3 with 
3 meaning severe levels of disability.  
 
Participants also completed the PAM in the questionnaire pack. The timing of 
participants’ completion of the PAM was considered in order to gather naïve 
responses to the questionnaire. This decision was made because discussing patient 
activation strategies, perspectives and techniques may have prompted participants to 
respond differently to the items on the PAM. 
 
The majority of the interview was taken up with discussing participants’ experiences 
of managing their health, things that made this easier or more challenging, how they 
made decisions related to their health, and other topics covered in the interview 
schedule. As the PAM items often had a biomedical focus on self-management, it was 
hoped that the broader interview would allow participants to consider wider 
psychosocial ways they managed their health. Considering these alternatives would 
offer a more holistic view of patient activation and self-management.  
  
Next, participants were asked whether they had heard the term “patient activation” 
previously, how they might define it, and their thoughts on the widely shared 
definition within the literature as outlined by Hibbard et al. (2015). Participants were 
reassured that there were no right or wrong answers in the way they defined these 
terms, and whatever definitions they used would be correct for them. This stage of 
the interview was intended to gather participants’ perspectives on the term, 
description and scope of this concept as far as they understood it, and its applicability 
to their lives and health. Finally, participants were asked to review the PAM for a 
second time. They were encouraged to consider how relevant the measurement 
seemed to how they managed their condition and whether there were things they 
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had discussed in the interviews or considered from their own lives that the PAM may 
benefit from including. The more holistic understanding they had from the interview 
might have made them more likely to recognise how the measure suited their needs 
or was insufficient. 
 
Reviewing the PAM towards the end of the interview schedule to discuss how 
comprehensive participants felt it was had also been considered carefully. It offered 
the opportunity to gather participants’ perspectives on how relevant they felt it was 
to the strategies and experiences they had discussed for the management of their 
own health. The timing may have also allowed them to appreciate behaviours and 
skills that they may not have immediately associated with patient activation.  
 
The interview schedule for the second set of semi-structured interviews focused on 
reviewing how the year had progressed for participants and how they had managed 
their health during this time (this will be discussed in more detail in chapter 6). These 
interviews also focused on feeding back to participants the collective categories and 
perspectives captured in the first interviews, based on the whole sample. The 
intention was to validate these findings by asking participants whether these 
accurately captured their experiences and understandings of patient activation 
overall. As with the first interviews, the format was designed with opportunities to 
explore aspects of participant responses further and to follow up on individual 
perspectives and behaviours from participants’ first interviews.  
 
As the data collection progressed, the interviews became an iterative process. Ideas, 
perceptions and questions that arose in the analysis of early interviews were 
incorporated into later interviews (Bradley et al., 2007). Field notes and reflections 
kept by the researcher between interviews also contributed to the data collection 
process and provided context on the interview data as well as contributing to the 
planning of follow-up interviews for individuals (Furber, 2010) (see appendix J for an 
example).  
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5.8 Analysis 
The interview recordings were transcribed by a university-approved, GDPR-
compliant transcription service.  The transcripts were checked against the original 
audio-recordings and reviewed by the researcher for accuracy. Participants were 
given pseudonyms in order to ensure anonymity and other potentially identifying data 
(e.g., relatives names, specifically named schools, towns and hospitals, the names of 
healthcare professionals) were removed and replaced with placeholder words or 
phrases.  
 
The interview transcripts were subsequently imported into the NVivo for Windows 
11 (QSR, 2012) software package that allowed for the coding and organising of data. 
This software was selected because of its capabilities for charting the processes of 
framework analysis. 
 
5.9 Framework analysis 
Data from the interviews were analysed using framework analysis (Ritchie and 
Spencer, 1994). The intention of framework analysis is to allow the opportunity to 
develop a thematic framework to capture and describe the data, and to compare 
between and within participants and both time points using the raw data (Ritchie and 
Spencer, 2013). This was done by developing a set of codes from the transcripts 
which were compiled into initial categories based on the first interview transcripts. 
This allowed comparison within participant perceptions across their two interviews 
and between different participants (Ritchie and Spencer, 1994). 
 
The framework analysis approach to data collection is categorised as a form of 
thematic analysis (Gale et al., 2013) but makes use of a matrix output to identify 
categories within the data and works with the research questions from the data 
collection process (Rabiee, 2004). It is a flexible tool that is suitable for approaches 
from a range of epistemologies, accommodates both inductive and deductive data 
analysis method and offers a systematic process to analysing qualitative data (Leal et 
al., 2015; Gale et al., 2013). Codes and framework categories are determined from 
both the data itself and the researcher’s prior knowledge and perceptions (Braun and 
Clarke, 2006). This suited both the intention for this study to conduct research with 
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an experiential aim and the pragmatic perspective held by the researcher (Parkinson 
et al., 2016). The flexibility of framework analysis allows a focus on inductive coding 
and the opportunity to bring deductive concepts to the analysis process (Lacey and 
Luff, 2007). 
 
Thematic analysis (Braun and Clarke, 2006) was considered as an alternative method 
of data analysis as it is similarly flexible, but it lacked a clear sense of how to review 
categories between participants as easily as framework analysis permitted. As this 
was a major aim for the research, the preference was to opt for a method that had 
been developed with this in mind. Grounded theory had also been considered as an 
approach for data analysis because of its intention to design a theory that was formed 
in the data (Raichle et al., 2001; McLeod, 2001). However, the researcher considered 
whether using grounded theory to develop a theory that described how participants 
understood and performed patient activation may have been too restrictive. This is 
because it would not allow enough space for individual differences that did not 
contribute towards the theory.  
 
The transparency of framework analysis also made it appropriate for sharing how the 
researcher reached initial conclusions when conducting analysis verification of the 
first interviews with participants taking part in their second interviews (Ward et al., 
2013). Framework analysis is suitable for concurrent data collection and analysis, both 
within and between participants. This meant that the first set of interview 
transcriptions could be analysed prior to the second set’s collection (Srivastava and 
Thomson, 2009, cited in Ward et al., 2013). Although much of the research using 
framework analysis is conducted with teams analysing concurrently (Parkinson et al., 
2016; Ward et al., 2013), framework analysis was chosen as an appropriate fit for the 
project. This outweighed the limitation of it often being a team-based method of 
analysis with multiple coders. 
 
5.10 Stages of framework analysis 
5.10.1 Stage One: Familiarisation with the data 
The interview transcriptions were checked for transcription errors and fully 
anonymised. This also formed an important aspect of familiarisation with the data. 
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Transcripts for each interview were repeatedly reviewed, and any sections of note 
requiring additional reflection or reading were highlighted or marked. After the data 
had been thoroughly reviewed, it underwent initial open coding by the researcher. 
The codes represented aspects of the data that appeared to be of interest or 
relevance to the researcher and the simplest way the data could be expressed 
coherently (Boyatzis, 1998). This coding was carried out in NVivo 11 (QSR, 2012). 
This involved attaching the codes to sections from the text of the interview 
transcripts. This allowed any codes to be linked to contextual information from the 
interviews and the words and phrasing of participants themselves. Field notes kept 
by the researcher were often read for context (see Appendix J). This process was 
ongoing while other interviews were being conducted which may have led to some 
aspects of the coding becoming slightly more deductive towards the later stages as 
the researcher had a sense of some of the shared experiences from participants so 
far. However, retaining an open mind to differences in experience, perspectives, and 
understanding remained a key part of the reflective process and preparation for each 
interview. One key aspect of the process was regular reference to the research aims 
and objectives, as advised by Ritchie and Spencer (2003). 
 
5.10.2 Stage Two: Developing a framework 
From these initial codes, an early theoretical framework was developed by the 
researcher. This involved reviewing and grouping the individual codes together into 
an initial coding framework and defining the recurring ideas, codes, and factors as 
categories and subcategories. The coding from the familiarisation process was again 
supplemented by field notes to understand the concepts underlying these categories 
to develop them further. These categories were named using participants’ own words 
from the data extracts where possible to ensure these categories and definitions 
were true to the original data. Given that the research question focused on 
understanding experiences, developing an initial framework required this 
understanding to be grounded within the data to ensure a good fit between the 
analysis approach and the aims of the study. Following the guidance of Ritchie and 
Spencer (1994), developing this framework also included considering the a priori 
understanding to complement the factors being identified in the data. 
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This initial framework also included an “other” category to contain the initial codes 
that did not clearly fall into identified categories. This approach to organising the data 
was conducted by the researcher and developed by sharing the initial framework with 
the supervisory team, two of whom had reviewed transcripts from at least one of 
the interviews. Two members of the supervisory team (Professor Sarah Hewlett and 
Dr Emma Dures) reviewed two transcripts each to conduct initial coding which was 
reviewed with the researcher and discussed to compare perspectives. The PRP 
reviewed sections of the transcripts, along with the analysis as a whole. 
 
5.10.3 Stage Three: Indexing 
This initial framework was applied to the dataset by re-reviewing the transcripts and 
organising them into the categories of the framework as a way of organising the 
dataset (Parkinson et al., 2016). This process is known as indexing and it was carried 
out using NVivo 11 (QSR, 2012). While there has been debate about whether 
computer-based tools are the best fit for qualitative data analysis, conducting this 
stage using this software allowed for the whole dataset be reviewed in one sheet to 
and retained the wider sense of the data (Furber, 2010). 
 
Indexing offered the opportunity for the initial framework categories to be clarified 
and developed with reference to the whole dataset by the end of this stage. This 
involved creating a matrix with each participant occupying a row, and columns were 
formed of each category from the dataset (see Appendix F). The illustrative quotes 
taken from interview transcripts were added to this matrix to embellish the initial 
framework and provide examples of how the categories related to participants’ 
experiences. This allowed a look at individual participants’ perspectives and schemas 
around patient activation, whilst holding the wider context and framework in mind 
(Gale et al., 2013). 
 
Reviewing categories and subcategories led to some being altered for accuracy or the 
initial categories were determined to be too broad or insufficiently detailed to 
capture the factors that participants described around how they managed their 
health. The thematic framework was refined throughout the iterative analysis process 
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to organise the data set, particularly around understanding how the thematic 
categories appeared within the transcripts across participants’ interviews.  
 
Where codes might have fitted into more than one category within the transcript, 
the definitions of the categories were reviewed and the codes placed into single 
categories to avoid double-placement (Rabiee, 2004). Comparing how the categories 
in the framework appear at various points within each interview looked to enhance 
the internal consistency of the framework and the researcher conducted some of 
these comparisons at this stage of the process as well as during the final interpretation 
stage (Rabiee, 2004).  
 
5.10.4 Stage Four: Charting 
The data were organised thematically by category (Leal et al., 2015), and were 
organised between participants for phase one of this study, and within participants 
once data were collected for phase two. An example of this is available in appendix 
K. The purpose of this was to provide a précised version of the indexed data with it 
summarised in chart form for each category initially and reviewed for each participant 
at the second stage of data collection and analysis. This stage of the process aims to 
make the data more concise and more easily reviewed (Parkinson et al., 2016). Each 
section of the chart included some key words describing the content of the category, 
either in participants’ words or in a paraphrased summary (Lacey and Luff, 2007; 
Parkinson et al., 2016). 
 
5.10.5 Stage Five: Mapping and interpretation 
The mapping and interpretation stage of the framework analysis process is intended 
to synthesise the data (Ritchie and Spencer, 2003). This stage required the researcher 
to compare the categories against the initial interview transcripts, reflective field 
notes and any other aspects of the audit trail to review the contextual factors 
surrounding the data and to confirm these have been represented (Ward et al., 2013). 
This also required the researcher to focus on reviewing the dataset to identify any 
additional patterns and make sense of the dataset as a whole with reference to the 
research aims (Parkinson et al., 2016). Sub-categories and categories were again 
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adapted, and the researcher shared the framework with the supervisory team again 
at this stage to discuss the findings.  
 
Both data sets were analysed using framework analysis. The second set of interview 
data were coded separately but were compiled and charted into a single matrix once 
initial coding was complete. 
 
5.11 Second interviews 
In order to analyse the data collected during the follow-up interviews, the first set of 
analysis was reviewed in order to write a summary of the initial findings to present 
to participants. Given that this analysis was already completed, the initial framework 
was a structure in which the additional analysis could be incorporated in addition to 
a summary of how participants managed their conditions. For the participants who 
completed follow-up interviews, these follow-up data were coded and analysed with 
reference to the transcript and analysis of their first interview so that the within-
participant summary was available to form part of the analysis.  
 
Lewis (2007) described the process taken to incorporate follow-up data collected 
and analysed using the framework approach. This example was used as guidance given 
the limited descriptions available on synthesising data from multiple time points. Once 
the follow-up transcripts had been reviewed for familiarity and transcribed, they were 
coded in the same way as the first set of interview data. The coded transcript was 
then mapped on to the initial framework that had been developed as part of the initial 
data analysis. Any new categories that could be developed or adapted when the 
follow-up data were incorporated upon review of the dataset. The data were 
indexed, and the framework applied to the follow-up transcripts using the same 
procedure as described throughout section 5.10 but with the existing data also 
included. This allowed for pertinent aspects of the second round of analysis to be 
incorporated and summarised in key-word form.  
 
The data and analysis were reviewed from multiple perspectives including: 
• Following individual participants to understand the impact of the year’s events 
on how they managed their health. 
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• Reflecting on the perspectives of health between participants and between 
timepoints to understand if they were substantially different from the original 
analysis or other participants’ perspectives. 
• Identifying whether there were any new behaviours, perceptions, or 
categories that appear to contribute to how people manage their health and 
have not been identified during the first interviews. 
 
5.12 Quality 
In order to ensure the data collection and analysis was rigorous and of sufficient 
quality for the findings to be deemed trustworthy, several criteria were consulted in 
the protocol development stage and regularly referred to throughout the process. 
 
Leal et al. (2015) described six strategies designed to increase rigor in studies using 
framework analysis. These were: transparency, researcher triangulation, discussion and 
refinement of the thematic framework, credibility, use of quotes and comparison within 
research literature (Leal et al., 2015 p. 140). These strategies have been implemented 
throughout this study. Regarding transparency, the analysis was clearly documented 
to demonstrate that it was systematic and thoughtful. The matrices and charts 
available for each stage of analysis are provided in the appendices (L and M) to 
demonstrate how the analysis progression was visible and trackable. 
 
While the analysis was conducted by the researcher, the process of developing the 
initial thematic categories was documented and shared with the supervisory team 
(most notably the PRP), and this was discussed and refined throughout data collection 
and analysis. Two members of the supervisory team independently reviewing 
transcripts also contributed to researcher triangulation. Their observations were 
compared to the initial framework developed by the researcher. Comparison and 
discussion indicated that there was congruence between the perspectives of the 
three researchers. The definitions of the framework categories were also refined 
throughout this iterative process. 
 
There was further refinement of the thematic framework when the findings were 
shared with the full supervisory team and discussed in detail. The addition of the 
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second round of data collection offered the opportunity to return to the framework 
after several months in order to refine it. The second interviews included discussions 
around the categories included in the framework as a form of member checking and 
to potentially increase the credibility of the findings. This, along with discussion with 
the PRP and dissemination at several research conferences allowed feedback to be 
offered by third parties to increase the credibility of the findings. 
 
The results section reporting the analysis in chapter 6 presents quotes demonstrating 
each aspect of the framework, and appendices L and M demonstrate the progression 
of the framework throughout the analysis process including the use of quotes. This 
chapter will also make use of existing publications to place the findings of this study 
within the context of the wider field and research literature. 
 
Another source of guidance which was consulted in order to ensure quality was the 
“big tent” criteria described by Tracy in 2010. This set of criteria described a model 
to ensure good quality qualitative research. The criteria set out in this model are 
determined to be: “worthy topic, rich rigor, sincerity, credibility, resonance, significant 
contribution, ethics, and meaningful coherence” (Tracy, 2010 p. 837). Again, steps were 
taken by the researcher to conduct the highest quality research possible.  
 
The topic has regularly been deemed to be relevant to current practice and literature 
in several ways. Tracy (2010) specifically recognises the strength in focusing research 
efforts on understanding how a concept demonstrates change over time. The 
refocusing of the concept of patient activation to include patients’ perspectives is 
novel and is timely given the substantial increase in patient activation research and 
implantation described in chapter three.  
 
Attempts were made to maintain rigour and sincerity about the data collection and 
analysis process in order to increase the credibility of the findings and the overall 
quality of the research (Tracy, 2010). Data were collected until the point of saturation 
and all participants from the first data collection phase were invited to return for a 
second interview to gather as much data as was ethical to support the claims being 
made in the analysis. There was regular reflection and discussion about the data 
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gathered from the interviews and supplemented by field notes and other reflective 
writing. Additionally, the descriptions above of the analysis process were intended to 
be as detailed as possible and the appendices show the procedures taken and 
demonstrate a clear audit trail of the raw data and the analysis process. 
 
Approaching the research with reflexivity and focusing on the role the researcher 
played in the interpretation of the data as well as the way participants responded in 
interviews was important to retain sincerity. As discussed earlier in this section, 
regular reflection and discussion with the supervisory team were prioritised 
throughout the process. 
 
The concept of credibility in this context describes the “trustworthiness… and 
plausibility of research findings” (Tracy, 2010 p.842). The aim was to produce credible 
research findings that rang true to participants and were perceived as dependable 
enough to potentially inform clinical decisions. One factor that Tracy (2010) describes 
as contributing to credible research is thick description. This is description that is of 
sufficient depth to capture detail and contextual meaning. The results reported in 
chapter six have been written with this intention in mind. Similarly, the tacit 
knowledge that might have been present around the experience of managing a long-
term condition in the context of the NHS in England required recognition. As the 
researcher lives with a different long-term condition, care was taken to try and 
identify tacit knowledge around life with a rheumatic condition from participants’ 
perspectives. Triangulation and member checking, as discussed previously, were 
conducted as intended by the study protocol.  
 
The sense of resonance and meaningful coherence within Tracy’s (2010) criteria for 
good qualitative research were intended in the planning of the research and the 
writing of the thesis. There was effort to ensure a good fit between the aims of the 
study and the methods, as well as how the findings were analysed and described. The 
significant contribution to knowledge is discussed in chapter one and is another 
important marker of study quality in qualitative research. 
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Chapter 6: Qualitative Results and 
Discussion 
Chapter 5 introduced the methods that were used for this study. This chapter reports the 
synthesised findings for both data collection points and discusses these findings. 
 
6.1 Participants 
Seventeen participants were recruited from two rheumatology departments in the 
South West of England.  The researcher undertook all the interviews herself both to 
ensure consistency and to become immersed in the data in order to be familiar with 
it more quickly. One participant had a relative join her for the interviews at both 
timepoints as she preferred not to be interviewed alone. All interviews took between 
45 and 90 minutes. 
 
Of the seventeen participants, there were twelve women and five men. Thirteen 
were living with RA, three with PsA and one participant had a diagnosis of SLE. There 
was substantial range in disease duration, but all participants had been diagnosed for 
at least two years at the time of the first interview. Details on the participants are 
available in table 6.1. Participants reported a range of education levels, from no formal 
qualifications to postgraduate study. HAQ scores were between 0 and 1.05 with an 
average score of 0.45 (SD: 0.37) indicating mild disability. Participants demonstrated 
generally high levels of patient activation as captured by the PAM, with four at level 
two, four at level three and six at level four. Four of these participants completed the 
PAM by responding with the same response to all items, and consequently rendered 
their completion invalid according to the guidance of Insignia Health who licence the 
measure (2017). However, the measure still provides them with a score and these 
scores are still listed below in table 6.1a in order to provide context about their 
current activation. This is because the study intended to understand more about 
patient activation. In light of participants’ critiques of the PAM the decision was taken 
to report the data in its entirety to further understand patient activation with 
reference to participants’ own abilities. 
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The high PAM scores and levels were anticipated and confirmed that this sample was 
suitable to discuss experiences of managing health conditions. The generally high PAM 
scores from those who completed the measure could also suggest that as a sample, 
the group were motivated to be engaged in research relevant to their health. Due to 
a requirement for deidentified data to be shared with the PAM licencing company as 
part of the licence agreement, the first three participants did not complete the PAM 
as the consent form and information they were provided about the study did not 
refer to this for them to provide informed consent. A minor amendment to the ethics 
approval was sought during this time for later participants to be aware of this issue 
when completing the PAM as part of the study. 
 
 
Table 6.1: Summary of participant demographics (n=17) 
 
Average (Standard deviation) 
Age (years) 58.64 (11.02) 
Disease duration (years) 16.26 (11.47) 
PAM level (to nearest level from 1-4) (n=14) 3 
PAM Score on the scale of 1-100 (n=14) 68.6 (12.17) 
HAQ Score (between 0-3) 0.45 (0.37) 
 
 
Details about individual participants are available below in Table 6.1a.  Participants 
are presented in chronological order for their first interview, and their demographic 
data is intended to provide contextual information about each participant.  
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Table 6.1a: Individual Participant Information (with pseudonyms) 
Participant Sex Age 
(years) at 
time of 1st 
interview 
Diagnosis Disease 
Duration 
(years) 
Highest 
level of 
education 
HAQ 
Score 
PAM Level PAM Score 
Mary Female  48 RA 13 International 
diploma 0 
N/A N/A 
Joanna Female 54 RA 2 GCSEs 0.35 N/A N/A 
Lindsay Female 57 RA 8.5 National 
diploma 0.4 
N/A N/A 
Tony Male 71 RA 26 National 
Vocational 
Qualification 1.05 
4 100 
Jim Male 68 RA 28 English 
language 
certificate 0 
4 90.7 
Jackie Female  69 RA 35 National 
Vocational 
Qualification 0.95 
4 75 
Avril Female 73 PsA 15 Bachelor’s 
degree 0.2 
3 63.1 
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Mark Male 46 RA 2 O-Levels 0 2 51 
Jan Female 71 RA 12 No formal 
qualifications 0.25 
2 51 
Richard Male 49 PsA 12 O-Levels 0.6 2 48.9 
Cheryl Female 54 PsA 3 Certificate of 
Secondary 
education 0.85 
3 70.2 
Greta Female 65 RA 10 O-Levels 0.25 4 77.7 
Christine Female 39 SLE 6 Postgraduate 
diploma 1 
3 63.1 
Patricia Female 64 RA 21 Bachelor’s 
degree 0.7 
3 63.1 
Stuart Male 45 RA 15 GCSEs 0 2 53.2 
Anne Female 53 RA 30 O-Levels 0.4 4 100 
Meryl Female 71 RA 38 No formal 
qualifications 0.8 
4 80.9 
RA= Rheumatoid Arthritis  
SLE= Systemic Lupus Erythematosus 
PsA= Psoriatic Arthritis 
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The following section will describe the framework analysis categories (and the 
relevant subcategories) that contributed to understanding patient activation in IA 
patients. This meets the aims of this study to identify factors that participants believed 
contributed towards actively managing their condition and their experiences of doing 
so.  It was identified during the data collection process that the discussions around 
the PAM and its contents often did not fit clearly into a coherent narrative for 
analysis. Additional aims were to gather opinions from participants on the PAM as a 
method of capturing patient activation and their perceptions of the description of 
patient activation. Consequently, these data were reviewed as part of the framework 
analysis for any sections of the transcripts that were appropriate for coding and 
indexing but the data from these questions were also separated and analysed as a 
standalone dataset using content analysis. These findings are presented in section 6.8.  
 
As discussed in sections 5.9 and 5.10¸ framework analysis results in a framework 
comprising categories and sub-categories. The analysis presented here are based on 
the findings of both sets of interviews synthesised and combined for clarity and 
brevity. However, specific details about the second interviews and participants’ 
responses to the member checking exercise are covered in section 6.9. 
 
These categories presented in Table 6.2 are the result of several iterations of 
reviewing and clarifying potential framework categories along with reflective logs, 
discussions with the supervisory team and consultation of literature. Codes were not 
allocated to more than one category. Although the categories were distinct and 
definitions for each were developed, they were closely related and often influenced 
each other. As the intention of the analysis was to understand participants’ 
perceptions, it was written using participants’ words as much as possible. For some 
categories, subcategories were created to clarify and refine the findings of the study. 
These are related aspects of a single category contained within the overarching idea. 
Separating some categories into subcategories helped to demonstrate different 
aspects of the overarching idea of the category. Some categories did not require this 
and would not have been clearer for including separate subcategories. 
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The interview data, which particularly covered the first three aims of the study noted 
in section 5.1.1 and the analysis outlined above led to the development of six main 
categories encapsulating the patient perspective on patient activation. Category 
definitions are available in appendix N. The matrices are also available to understand 
how many participants referenced each framework factor in their interviews. These 
are below in Table 6.2. 
 
The findings presented in this chapter reflect a summary of the data, particularly 
where patterns and commonalities occurred across the data. Occasionally, 
participants had diverging views or approached aspects of patient activation 
differently. Sometimes these are documented in the chapter where contradicting 
views appears to fit in a similar framework category. In others, the researcher 
reflected on and discussed the differing views with the PRP and the supervisory team 
in order to determine how to interpret and present the 
 
In other circumstances, particularly where participants were managing multiple 
conditions, it was unclear whether their self-management was around actively 
managing their rheumatic condition or another health issue. Where this was the case, 
the researcher tried to unpick this during interviews where possible or reflected on 
the data and messiness during the analysis process. The findings have been analysed 
and written to reflect the rheumatology-specific aspects of participants’ self-
management where possible. 
 
Table 6.1b: Framework analysis categories reporting how participants understand 
patient activation 
“You do it because you have to”: Determined independence 
“You find ways to do different things”: Making small changes 
“If you have a problem just phone up”: Navigating the system  
• “If I have that knowledge then it helps”: How to seek and get help and 
information 
• “If I feel there’s a concern, I will raise it”: Collaborating with healthcare 
professionals 
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“I think I've recognised what works for me, and what I need”: Knowing 
oneself 
• “I knew it was obviously something shook up in my body”: When to seek 
help and information 
• “It just helps me”: Knowing what techniques work for individuals 
• “I know what each tablet is for”: Health-related knowledge 
“There are people far worse than me”: Positive perspectives on health 
“Just does a lot of fetching and carrying”: Practical social support 
 
6.2 “You do it because you have to”: Determined 
independence 
This framework category describes participants’ sense of needing to “get on with it” 
(Mary) and not let their rheumatic condition rule their lives. Participants often stated 
that they needed to learn to live with their condition in order to manage their health 
and their day-to-day lives. There was a broad consensus that getting on with things 
was often because participants had responsibilities that continued despite their 
rheumatic condition. 
 
“Yes, obviously it’s …. painful but you just you’ve got to cook lunch for [family] and you just. 
I just got on with it really and some days were more painful than others.” (Meryl) 
 
“You can’t just live life with your feet up, you’ve got to do things” (Lindsay) 
 
“Yeah, you do it because you have to, but it was a struggle … I suppose there's that sense 
of not being able to look after them [children] properly, because I couldn't do the physical 
stuff.  Although I did, because I made myself do it, but it was hard.” (Mary) 
 
Some participants identified that this did not mean that continuing with activities was 
easy, or that they were always able to do so. They described the challenges and 
barriers involved in learning to live with their condition and make the best of life.  
 
“I’ve never missed work because of [condition], even though there’s been times when it’s 
actually a struggle” (Mary) 
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“I cope because I have to, I’ve got no choice, but it doesn’t mean to say I don’t get upset 
occasionally” (Tony) 
 
For some, the sense of responsibility for dependents or work (unpaid or paid) 
occasionally was a barrier to them being able to recuperate and reduce the impact 
of their symptoms.  
 
“And in those days, I guess, because I didn't have the kids and [husband] was around, I was 
probably able to sit and relax … so I think if I had the luxury of being able to do what I 
wanted to do with it, then there would be more rest involved” (Mary) 
 
“I do sometimes think, well please not today. I just don’t want to be tired today, but yeah so 
you do a bit of forward thinking I hope I am going to be alright.” (Johanna) 
 
Others deliberately attempted to work against the impact that their condition had to 
feel more in control. This was often described using the language of struggling, with 
the alternative being to “give in”.  
 
“Your mindset sometimes gets to the point of I’m damned if I’m going to give in to this.” 
(Greta) 
 
“I find very often, with me personally, it's mind over matter.  I won't give in.” (Jackie)  
 
“Sometimes it’s easy to just give in, if you’ve got the pain. I think sometimes if you just keep 
persevering with it …” (Cheryl)  
 
This cognitive dichotomy between “giving in” and “persevering” did not always lead to 
a “boom and bust” behaviour pattern. This occurs when someone perseveres in 
activity until they reach the point of exhaustion (Hewlett et al., 2011).  Greta 
described the challenges she faced when trying to find a balance between “giving in” 
and taking the rest she needed to in order to manage longer term. Sometimes this 
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meant that she could carry on because she felt she needed and wanted to, but in a 
more measured way.  
 
“[Feeling] the need to do things, the need to get things done in the house, but also the need 
not to give in to the disease, which is very, very stupid and the opposite of what you should 
be doing. I don’t mean give in, but pace yourself, it’s not giving in, but in my head at the time 
it’s not getting the better of me, I’m going to wash this floor.” (Greta) 
 
The description Greta gave of feeling like she was “stupid” but also identifying her 
meta-cognitions about her condition provides a sense of how she is beginning to step 
back from life with her condition to critically analyse how she manages and how 
helpful her coping mechanisms are. This may reflect the patient activation process of 
being able to skilfully consider how someone manages their health by distancing 
themselves from their immediate responses and actions. 
 
Sometimes, carrying on also included experimenting with how much participants 
were able to do, or pushing through to do a little more so they didn’t feel held back 
by their condition. 
 
“I would say to someone keep positive and sort of live within your [limits], just try and do a 
little bit more and don’t think “I can’t do so-and-so because I’ve got arthritis”. Just try and if 
it proves that you can’t do it well you’ve had a little go.” (Meryl) 
 
“Don’t just sit down and put up with it, carry on and see how you go on.” (Jan) 
 
In some circumstances, participants reflected that their daily activities and 
responsibilities were beneficial and protective as a way of finding determination to 
cope with life and their condition. This provided a sense of wider context in their life 
that helped them to feel less like they were ruled by their condition: 
 
“I find very often, with me personally, it's mind over matter.  I won't give in.  I have to give 
in sometimes if it gets … and I know I'm going to do something silly, but I try to manage it 
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daily, by carrying on. You know, I don't do physiotherapy, I do my ironing and I do my 
housework, and I carry on like that.” (Jackie) 
 
“If I just sat in a chair it wasn’t going to get any better probably.” (Cheryl) 
 
Participants also considered that the idea of actively managing their health was a 
moral responsibility (Dwarswaard et al., 2016): 
 
“I mean clearly if every patient, if every person was more active in terms of looking after 
their own health it would solve a lot of problems in terms of getting appointments and 
whatever.  People wouldn't need as many.  It would help.” (Mark) 
 
Participants reported a need to “do it because they needed to”. Sometimes the belief 
that participants needed to carry on and get on with life was intrinsic and self-
generated. As part of learning to actively take responsibility for their condition, many 
participants identified themselves as very determined people who were willing to 
persevere with doing what was important or necessary for them. For them, this 
formed part of their identity and coping mechanisms. This intrinsic motivation 
reflected a sense of determination that contributed to their feelings of engagement 
with activity: 
“I'm quite a determined, independent person.  I just have to get on and do it, regardless” 
(Mary) 
 
“Being self-determined counts for more than anything else and I had to look after my wife 
and I just got on with it, okay so I’m hurting, I’ve got to do it” (Tony)  
 
“I’ve just got to get on, I’ve got to do this, I’ve got to do that” (Avril) 
 
“There’s nothing I can’t do or won’t do just because I won’t let it get in the way” (Richard) 
 
Many participants sometimes recognised that their perseverance could be impaired 
by fluctuations and flares that were out of their control. In these circumstances they 
often reported being focused and carrying out necessary tasks, for example self-care 
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and caring for children. Where possible, they would make room for doing this in a 
more paced way to account for symptoms of a flare: 
“In the morning, obviously you've got to get yourself up, get yourself ready, so you have to 
move then, to clean yourself and to dry yourself.” (Mary) 
 
“[When feeling unwell] I know then that I need to rest, just take things, just try and slow 
down and until I’m feeling a bit better with it, carry on taking the medication, and gradually 
build yourself back up to it.” (Jan) 
 
“Well, a flare up will change [how I manage], yeah. I could, sometimes it will not work, or 
I’ll put off a job, or something that I was doing. Or I’ll ask another family member to do 
some things. Just put things on hold for a little bit. It could be a job, I might put a job off for 
a few days until I’m feeling better.” (Stuart) 
 
This determination reflects the aspect of patient activation that is often central to its 
definition in publications, that someone feels that for their own sake they must take 
responsibility for managing their health (Dwarswaard et al., 2016). This appeared to 
be central to how participants made decisions and lived their lives, reflecting a 
rejection of passivity that is the alternative to active management.  
 
Participants often reported doing as much for themselves as possible instead of 
depending on those around them. This was a combination of preference, pride, and 
a sense of responsibility for themselves.  
 
“I'm that sort of person anyway, I'm sort of like, I don't need anyone else, I'm fine” (Mary) 
 
This independence also reflected participants’ attempts to retain control over parts 
of their lives when they were able:  
 
“I said well while I can still do it, I will do it” (Cheryl) 
 
“We had to buy a different hoover … just so that I can feel a bit more independent and still 
do it myself, on a good day.” (Christine) 
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Patient activation was reflected in this category as a clear sense that participants felt 
the responsibility for their own health: 
“Overall you are the only one that can manage it [condition]” (Joanna) 
 
“I am personally responsible for my own health, it’s not my Consultant… I’m responsible so 
I strongly agree with that” (Patricia) 
 
For participants, actively managing their condition and taking responsibility for their 
health was often closely connected with independence. As a result of this, those who 
were able to do less than they could before their diagnosis struggled to deal with 
these changes: 
“Being very independent, quite fiercely independent, it was quite hard to have to accept I 
couldn't do certain things” (Mary) 
 
“That is the toughest part … nobody can give you a way out” (Tony) 
 
This reflects findings of prior rheumatology self-management research where patients 
have clarified that independence is a valuable treatment outcome for them, 
particularly after the initial, acute phase of their condition (Carr et al., 2003; Yoshida 
and Stephens, 2004). The space that participants had created for their illness and how 
it related to their identity was broadly beneficial as they focused on how it made 
them determined to do particular activities. However, other arthritis patients could 
report that their illness contributing to their identity in a way that sees them paying 
more attention to their symptoms, consequently having lower activity levels.  
 
Participants feeling the responsibility for their condition closely reflects the definition 
of patient activation described by Hibbard et al. (2004) that has been embraced in the 
literature and is outlined in section 3.1. However, the sense of responsibility 
occasionally being a barrier to participants’ rest and recuperation might provide some 
insight into how patients learn to actively manage their condition at level 4 of the 
PAM. At this level, patients can make use of strategies and resources to problem-
solve for alternative solutions if responsibilities are preventing them from balancing 
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rest with responsibility. This might also reflect the confidence held by patients who 
are at level 4 according to the PAM in testing skills and being aware when they require 
recuperation time.  
 
The balance between “giving in” and “persevering” and its relevance to patient 
activation could reflect some of the learning processes required to move from 
moderately skilled active management of a condition to the requirements of level 4 
of the PAM. Knowing when to stop, and how to respond may form part of the 
process of establishing how to actively respond to cues in one’s health when 
presented with challenges.  
 
The way these participants identified themselves as determined demonstrates some 
of the resilience required to manage a fluctuating condition. The “mind over matter” 
that Jackie referred to could be interpreted as an expression of self-efficacy, with a 
belief that she could carry out some activities and carry on even if things are 
challenging. However, it may also be interpreted as a reflection on how participants 
felt that being determined made more things possible. 
 
Participants reported that there was nobody else they could rely on to manage their 
condition and symptoms for them. Consequently, the responsibility lay with them. 
This reflects an internal HLOC (Wallston, 2005) whereby participants felt the success 
of their self-management, and consequences of their choices and decisions were the 
result of their own skills and efforts. This sense of independence and confidence to 
manage without support has the potential to contribute towards the self-
management style that has been referred to as being a “dangerous self-manager” 
(Náfrádi et al., 2017; Yadav  et al., 2018). This occurs when somebody has the 
confidence and self-management skills in the form of patient activation to choose to 
manage their own health. However, this person’s health literacy would not be enough 
to identify when they need additional support and their health is at risk. Therefore, 
participants perceived an effective self-manager to have this sense of independence 
for managing their own health but combined with health literacy skills to recognise if 
they do not have sufficient support (which will be discussed in more detail in section 
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6.7). This does not incorporate those who feel they need additional support but to 
whom this support is not available. 
 
The findings of this framework category partially relate to an internal health locus of 
control. The feeling that the outcome of one’s health would, in this example, be 
determined by the individual is reflected in this category. 
 
6.3 “You find ways to do different things”: Making small 
changes  
For many participants, actively taking responsibility for their health came in the form 
of smaller, day-to-day decisions or tweaks to their lifestyle that allowed them to 
continue with health behaviours, activities or identities that they valued. These 
smaller changes were discussed at length and were considered to capture actively 
managing a condition, as opposed to making broader lifestyle changes. Participants 
reported the changes they had made which often focused on common self-
management skills such as pacing, goal setting, altering their routines, and organising 
or adapting equipment to suit their physical requirements. Given that changing health-
related behaviour is generally accepted to be challenging (Kelly and Barker, 2016), 
making changes and introducing skills in small, manageable ways is to be expected and 
means that these behaviour changes are more likely to be successful (Hibbard and 
Mahoney, 2010).  
 
Participants described the volume of micro-decisions and changes that were involved 
in managing their life with a rheumatic condition overall: 
“It does affect your whole lifestyle, even how you sit in the chair, the chairs you’ve got, the 
chairs at the table, it’s little things like that and you did, getting in and out of the car, but 
even when you’re in the car, does it stop you driving, because have you changed from a 
manual gearstick to automatic.” (Avril) 
 
“That’s the mentality of it, making small changes to manage over the year” (Jim) 
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These changes were often practical to be able to continue carrying out self-care and 
domestic tasks, and it was clear that this required planning and thought from 
participants: 
“I have learnt that lesson, don’t just pick up the basket, even if it’s only for a few items, take 
the smallest trolley in with you, because by the time you get round and you put even just a 
few items in, that really weighs down quite a lot.” (Lindsay) 
 
“I can step over and step in to the bath but it’s the actual bending your knees to a right 
angle to sit down and even worse, getting back up because your arms aren’t strong enough 
to push you up and you can’t bend your knees enough. So I have to sort of let the water out 
of the bath and then the narrowest of the bath sort of roll over onto my tummy and then 
get on my hands and knees. It’s a bit of a beached whale. So a good many years it’s been 
showers you know.” (Meryl) 
 
“Drying my hair sometimes, a normal hairdryer I find too heavy to dry my hair and I’ve only 
got short hair, but I have to hold my hand up and hold on to the hair dryer while using the 
brush in the other hand I find it too heavy to hold a normal hair dryer. I’ve got a travel one 
which is only light and it does the same job. You do, you find ways to do different things.” 
(Cheryl) 
 
Those who were better at actively managing were more likely to identify and tackle 
external challenges to their self-management. One of these challenges was physical 
health preventing people from carrying out valued activities in the way they did prior 
to their IA diagnosis. Participants described how they responded to this by making 
changes that allowed them to maintain activities. This included doing activities 
differently, or perhaps missing out on aspects of activities in order to stay engaged 
with their social circles, to remain lightly active, or to fulfil a role they valued: 
“I just think I keep going, I go to darts, I go to skittles, I don’t play because the balls are too 
heavy now, but I still go." (Jan) 
 
Small changes that participants had been proactive in introducing also included 
physical adaptations to carry out activities: 
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“Physically, I’ve got things at home, like, there's raised toilet seats, we bought a new mattress 
and a bigger bed that was higher. We changed our car to a higher car. That was really 
important. I’m really weak in my left leg so we had to change to an automatic.” (Christine) 
 
“I know that I’ll struggle getting back up off it. I try and get arms on a chair if I can, I changed 
my car so I’ve got a higher seat on the car.” (Greta) 
 
Participants also approached health-related decisions in smaller, more manageable 
ways rather than broader lifestyle changes. They reported how walking a dog once a 
day, or using an upstairs toilet helped them engage in exercise without making them 
feel overwhelmed: 
“I try to keep active, try to go out every day and walk, even if it’s only from one end of [town] 
to the other.” (Avril) 
 
“I’ve got a downstairs toilet, but if I want to go to the loo, I usually go upstairs, just to get a 
bit of exercise going up and down the stairs. It hurts my ankles and it hurts my knees, but I 
still do it rather than, you know getting up out of the chair and walking a couple of paces 
… There’s lots of things you can do within your own home without even leaving your own 
home.” (Cheryl) 
 
“I still see them [friends] but they tend to come to me now” (Joanna) 
 
These attempts to remain engaged in things that participants valued were discussed 
with reference to the ways that participants felt they had lost aspects of their life 
because of their condition. They made use of the skills they developed where possible 
to do what mattered to them and to introduce healthy behaviours: 
“Okay. It came on very, very suddenly. Myself, I was very active both in my work and also 
used to play lots of sports and that kind of thing, do DIY, walk the dogs, just generally an 
active person, and physically fit and healthy. And suddenly, in a really short space of time, 
while constructing a shed, or workshop, in the garden, my hands started to swell for 
absolutely no reason. So much so that I couldn’t hold the tools that I was using.” (Stuart) 
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Pacing was the most commonly noted strategy that was required to manage a 
rheumatic condition, with most participants referencing it at least once during their 
first interviews. Pacing is considered part of the process of becoming an expert in 
one’s health, along with the ability to plan and prioritise (Schulman-Green et al., 2012). 
Understanding how to adapt, make changes to and pace their activities allowed 
participants to manage their lives: 
“Regarding like doing my housework, don't … I've only got a bungalow, but don't do the 
whole bungalow at once.  You know, do your lounge, and if you feel you need to sit down, 
sit down” (Jackie) 
 
“I’ve learnt that… you’ve got to pace yourself really well.” (Mary) 
 
“You take more time to do it, but you still do it” (Jan) 
 
Other participants described changes they made in order to continue with activities 
and roles that they valued in a modified way. One prominent example was Jackie, 
who described how she had incorporated a planning process into packing for a 
holiday. She reported that without this planning, the potential temperature changes 
on her trip would render her unable to continue to travel: 
“I'm planning right, what am I going to wear on … and what's going to be comfortable for 
me to stay warm and to be able to move? If I'm out in the cold, and I start creaking, and it 
starts hurting, then I might as well go and sit down. I have to pre-plan it… I can't just think 
oh, I'll take that … because I like the look of it” 
 
Her organisation and forward-thinking often went under-valued by those around her 
while she centred her health in this planning process: 
“Yes, [husband] thinks I'm … without saying it, sort of making perhaps a bit of a fuss of 
what I'm taking.  I don't think any of them really understand, to be honest, how my mind 
works, about what clothes I take…  They don't realise what's behind it.” (Jackie)   
 
Considering all these possibilities reflected the experience and thought that Jackie 
had used to problem-solve ways to approach her travelling and continue to do things 
that mattered to her. Problem-solving skills are considered a form of self-care that 
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contributes to improved patient outcomes (Paasche-Orlow and Wolf, 2007) and are 
common features in self-management programmes because of the benefits of being 
able to more helpfully respond to situations (Hibbard and Greene, 2013). Problem 
solving is considered to be an aspect of patient activation most commonly seen at 
level 4 of the PAM as it is deployed in order to return to, or maintain, effective self-
management during a flare-up (Hibbard and Helen, 2014). How patients perceive 
barriers also shaped their problem-solving abilities. In a prior study, participants with 
low patient activation considered themselves as the major barrier to being able to 
effectively and actively cope with their condition (Dixon, Hibbard and Tusler, 2009).  
 
This reflects prior research into how patients adjust to living with long-term 
conditions and health-related behaviour change. It also closely matches the sense that 
participants report of needing to take responsibility for their condition and living well 
(Dixon, Hibbard and Tusler, 2009). Given that research into specific self-care 
behaviours such as exercise and patient activation has often been contradictory 
(Harvey et al., 2012; Zimbudzi et al., 2017) and that some but not all self-care 
behaviours have been associated with patient activation (McCusker et al., 2016), it is 
likely that the underlying organising, planning and problem-solving skills contributed 
to success with participants’ self-management.  
 
6.4 “If you have a problem just phone up”: Navigating the 
system 
When participants discussed the way that they managed their health and how they 
took responsibility for it, one skill they regularly used was learning to navigate the 
NHS. This included being able to work with healthcare professionals to get the 
support, tests and medications required.  
 
Overall, participants demonstrated a range of abilities in order to access the health 
and support they needed. This appeared to be key to their sense of managing. There 
was an expectation for some participants that taking responsibility for their health 
included always taking the lead in appointments, but this was not always the case. 
Participants who discussed their future health had a clear sense of actions they would 
take to gather further health-related information. 
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Something that impacted this framework category was that data collection took place 
in two departments that use a direct access system. This allows long-term patients 
with a relatively stable condition to have fewer unnecessary review appointments 
with a rheumatologist, but they can call a telephone line for advice, support and to 
arrange appointments if they are required. This process is described by Kirwan et al. 
(2003) who report that in this initial trial of the system, there were no significant 
differences in disability at follow-up between participants receiving direct-access care 
and a control group receiving usual care. However, participants who had been 
receiving direct access care had significantly higher levels of satisfaction and 
confidence in the system of care in comparison to the control group.  
 
Within this framework category there are two subcategories: How to seek and get 
help and information and collaborating with healthcare professionals. 
 
6.4.1 “If I have that knowledge then it helps”: How to seek and get help and 
information 
This subcategory refers to participants’ ability to select appropriate ways to get help 
and information about their condition. Within this sample, participants reported using 
a variety of sources of help and information. They sought answers to queries using 
friends, relatives and often the internet. This did not necessarily mean that they 
needed to find it independently, but participants often chose to use NHS web-
resources or charitable organisations as reputable sources of support and 
information. For physical aspects of their conditions, participants generally sought 
support from a healthcare professional and were able to select an efficient and 
appropriate route to contact them depending on the urgency of the issue. Given that 
there has been a documented relationship between use of urgent care sources and 
patient activation, the literature suggests that those who are activated are more likely 
to be able to recognise setbacks in their health, and to seek help earlier (Hibbard and 
Helen, 2014). These two separate framework subcategories reflect this in practice, 
with participants making judgements about effective but measured sources of support 
to know when problems are occurring and to promptly seek care: 
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“I know they say you shouldn’t read everything, but there are some good sites on there. You 
have got the NHS one for a start, and you have got the arthritis association haven’t you…so 
they are genuine sites.” (Joanna) 
 
“I’ve got books and I’ve got, just in terms of basic, when I first got diagnosed I wanted to 
know everything there was about it. And then, basically, for me, I think if I have that 
knowledge then it helps me manage the situation.” (Anne) 
 
Participants reported critiquing information for accuracy and trustworthiness, 
demonstrating their critical and communicative health literacy skills to identify 
information and consider its relevance to their own health (Ledford, Cafferty and 
Russell, 2015). The skills to review information identified, and effectively apply it to 
their personal circumstances were fundamental to the process of gathering 
information for participants. Participants particularly made use of online resources. 
There were repeated references to credibility, trustworthiness and being sceptical 
about information gathered online unless it was from a reputable source.   
 
Participants had clear ideas about the kind of support they would seek out when they 
required it. They reported a preference for rheumatology clinics rather than their 
GP for the specialist knowledge and valued the consistency of seeing someone who 
knew them and their experiences personally: 
“If you go to your doctor and yes the doctor is a GP, they don’t specialise in rheumatoid, 
that’s why you get sent to the hospital about it” (Lindsay) 
 
“That's me taking control and going to see this lady doctor who's been fabulous.  I then 
phoned up, and said I wanted to see my consultant again, from [hospital] so she saw me 
out at [town], because I wasn't happy.” (Jackie) 
 
“When you are under a consultant you trust them, and the nurse you see more often. You 
trust in what they are doing and the doctor [GP] doesn’t know any of that. Alright, he might 
read reports when he gets back…” (Jan) 
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However, there were several things participants mentioned that contributed to them 
trying to resolve problems themselves. One of these was the delay in organising an 
appointment to see a healthcare professional: 
“If I ring the doctor and I need to see them urgently, they will generally fit me in today, but 
other than that, it can be, when I wanted to speak to my own doctor, as opposed to a doctor, 
I had to wait nearly three weeks, which is not ideal, but it’s not their fault.” (Avril) 
 
“I mean in terms of the health service in general doctor's appointments now are tricky, you 
wait two weeks for a doctor's appointment, they then tell you that you need a blood test, 
that's another two-week wait.  And then of course then you need to book an appointment 
to see your GP to discuss the results, that's another two-week wait.” (Mark) 
 
Another reason that participants chose not to seek support from healthcare 
professionals was a fear of wasting resources. This was particularly the case for 
participants who had prior work experience within the NHS, contributing to a need 
for purpose during appointments: 
 
“I know you’ve got the nurse emergency number that you can ring but you don’t like wasting 
her time” (Cheryl) 
 
“The NHS is very badly stretched, it’s got a lot of people doing a lot of jobs and they don’t 
have time for general chit chat. If you’ve got a problem, they’ll deal with it but you have to 
go and see them officially when you want one, they’re doing, you can’t go and see somebody 
and have a chat.” (Tony) 
 
The direct access system was commonly referred to as a comforting and quicker 
option to pursue: 
“I've got the direct access between appointments if you have a problem just phone up, which 
is great … I like the fact that I can, that it's there.  I wouldn't want to go through the GP, 
it's like sometimes it just takes forever.  So the fact that I can come straight here if I've got 
a problem is great” (Mary) 
 
“Within 24 hours they will phone me back, so that's a peace of mind.” (Tony) 
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“The support I get from the hospital is good.  I just ring a number and two or three days 
later I can get an appointment, which is very helpful.  The GP, he will only ever refer me 
back down to here anyway.” (Richard)  
 
Participants reported that they did not always seek out support for flares, often 
choosing instead to rely on plans that have been suitable before. They appeared able 
to use their experience from previous flares along with information about the severity 
and impact of a flare in order to judge how best to manage it. Where they could 
proactively manage the flare without healthcare professional intervention, they 
generally chose to do so: 
“I look at ways that I could probably sort [a flare] myself” (Avril) 
“[Seeking help] took a while because I thought give it a month or two” (Jim) In these 
circumstances Jim found that his initial instincts were accurate and that he was able 
to manage the impact of his medication change himself.  
 
Aspects of this subcategory in particular reflect some of the ways that there may be 
a “hidden curriculum” that does not reflect conscious patient education or learning 
but captures knowledge and abilities that underpin patient’ abilities to learn to self-
manage (Kentli, 2009). The kind of challenges that require self-management as 
opposed to specified levels of care may not always be explicitly described to patients 
and these are judgements that they learn to make themselves.  
 
Ledford, Cafferty and Russell (2015) found that participants with higher patient 
activation were more likely to receive favourable responses from healthcare 
professionals when sharing health information that they had researched themselves. 
High levels of critical health literacy are required to effectively gather health-related 
information on the internet in the current digital age, and this is particularly relevant 
given how widely used internet and technology-based systems are becoming in 
healthcare (Kim and Xie, 2017). 
 
The value of patients being able to effectively consider and report personal 
knowledge has been reflected in prior research. As an example, healthcare 
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professionals with increased knowledge about their patients’ life circumstances were 
more likely to develop a care plan that takes patients’ personal skills and resources 
into account (Bilello et al., 2018). In the same study, participants’ preferences for 
prompt access to healthcare professionals were also an important consideration in 
the sources of support they sought out. Some of the skills discussed in this framework 
category demonstrate forms of functional health literacy, with participants appearing 
able to determine the most appropriate person in their healthcare team to approach 
and creating an opportunity to discuss their needs. 
 
 
6.4.2  “If I feel there’s a concern, I will raise it”: Collaborating with healthcare 
professionals 
This sub-category highlights the roles participants played in decision making, care 
planning, and agenda setting when in appointments in a clinical setting. While they all 
generally implied that being more active in consultations demonstrated being more 
involved in managing one’s health generally, the extent to which individual participants 
were currently involved differed. This framework category closely matches the 
taxonomy of activated behaviours captured by Ledford, Ledford and Childress (2013) 
describing behaviours in clinic.  
 
When in appointments, participants reported feeling able to ask clarifying questions, 
a general confidence in being able to disagree with the opinions of healthcare 
professionals, and a keenness to be involved in (but not always leading) decision 
making. Participants conveyed the value of collaboration and working in conjunction 
with healthcare professionals as partners with different roles. This was particularly 
evident when reviewing item one of the PAM, in which participants were asked how 
much they agreed that they are ultimately the one responsible for their health 
condition: 
“So I mean question one… I've put agree because actually there's only so much I can do 
and therefore the health service have a degree of responsibility as well.” (Mark) 
 
“Obviously with help with doctors, but overall you are the only one that can [manage a 
condition]” (Joanna) 
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This doesn’t necessarily line up with the sense of independence for health described 
in the framework categories, but perhaps reflected more of a collaborative process 
that participants felt they should have a role in. 
 
There was a clear sense that participants felt able to disagree with health 
professionals to varying extents to develop a plan for their care: 
“I’ll wait until he’s finished waffling on and ask him at the end. Oh yeah, if there’s something 
I want an answer to, I’ll make sure he answers it” (Tony) 
 
“They listen to me. If I say I'm not very keen on doing that, it's not a case of close the book 
then, you won't take the tablets, I don't ever feel that. I don't ever … they will listen, and I 
mean, they've given me an option once with some tablets, and carcinoma was mentioned, 
in a leaflet, and I just said oh, I'm not taking that.” (Jackie) 
 
“I’m still not convinced changing the medication has helped but I’ll discuss that with the 
doctor when I see him again.” (Richard) 
 
Participants who felt comfortable and able to raise concerns, offer opinions or take 
the lead in appointments reported a sense of openness and comfort in doing so. This 
reflects strong communicative health literacy as participants were able to clearly raise 
the issue and outline the problems they experienced: 
“I will raise, if I feel there’s a concern, I will raise it, and to I think it’s only by being able to 
raise it and discuss it that I can get my own mind around it … it is a case of being, I suppose 
open, being honest.” (Greta) 
 
Participants also used practical strategies to be able to communicate challenges with 
their health efficiently: 
“I take my folder with me everywhere of all my letters…. I’d done a summary from my 
letters of all the things that I’d been sent for and what, and that’s in the notes now.” (Mary) 
 
Some participants were less confident around taking charge in appointments: 
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“Ah yes. I’m not too good at taking the lead. Sitting here chatting with you I’m not too good. 
I’m alright coming in and saying how I am but I’m not a patient that can say “well so-and-
so, now I think I ought to have so-and-so” (Meryl) 
 
While healthcare professionals were likely to be the ones to suggest specific 
treatment options because of their specialist knowledge, participants generally had 
an openness to trusting them and trying strategies out, having brought up the initial 
issues: 
“Yeah I don’t know that I would have the conviction to say ‘I disagree with you’, I might say, 
what I tend to do, if I’ve gone there with a problem, I will initially say ‘I think it’s this, this 
and this’, but if they came back and said ‘No, no’, I’d say ‘Okay we’ll go down that route 
and see how it goes’. (Patricia) 
 
Some participants referred to the sense that there was only so much the healthcare 
professionals could do, and that other patients may have higher expectations for 
these appointments: 
“A lot of people that think oh well I’m going to go to Rheumatology, or I’m going to my GP 
and they’re going to wave a magic wand and it’s all going to disappear.” (Cheryl) 
 
“If you go to see a doctor, unless you tell them everything, there’s no way they can make a 
decision, or what is best necessarily for you” (Greta) 
 
“So I do think that lots of people could, not do more, but my husband's a bit like that, he 
thinks there's a tablet for everything.” (Jackie) 
 
At times, participants were critical of the way they believed other patients viewed 
healthcare professionals and the passive way these patients managed their conditions: 
“It's them acknowledging and recognising and acknowledging that there's things that they 
can do, or ought to be doing to help them manage their condition.”  (Mary) 
 
Some participants recognised ways that other patients may feel less able to assert 
themselves and their wishes in consultations: 
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“I suppose, maybe I’m different from other people. There are people that don’t feel confident 
in discussing things, but then if you don’t discuss it with your health care provider, or whoever 
it may be.” (Cheryl)  
 
The ability to disagree with healthcare professionals was particularly important given 
the often-present power imbalance between patient and healthcare professional 
(Becker and Roblin, 2008). The immediate and personal support that participants 
discussed appeared to give them the confidence to continue life self-managing as 
actively as possible, knowing that they had the service available as a safety net if they 
required it. The descriptions above of effective, useful contact from their 
rheumatology team suggest a positive working alliance. As patient activation has been 
positively associated with working alliance, the participants appeared to bring 
optimistic and open contributions to the therapeutic relationship (Eliacin et al., 2016). 
 
Given that Meryl’s PAM level was a level 4, this reflects that the measure may not 
capture her reluctance to take the lead, even if she was comfortable raising issues to 
healthcare professionals. 
 
For participants in this study, they often viewed healthcare professionals as a guide 
to support them and their health:  
“Just stay in touch with the medical professionals - whether it’s GPs or specialists and they 
can guide you on the right track medication wise.” (Richard) 
 
Given the documented relationship between clinicians valuing patient activation and 
patients’ overall healthcare outcomes, it is clear that participants would also be more 
likely to take responsibility for their condition if they had a supportive consultant and 
nursing team (Bastas-Bratkic, Weismuller and Brady, 2018). Healthcare professionals 
have been criticised for potentially focusing too much on their own goals, rather than 
those set by patients (Volpp, 2018). This is what Tony may have meant earlier in this 
section, when he referred to waiting for his doctor to finish “waffling on” to have the 
opportunity to focus the consultation on the information he needed. However, 
patient activation interventions rarely focus on providing training and support to 
healthcare professionals and consequently this burden may fall to patients to be 
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activated and confident enough to take the lead without prompting. There are 
training and resources aimed at encouraging patients to contribute to conversations, 
e.g., the “Ask 3 Questions” initiative that provides summary questions for patients to 
ask appropriate questions about their care (Joseph-WIlliams et al., 2017). The 
intention of this is for patients to understand their options, the risks and benefits of 
the options available, and the likelihood of these risks/benefits occurring. This has 
been implemented across primary and secondary care services within the NHS but 
is primarily a patient-focused resource. 
 
There is a clear need for further training for healthcare professionals to support 
patients to actively manage their condition by communicating and prioritising their 
needs and information requirements. One way this is currently being provided is in 
the form of agenda setting interventions for patients and healthcare professionals. 
This was included in the CCH Programme in both the self-management arm and the 
healthcare professionals training and was considered a key enabler of self-
management (Newbronner et al., 2013). Given that question formulation is a common 
aspect of patient activation interventions (Ngooi and Packer, 2017) and that patient 
empowerment interventions have demonstrated that activated participants are more 
able to extract information from healthcare professionals (Roberts, 1999), this is 
another vital skill in actively managing a health condition that participants have 
discussed in this subcategory.   
 
Given that patients with low health literacy have been found to receive less 
preventative care (Rowlands et al., 2015), the experience within clinics for patients 
may differ based on how focused consultations are on preventative care. The relative 
contributions of patient and healthcare professional could depend on whether there 
are current issues requiring reactive care. Responding to current difficulties would 
likely require more of the healthcare professionals’ specific biomedical knowledge 
and thus would shape the consultations. The findings of this subcategory are in line 
with prior research indicating that people with higher patient activation are also more 
likely to rate their patient experience more positively (Mosen et al., 2007). This may 
be due to a greater ability to work collaboratively with healthcare professionals. 
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6.5  “I think I've recognised what works for me, and what I 
need”: Knowing oneself 
This category describes the participants’ experiences of their own body that appeared 
to be vital to their ability to take charge in managing their condition effectively. 
Participants had a clear sense of what techniques for self-care were useful for them 
and relied on a knowledge of their own body and condition to know when they 
needed additional help and information from the sources described above. This is 
distinct from participants knowledge of how to seek help when it was required. Their 
sense of knowing their body included demonstrating knowledge of the healthcare-
related routines required to manage their health. This particularly referred to regular 
appointments, treatment regimens and requirements from them to manage their 
health.  Three subcategories contributed to this overall category: “when to seek 
help”, “what works for me”, and “how my healthcare works”. 
 
6.5.1 “I knew it was obviously something shook up in my body”: When to seek 
help and information 
When asked about how they knew when they needed to seek help, participants’ 
answers often differed based on their circumstances. A common aspect of their 
responses was that it related to the duration and severity of a flare-up compared to 
how they understood their day-to-day health. Participants were aware of their 
baseline, as well as a sense of their fluctuations and how their body felt during a flare. 
This allowed them to identify when something was out of the ordinary to monitor 
this in case support was required: 
“I am tuned in, I am.  I do find, it's awful really, but I am very tuned in” (Jackie) 
 
“Because I know my condition, I know I can manage it and I know usually taking the 
medication, it’s sort of level at all times and as soon as something’s wrong, I know, so even 
through pain or swelling.” (Richard) 
 
Sometimes participants felt clearly when there was something with their body that 
needed attention: 
“I thought what's happened to me?  I knew it was obviously something shook up in my 
body.” (Jim) 
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“Listen to your body basically, you have to listen to it and you know something isn’t right, or 
something’s changed, and change it accordingly. Either stop taking that medication and then 
seek medical advice.” (Greta) 
 
When participants referred to this sense of knowing their own body, this was 
explored further during the interviews and they were asked about how they had 
come to understand this. Participants could not always describe how they developed 
the awareness to identify the onset of an issue: 
“I don’t think I consciously do it either, I think sometimes it's just a case of I realise when 
I'm pushing my luck, so I draw back” (Mary) 
 
Some experienced clear warning signals of a change to their health: 
“It’s obviously because the main areas where it was, it’s mainly the knees, so … if my knees 
swelled up, then I know that that isn’t right.” (Anne) 
 
Participants also used this knowledge to anticipate if they were likely to be overly 
active, or more likely to contribute towards a “boom and bust” pattern of over- and 
under-activity (Hewlett et al., 2011), as Mary described her awareness of when she 
was “pushing her luck”. 
 
6.5.2 “It just helps me”: Knowing what techniques work for individuals 
Participants used a wide range of techniques and products specifically targeting the 
symptoms of their condition. These included both pharmacological and non-
pharmacological techniques and allowed participants to manage the impact of their 
condition. They relied on this toolkit to manage fluctuations and occasionally some 
specific routines for flares, as well as being aware of what techniques they had 
available to deal with the specific symptoms they were experiencing. This contributed 
to confidence in managing symptoms and meant that they were potentially less likely 
to seek excessive support from healthcare professionals: 
"I think I've recognised what works for me, and what I need, whether I get or can have what 
I need." (Mary) 
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"But I like to try things anyway and try for myself, see if it’s beneficial or not. If it’s not then 
it’s fine, you know, go on to something else." (Stuart) 
 
“I know what to do [to manage] and I think I’ll do that.” (Christine) 
 
“I go to an Osteopath every six weeks, occasionally I go more frequently if I’ve got, if I’ve 
had things are tighter or whatever, and that obviously helps a lot, it’s just, and the other 
thing is I do find the sun helps.” (Avril) 
 
“It’s about knowing what suits you … what works for me might not work for someone else” 
(Jim) 
 
Participants did not always use analgesic medication as a part of their routine. 
However, sometimes they were a preferred tool when experiencing flares, in order 
to continue living life: 
"I think to myself right, I need to stay in the warm today, might take a couple of paracetamols 
if its really bad, put a bit of Deep Heat on” (Jackie) 
 
“A necessary evil” (Christine) 
 
Participants were sometimes reluctant to use them too often: 
“The painkillers usually do it, but I try not to take too many of them, because I just don’t 
want to become reliant on them really.” (Lindsay) 
 
“I might take a couple more pain killers or something, but it doesn’t change my lifestyle, no.” 
(Jan) 
 
Medication regimens prescribed by healthcare professionals as part of a toolkit to 
self-manage were rarely discussed, despite how commonly this has been associated 
and discussed in conjunction with patient activated behaviours (Mosen et al., 2006). 
When participants talked about their medication, it was implied that they took it 
regularly and monitored their regular reviews as well as their intake, when 
appropriate: 
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“I should go to a pharmacist, because that’s where I get my repeat prescriptions from, they 
offer that service, so it might be, I’m due to go there this afternoon to pick up my prescription, 
so I might ask about [annual review].” (Avril) 
 
“I have been given more freedom by the consultant to up my steroids by 2 milligrams to 5 
milligrams based on blood tests rather than waiting and getting delayed and more ill.” 
(Christine) 
 
It was unclear whether prescribed pharmacological medications were rarely 
mentioned as part of self-management was because people did not consider that 
taking them was part of their routine, or whether it was simply assumed that they 
would adhere to the routines. One participant who did not adhere to her medication 
justified her decision to stop taking her medication because she felt that she was 
managing well without them after a period of inconsistently taking them: 
“I just kept forgetting to take them. And in the end I thought oh, there's no point now, I'll 
see how it goes.  And it seems to have been okay. So it wasn't really a conscious decision, 
but because it seemed to be okay, I thought well, let's try it.  I knew I'd be coming here soon, 
so I thought well I'll have a word with [nurse] and see what he says and obviously he was 
fine about it.”  (Mary) 
 
This may reflect an example of the potentially “dangerous self-manager” (Náfrádi et 
al., 2017) if the decision had been taken without a knowledge of what the medications 
do. However, this was not explored in detail during the interview. 
 
6.5.3   “I know what each tablet is for”: Health-related knowledge 
Participants demonstrated knowledge of their condition, their responsibility for 
effectively managing their routine, and why certain behaviours, investigations and 
interventions needed to be performed. The knowledge and skills discussed in this 
category closely reflect functional health literacy as an aspect of patient activation 
that participants perform regularly: 
“At my doctor’s surgery you have to go for like a rheumatology test. It’s the nurse she just 
checks the medication you are on, and she will talk to you about things. And she sent me 
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for a bone scan last year and I am due another one at the moment an appointment with 
her.” (Joanna) 
 
“I'm aware of other options, certainly with the biological medication that leaves you 
vulnerable to infection etc., but it stops the progression of the disease.” (Mark) 
 
This knowledge allowed participants to advocate for themselves if they felt they were 
not receiving sufficient contact with healthcare professionals, or if they were 
concerned about how prompt processes were: 
“If it comes back in a letter, you’ll see the Consultant in say four months, you will get the 
letter from the hospital then in four months, but then you have to ring in to make the 
appointment and then the next space is might be another month again, so that’s five months 
rather than four months that you’ve seen. So you do need to be proactive with actually 
making sure that you’ve got that appointment on the four months, rather than it might be 
five or six months before you actually see someone again.” (Lindsay)  
 
Participants demonstrated knowledge about their medications that contributed to 
them being able to play a role in decision making, including some understanding of 
the reasons for medication changes. One example is Jim, who had reviewed and 
discussed his move from one medication to a biosimilar medication following the 
expiry of the patent. He demonstrated his knowledge of the process and the rationale 
behind this medication change: 
“[biosimilar]'s exactly the same.  They've taken, what I understand is they've taken an 
element of it out which is a cost- effective saving” (Jim) 
 
Participants were generally keen to be informed about these matters in order to feel 
in control of their condition: 
“And I started to understand about RA, really, looking up lots of different things, the leaflets 
I was given then, the explanation I was given. And I was really interested in finding out.” 
(Stuart) 
 
“I like to be informed to a point, and I know there’s information out there if I need more.” 
(Mary) 
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This is in line with prior qualitative research indicating that patients often differed 
with the amount of information they required to self-manage, and Mary being 
“informed to a point” offered her the opportunity to seek out more information if 
required rather than being initially overwhelmed. Given that people with low health 
literacy have been found to disengage from seeking out information if the information 
provided is unclear, it is presumed that the information provided was acceptable to 
participants and they felt able to seek out further clarification if required (Parsons 
and Adams, 2018). 
 
 
 
6.6 “There are people far worse than me”: Positive illness 
beliefs 
Participants often made sense of their health and how they managed it by comparing 
their own experiences with those around them to make them more determined to 
take action. These were often relatives with rheumatic conditions, but sometimes 
friends, peers at support-groups or patients in waiting rooms when they visited their 
rheumatology department. These downward comparisons seemed to be a factor in 
their coping, particularly as participants generally viewed themselves to be 
comparatively well and with good function and symptom control. This has been 
identified in prior research about how downward comparisons have motivated 
people to make changes to their health to avoid moving towards the downward 
comparison (Martinez et al., 2018). 
 
“So yeah, as I say I do manage it, ninety-nine per cent of people wouldn’t know there’s 
anything the matter with me.” (Avril) 
 
“[Mother] has always had a far more significant problem with it than I have.  Her hands 
don't move, she's in a nursing home now.  So it's had a drastic impact on her health It hasn’t 
had a drastic effect on my life, particularly. I probably put it down to luck because there are 
a percentage of people that do get lucky and maybe I'm just one of them…” (Mark) 
 
 158 
 
“My daughter only goes out a couple of times a week. She has it in her legs as well, so she 
has it worse than I.” (Jan) 
 
“When you then speak to other people at the group you realise that it affects people in 
different ways. That’s been really helpful." (Greta) 
 
The perceived benefits of comparison could be because their own experiences were 
normalised following the opportunity to see how other patients manage similar or 
potentially worsening symptoms (Dwarswaard et al., 2016). The use of the local 
patient groups that Greta refers so here also reflects findings of a systematic review 
looking to understand the impact of social networks and groups on self-management 
(Vassilev et al., 2014). This review identified the value of sharing experiences with 
social groups and how social comparison with network members contributed to self-
management. In this way, peer support groups may be a form of intervention for this 
aspect of patient activation and are a common feature of third sector service 
provision for patients with long-term conditions. 
 
People were generally keen not to end up with the health of whoever they were 
comparing with their own. This contributed to the determination to act. Participants 
also felt their general health and situation were positive in comparison to others, 
echoing the benefits of downward comparison identified in prior health research 
(Suls, Martin and Wheeler, 2002): 
“Not really.  I don’t normally get ill, touch wood.  I’m not a sicky person.  I’ve had this for 12 
years and never lost a day of work through it” (Richard) 
 
“There’s an awful lot of people out there who are an awful lot worse off than I am and it’s 
just a case of getting on with it” (Cheryl) 
 
Sometimes this feeling of good health contributed to participants feeling fraudulent, 
or like they didn’t need, or shouldn’t be using the services they were offered: 
“They just sort of come round.  Because I am so well-managed I feel a bit of a fraud. I am 
so well managed now I don’t have to go to the GP very often and I don’t really have to use 
direct access.” (Meryl) 
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“I mean I shouldn't really see a consultant because there are people far worse than me.  I'm 
sure 99 percent of people with RA are worse than me, so I shouldn’t really get to see a 
consultant.” (Mark) 
 
This comparison captured participants’ sense that their condition was not as 
impactful as it might have been. One factor that may have contributed to this is that 
participants’ levels of disability (as captured by the HAQ) were low with an average 
score of 0.45. Illness beliefs that helped them to feel as though their condition was 
not as serious as those around them gave them the confidence to “get on with it” 
(Cheryl). Illness beliefs have been suggested to play a role in patients’ self-regulation 
in health behaviours for long-term conditions (Broadbent et al., 2006). Positive 
perceptions of the severity, perceived illness duration and the impact of the condition 
contribute to how patients adjust to life with a long-term condition (Graves et al., 
2009). Understanding and working with patients to overcome unhelpful thoughts that 
prevent them from effectively managing and living well with their condition would be 
a relevant intervention to support those to feel more positive about their health 
(Graves et al., 2009). In the circumstances of this study, the fact that participants’ 
conditions were not as serious and limiting as they could be might have contributed 
to increased confidence in managing and choosing to carry out behaviours that others 
may perceive to be too risky. This is particularly relevant as a statistically significant 
relationship has been identified previously between illness perceptions and HAQ 
scores in rheumatoid arthritis patients (Rose et al., 2012). The low levels of disability 
of participants in this PhD study may have been associated with the positive illness 
beliefs that participants had. 
 
The association between illness beliefs and patient activation has been documented 
(Rask et al., 2009), and people enjoying high levels of good health are more likely to 
demonstrate high patient activation scores (Bilello et al., 2018). Particular health 
beliefs that are open to intervention can increase health literacy. These may include 
perceptions of risks, expectations about the impact of symptoms on one’s life and 
expectations about the nature and severity of one’s condition (McCormack et al., 
2016). 
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The impact of illness beliefs on life with a rheumatic condition has been explored 
qualitatively with participants diagnosed with a range of diagnoses (Berenbaum et al., 
2014; Chisholm et al., 2016; Pouli et al., 2013). These studies have reported the need 
for reassurance about the future for some interview participants who had more 
pessimistic illness beliefs (Berenbaum et al., 2014), particularly with relevance to the 
fluctuating nature of the condition and the struggle to respond to this. Chisholm et 
al. (2016) identified participants who conducted social comparisons but to peers with 
more favourable health. Information was not provided about participants’ health and 
physical function in order to understand the context behind their experiences and 
the data. 
 
6.7 “Just does a lot of fetching and carrying”: Social support 
Although participants attempted to be independent where possible (as discussed in 
section 6.2), a factor that contributed to them being able to effectively manage their 
health was their support networks. This often came in the form of partners, family, 
friends and neighbours and they demonstrated love and care for the participants. 
While participants often did not seek support from their loved ones related to the 
overall management of their condition such as accompaniment to clinic appointments 
or discussing the impact of their conditions, they did often ask for physical, practical 
help. This was often housework, driving, lifting or carrying: 
“It is more the practical stuff of opening things, that I've needed help with.” (Mary)  
 
“Yeah [family] carry the bags in for me, from the car yeah they will, they lift things down 
shelves for me, when I can’t reach them, and stuff like that, change lightbulbs and that.” 
(Lindsay) 
 
“Just does a lot of fetching and carrying for me.  If I can’t open something, she’ll open it for 
me.  If I can’t lift something, she’ll lift it for me.  So yes, it’s just helping out.” (Richard) 
 
“If I need to go and shop, my husband will always go with me, so he will take the brunt of 
that. He’ll push the trolley and I just sort of trail behind him saying “I want that, I want that”, 
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yeah, otherwise, and the other option is I send him with the list, to do the shopping.” 
(Patricia) 
 
Sometimes this was flexible depending on participants’ needs at that time: 
“We share the workload, really. If I’m doing well, I’ll do more and if she’s doing well, she’ll 
do more.” (Stuart) 
 
“When I’m really bad in flare, my mum comes and stays…and she’ll do the school runs, 
and things like that” (Christine) 
 
This is in line with the perspective of participants in other qualitative research into 
self-management, reflecting that while sometimes this support was necessary, 
patients did not want too much support from their loved ones (Dwarswaard et al., 
2016). 
 
Given the documented emotional impact of living with a rheumatic condition 
(Gettings, 2010), the researcher had anticipated that actively managing a condition 
would also require emotional support from participants’ friends, family and other 
social connections. However, participants often did not refer to specifically relying 
on their loved ones for emotional support. It is possible that the practical help being 
provided by participants’ loved ones were offering peace of mind for both them and 
their friends and family. Similarly, participants did not necessarily welcome support 
during appointments and one participant explicitly referenced choosing not to have 
her partner accompany her to appointments: 
“My husband really really wants to come to appointments with me but I let him come to 
one recently” (Christine) 
 
Sometimes a wider circle of social support provided participants with practical help: 
“[Neighbours] see me struggling, getting in and out of the car and getting things like having 
my shopping delivered and what have you, they see me there struggling and they’ll come 
and help. They’ll help get everything into the kitchen, I put it away from there.” (Tony) 
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Social support has been discussed as a valuable part of maintaining health-related 
behaviour change (Michie and Abraham, 2013) and has been integrated into the HLQ  
(Osborne et al., 2013) because of its value in how people make use of their social 
network to effectively manage their health. Given that those without a social network 
are less likely to engage in health-related behaviours and that rheumatology patients 
in the UK have reported both the value of being understood by their social network 
and the isolation when they do not have one,  this has relevance for how to support 
people to prepare to make  behaviour changes (Lauder et al., 2006; Dures et al., 
2016b). Social context and environment has also been previously under-represented 
in self-management support, despite how relevant and important it is to how people 
make and maintain health-related behaviour change (Rogers et al., 2011).Social 
support has also been identified as having associations with both health outcomes 
and health-related quality of life (Wan et al., 2016; Gong and Mao, 2016). 
 
As rheumatology patients have identified a gap between the need for additional social 
and emotional support and current service provision (Dures et al., 2014) it should 
provide a valuable target for intervention. However, interventions targeting patient 
activation might be unlikely to focus on improving social support as this is often less 
amenable to change. Instead, social skills or communication training may support 
people to build social networks. This could include social network approaches to 
embrace collective self-management so that individuals are not required to be entirely 
self-sufficient with their self-management and can consider the roles of others and 
how they can contribute to their self-management (James et al., 2020). Again, this is 
an example of where network mapping such as the GENIE intervention may be a 
future intervention implemented to focus on this aspect of patient activation, either 
in rheumatology departments or through specialist links worker or third sector 
provider (Band et al., 2019). 
 
6.8 Patient activation perceptions and opinions on the PAM 
The final part of the interview schedule focused on the definition and methods of 
capturing patient activation. This was discussed with participants to understand how 
closely their perspectives matched the items on the PAM.  
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This section was introduced by asking participants if they had heard the term patient 
activation before, and what they would guess that the term meant. The term “patient 
activation” was not specifically presented to patients before the day of the interview, 
however it was available on both the study title and on the consent form that 
participants signed, referred to in the patient information sheet and participants did 
complete the PAM before the interview. Participants generally stated that they had 
not heard the term before, but some mentioned that it must be relevant to the study. 
When asked to speculate what that term may mean, responses varied.  Some 
participants suggested that how they lived now was likely to be “patient activation”, 
others made references to “perhaps getting more active, with what you’re doing” 
(Cheryl). 
 
Some definitions were closer to the understanding of the term used in the literature: 
“I suppose it’s just about being proactive, just generally, it’s about everybody being proactive.” 
(Greta) 
 
“The only thing I can think of is the patient actively seeking help, but I have a suspicion that’s 
not it.” (Patricia) 
 
“Giving a bit more power to the patient…” (Christine) 
 
“How you understand arthritis. Sort of how you understand it and how you deal with it in 
your mind sort of thing. That’s what I think it might be related to” (Meryl) 
 
“I would guess that it meant more patient input, I suppose, more patient-led.” (Stuart) 
 
The researcher provided the definition of patient activation used by Hibbard et al. 
(2004) for patients to discuss. This offered the opportunity to explore participants’ 
perceptions of what patient activation specifically involved, including the behaviours, 
knowledge and skills they perceived to be relevant. Particular behaviours referenced 
by participants at this stage included managing treatments and taking steps to 
continue to improve the management of their condition: 
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“Making sure that they take their meds on a regular basis, probably making sure that they 
get the rest that they need throughout the day, yeah, and maybe asking for help off of other 
people to do things as well.” (Anne) 
 
“Somebody that has a relationship with their medical team, medical professionals, and is 
given feedback with medication, whether it’s working or not. What they could be doing within 
their own lifestyle to benefit their own condition, I think.” (Stuart) 
 
Anne had a very specific visual image when presented with the term, saying:  
“It makes me think of something chemical like, [chuckling], there’s going to be an alarm 
going off any minute.” 
 
Some participants referred to a perception they held about the term activation and 
its imagery of “switching someone on” (Richard). This would imply that, to these 
participants, the responsibility for “activating patients” lies with healthcare 
professionals. This would still leave patients passive yet being encouraged to take 
responsibility for their health, rather than proactively doing so.  
 
The terms patients suggested as an alternative to patient activation that still reflect 
the skills, experience and knowledge they drew upon to manage their health, varied. 
These included “engagement” and “sort yourself out”. These placed the expectations 
for self-management and responsibility for one’s health more firmly with patients.  
 
Finally, participants’ perceptions of the PAM were discussed. The researcher clarified 
when introducing this block of questions and emphasised again at this point that she 
did not develop this definition, and she was not related to the group of researchers 
that developed the PAM. She encouraged participants to respond honestly to explain 
what they liked and did not like about the questionnaire. This included stressing that 
there were no wrong answers and she was interested in participants’ thoughts about 
the questionnaire from those who really liked it, those who did not like it at all and 
everything else in between. The intention from this introduction was to reduce the 
risk of participants feeling pressure to give socially desirable answers if they perceived 
the researcher to be personally connected with the outcome measure, or with an 
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agenda. If they asked the researcher what her thoughts were, this was redirected 
with gentle steering and the phrase “I’m interested in what your thoughts are, but I 
can tell you a little about mine later”. 
 
Participants’ feedback on the PAM covered a wide range of perspectives. Some 
participants felt that this measure was entirely appropriate and fit for their 
understanding of patient activation, capturing the things that they felt demonstrated 
how they took responsibility for their health: 
“No, I think the questions here are quite good, yeah … I think they're really good, bold 
questions.” (Jim) 
“I agree with all of it actually.” (Jackie) 
“It covers all the general things on there.” (Jan) 
“I think most of them are relevant.” (Richard) 
 
Others recognised that their understanding of patient activation was broader and 
gave specific suggestions for where they performed behaviours or had knowledge or 
skills that were not captured in the PAM. For Lindsay, she felt like how she managed 
work reflected being able to effectively and actively manage her condition: 
“This here basically is just asking you basically all these questions are tailored for how you’re 
getting on at home, or how you’re managing your medication basically, and I think work is 
a big part of everybody’s life if they go to work and there’s not enough questions or studies 
about how work has an impact.”  
 
Other participants provided critiques on the phrasing of items of the PAM that did 
not reflect their experience of actively managing their health. Item one of the PAM 
(“I am the person who is responsible for taking care of my health”) (Hibbard et al., 2004; 
Hibbard et al., 2005) was critiqued by several participants who made reference to the 
benefits and necessity of working collaboratively with healthcare professionals, as 
referenced in section 6.4.2. While participants recognised that they had a valuable 
part to play in being responsible for their health, they did not feel they held this 
responsibility alone. They referenced the responsibilities held by healthcare 
professionals, particularly when it came to determining the course of medical 
treatment and for their knowledge: 
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“I mean things like that, the top one, I'm the person responsible for managing.  Yes, but 
then you see you need help with the medical professionals.” (Mary) 
 
“Yeah number one when all said and done, yeah which you are really aren’t you, you are 
responsible for managing your own health condition. With obviously with help with doctors, 
but overall you are the only one that can…” (Joanna) 
 
“Well that first one, I know really disagree with that, because at some stage it’s got to be 
what the Consultant says, you can’t just come in and say yes I’d like this, I’d like that.” 
(Lindsay) 
 
“I mean question one on the person responsible for managing my health condition, I would 
agree strongly, but I've put agree because actually there's only so much I can do and 
therefore the health service have a degree of responsibility as well.” (Mark) 
 
“You’ve got to do your bit at helping. [Healthcare professionals] are there to sort of instruct 
and do what they can to help but you’ve got to do your bit as well I feel. You know, sort of 
go half-way to meet them sort of half-way.” (Meryl) 
 
This suggests more of a mixed health-related locus of control, where these 
participants felt both personal responsibility for their health, but that doctors or 
powerful others also had a role to play (Wallston, 2005). This also reflects some of 
the complex nature around patients’ expectations of both their role and that of the 
healthcare professionals. The independence they wanted to retain, the collaborative 
relationship participants discussed being optimum and yet the sense here that 
healthcare professionals were also ultimately responsible for patients’ health 
conditions suggested some conflicting perspectives. 
 
Item three on the PAM (“I am confident I can help prevent or reduce problems associated 
with my health”) and item eleven (“I know how to prevent problems with my health) were 
commonly cited by participants as problematic and not aligned with their 
understanding of managing their conditions. At this point participants often referred 
to setbacks or flares that they were often unable to prevent or predict. Given that 
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flares within arthritis are common, being able to respond effectively to fluctuations 
and changes in a long-term condition must be a part of self-management (Box, Bonney 
and Greenfield, 2005). Participants reported that they felt that this question did not 
reflect the unpredictable and permanent nature of their conditions: 
 
“I don’t know that you could sort of actually prevent it” (Meryl) 
 
“I know how to prevent further problems with my health condition, because you can’t prevent 
it, once you’ve got it, you’ve got it.” (Anne) 
 
“I know how to prevent further problems with my health condition, again, I’ve put agree, 
because again, there’s always the unknown, that we don’t have control about, so again, so 
rather than strongly agree, I’ve put agree.” (Greta) 
 
“I am confident that I can take actions that will help prevent and minimise, I don’t can’t 
strongly agree, because you don’t always know what you should be doing.” (Patricia) 
 
“And the reason I put ‘agree with’ in 11 is, I know how to manage physically but I can't 
control what my body does in terms of flare. So that was the only reason I put ‘agree’, 
otherwise I would have put ‘strongly agree’.” (Christine) 
 
“I’ve put, ‘disagree” with a couple of things. For example, ‘I know how to prevent further 
problems with my health condition.’ And I’ve put, ‘I disagree.’ And the reason I put that is 
because the random nature of the condition, you know, I suppose, thinking about it, I can 
limit, perhaps, to a certain degree, further problems. But I certainly can't prevent it, other 
than taking the medication…” (Stuart) 
 
The phrasing of items in the PAM may have been interpreted by participants as being 
black and white, without much interpretation for middle ground in collaborative care 
or the fluctuating nature of conditions. However patients may still be actively 
managing health conditions working collaboratively with healthcare professionals. 
They could also be able to manage their condition even in the presence of 
unpredictable flares and fluctuations. 
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The interpretation of “problems” from item 11 of the PAM could also be broad. Anne 
seemed to feel that the problems referenced was the onset of  her arthritis, whereas 
Christine interpreted problems as potential flares. 
 
The PAM is intended to be a generic measure suitable for all kinds of conditions. 
However, patients with long-term conditions have reported it is not always suitable 
for conditions that fluctuate (Roberts et al., 2016). Developing an understanding of 
what contexts are most appropriate for the use of the PAM and its acceptability to 
patients will allow for changes in how the measure is used in practice.  
 
“Generally of course it's my responsibility to you know … And I guess for number nine (I 
know what treatments are available for my health problems), again, to a point, because 
I know the medication that I was offered, and I know the names of both of them, what I 
don’t know is whether anything has changed or whether there is anything else available.” 
(Mary) 
 
“I know the different medical treatments, options available for my health condition, well you 
don’t really know them all at the beginning. I mean going back probably a couple of years 
ago, the Consultant would say “Well you’ve got lots of options and then we’ll give you like 
two leaflets to take away”, you wouldn’t be given all of them and you would pick between 
all of them, you tend to get two at a time” (Lindsday) 
 
Some participants reflected on the responses that they had provided to the PAM in 
light of the discussions had within the interview: 
 
“I don’t want to be patronising but I consider myself quite educated, and whether a lot of 
people would be able to go into, I mean I don’t think I’d gone in, really picked out the detail 
in them, but I think they probably could almost cut it down a bit, but that’s only nit-picking” 
(Avril) 
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“So even though I agree and everything seems wonderful, actually a lot of the questions I 
agree with simply because of my own research rather than what information I maybe should 
have been given.” (Mark) 
 
How participants carried out their own research to find out information, attend talks 
and groups, and ask questions was important to them, and having this reflected in the 
PAM was a suggestion. Mark noted that doing his own research to gather knowledge 
felt more like actively managing his condition than passively receiving information 
unprompted from healthcare professionals. This reflected the idea that actively 
managing a rheumatic condition may be a skill learned outside of rheumatology 
departments (Roberts, 1999): 
“I’m in favour of it in that I actually think that not just within Rheumatology but within health 
completely, we need to be taking responsibility for our own health and seeking advice and 
doing things to improve our health” (Patricia) 
 
 
6.9  Specific second interview findings 
This section is shorter as much of the data gathered for the second interviews were 
discussing topics and aspects related to the framework and the first interviews. 
Relevant data abstracts that are incorporated into the overall framework were 
included in the preceding subsections. Additionally, if findings from the second 
interviews did not provide detail that was novel it was not included in this current 
subsection. 
 
Nine participants returned for a second interview. Of the eight participants who did 
not return for a second interview, two were unable to as they were now working 
and were no longer able to commit to meeting during their working hours. One was 
no longer well enough to continue to participate,  two were not able to attend due 
to other life commitments and three were lost to follow-up.  
 
During the second interviews, each participant had the opportunity to individually 
review their year and their health during this time. Many of them had experienced 
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flares and specific life challenges and reflected on how they managed their health in 
the time since the first interview: 
“You get your ups and downs, you get your flare ups but you cope with them. You have to, 
don’t you?” (Jan) 
 
“My usage of [pain medication] goes up in August, always has done for the last [number] 
years, I have children at home. I’m always really careful with it.” Christine 
 
“I got healthier in one way because I walk a lot now, I use the bus a lot, I have my car but 
I do walk” 
 
Within the interviews, participants noted that they reviewed and reconsidered 
aspects of their self-management. One participant set a goal to return to swimming 
during the interview as she had recognised that she wasn’t doing enough exercise, 
and another participant reported how she had found herself considering how much 
her health and self-management had improved over the last year when preparing to 
return to the second interview.   
 
The researcher also provided participants with a summary of the findings of the 
research (see Appendix O) and discussed this in detail with them. She was clear that 
the findings provided a general summary of participants’ data and therefore there may 
have been things that did not seem credible or accurate for individuals but she would 
welcome feedback on these. Participants responded to this summary positively, 
generally taking time to embellish the summary points with descriptions of their 
experiences and how they felt it resonated with them. They also provided positive 
feedback about how they felt it resonated with their experiences: 
“I can’t think of anything [to add], I think you’ve covered the full area” (Mary) 
“I think you’ve really covered everything here” (Jan) 
 
“[positive illness beliefs] was the only one I didn;’t agree with, I think everything else kind of 
rang true” (Christine) 
 
 171 
 
“I think it’s been really good to behonest, it’s nice to see that the other people are of the 
same mindset really” (Jim) 
 
“That’s an absolute yes…I think all the points” (Jackie) 
 
6.10   Study strengths and limitations 
6.10.1 Strengths 
This study was strengthened by the patient and public involvement contributing to a 
carefully considered interview schedule that was piloted to ensure it was accessible 
and easily understood by participants. The member checking exercise and 
opportunity for participants to clarify the findings, contribute additional detail and 
correct where they felt aspects of the framework were not credible.  
 
6.10.2  Limitations 
The attrition rate for the second interviews limited the opportunity to investigate 
the temporal aspect of patient activation with all participants. This also would have 
limited the helpfulness of the member checking as some participants whose health 
was now good enough to work full time or those who were now too unwell to 
interview did not have the opportunity to discuss the findings with the interviewer in 
a second interview. 
 
6.11  Summary 
Skilled self-managers summarised that they actively managed their conditions by being 
determined and independent about managing their health, finding ways to make small, 
sustainable behaviour change and effectively navigating the NHS. They reported that 
knowing what techniques suited them individually, having positive perceptions about 
their health and good social support. They felt that while aspects of the PAM reflected 
how they performed patient activation it was not suitable for capturing the fluctuating 
nature of their IA and the collaborative nature of care. These findings were confirmed 
by study participants at the follow-up interviews. 
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Chapter 7: Quantitative Methods 
The qualitative study provided a sense of how rheumatology patients understood patient 
activation, and the behaviours, skills and knowledge that they believed contributed to how 
they managed their health. After reviewing the findings of that study, the nature of patient 
activation in a wider sample needed to be understood. This included establishing how stable 
the construct of patient activation remains over time, and investigating factors that were 
significantly associated with patient activation in a sample of patients with inflammatory 
arthritis. This contributed to the overall aim of the thesis to describe patient activation, and 
factors which contribute to patient activation, in the context of inflammatory arthritis. This 
chapter reviews how the survey variables were selected. Next, it describes the methods 
selected in order to conduct a survey to understand patient activation across a wider 
population as captured using the PAM. 
 
7.1 Study aims and objectives 
7.1.1 Aim 
The aim of this study was to describe the nature of patient activation (measured using 
the PAM) in patients with IA. 
 
7.1.2 Study objectives 
• To identify levels of activation in an opportunity sample of patients. 
• To examine changes in PAM scores in a cross-section of patients with 
inflammatory arthritis at two different timepoints. This will include within-
patient changes at both timepoints, as well as between-patient variation at 
each timepoint. 
• To understand changes to PAM scores in this sample over time. 
• To examine the associations between PAM scores and other related 
constructs and demographic characteristics. 
 
7.2 Rationale 
As discussed in Chapter 3, there is limited evidence demonstrating patient activation 
levels and scores in rheumatology patients. This information on activation will be 
relevant in understanding the types of interventions that may be appropriate for 
rheumatology patients, as well as investigating whether activation fluctuates. This has 
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implications for the timing, length and opportunities for patients to top-up the skills, 
knowledge and confidence offered by potential interventions. The stability of patient 
activation also has implications for service design and delivery as if patient activation 
fluctuates, there can be difficulty in aligning services to individuals’ needs and 
activation levels. 
 
The previous interview study was designed to be broad and exploratory in order to 
inductively gather data on participants’ experiences and perceptions of patient 
activation. The major findings formed a framework of factors that participants felt 
captured how they actively managed their health. Understanding how these 
framework categories mapped onto current existing theory and factors relevant to 
patient activation was the next step of the process. This moved the project in a more 
deductive direction and allowed the researcher to test whether these factors were 
relevant in a wider rheumatology population. This survey investigated some of these, 
along with other factors associated with patient activation in order to identify those 
that are statistically significant contributors to differences in PAM scores. These 
factors may be amenable to intervention in order to increase patient activation. 
 
7.3 Study design 
The survey study was designed following consultation with the PRP, an independent 
statistician, and the researcher’s supervisory team to ensure scientific rigour and 
potential benefit to the patient population.  
 
The study design was a longitudinal, quantitative survey with two phases of postal 
data collection that were nine months apart. Postal survey packs are a commonly 
used method of collecting survey data (Kelly et al., 2003) in order to efficiently gather 
large amounts of data. Postal surveys were selected to allow participants to complete 
the measures at their leisure in a time and location that suited them in order to make 
participation as easy and accessible as possible. This method also offered the 
opportunity to gather data from a wide geographical area easily and efficiently. 
Additionally, in comparison to telephone data collection with a researcher, this 
allowed participants’ responses to remain anonymous by returning their survey 
responses without providing any identifying information. Completing the pack on 
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paper also gave participants the time to consider their responses to questions and 
reread them if necessary. This reduced any risk of them feeling pressured to give less 
considered responses or more socially desirable answers over the telephone. 
 
Offering the option to complete the survey electronically was considered as an 
alternative method of data collection. The benefit of this would be that participants 
could decide how they preferred to complete the survey pack. This method could 
also reach participants who may have been otherwise unable to participate, e.g. those 
lacking the mobility to be able to access and use the postal system (Wright, 2005). 
However, the decision was taken not to include this additional method of data 
collection. The reason was to reduce the risk of participants responding differently 
to internet-based data collection compared to pen and paper completion. 
 
7.4 Timeline explanation and justification 
One of the aims of this study was to compare the two data collection time points in 
order to identify if the PAM changed over time. Following a review of the literature, 
the decision was taken to set the follow-up data collection point at nine months. 
Other studies that had conducted multi-timepoint surveys into patient activation had 
used differing follow-up lengths. These have included six months (Blakemore et al., 
2016), eighteen months (Rijken et al., 2014), and up to three years (Aung et al., 2016). 
Nine months offered the opportunity for participants to experience fluctuations in 
their health, to have the opportunity to actively manage setbacks, and to be able to 
make use of some of the skills the PAM asks about in the measure’s items (e.g., being 
able to raise concerns with health professionals). Given that one of the aims of the 
study was simply to map natural changes over time, and there was no planned 
intervention during this time, the precise timescale was somewhat arbitrary and it 
was simply important that time passed.  
 
7.5 Survey pack design 
The measures in the survey pack (see Appendices P and Q) were chosen for a variety 
of reasons, including their psychometric properties, prior use with patients with 
rheumatic conditions, and minimal participant burden. Some of the copies of 
measures in the appendices are inspection copies in order to comply with copyright. 
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The format and order of the measures in the survey pack went through multiple 
iterations to improve clarity and flow. 
  
The researcher determined what measures to include in the survey pack based on 
several sources of information. One of these were the findings of the qualitative 
interviews and Table 7.6 demonstrates how the framework categories discussed in 
chapter 6 were captured in the survey. Other constructs of interest were identified 
from the literature review detailed in section 8.3. Once the constructs had been 
determined, appropriate measures that captured them were selected for the survey 
pack.  
 
7.5.1 Demographic factors included in the survey  
The inclusion of most constructs and outcome measures included in the survey was 
decided on following the analysis of the first phase of qualitative data (see chapter 6). 
However, some factors were included in the survey pack after reviewing recent 
literature. Section 3.3 summarised the evidence available related to demographic 
factors and patient activation.  
 
7.6 Measures included in the pack 
The measures in the survey pack included: 
7.6.1 Measure used to capture patient activation 
• Patient Activation Measure: Short form (PAM) (Hibbard et al., 2005): 
The PAM is a commercially licenced measure designed to capture patient 
activation over 13 items and categorise patients into one of four activation 
levels ranging from one (passive) to four (actively managing their health). It 
is the most widely used measure to capture patient activation, having been 
used internationally and translated into a wide range of languages (Hibbard, 
Greene and Tusler, 2009). The PAM was the dependent variable for the data 
analysis and was selected because it was the dominant measure used to 
capture patient activation. Details on how to score the PAM are available in 
section 3.2.1. 
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7.6.2 Measures used to capture variables that may be related to patient 
activation  
• Rheumatoid Arthritis Self Efficacy Scale (RASE) (Hewlett et al., 2001): 
The RASE is a 28-item measure, developed to capture self-efficacy in British 
rheumatology patients (Hewlett et al., 2001). It was selected for its clarity, 
appropriateness for a sample of British rheumatology patients and its strong 
psychometric properties with good construct, face and content validity as 
well as good reliability (Hewlett et al., 2008). The measure is scored by 
providing responses to the items based on how participants feel they could 
do the precise activities. The responses range from 1 (strongly disagree) to 
5 (strongly agree) and final scores range from 28 to 140. 
• Brief Illness Perceptions Questionnaire (BIPQ) (Broadbent et al., 2006): 
This 9-item measure captures participants’ understanding of the timeline 
and nature of their condition, the emotional impact of their health changes 
and the impact to their sense of identity. It also includes an open-ended 
question focused around the causes they attribute to their illness. The first 
8 items are numerical with participants circling on a scale of 0 to 10. Items 
3, 4 and 7 are reverse scored to calculate the final total. The higher the 
final total score, the more threatening and severe the participant views 
their illness to be. The final score could be between 0 and 80. Item 9 is the 
more open-ended item and the responses to these can be analysed 
separately by grouping into categories.  
• Multidimensional Health Locus of Control Scale – Form C (Wallston, Stein 
and Smith, 1995): 
This 18-item measure captures participants’ beliefs about how much of their 
health is related to their own personal control or because of chance. It 
captures data on four subscales that determine how much participants feel 
changes to their health are due to their actions, to chance, to doctors or 
powerful others. Participants respond to the items with one of six responses: 
“strongly disagree, moderately disagree, slightly disagree, slightly agree, 
moderately agree or strongly agree”. Each item contributes to the four 
subscales and the higher the score on each subscale, the higher the 
participants’ locus of control in this type is. The subscales for doctors and 
powerful others have a range of 3 to 18 with higher scores indicating greater 
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locus of control here. The internal and chance subscales have a range of final 
scores from 6 to 36. This measure was selected because of its dominance as 
a measure of health locus of control. 
• Health Literacy Questionnaire (Osborne et al., 2013) 
This 44-item measure captures participants’ abilities to navigate the healthcare 
system confidently, to gather and apply health-related information and to 
work with healthcare providers. There are nine total subscales capturing 
various dimensions of health literacy in this measure. The measure was 
selected because of the breadth of types of health literacy it captures and 
because it was appropriate for remote data collection, rather than the “test” 
style measures that other health literacy measures often employ. The nine 
subscales are: 
o Subscale 1 Feeling understood and supported by healthcare 
provider.  
o Subscale 2 Having sufficient information to manage my health. 
o Subscale 3 Actively managing my health. 
o Subscale 4 Social Support for health. 
o Subscale 5 Appraisal of health information.  
o Subscale 6 Ability to actively engage with healthcare providers.  
o Subscale 7 Navigating the healthcare system.  
o Subscale 8 Ability to find good health information. 
o Subscale 9 Understanding health information enough to know 
what to do.  
Participants are presented with statements to respond to, and scores for the 
first five scales range from 1 (strongly disagree) to 4 (strongly agree). For the 
last four scales the scores range from 1 (cannot do/always difficult) to 5 (always 
easy). Mean scores for each subscale are calculated based on participants’ 
responses to the items in the subscales.  The higher the score, the greater the 
health literacy for participants. 
• Positive and Negative Affect Scale (Watson et al., 1988): 
This 20-item measure, selected for its use in prior patient activation research 
(Hibbard and Mahoney, 2010) has been demonstrated to reliably capture 
participants’ positive and negative affect. It has been validated for use with 
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rheumatology patients and was selected for these reasons (Zautra et al., 
1995). Participants provide a numerical value for how strongly they have felt 
each emotion recently from 1 (very slightly or not at all) to 5 (extremely). 
Both positive and negative affect have 10 items listed each, and this 
contributes to a total score for each that can range between 0 and 50. The 
higher the score, the greater positive or negative affect the participant has 
experienced recently. 
 
7.6.3 Measures of clinical status and health 
• Fatigue Numerical Rating Scale (Fatigue NRS) (Nicklin et al., 2010): 
This is a brief measure of fatigue from the Bristol Rheumatoid Arthritis 
Fatigue Scale, asking participants about their fatigue levels over the 24 hours 
prior to their completion of the survey.  There are three items and they 
each capture a different aspect of the fatigue: average level over the last 
week, the effect it has had on participants and how well they have coped. 
Participants respond from 0 to 10 for each of these. For the average level 
and the effect of fatigue, higher scores report more debilitating fatigue. For 
the coping item, higher scores reflect participants positively coping with pain. 
For the purpose of this study, only the average level was used. 
• Pain Numerical Rating Scales (Pain NRS): 
This is a brief measure of pain based on the measure of fatigue present in 
the Bristol Rheumatoid Arthritis Fatigue Scale, asking participants about their 
pain levels over the 24 hours prior to their completion of the survey. This 
and the fatigue NRS were selected because they have been identified as being 
sensitive to change in patients with IA (Hawker et al., 2011). The “average” 
level over the last week was the measure included in this study. Participants 
respond from 0 (no pain) to 10 (pain as bad as you can imagine). The higher 
the score, the greater the level of pain.  
 
7.6.4 Demographic information 
• Demographic information collected included sex, age, ethnicity, rheumatic 
condition and disease duration.  
• Health Assessment Questionnaire (HAQ) (Fries et al., 1980): 
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The disability component of the HAQ captures participants’ level of physical 
disability, and the impact that the rheumatic condition has on participants’ 
level of physical function. This is commonly used to situate the sample in 
studies with rheumatology participants. Details about how to score the 
HAQ are available in section 5.7. 
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7.7 Concepts of interest 
Table 7.6: Links between qualitative findings and quantitative survey 
Framework analysis overarching 
category 
Constructs to be captured Measure used with examples of key items 
“You do it because you have to” 
Determined independence 
Patient activation, self-efficacy 
PAM e.g., item 1: “I am the person who is 
responsible for taking care of my health” 
RASE: e.g., item 16 “I believe I could explain to 
friends and family when I do or do not need 
help” 
PANAS e.g., item 16: “Determined” 
“You find ways to do different things”: Making 
small changes  
Self-management behaviours e.g. pacing, 
adaptation, problem solving 
RASE examples: “Believe I could pace myself and 
take my arthritis into account to help deal with 
tiredness”. “Believe I could plan or prioritise my 
day to deal with difficulties of doing everyday 
tasks” 
“If you have a problem just phone up”: 
Navigating the system 
Health literacy 
HLQ – items about deciding which healthcare 
professional to see, making sure they 
understand problems, get health information by 
yourself, ask questions to get the health 
information you need 
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“I think I've recognised what works for me, 
and what I need”: Knowing oneself 
Health literacy 
Lots of HLQ questions related to knowing when 
to seek help. However, it is possible that 
perhaps the sense of “knowing oneself” isn’t 
easily captured in a tangible way using measures. 
Therefore, it was not specifically captured in this 
study. 
There are people far worse than me”: 
Positive illness beliefs 
Illness beliefs 
BIPQ: “How concerned are you about your 
illness?” “How much does your illness affect 
your life?” 
“Just does a lot of fetching and carrying”: 
Practical social support 
Sense of social support 
 
HLQ: “If I need help, I have plenty of people I 
can rely on”, “I have strong support from family 
and friends” 
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7.8 PRP involvement 
The PRP was consulted throughout the study. This included input into the study 
design, including his perspective on postal surveys as opposed to electronic data 
collection and the time period of follow-up. He was involved in selecting the 
constructs being captured with reference to the findings of the qualitative study. He 
reviewed the outcome measures included and the format and order of the final 
survey pack. His feedback contributed to a final survey pack design that was as 
accessible as possible, easy to follow, and with clear wording and layout. The PRP 
completed the survey pack as a pilot in order to review for clarity and length, and 
discussed his experience at a follow-up meeting. He also reviewed and consulted on 
the protocol (see Appendix R), patient information sheet (see Appendix S) and other 
study documents prior to applying for ethics approval. 
 
7.9 Ethics 
Ethics approval to carry out this research was granted by the Yorkshire and the 
Humber South Yorkshire Research Ethics Committees (reference 18/YH/0227) 
following proportionate review and ratified by the University of the West of England 
as the research sponsor (reference HAS.18.06.191). All six recruiting sites carried 
out capacity and capability assessments and approved the research at these sites. 
 
Consent to participate in the research was presumed based on participants having 
completed and returned the anonymous questionnaire survey pack to the researcher. 
The option to tick to be posted the second survey pack allowed participants to only 
take part in the research to the point they were comfortable with. For this reason, a 
second pack was not sent to participants who had received the first survey pack but 
not returned it. This was because they had not yet provided a form of agreement to 
take part in the study. This was also the case with participants who completed a first 
survey but did not tick the option to receive a second one. These participants were 
not sent a second survey pack as they had not consented to receiving ongoing 
correspondence about the study. 
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7.10 Participant identification and recruitment  
7.10.1 Inclusion criteria 
Participants were eligible to take part if they were: 
• over 18 years old; 
• living with a diagnosis of IA confirmed by a rheumatologist; 
• a patient at one of the recruiting sites; 
• able to communicate, read, and write in English. 
 
7.10.2 Identifying the patient population 
The intention was to ensure a range of participants were represented in the sample 
of this study. In order to access a range of patients to form the sample, recruitment 
took place at six rheumatology departments throughout England. These secondary 
care departments were selected to cover diverse geographical locations, urban and 
rural communities, ethnically and socioeconomically diverse areas, and varying size 
and scope of the rheumatology department. The inclusion criteria were also 
deliberately broad to ensure as many interested patients as possible could participate.  
The collaborating rheumatology units across hospitals in England were: 
• Bristol Royal Infirmary, Bristol; 
• Haywood Hospital, Stoke-On-Trent; 
• Torbay Hospital, Torquay; 
• North Shields Hospital, Northumbria;  
• St Peter’s Hospital, Chertsey; 
• Weston General Hospital, Weston-Super-Mare. 
 
Participants were identified by the researcher based in Bristol, or a collaborator at 
the recruiting sites, by reviewing the clinic lists and screening for inclusion. Those 
who were eligible were approached and offered the opportunity to participate in the 
research or the packs were posted to them with an invitation to participate. 
 
This was an opportunity sample, with no pre-determined sampling framework. The 
aim was to capture all those who were interested in participating. One limitation of 
this, which will be discussed in more detail in section 10.10, is that this will have 
contributed to a sample of participants who were more likely to be already engaged. 
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This is because those who are already proactively managing their health condition 
are more likely to consider taking part in a research study related to their condition 
(Bombak and Hanson, 2017). 
 
7.10.3 Sample size 
The intention was to collect approximately 350 datasets across the six sites at the 
first time point. This target sample size was based on the Draper & Smith (1998) 
guidance that there should be at least 10 participants for each independent variable 
being measured. The list of variables is available in 7.11.2. 
 
Approximately 700 survey packs were provided across all sites (i.e. 100-120 per site), 
assuming an estimated return rate of 50%. This estimation was based on similar postal 
surveys following these methods that have been used previously in rheumatology 
(Sanderson et al., 2010). 
 
7.11 Study procedure 
Recruitment took place between August and October 2018. Eligible patients were 
given a study information pack when they attended an outpatient clinic appointment 
at their rheumatology department or received a pack through the post from the 
department. This information pack contained a patient information sheet (see 
Appendix S), an invitation to participate from the local clinical lead (see Appendix T), 
the survey pack, a reply slip and a reply-paid envelope. Potential participants were 
asked to read the patient information sheet, and providing they wanted to participate, 
they were asked on the patient information sheet to sign the consent form and 
complete the survey pack. Participants had the option of completing survey packs in 
clinic or taking them home, then posting them back to the researcher in Bristol using 
the reply-paid envelope.  
 
While there was an opportunity to follow-up with non-responders for the second 
surveys, there was not an opportunity to contact patients who had been given initial 
survey packs to prompt them to complete them. This is because consent was only 
presumed once participants had returned their questionnaire pack which included 
their consent to receive future surveys. This choice was made as there was at this 
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point, an unknown delay between participants’ returning their survey packs in the 
post and the packs being received by the researcher in Bristol.  Choosing not to send 
a reminder was intended to avoid undue coercion of participants with reminders 
either unnecessarily early, or without their consent to receive follow-up information. 
Given that there was a risk of attrition, it was decided that sending a reminder letter 
for the second phase of data collection would be acceptable provided that 
participants had confirmed they were happy to receive the second survey pack. Non-
responders to the second pack were sent an identical chase pack with a reminder 
letter 2 months later (Appendix U). 
 
The survey packs were labelled with unique pack numbers. Each local site kept a 
record of which patients had been handed which survey pack number. The researcher 
kept the sites regularly updated on which packs had been returned in the post for 
the sites’ records. Study participants were allocated a unique ID number and data 
was entered from the returned survey pack into a password-protected spreadsheet 
on SPSS for Windows (SPSS Inc. Chicago. Illinois). The hard copies of the survey 
packs were then stored in a locked filing cabinet within the researcher’s office. 
 
7.12 Analysis 
7.12.1 Descriptive statistics 
Once all data were collated onto one spreadsheet on SPSS for Windows (SPSS Inc. 
Chicago. Illinois), the data were reviewed and cleaned. Any data sets with insufficient 
data were excluded. This occurred when the response to one full demographic factor 
or the responses to one full measure were missing or when there were so many 
items missing in a measure that a score could not be calculated or there was 
insufficient data to impute the final value. Following the guidance of Insignia Health 
(2017), any participants who had responded with either “Strongly Agree” or 
“Strongly Disagree” for all items on the PAM were excluded. Frequencies were 
calculated and the data visually screened to reduce the risk of a data entry error 
being incorporated into the final analysis. Disease duration was calculated by 
calculating the current age minus the age at diagnosis.  
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Descriptive statistics were calculated to identify the mean, median, standard 
deviation, variance, maximum and minimum values for all continuous variables. The 
skew and kurtosis were also checked for all continuous variables. For discrete 
variables the frequencies of responses were calculated. Cronbach’s alpha was also 
calculated for each measure at both timepoints to understand the internal 
consistency of each measure in this sample. 
 
The BIPQ data provided by participants was collated and a content analysis 
conducted. This information is available in Appendix V. 
 
7.12.2 Regression analysis 
A regression analysis is a way of predicting the value of one variable based on 
participants’ responses, and once all the relevant variables are entered, the overall 
model is assessed as well as the impact of each individual variable (Pallant, 2005). For 
this analysis, the participants’ PAM scores were the continuous dependent variable, 
and there was a series of independent variables. 
 
An a-priori plan was developed on theoretical grounds with each variable being added 
after controlling for the prior variables (Pallant, 2005). The variables of interest were: 
1. Self-efficacy (RASE); 
2. Internal Health Locus of Control (MHLC subscale); 
3. Illness beliefs (BIPQ); 
4. Health Literacy (9 HLQ Subscales); 
5. Positive affect (PANAS positive and negative subscales). 
 
To conduct a multiple regression, certain assumptions need to have been met. Each 
of these will be discussed in turn: 
1. Sample size of N> 50+8m (m = number of independent variables) based on 
the formula of Tabachnick and Fidell (2007). However, the authors note that 
if the dependent variable is skewed then more cases are needed. While this 
will be discussed in detail in chapter 8, the recruitment was sufficient that this 
sample size was large enough to proceed with analysis.  
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2. Multicollinearity occurs when any of the independent variables are highly 
intercorrelated. Alternatively, it occurs during singularity, when an 
independent variable is a combination of other independent variables (Pallant, 
2005). Multicollinearity is checked in SPSS for Windows (SPSS Inc. Chicago. 
Illinois) as a routine part of the analysis process. An intercorrelation of above 
0.9 would indicate multicollinearity and would require one of the correlated 
variables to be removed from the analysis.  
3. A normal distribution of residuals about predicted dependent variable scores 
is also required and this is investigated as part of the regression analysis 
process. 
4. Linearity is required to be able to generalise findings beyond the sample 
present in the analysis (Field, 2013). This occurs when residuals and predicted 
dependent variables have a “straight line relationship” and is confirmed by 
reviewing the scatterplot plotting the regression standardised residuals 
against the regression standardised predicted values (Pallant, 2005). 
5. Homoscedasticity occurs when “the variance for the residuals about predicted 
DV scores is the same for all predicted scores” (Pallant, 2005).  
6. Outliers needed checking to ensure they did not impact on the regression. 
Tabachnick and Fidell (2007) define outliers as participants’ scores with 
standardised residual variables above 3.3. or less than -3. Following a review 
to establish whether the means of variables required trimming, it was 
established that there were very few outliers within the data. Of those that 
were present, few were extreme enough to be placed outside of the whiskers 
of a standard box plot created in SPSS. In order to avoid distorting the data 
as much as possible, participants’ data were not removed when their 
responses contributed to outliers. 
7. Assumptions of the independence of residuals refers to the way that residuals 
(i.e. the difference between the actual and the predicted scores for dependent 
variables) are distributed (Pallant, 2005). This, along with confirming the 
impact of outliers, normality and homoscedasticity are measured using a 
Normal Probability Plot of the Regression Standardised Residual and Scatter 
plot. If there is no deviation from normality, the points would form a bottom-
left to top right diagonal line that is straight. Outliers will be evident in the 
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scatterplot. The review of the scatterplot and the regression standardised 
residuals plot confirmed that the dataset was appropriate to proceed with the 
anticipated multiple regression. 
 
If any of these assumptions are violated, findings from the regression cannot be 
generalised beyond the sample available (Field, 2013). 
 
7.12.3 Logistic regression 
To understand whether the same variables contribute to understanding the variation 
in PAM levels as in PAM scores, a multinomial logistic regression was also performed. 
This type of regression is suitable for categorical dependent variables such as PAM 
levels. This was performed in the same way, with a stepwise method forming the 
basis for the selection of the independent variables. The independent variables for 
this regression were selected based on which dependent variables were statistically 
significant predictors of PAM scores in the multiple regression. 
 
The specific assumptions that need to be met to conduct a logistic regression are as 
follows: 
1. Linearity, which refers to the likely linear relationships between predictors 
and outcomes. If the interaction term between the PAM level and the log 
transformation is significant, it can be assumed that this the relationship is not 
linear and the assumption cannot be met (Field, 2013). 
2. Independence of errors, which means that for a logistic regression, the data 
for each case is not related to each-other (Field, 2013). 
3. Multicollinearity, which is understood in the same way as multicollinearity in 
multiple regressions. 
 
7.13 Second data collection analysis 
For the second set of data collected in the follow-up survey packs, the process of 
analysis was identical to that discussed in 7.12.1. The only addition was a related 
sample t-test calculated in order to understand whether there were significant 
differences between participants’ first and second PAM scores at both within and 
between patient levels. 
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7.14 Summary 
This chapter introduced the methods for the survey investigating patient activation. 
The results of the study are presented in the next chapter. 
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Chapter 8: Quantitative Survey Findings 
The previous chapter introduced the methods that were used to gather quantitative data 
from participants related to patient activation and potentially associated personal and 
demographic factors. This chapter presents the findings of this data collection following 
statistical analysis. 
 
8.1 Timepoint one 
In total, there were initially 267 full datasets included in the analysis of the first data 
collection timepoint. Nine were excluded following the guidance of Insignia Health 
(2018) as they had responded to the PAM with the same responses for each item 
and seven were excluded due to missing data on any other outcome measures or 
demographic factors. Where appropriate, data were imputed for items that were 
missing within measures. This left 251 cases of data to be analysed (Figure 8.1). The 
initial protocol intended for 350 participants to complete data to allow for attrition. 
This reduction is a limitation as this target was not reached. 
 
Figure 8.1: Flowchart of datasets and their inclusion or exclusion in the data 
 
 
 
 
 
 
 
 
 
 
Total datasets collected = 267 
 
Articles excluded n= 44   
Protocols = 18 
Not an RCT = 9 
Not physical health = 6 
Not a LTC = 3 
No activation outcome = 4 
Pediatric participants = 3 
Prior to 2004 = 1 
e searching n=156   
Complete datasets = 260 Incomplete datasets removed = 7 
 
 
Complete datasets with valid PAM 
responses 
 
Invalid PAM responses removed = 9 
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8.1.1 Demographic characteristics 
Of the 251 cases eligible for analysis, 185 (74%) were female and 66 (26%) were male. 
The majority of participants (235, 94%) were white British, with a small number of 
other ethnicities represented (Table 8.1). The diagnosis most represented was RA 
with 66% of participants living with this condition. Participants with PsA and AS also 
represented a large proportion of the sample. The average age of participants was 
59.3 years old (SD: 12.7), with an average of 14.5 years of disease duration (SD: 12.5).  
The average HAQ score was 0.75 (SD: 0.65), indicating mild levels of disability overall 
as the higher the score, the greater the severity of disability (Bruce and Fries, 2003). 
 
 
Table 8.1: Summary baseline demographic characteristics 
Variable N (%), or Mean (SD) and range 
Sex, N (%) Female: 185 (74%) 
Male: 66 (26.3%) 
Ethnicity, N (%) White British: 235 (94%) 
Other White: 8 (3%) 
Black: 1 (<1%) 
Chinese: 1 (<1%) 
Other Asian: 2 (<1%) 
Other: 3 (1%) 
Prefer not to say: 1 
Diagnosis, N (%) RA: 166 (66%) 
SLE: 3 (1%) 
Inflammatory Polyarthritis: 1 (<1%) 
Ankylosing Spondylitis: 31 (12%) 
Juvenile Idiopathic Arthritis: 2 (<1%) 
Psoriatic Arthritis: 35 (14%) 
Other: 10 (4%) 
Don’t Know: 3 (1%) 
Age (years) 59.31 (SD: 12.69), range 22 to 88 years 
Disease Duration (years) 14.48 (SD: 12.52), range <1 to 60 years 
HAQ Score (Possible range: 0 to 3) 0.75 (SD: .65) range 0 to 2.55 
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8.1.2 PAM reporting 
The analysis identified both levels and scores of patient activation (as captured using 
the PAM) in the sample of patients. The average PAM score was 58.3 (SD: 11.46) and 
scores were distributed between 33 and 90.7 out of a possible range of 0-100, 
indicating a wide range of patient activation between participants. PAM scores were 
distributed with a skew towards participants being more highly skilled (distribution 
graph is available in Appendix V). Given the non-normal distribution, the median and 
interquartile range also report useful information to understand central tendency for 
this data. These figures are 55 (median) and 51 (Q1) and 65 (Q4), respectively. Given 
the non-normal distribution of the data a Kruskal-Wallis test was performed in order 
to identify whether there were significant differences in PAM scores between 
participants recruited at the different sites. The findings of this test indicated that 
there were not significant differences in PAM scores between sites (Chi square = 
4.45, p = 0.47, df = 5).  
 
The most common PAM level was level 3, with 41.8% of the sample falling into this 
category.  
 
Table 8.1a: Summary PAM levels at baseline 
 
PAM Level: Number of Participants: 
1 42 (16.7%) 
2 67 (26.7%) 
3 105 (41.8%) 
4 37 (14.7%) 
 
 
8.1.3 Outcome measure reliability testing 
As determined by the study protocol, Cronbach’s alpha was calculated for each of 
the continuous outcome measures. The intention of this was to understand the 
internal consistency of each measure included in the survey pack. This captured how 
well each item on a measure relates to the other items (Pallant, 2007). A Cronbach’s 
alpha coefficient of above 0.7 and above reflects good internal consistency, with 
responses to the items in the outcome measure correlating well with each-other 
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(DeVellis, 2003). All the measures that were tested for their internal consistency 
demonstrated Cronbach’s alpha coefficients of above 0.7, reflecting acceptable 
internal consistency with the measures and this sample. While the assumption could 
be made that the measures all had good internal consistency as they were validated 
outcome measures, confirming this with the sample was useful for strengthening the 
validity of the study and its findings. The table of Cronbach’s alpha coefficients for 
each measure is available in Appendix W. 
 
8.1.4 Descriptive data for continuous variables 
The table below provides details of the measures of central tendency for all the 
continuous variables being considered for inclusion in the regression model. As much 
of these data have non-normal distributions, the median and interquartile range are 
also provided.  
 
Table 8.1b: Descriptive data 
Variable Mean (SD), range Median (interquartile 
range) 
Age 59.31 (SD: 12.69) 
Range 22 to 88 years 
60  
(Q1: 52 and Q3: 69) 
Disease duration 14.48 (SD: 12.52) 
Range <1 to 60 years 
11  
(Q1: 5 and Q3: 20) 
HAQ  
(possible range 0-3) 
0.75 (SD: 0.65)  
Range 0 to 2.55 
0.55 
(Q1: 0.2 and Q3: 1.1) 
RASE  
(possible range 28-140) 
101.61 (SD: 15.24) 
Range 57 to 140 
103.0 
(Q1: 92 and Q3: 110) 
Internal HLOC  
(possible range 6 to 36) 
16.98 (SD: 6.14) 
Range 6 to 36 
17 
(Q1: 12 and Q3: 21) 
Chance HLOC  
(possible range 6 to 36) 
16.33 (SD: 6.47) 
Range 5 to 35 
16 
(Q1: 11 and Q3: 20) 
Doctors HLOC  
(possible range 3 to 18) 
11.31 (SD: 3.23) 
Range 3 to 18 
11 
(Q1: 9 and Q3: 14) 
Powerful Others HLOC 
(possible range 3 to 18) 
8.71 (SD: 3.57) 
Range 2 to 18 
8 
(Q1: 6 and Q3: 11) 
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BIPQ 
(possible range 0 to 80) 
45.55 (SD: 10.13) 
Range 15 to 68 
46 
(Q1: 39 and Q3: 52) 
HLQ 1 
(possible range 1 to 4) 
2.96 (SD: 0.71) 
Range 1 to 4 
3 
(Q1: 2.75 and Q3: 3.5) 
HLQ 2 
(possible range 1 to 4) 
2.91 (SD: 0.48) 
Range 1.5 to 4 
3 
(Q1: 2.75 and Q3: 3.25) 
HLQ 3 
(possible range 1 to 4) 
2.89 (SD: 0.47) 
Range 1 to 4 
3 
(Q1: 2.6 and Q3: 3) 
HLQ 4  
(possible range 1 to 4) 
2.92 (SD: 0.57) 
Range 1 to 4 
3 
(Q1: 2.6 and Q3: 3.2) 
HLQ 5 
(possible range 1 to 4) 
2.68 (SD: 0.53) 
Range 1 to 4 
2.8 
(Q1: 2.4 and Q3: 3) 
HLQ 6 
(possible range 1 to 5) 
3.78 (SD: 0.73) 
Range 1 to 5 
4 
(Q1: 3.4 and Q3: 4.2) 
HLQ 7 
(possible range 1 to 5) 
3.59 (SD: 0.66) 
Range 1.17 to 5 
3.67 
(Q1: 3.33 and Q3: 4) 
HLQ 8 
(possible range 1 to 5) 
3.83 (SD: 0.63) 
Range 1.2 to 5 
4 
(Q1: 3.6 and Q3: 4.2) 
HLQ 9 
(possible range 1 to 5) 
4.08 (SD: 0.55) 
Range 1.8 to 5 
4 
(Q1: 3.8 and Q3: 4.4) 
Pain NRS 
(possible range 0 to 10) 
5.43 (SD: 2.51) 
Range 0 to 10 
6 
(Q1: 4 and Q3: 7) 
Fatigue NRS 
(possible range 0 to 10) 
6.43 (SD: 2.28) 
Range 0 to 10 
7 
(Q1: 5 and Q3: 8) 
Positive affect (PANAS) 
(possible range 0 to 50) 
30.03 (SD: 8.85) 
Range 10 to 49 
30 
(Q1: 24 and Q3: 37) 
Negative affect (PANAS) 
(possible range 0 to 50) 
19.88 (SD: 7.73) 
Range 10 to 44 
19 
(Q1: 13 and Q3: 24) 
 
Participants’ responses to the measures often use the range of responses available 
and the medium value was often close to the mean value for each variable.  
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8.1.5 Outliers 
The presence and impact of individual outliers in PAM scores and other measures 
were considered at this stage of the analysis. Given that multiple regressions are 
particularly sensitive to outliers (Pallant, 2007), extreme values in response to 
outcome measures needed to be identified in order to determine how much impact 
they had on the sample. A table of extreme values was generated in order to identify 
which cases had a substantial impact on the mean scores for each outcome measure 
and this is available in Appendix X. A mean value with the top and bottom 5% of all 
cases for each measure (or measure subscale, where appropriate) was also generated 
in order to review how much of an impact the extreme cases previously identified 
were having upon the mean. Given that the trimmed means did not substantially 
impact the mean value, no outliers were removed from the analysis. 
 
8.1.6 Univariable analysis  
Candidate variables for the multiple regression were identified using univariable 
analysis. The intention was to identify the relationship between PAM scores and all 
the variables in the analysis. Those variables without a significant correlation with 
PAM scores were removed as candidate factors from the full analysis. 
 
Table 8.1c: Spearman’s rank correlation coefficient tests of candidate variables and 
their relationship with PAM scores 
Variable p  Correlation  
Age 0.03 -0.14 
Disease duration 0.59 0.03 
HAQ <.01 -0.36 
RASE <.01 0.50 
Internal HLOC <.01 0.25 
Chance HLOC 0.26 -0.07 
Doctors HLOC 0.02 0.14 
Powerful Others HLOC 0.97 <-0.01 
BIPQ <.01 -0.47 
HLQ 1 <.01 0.27 
HLQ 2 <.01 0.48 
HLQ 3 <.01 0.41 
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HLQ 4 <.01 0.33 
HLQ 5 <.01 0.38 
HLQ 6 <.01 0.33 
HLQ 7 <.01 0.30 
HLQ 8 <.01 0.41 
HLQ 9 <.01 0.42 
Pain NRS <.01 -0.33 
Fatigue NRS <.01 -0.31 
Positive affect (PANAS) <.01 0.41 
Negative affect (PANAS) <.01 -0.33 
 
The findings of the univariable analysis presented in the table above indicated that the 
only continuous variables that did not have a significant correlation with PAM scores 
were disease duration, the chance HLOC subscale and the powerful others HLOC 
subscale. These variables were excluded from consideration in the multiple 
regression. 
 
8.1.7 Reporting of regression assumptions 
Following the protocol, a forced entry multiple regression was conducted with the 
PAM as the continuous dependant variable and the list of variables noted below as 
blocks of independent variables. The intention was to examine the relationship 
between PAM scores and other potentially related variables. 
 
1. Sample size of N> 50+8m (m = number of independent variables. In this case 
there were 23 variables including the continuous demographic 
characteristics) based on the formula of Tabachnick and Fidell (2007). As 
discussed in section 8.1, the sample size of 251 cases was ultimately large 
enough to be appropriate for the analysis at this data collection point.  
2. Multicollinearity was investigated during the analysis process. Overall, there 
were limited high intercorrelated variables. Those that were higher included 
the correlation between average pain level and overall BIPQ score (.701, 
p<.001) and fatigue and BIPQ score (.591, p<.001). The HLQ1 and HLQ2 
scores were correlated (.677, p<.001), as well as the Fatigue NRS and Pain 
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NRS (.658, p<.001). These correlations fell above 0.5, but none of them 
reached the intercorrelation mark of .9 advised by Pallant (2007) that would 
have necessitated that one of the intercorrelated variables to be removed 
from the analysis.  Only one of these intercorrelations fell above the 
suggested intercorrelation cut-off of 0.7 suggested by Field (2009) and as it 
was very marginally over this cut-off the decision was taken to retain it in the 
analysis. This decision was made following a review of both the tolerance and 
the Variance Inflation Factors (VIF) of the correlations. The tolerance refers 
to the amount of variability in the variable that is not explained by the 
remaining independent variables within the model. A tolerance of below .1 
implies that there is a risk of multicollinearity (Pallant, 2007). In these 
circumstances, the tolerance of the BIPQ was .339, not near the risk level. 
The VIF has a cut-off value of 10 and hence any VIF above 10 implies 
multicollinearity. The VIF for the relevant factors were 2.95 (BIPQ), 2.31 
(fatigue average score) and 2.83 (pain average score). These are below 10 
and therefore do not suggest multicollinearity had a substantial confounding 
impact on the findings of the analysis. 
3. To establish a normal distribution of residuals there was a review of the 
normal probability plot of the regression standardised residual (NPP) (see 
Appendices L and M). The observed values lay apart from the line of best fit, 
suggesting deviations from normality (Pallant, 2005). None of the points in 
the scatterplot lay below -3 or above 3, suggesting that there were no 
extreme outliers (Tabachnick and Fidell, 2007).  
4. The presence of linearity (i.e. a “straight line relationship” between residuals 
and predicted dependent variables (Pallant, 2005) required a review of the 
NPP. Again, there was some deviation from the line of best fit. 
5. Homoscedasticity was established during the review of the NPP.  
6. The impact of outliers was clarified with a review of trimmed means to 
identify and examine extreme values and cases (Appendix X). 
  
Following a review by the researcher, it was evident that the non-normal distribution 
of PAM scores contributed to some of the assumptions for the analysis not being 
met. This means that the findings in their current form could not be generalisable 
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beyond the study sample to a wider UK rheumatology population. To manage this, 
the analysis was performed as anticipated. A second review of the regression analysis 
was conducted with the non-normally distributed data having been transformed to 
move the distribution closer to a normal distribution. The intention of this was to 
confirm the findings and conduct a sensitivity analysis and increase the 
trustworthiness of the results. These additional findings are detailed in Appendices Z 
to CC and referred to at each stage of the analysis. However, the transformation of 
non-normal data could be considered unnecessary under the principles of central 
limit theorem. The central limit theorem proposes that the sample mean of data in a 
large enough sample will approach normality (Coolican, 2018). 
 
 
8.1.8 Conducting the multiple regression analysis 
The list of variables had been determined following the univariable analysis. Initially, 
all candidate variables were entered in a preliminary forced entry multiple regression. 
This was intended to identify variables that contributed to the model to a statistically 
significant degree at a 0.1 level (See Table 8.1d). The variables that contributed to the 
model and were taken forward to the final regression model were:  
1. RASE total score (capturing self-efficacy); 
2. Internal HLOC; 
3. HLQ subscale 2 (Having sufficient information to manage my health); 
4. HLQ 9 (Understanding health information enough to know what to do). 
 
The findings of this preliminary model are available in table 8.1d. Overall, this initial 
regression model accounted for 42.7% of the variance in PAM scores within this 
sample. The multiple regression was calculated to predict PAM scores based on the 
predetermined list of independent variables. The regression equation identified: [F 
(22,228) = 9.47, p <.001] with an adjusted R2 of 0.43.  
 
Following this, the variables that did not significantly contribute to the regression 
model were removed from the syntax and the regression was rerun without these. 
The findings of this final model are also available in Table 8.1d.  
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This regression model accounted for 40.4% of the variance in PAM scores within this 
sample. The multiple regression was calculated to predict PAM scores based on the 
predetermined list of independent variables. The regression equation identified: [F 
(4,246) = 43.39, p<.001], with an adjusted R2 of 0.404.  
 
RASE scores, internal HLOC, and HLQ subscales 2 and 9 were significant predictors 
of PAM scores in participants. In the final model containing all of these predictors, 
HLQ subscale 9 recorded the highest beta value (β = 0.264 p< .01) with RASE scores 
demonstrating the next greatest beta value (β = 0.262, p< .001). This was followed 
by HLQ subscale 2 (β = 0.25, p< .001). Finally, internal HLOC had the next greatest 
contribution. (β = 0.16, p= .02).
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Table 8.1d: Multiple linear regression to analyse the association between PAM scores and other personal and contextual factors captured 
by the survey: 
Variables Preliminary multiple regression Final multiple regression 
Standardised β 95% CI P value Standardised β 95% CI P value 
Sex 0.03 -1.84 to 3.61 0.52    
Age -0.07 -0.17 to 0.04 0.21    
Ethnicity -0.23 -1.4 to 0.94 0.70    
Condition 0.06 -0.22 to 0.70 0.30    
HAQ -0.11 -4.27 to 0.46 0.11    
RASE 0.20 0.06 to 0.25 0.002 0.26 0.11 to 0.28  <0.001 
Internal HLOC 0.10 -0.03 to 0.38 0.09 0.16  0.11 to 0.49 0.002 
Doctors HLOC 0.05 -0.21 to 0.56 0.37    
BIPQ -0.12 -0.33 to 0.05 0.15    
HLQ 1 -0.01 -2.53 to 2.26 0.91    
HLQ 2 0.21 1.35 to 8.42 0.007 0.25 3.29 to 8.62 <0.001 
HLQ 3 0.05 -2.07 to 4.51 0.47    
HLQ 4 0.01 -2.64 to 2.89 0.93    
HLQ 5 0.07 -1.25 to 4.36 0.27    
HLQ 6 0.01 -2.95 to 3.13 0.95    
HLQ 7 -0.15 -5.94 to 0.89 0.15    
HLQ 8 0.04 -2.51 to 4.09 0.64    
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HLQ 9 0.23 1.58 to 7.96 0.004 0.26 3.22 to 7.72 <0.001 
Pain NRS 0.08 -1.04 to 0.40 0.39    
Fatigue NRS -0.06 -0.39 to 1.09 0.36    
Positive affect (PANAS) 0.03 -0.14 to 0.21 0.68    
Negative affect 
(PANAS) 
-0.03 -0.23 to 0.15 0.69    
 
 
Non-normal data were transformed to reduce the non-normality by taking the square root of data cases for relevant non-normal 
distributions. In the case of variables that had values of 0, the data were first transformed to add 1 to each of the responses to be sure 
that there were no issues in the data transformation caused by the 0s.  The findings of this regression largely support the initial 
findings (with the exception of the RASE no longer being a significant predictor of PAM scores in the preliminary regression) and are 
available in Appendix Y.
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8.1.9 Logistic regression 
A logistic regression was also conducted. The intention of this was to determine 
whether the variables that accounted for variance in PAM scores also accounted for 
the variance in PAM levels. The assumptions for a logistic regression were met in the 
following ways: 
 
1. The assumption of multicollinearity was assumed to have been met given that 
no variables were identified to have been interrelated during the linear 
regression process. 
2. Similarly, the sample size was assumed to have been suitable for this method 
of analysis given that the sample size requirement had already been met for 
the prior linear regression analysis. 
3. Independence of errors: this assumption was met as the dependent variable 
had mutually exclusive categories. 
 
Again, an initial logistic regression was run with all candidate variables to identify the 
variables that were significant predictors of PAM levels at the 10% level based on the 
significance of the regression coefficient (Β) for any PAM level.  
 
Overall, the initial model was statistically significant, χ2 (72, n = 251) = 187.15, p < 
.001. The model explained between 28.7% (McFadden test) and 56.8% (Nagelkerke 
test) of the variance in PAM levels. The following variables were taken forward to a 
final logistic regression: 
1. Age 
2. HAQ 
3. RASE 
4. BIPQ 
5. Doctors HLOC 
6. HLQ subscale 2 
7. HLQ subscale 5 
8. HLQ subscale 7 
9. HLQ subscale 9 
10. Pain NRS 
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Table 8.1e below reports parameter estimates for the model using PAM level 4 as 
the reference category. 
 
These variables were then included in a backwards exclusion hierarchical regression 
based on how likely they were to predict PAM levels. Overall, this final model was 
statistically significant, χ2 (30, n = 251) = 158.65, p < .001. The model explained 
between 24.3% (McFadden test) and 46.9% (Nagelkerke test) of the variance in PAM 
levels. Table 8.1f below reports parameter estimates for the model using PAM level 
4 as the reference category.
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Table 8.1e: Logistic regression to analyse the association between PAM levels and other personal and contextual factors captured by 
the survey: 
  PAM Level 1 PAM Level 2 PAM Level 3 
Factor Β df p Exp 
(Β) 
95% CI 
Lower 
Bound 
95% CI 
Upper 
Bound 
Β df p Exp 
(Β) 
95% CI 
Lower 
Bound 
95% CI 
Upper 
Bound 
Β 
 
df P Exp 
(Β) 
95% CI 
Lower 
Bound 
95% CI 
Upper 
Bound 
Sex -0.50 1 0.55 0.61 0.12 3.06 0.31 1 0.65 1.36 0.37 5.03 -0.05 1 0.9
3 
0.95 0.30 3.01 
Age 0.07 1 0.04 1.07 1.00 1.14 0.03 1 0.26 1.03 0.98 1.08 0.02 1 0.4
2 
1.02 0.98 1.06 
Disease duration -0.00 1 0.90 1.00 0.94 1.06 <-
0.01 
1 0.90 1.00 0.95 1.05 -0.01 1 0.7
9 
0.99 0.95 1.04 
Ethnicity 0.22 1 0.64 1.24 0.49 3.13 0.28 1 0.34 1.32 0.75 2.33 0.18 1 0.4
9 
1.20 0.72 2.02 
Condition -0.05 1 0.75 0.96 0.72 1.27 -0.03 1 0.82 0.98 0.79 1.21 0.06 1 0.5
1 
1.06 0.89 1.28 
HAQ 1.25 1 0.10 3.48 0.79 15.27 0.64 1 0.30 1.90 0.57 6.36 0.69 1 0.2
1 
2.00 0.67 5.95 
RASE -0.10 1 0.00 0.91 0.86 0.97 -0.07 1 0.01 0.94 0.89 0.98 -0.04 1 0.0
8 
0.96 0.92 1.00 
Internal HLOC -0.11 1 0.10 0.90 0.79 1.02 -0.08 1 0.13 0.93 0.84 1.02 -0.40 1 0.4
9 
0.97 0.89 1.06 
Chance HLOC 0.02 1 0.71 1.02 0.92 1.14 -0.01 1 0.76 0.99 0.91 1.07 -0.01 1 0.7
2 
0.99 0.92 1.06 
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Doctors HLOC -0.16 1 0.21 0.86 0.67 1.09 -0.18 1 0.06 0.83 0.69 1.00 -0.12 1 0.1
3 
0.89 0.76 1.04 
Others HLOC 0.10 1 0.34 1.10 0.90 1.35 0.05 1 0.56 1.05 0.89 1.24 -0.01 1 0.8
8 
0.99 0.85 1.15 
BIPQ 0.15 1 0.02 1.16 1.02 1.32 <-
0.01 
1 0.96 1.00 0.91 1.10 -0.03 1 0.4
4 
0.97 0.89 1.05 
HLQ 1 -0.15 1 0.84 0.86 0.21 3.60 -0.28 1 0.63 0.76 0.24 2.39 0.14 1 0.7
9 
1.15 0.42 3.17 
HLQ 2 -2.36 1 0.03 0.10 0.01 0.79 -0.42 1 0.63 0.66 0.12 3.61 -0.09 1 0.9
1 
0.91 0.21 3.96 
HLQ 3 -0.06 1 0.96 0.94 0.11 7.96 -1.07 1 0.21 0.34 0.07 1.83 -0.70 1 0.3
6 
0.50 0.11 2.20 
HLQ 4 -0.35 1 0.68 0.70 0.13 3.71 -0.18 1 0.79 0.83 0.21 3.26 -0.69 1 0.2
6 
0.50 0.15 1.67 
HLQ 5 -1.86 1 0.04 0.16 0.03 0.93 -0.74 1 0.26 0.48 0.13 1.73 -0.53 1 0.3
7 
0.59 0.18 1.88 
HLQ 6 0.62 1 0.48 1.86 0.34 10.09 0.14 1 0.85 1.14 0.27 4.80 0.72 1 0.2
8 
2.05 0.56 7.54 
HLQ 7 1.26 1 0.23 3.53 0.44 28.06 1.14 1 0.18 3.12 0.59 16.62 -0.31 1 0.6
8 
0.73 0.17 3.22 
HLQ 8 -0.20 1 0.84 0.82 0.12 5.70 -0.82 1 0.30 0.44 0.09 2.10 -0.37 1 0.5
9 
0.69 0.18 2.66 
HLQ 9 -1.63 1 0.11 0.20 0.03 1.45 -1.61 1 0.06 0.20 0.04 1.08 -0.44 1 0.5
7 
0.64 0.14 2.93 
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Fatigue NRS 0.31 1 0.18 1.37 0.86 2.17 0.11 1 0.50 1.11 0.82 1.52 0.01 1 0.9
2 
1.01 0.77 1.33 
Pain NRS -0.60 1 0.02 0.55 0.34 0.09 -0.13 1 0.44 0.88 0.62 1.23 <0.0
1 
1 0.9
8 
1.00 0.75 1.33 
Positive affect 
(PANAS) 
-0.08 1 0.17 0.93 0.83 1.03 -0.01 1 0.79 0.99 0.90 1.08 -0.03 1 0.4
8 
0.97 0.90 1.05 
Negative affect 
(PANAS) 
0.07 1 0.25 1.07 0.95 1.20 <-
0.01 
1 0.99 1.00 0.91 1.10 0.01 1 0.8
8 
1.01 0.93 1.09 
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Table 8.1f: Updated logistic review   
  PAM Level 1 PAM Level 2 PAM Level 3 
Factor Β df p Exp 
(Β) 
95% CI 
Lower 
Bound 
95% CI 
Upper 
Bound 
Β df p Exp 
(Β) 
95% CI 
Lower 
Bound 
95% CI 
Upper 
Bound 
Β 
 
df P Exp 
(Β) 
95% CI 
Lower 
Bound 
95% CI 
Upper 
Bound 
Age 0.06 1 0.03 1.06 1.00 1.12 0.03 1 0.19 1.03 0.99 1.07 0.01 1 0.59 1.01 0.97 1.05 
HAQ 1.28 1 0.05 3.58 1.01 12.72 0.80 1 0.14 2.23 0.77 6.47 0.53 1 0.28 1.71 0.65 4.45 
RASE -0.11 1 <0.01 0.90 0.85 0.94 -0.07 1 <.01 0.93 0.89 0.97 -0.05 1 0.02 0.96 0.92 0.99 
BIPQ 0.16 1 <0.01 1.18 1.06 1.31 0.02 1 0.70 1.02 0.94 1.10 -0.06 1 0.88 1.00 0.93 1.06 
Doctors HLOC -0.14 1 0.18 0.87 0.72 1.07 -0.16 1 0.04 0.85 0.73 0.99 -0.11 1 0.09 0.89 0.78 1.02 
HLQ subscale 2 -2.51 1 0.01 0.08 0.01 0.52 -0.89 1 0.23 0.41 0.10 1.75 -0.28 1 0.66 0.75 0.22 2.60 
HLQ subscale 5 -1.56 1 0.03 0.21 0.05 0.82 -1.17 1 0.04 0.31 0.10 0.94 -0.84 1 0.10 0.43 0.16 1.16 
HLQ subscale 7 1.62 1 0.02 5.07 1.30 19.84 0.94 1 0.09 2.57 0.86 7.70 0.25 1 0.61 1.28 0.49 3.32 
HLQ subscale 9 -1.75 1 0.02 0.17 0.04 0.72 -1.68 1 0.01 0.18 0.06 0.64 -0.62 1 0.27 0.54 0.18 1.61 
Pain NRS -0.32 1 0.10 0.73 0.50 1.06 -0.07 1 0.63 0.93 0.71 1.24 0.02 1 0.85 1.02 0.80 1.31 
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8.2 Timepoint one discussion 
The average PAM score was in line with the findings of prior studies gathering data 
on PAM results distributions across different populations (Gleason-Comstock et al., 
2016). However, the proportion of participants with level 4 PAM scores was lower 
than those within samples of older adults or a sample of participants from two large 
companies in the USA with and without long-term conditions (Gleason-Comstock et 
al., 2015; Harvey et al., 2012). This may be as a consequence of people living without 
long-term conditions over-estimating how able and willing they might be to manage 
a diagnosis based on their expectations of dealing with more minor or short-lived 
health problems. The distribution of PAM scores across the rheumatology sample in 
this PhD study was closer to those identified in a survey of patients with COPD 
(Korpershoek et al., 2016).  
 
The average PAM scores at the time of the first data collection were lower for the 
sample in this study that those identified in studies with other populations (Harvey et 
al., 2012) and older adults with multimorbid conditions (Blakemore et al., 2016). 
 
The distribution of PAM levels across the sample demonstrates the range of 
experience and skills that rheumatology patients have in order to manage their health. 
There is a broad ability represented in this sample and the low correlation between 
PAM scores/levels and disease duration implies that people do not necessarily 
become more able to manage their health after a longer time living with their 
condition. The implication of this is that some people do not learn to manage their 
condition effectively within the early years of diagnosis and would benefit from 
support to self-manage even further down the line. Patients may not remain activated 
and could experience fluctuations in their ability and willingness to actively manage 
their health. The use of the PAM as a tailoring tool (Hibbard et al., 2004) would be 
appropriate here to identify patients who would require additional support to manage 
their condition. This is particularly relevant as there were no specific demographic 
characteristics that were significantly associated with PAM scores that could help 
identify rheumatology patients more likely to passively live with their condition. 
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The majority of participants were white British. There has been limited research 
investigating detailing whether perceptions of patient activation are different for 
people from different backgrounds to this. However, a gap in PAM scores has been 
identified between research participants of different racial backgrounds in the USA 
(Hibbard et al., 2008). It is possible that Western expectations of health may 
contribute to specific expectations of health and healthcare that shape patients’ 
activation. This isn’t represented in this study with a largely white British sample. 
 
An important aspect of the findings is that positive and negative affect (captured using 
the PANAS) did not have a statistically significant relationship with PAM scores and 
therefore were not included in the regression model. This does not provide support 
for the model of patient activation proposed by Hibbard and Mahoney (2010) where 
they assert that positive and negative affect contribute to patients’ levels of activation 
via their ability to carry out small behaviour changes related to their health. 
 
The clear contribution of self-efficacy to patient activation reflects that a person’s 
belief that they have an active role to play in their healthcare is related to the idea 
that they could carry out behaviours relevant to their health. As self-efficacy has been 
identified as a mechanism by which self-management interventions for long-term 
conditions have benefits (Blakemore et al., 2016), this is not an unanticipated finding. 
The association between self-efficacy and patient activation strengthened prior 
findings where the two constructs had been associated (Skolasky et al., 2008; Do et 
al., 2015; Goodworth et al., 2016). This contributes to the suggestion that increasing 
patients’ confidence and belief in their ability to carry out activities related to their 
health increases their willingness to do so. 
 
The association between health beliefs (captured by the BIPQ) and patient activation 
supports the findings identified in similar studies with other clinical populations 
(Chen, Mortensen and Bloodworth, 2014; Rijken et al., 2014; Hibbard et al., 2008). 
There was a moderate correlation between BIPQ as a measure of illness beliefs and 
the HAQ as a more objective measure (albeit of disability). This relationship suggests 
that how people perceive their health is more critical to their patient activation, 
rather than how severe their condition objectively is.  
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The internal locus of control scores within this sample supports the initial suggestions 
made by Sacks et al. (2017) that it is relevant to patient activation. This contributes 
to the understanding of patient activation as incorporating many other concepts, 
including locus of control (Smith et al., 2013). 
 
The lack of relationship between the demographic factors captured in the survey and 
PAM scores demonstrated that internal, psychosocial skills and abilities appear to be 
more valuable in increased patient activation than factors that are less likely to be in 
patients’ control. The relationship between predictors of PAM scores and levels was 
explored in this study. Self-efficacy, HLOC and aspects of health literacy all 
significantly contributed to variance in PAM scores.  
 
8.3 Timepoint two 
The second data collection point allowed the researcher to explore changes to PAM 
scores in a sample of people with rheumatic conditions. 
 
180 participants completed the follow-up survey pack, and the remainder of 
participants who completed a first questionnaires were lost to follow-up. Of the 180 
participants who returned follow-up survey packs, 21 were excluded because they 
had not sufficiently completed the pack to be included in the analysis and 5 were 
excluded because they had completed the PAM in a way that rendered their 
completion invalid. 154 full data cases could be included in the analysis. This suggests 
that while the first sample of 251 participants from an anticipated 350 participant 
sample may have been sufficient to have met the sample size assumption, this smaller 
group of participants who completed both survey packs were unlikely to have had 
sufficient power to produce reliable results. 
 
8.3.1 Demographic reporting and comparing completers to non-completers 
The characteristics of those who completed the follow-up survey pack compared to 
those who did not were compared using the initial data to determine if there were 
significant differences between groups. These were carried out using a Mann Whitney 
U test for continuous variables and chi square tests for categorical variables. This 
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analysis identified that there were not statistically significant differences between 
participants who completed both questionnaires and participants who were lost to 
follow-up in: 
• Initial PAM scores: U = 7195, p = 0.62 
• Initial PAM levels: χ2 (3, n = 251) = 0.64, p = 0.890, phi = 0.05 
• Sex: χ2 (1, n =251) = 0.20, p = 0.66, phi = 0.28 
• Age: U = 6947, p = 0.35 
• Disease duration:  U = 6415, p = 0.06 
• Ethnicity: χ2 (6, n = 251) = 9.89, p = 0.13, phi = 0.20 
• Condition: χ2 (6, n = 251) = 7.27, p = 0.40, phi = 0.17 
• HAQ score: U = 6997, p = 0.40 
The demographic information for the second timepoint analysis is shown in Table 
8.2: 
 
Table 8.3: Summary follow-up demographic characteristics  
Variable N (%), or Mean (SD) and range 
Sex N, (%) Female: 112 (73%) 
Male: 42 (27%) 
Ethnicity N, (%) White British: 146 (95%) 
Other White: 5 (3%) 
Other: 3 (2%) 
Diagnosis N, (%) RA: 107 (69%) 
SLE: 1 (<1%) 
Ankylosing Spondylitis: 19 (12%) 
Psoriatic Arthritis: 20 (13%) 
Other: 5 (3%) 
Don’t Know: 2 (1%) 
Age (years) 61.06 (SD: 11.76) 26 to 84 years 
Disease Duration (years) 16.66 (SD: 13.02) 1 to 61 years 
 
Again, the trimmed means were reviewed in order to understand the impact that 
outlier cases had on the dataset and skew and kurtosis calculated to understand 
normality of data distribution. This information is available in Appendix Z. 
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8.3.2 PAM levels and scores at the second round of data collection 
At the second timepoint PAM scores and levels were identified for participants. The 
average PAM score was 57.21 (SD: 12.0) and scores were distributed between 33 
and 90.7.  A Kruskal-Wallis test determined that there were no statistically significant 
differences in age (p =0.98), HAQ (0.62) or disease duration (0.77) between the 
groups that increased, decreased or remain the same in PAM levels. However, while 
the average PAM level often did not change, many participants experienced changes 
to their PAM scores between the two timepoints. Details of the distribution of PAM 
scores at this timepoint are available in Figure 8.3. Changes to PAM scores within 
participants are available in Figure 8.3a. 
 
Figure 8.3: Distribution of PAM scores at follow-up 
 
 
0
5
10
15
20
25
30
35
40
30-39 40-49 50-59 60-69 70-79 80-89 90-99
Fr
eq
u
en
cy
PAM Score
PAM score distribution at timepoint 2
 213 
 
Figure 8.3a: PAM score changes within participants over 9 months 
 
The most common PAM level remained level 3. 83 participants remained at the same 
PAM level, 41 went down at least one PAM level and 30 went up at least one PAM 
level at the second data collection point. 
 
Table 8.3a: Summary PAM levels at follow-up 
PAM Level: Number of Participants: 
1 34 (21%) 
2 42 (27%) 
3 57 (31%) 
4 21 (14%) 
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Figure 8.3b: PAM level changes within participants 
 
 
Like the first round of data collection, there was not a significant difference in PAM 
scores between sites when a Kruskal-Wallis test was conducted χ2(5) = .5.23, p = 
.39. 
 
To achieve the aim set out for the study of reviewing change to PAM scores over 
time, a Wilcoxon matched-pair signed rank test was conducted to investigate if there 
were significant differences between participants’ first and second PAM scores. With 
the 154 participants who fully completed both surveys, there was a statistically 
significant difference in participants’ PAM scores between timepoint one and 
timepoint two, Z = 3362.5, p = 0.02.  
 
8.3.3 Descriptive data for continuous variables 
The table below provides details of the measures of central tendency for all the 
continuous variables being considered for inclusion in the regression model. In the 
event that these data have non-normal distributions, the median and interquartile 
range are also provided.  
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Table 8.3b: Descriptive data at second timepoint 
Variable Mean (SD), range Median (interquartile 
range) 
HAQ  
(possible range 0-3) 
0.70 (SD: 0.63)  
Range 0 to 2.50 
0.50 
(Q1: 0.15 and Q3: 1.05) 
RASE  
(possible range 28-140) 
102.63 (SD: 14.78) 
Range 53 to 120 
103.0 
(Q1: 94.5 and Q3: 111) 
Internal HLOC  
(possible range 6 to 36) 
16.87 (SD: 5.28) 
Range 6 to 33 
17 
(Q1: 12.75 and Q3: 20) 
Chance HLOC  
(possible range 6 to 36) 
16.19 (SD: 6.0) 
Range 6 to 34 
17 
(Q1: 11 and Q3: 20) 
Doctors HLOC  
(possible range 3 to 18) 
10.81 (SD: 2.91) 
Range 3 to 18 
11 
(Q1: 9 and Q3: 13) 
Powerful Others HLOC 
(possible range 3 to 18) 
8.55 (SD: 3.10) 
Range 3 to 17 
8 
(Q1: 6 and Q3: 11) 
BIPQ 
(possible range 0 to 80) 
44.99 (SD: 11.15) 
Range 21 to 77 
44 
(Q1: 37.75 and Q3: 52.25) 
HLQ 1 
(possible range 1 to 4) 
2.87 (SD: 0.65) 
Range 1 to 4 
3 
(Q1: 2.5 and Q3: 3.25) 
HLQ 2 
(possible range 1 to 4) 
2.88 (SD: 0.51) 
Range 1 to 4 
3 
(Q1: 2.73 and Q3: 3) 
HLQ 3 
(possible range 1 to 4) 
2.88 (SD: 0.48) 
Range 1 to 4 
3 
(Q1: 2.6 and Q3: 3.2) 
HLQ 4  
(possible range 1 to 4) 
2.82 (SD: 0.58) 
Range 1.2 to 4 
2.8 
(Q1: 2.4 and Q3: 3.2) 
HLQ 5 
(possible range 1 to 4) 
2.64 (SD: 0.51) 
Range 1.2 to 3.8 
2.8 
(Q1: 2.2 and Q3: 3) 
HLQ 6 
(possible range 1 to 5) 
3.59 (SD: 0.83) 
Range 1.2 to 5 
3.8 
(Q1: 3.15 and Q3: 4) 
HLQ 7 
(possible range 1 to 5)  
3.49 (SD: 0.73) 
Range 1 to 5 
3.67 
(Q1: 3 and Q3: 4) 
HLQ 8 
(possible range 1 to 5) 
3.76 (SD: 0.66) 
Range 1.2 to 5 
4 
(Q1: 3.4 and Q3: 4) 
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HLQ 9 
(possible range 1 to 5) 
4.01 (SD: 0.62) 
Range 1 to 5 
4 
(Q1: 3.8 and Q3: 4.4) 
Pain NRS 
(possible range 0 to 10) 
5.11 (SD: 2.45) 
Range 0 to 10 
5 
(Q1: 3 and Q3: 7) 
Fatigue NRS 
(possible range 0 to 10) 
6.57 (SD: 2.20) 
Range 1 to 10 
7 
(Q1: 5 and Q3: 8) 
Positive affect (PANAS) 
(possible range 0 to 50) 
30.66 (SD: 8.23) 
Range 10 to 45 
31 
(Q1: 25.75 and Q3: 37) 
Negative affect (PANAS) 
(possible range 0 to 50) 
20.37 (SD: 8.47) 
Range 10 to 45 
18 
(Q1: 13.75 and Q3: 26) 
 
 
8.3.4 Changes to other variables within participants 
Data on the changes in mean and median between two data collection timepoints are 
available in Table 8.3c. 
 
Table 8.3c: Changes in mean and median between the two data collection timepoints 
Variable Time 1 
mean  
Time 2 
mean 
Change 
in means 
from 
time 1 to 
2 
Time 1 
median 
Time 2 
median 
Change 
in 
median 
from 
time 1 
to 2 
RASE  101.61  102.63 +1.02 103.0 103.0 
 
0 
Internal 
HLOC  
16.98  16.87 -0.11 17 17 0 
Chance 
HLOC  
16.33  16.19  -0.14 16 17 +1 
Doctors 
HLOC  
11.31  10.81 -0.5 11 11 0 
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Powerful 
Others 
HLOC  
8.71  8.55  -0.16 8 8 0 
BIPQ 45.55  44.99  -0.56 46 44 -2 
HLQ 1 2.96 2.87 -0.09 3 3 0 
HLQ 2 2.91 2.88 -0.03 3 3 0 
HLQ 3 2.89 2.88 -0.01 3 3 0 
HLQ 4  2.92 2.82 -0.1 3 2.8 -0.2 
HLQ 5 2.68 2.64 -0.04 2.8 2.8 0 
HLQ 6 3.78 3.59 -0.19 4 3.8 -0.2 
HLQ 7 3.59  3.49 -0.1 3.67 3.67 0 
HLQ 8 3.83 3.76 -0.07 4 4 0 
HLQ 9 4.08 4.01 -0.07 4 4 0 
Pain NRS 5.43 5.11 -0.32 6 5 -1 
Fatigue 
NRS 
6.43 6.57 +0.14 7 7 0 
Positive 
affect 
(PANAS) 
30.03 
 
30.66 
 
+0.63 30 31 +1 
Negative 
affect 
(PANAS) 
19.88 
 
20.37  
 
+0.49 19 18 -1 
 
 
Wilcoxon signed rank tests were conducted to establish if there were significant 
changes to other variables within participant at the two data collection points. Of 
these, the variables that had demonstrated statistically significant changes between 
the two points of data collection were HLQ subscale 1 (Feeling understood and 
supported by healthcare providers), subscale 4 (social support), subscale 6 (ability to 
actively engage with healthcare professionals), subscale 8 (ability to find good health 
information) and subscale 9 (understanding health information enough to know what 
to do). Details are available in table 8.3d. These findings suggest that many of the 
variables were relatively stable between the two timepoints.  
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Table 8.3d: Wilcoxon signed rank tests reporting changes within participants 
Variable Z score P value 
RASE -1.07 0.28 
BIPQ -0.06 0.95 
HLOC Internal -0.97 0.33 
HLOC Doctors -1.64 0.10 
HLOC Chance -0.44 0.66 
HLOC Others -1.07 0.29 
HLQ Subscale 1 -2.41 0.02 
HLQ Subscale 2 -1.37 0.17 
HLQ Subscale 3 -1.27 0.20 
HLQ Subscale 4 -3.13 0.002 
HLQ Subscale 5 -1.58 0.12 
HLQ Subscale 6 -3.49 <0.001 
HLQ Subscale 7  -1.91 0.06 
HLQ Subscale 8 -2.78 0.005 
HLQ Subscale 9 -2.88 0.004 
Fatigue NRS -0.67 0.50 
Pain NRS -1.02 0.31 
PANAS Positive -0.12 0.91 
PANAS Negative -1.27 0.20 
 
 
8.3.5 Timepoint two univariable analysis 
For the second set of data, candidate variables for the multiple regression were again 
identified using univariable analysis. Similarly, variables without a significant 
correlation with PAM scores at the 5% level were removed as candidate factors from 
the full analysis. 
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Table 8.3e: Spearman’s rank correlation coefficient tests of candidate variables and 
their relationship with PAM scores 
Variable p  Correlation  
HAQ <0.01 -0.41 
RASE <.01 0.55 
Internal HLOC 0.1 0.13 
Chance HLOC 0.70 -0.31 
Doctors HLOC 0.20 0.10 
Powerful Others HLOC 0.03 -0.18 
BIPQ <.01 -0.55 
HLQ 1  <.01 0.35 
HLQ 2  <.01 0.55 
HLQ 3 <.01 0.41 
HLQ 4 <.01 0.39 
HLQ 5 <.01 0.42 
HLQ 6 <.01 0.50 
HLQ 7 <.01 0.47 
HLQ 8 <.01 0.41 
HLQ 9 <.01 0.42 
Pain NRS <.01 -0.28 
Fatigue NRS <.01 -0.31 
Positive affect (PANAS) <.01 0.37 
Negative affect (PANAS) <.01 -0.33 
 
The findings of the univariable analysis presented in the table above indicated that the 
only continuous variables that did not have a significant correlation with PAM scores 
were the internal, chance and doctors HLOC subscales. These variables were 
excluded from consideration in the multiple regression. 
 
8.3.6 Timepoint two multiple linear regression assumptions 
1. Sample size of N> 50+8m (m = number of independent variables (Tabachnick 
and Fidell, 2007). While the sample size for the preliminary multiple 
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regression to identify candidate variables did not meet this assumption, the 
second confirmatory regression analysis did so. 
2. Multicollinearity was investigated during the analysis process. As with the first 
round of data collection, there were limited high inter-correlated variables. 
High correlations existed between HLQ subscales 1 and 6 (.704, p<.001), 6 
and 7 (.893, p<.001), 7 and 8 (.714, p<.001) and 8 and 9 (.762, p<.001). The 
researcher reviewed the VIF and the tolerance of the correlations. Again, 
none of the VIFs reviewed were above 10 which does not suggest 
multicollinearity had a substantial confounding impact on the findings of the 
analysis. While HLQ subscales 6 and 7 had low tolerances (.143 and .148 
respectively), they were not below the 0.1 cut-off that suggests 
multicollinearity (Pallant, 2007). 
3. The NPP was reviewed (see Appendix AA). There was some deviation from 
the line of best fit, suggesting some non-normality across the dataset. The 
scatterplot suggested there were some extreme outliers in this dataset with 
one residual reaching +3 on the standardised residual axis. 
4. Because of the substantial deviation from the line of best fit on the NPP, 
linearity could also not be assumed for this sample and data collection point. 
 
The review of the assumptions for the second round of data analysis suggested that 
not all of these were met. Consequently, the findings cannot be generalised beyond 
the sample who took part in data collection. As with the first set of data for this 
study, the non-normally distributed data were transformed in order to confirm the 
strength of the findings. This is discussed in more detail in section 8.3.7. 
 
8.3.7 Timepoint two multiple linear regression 
The list of variables had been determined following the univariable analysis. Initially, 
all candidate variables were entered in a preliminary forced entry multiple regression. 
This was intended to identify variables that contributed to the model to a statistically 
significant degree at a 0.1 level (See Table 8.3f). The variables that contributed to the 
model and were taken forward to the final regression model were:  
1. HAQ 
2. RASE total score (capturing self-efficacy) 
3. Powerful others HLOC 
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4. BIPQ 
5. HLQ subscale 2 (Having sufficient information to manage my health) 
6. PANAS Negative affect 
 
The findings of this preliminary model are available in Table 8.3f. Overall, the 
regression model accounted for 48.9% of the variance in PAM scores within this 
sample. The multiple regression was calculated to predict PAM scores based on the 
predetermined list of independent variables. The regression equation identified: F (17, 
135) = 9.57, p<.001, with an adjusted R2 of 0.49.  
 
Following this, the variables that did not significantly contribute to the regression 
model were removed from the syntax and the regression was rerun without these. 
The findings of this final model are also available in Table 8.3f.  
 
This regression model accounted for 49% of the variance in PAM scores within the 
sample. The multiple regression was calculated to predict PAM scores based on the 
predetermined list of independent variables. The regression equation identified: F (6, 
146) = 25.36, p<.001, with an adjusted R2 of 0.49.  
 
All variables in this model were significant predictors of PAM scores in participants. 
In the final model, HLQ subscale 2 recorded the highest beta value (β = 0.34 p< .001). 
This was followed by RASE scores (β = 0.33, p< .001). Next, HAQ scores had the 
next greatest beta values (β = -0.21, p = <0.01), followed by PANAS negative affect 
(β = -0.19, p  = 0.02) and BIPQ scores (β = -0.18, p = 0.04) and then finally the HLOC 
powerful others subscale (β = -0.13, p = 0.03). 
 
The non-normal data were transformed to common logarithm (log10) to reduce the 
non-normality by taking the square root of data cases for relevant non-normal 
distributions. In the case of variables that had values of 0, the data were first 
transformed to add 1 to each of the responses to be sure that there were no issues 
in the data transformation caused by the 0s.   The findings of this regression support 
the initial findings and are available in appendix BB. However, in the regression with 
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data transformed to a more normal distribution did not have the powerful others 
HLOC subscale as a significant predictor in the final model. 
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Table 8.3f: Multiple linear regression to analyse the association between PAM scores and other personal and contextual factors captured 
by the survey: 
Variables Preliminary multiple regression Final multiple regression 
Standardised β 95% CI P value Standardised β 95% CI P value 
HAQ -0.23 -7.33 to -
1.15 
<0.01 -0.21 -6.60 to -1.18 <0.01 
RASE 0.26 0.08 to 0.36 <0.01 0.33 0.15 to 0.40 <0.001 
Powerful others HLOC -0.15 -1.04 to -
0.09 
0.02 -0.13 -0.95 to -0.05 0.03 
BIPQ -0.24 -0.47 to -
0.04 
0.02 -0.21 -0.38 to -0.01 0.04 
HLQ 1 -0.15 -6.18 to 0.68 0.12    
HLQ 2 0.29 1.91 to 11.49 <0.01 0.34 4.56 to 11.26 <0.001 
HLQ 3 0.10 -1.25 to 6.23 0.19    
HLQ 4 0.08 -2.28 to 5.37 0.43    
HLQ 5 0.09 -1.60 to 6.12 0.27    
HLQ 6 0.14 -2.23 to 6.19 0.35    
HLQ 7 -0.06 -5.82 to 3.75 0.67    
HLQ 8 -0.01 -4.54 to 4.12 0.94    
HLQ 9 0.01 -3.96 to 4.24 0.95    
Pain NRS 0.12 -0.24 to 1.43 0.91    
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Fatigue NRS -0.01 -0.91 to 0.81 0.16    
Positive affect (PANAS) -0.03 -0.26 to 0.18 0.73    
Negative affect 
(PANAS) 
0.16 -0.01 to 0.46 0.06 0.19 0.04 to 0.48 0.02 
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8.3.8 Logistic regression on PAM levels at follow-up 
As with the first set of data, an initial logistic regression was run with all candidate 
variables to identify the variables that were significant predictors of PAM levels at the 
10% level based on the significance of the regression coefficient (Β) for any PAM level.  
 
Overall, the initial model was statistically significant, χ2 (60, n = 154) = 181.65, p < 
.001. The model explained between 44.6% (McFadden test) and 74.6% (Nagelkerke 
test) of the variance in PAM levels. The following variables were taken forward to a 
final logistic regression: 
• HAQ 
• RASE 
• Powerful others HLOC 
• BIPQ 
• HLQ subscale 1 (feeling 
understood and supported) 
• HLQ subscale 3 (actively 
managing my health) 
• HLQ subscale 5 (appraisal of 
health information) 
• HLQ subscale 9 (understand 
health information enough to 
know what to do) 
• PANAS negative affect 
 
This final model was statistically significant, χ2 (27, n = 154) = 143.39, p < .001. The 
model explained between 35% (McFadden test) and 65.2% (Nagelkerke test) of the 
variance in PAM levels. All the blocks within the model were statistically significant 
contributors to the model. In comparison to the first logistic regression model from 
the baseline data collection, BIPQ scores contributed more to variance in PAM levels 
at timepoint 2.  
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Table 8.3g: Logistic regression findings at follow-up 
  PAM Level 1 PAM Level 2 PAM Level 3 
Factor Β d
f 
P Exp 
(Β) 
95% 
CI 
Lower 
95% CI 
Upper 
Β d
f 
p Exp 
(Β) 
95% 
CI 
Low 
95% 
CI 
Upper  
Β 
 
d
f 
P Exp 
(Β) 
95% 
CI 
Low 
95% CI 
Upper 
HAQ 6.12 1 <0.01 491.
74 
15.13 15982.02 4.86 1 0.01 129.37 4.52 3705.8 4.92 1 <0.01 137.05 5.50 3413.32 
RASE -
0.18 
1 <0.01 0.84 0.74 0.94 -0.02 1 <0.0
1 
0.85 0.77 0.94 -0.06 1 0.15 0.94 0.87 1.02 
Internal 
HLOC 
-
0.11 
1 0.33 0.90 0.72 1.12 -0.10 1 0.33 0.91 0.75 1.10 -0.08 1 0.33 0.92 0.78 1.09 
Chance 
HLOC 
-
0.12 
1 0.31 0.89 0.71 1.11 0.01 1 0.92 1.01 0.84 1.22 -0.05 1 0.57 0.95 0.80 1.13 
Doctors 
HLOC 
0.22 1 0.349 1.24 0.79 1.97 0.31 1 0.11 1.37 0.94 2.01 0.13 1 0.44 1.14 0.81 1.61 
Others 
HLOC 
0.56 1 <0.01 1.76 1.18 2.62 0.30 1 0.08 1.36 0.96 1.91 0.11 1 0.47 1.12 0.83 1.52 
BIPQ 0.25 1 <0.01 1.29 1.07 1.55 0.12 1 0.12 1.13 0.97 1.30 0.08 1 0.22 1.09 0.95 1.24 
HLQ 1 2.45 1 0.11 11.6
0 
0.56 242.31 1.54 1 0.27 4.67 0.30 72.82 2.74 1 0.04 15.43 1.21 196.95 
HLQ 2 -
4.42 
1 0.02 0.01 0.00 0.46 -2.57 1 0.10 0.08 0.00 1.65 -2.24 1 0.11 0.11 0.01 1.65 
HLQ 3 -
0.67 
1 0.66 0.51 0.03 9.70 -2.07 1 0.05 0.13 0.03 1.00 -1.23 1 0.14 0.29 0.06 1.50 
HLQ 4 -
2.06 
1 0.21 0.13 0.01 3.24 -1.50 1 0.30 0.22 0.01 3.826 -1.75 1 0.18 0.17 0.01 2.25 
HLQ 5 -
3.19 
1 0.03 0.04 0.00 0.77 -0.96 1 0.46 0.38 0.03 4.94 -1.54 1 0.20 0.22 0.02 2.29 
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HLQ 6 -
0.71 
1 0.68 0.49 0.02 13.92 -0.76 1 0.59 0.47 0.03 7.55 -0.14 1 0.91 0.87 0.08 10.02 
HLQ 7 -
0.08 
1 0.97 0.93 0.02 42.41 -0.05 1 0.97 0.95 0.04 20.96 -0.95 1 0.50 0.39 0.03 5.92 
HLQ 8 1.76 1 0.36 5.83 0.14 246.54 1.31 1 0.45 3.71 0.12 112.79 2.24 1 0.16 9.38 0.41 214.23 
HLQ 9 -
3.28 
1 0.08 0.04 0.00 1.47 -3.12 1 0.07 0.04 0.00 1.24 -2.59 1 0.09 0.08 0.00 1.54 
Fatigue 
NRS 
-
0.33 
1 0.36 0.72 0.35 1.47 -0.15 1 0.58 0.86 0.50 1.48 -0.37 1 0.13 0.69 0.43 1.12 
Pain NRS -
0.41 
1 0.19 0.66 0.36 1.23 -0.28 1 0.30 0.76 0.45 1.27 -0.35 1 0.13 0.70 0.44 1.11 
Positive 
affect 
(PANAS) 
0.05 1 0.60 1.05 0.88 1.25 0.04 1 0.63 1.04 0.89 1.21 0.02 1 0.81 1.02 0.89 1.16 
Negative 
affect 
(PANAS) 
-
0.22 
1 0.02 0.80 0.67 0.97 -0.20 1 0.03 0.82 0.69 0.98 -0.12 1 0.15 0.89 0.76 1.05 
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Table 8.3h: Final logistic regression at second timepoint 
  PAM Level 1 PAM Level 2 PAM Level 3 
Factor Β d
f 
p Exp 
(Β) 
95% 
CI 
Lowe
r 
Boun
d 
95% 
CI 
Uppe
r 
Boun
d 
Β d
f 
p Exp 
(Β) 
95% 
CI 
Lowe
r 
Boun
d 
95% 
CI 
Uppe
r 
Boun
d 
Β 
 
d
f 
P Exp 
(Β) 
95% 
CI 
Lowe
r 
Boun
d 
95% 
CI 
Uppe
r 
Boun
d 
HAQ 6.20 1 <.01 491.7
4 
15.13 15982.0 4.86 1 0.01 129.3
7 
4.52 3705.83 4.92 1 0.0
0 
137.0
5 
5.50 3413.3
2 
RASE -0.18 1 <.01 0.84 0.74 0.94 -0.16 1 <0.0
1 
0.85 0.77 0.94 -0.06 1 0.1
5 
0.94 0.87 1.02 
Internal 
HLOC 
-0.11 1 0.33 0.90 0.72 1.12 -0.10 1 0.33 0.91 0.75 1.10 -0.08 1 0.3
3 
0.92 0.78 1.09 
Chance 
HLOC 
-0.12 1 0.31 0.89 0.71 1.11 0.01 1 0.92 1.01 0.84 1.23 -0.05 1 0.5
7 
0.95 0.797 1.13 
Doctors 
HLOC 
0.22 1 0.35 1.24 0.78 1.97 0.31 1 0.11 1.37 0.94 2.01 0.13 1 0.4
4 
1.14 0.812 1.61 
Others 
HLOC 
0.56 1 <0.0
1 
1.76 1.18 2.62 0.30 1 0.08 1.37 0.96 1.91 0.11 1 .04
7 
1.12 0.83 1.52 
BIPQ 0.25 1 <0.0
1 
1.29 1.07 1.55 0.12 1 0.12 1.14 0.97 1.30 0.08 1 0.2
2 
1.09 0.95 1.24 
HLQ 1 2.45 1 0.11 11.60 0.55 242.31 1.54 1 0.27 4.67 0.30 72.82 2.74 1 0.0
4 
15.43 1.21 196.95 
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HLQ 2 -4.42 1 0.02 0.01 0.00 0.46 -2.57 1 0.10 0.08 <0.00 1.65 -2.24 1 0.1
1 
0.11 0.01 1.65 
HLQ 3 -0.67 1 0.66 0.51 0.03 9.70 -2.07 1 0.05 0.13 0.02 1.00 -1.23 1 0.1
4 
0.29 0.06 1.50 
HLQ 4 -2.06 1 0.21 0.13 0.01 3.24 -1.50 1 0.30 0.22 0.01 3.83 -1.75 1 0.1
8 
0.17 0.013 2.25 
HLQ 5 -3.19 1 0.03 0.04 0.00 0.77 -0.96 1 0.46 0.38 0.03 4.94 -1.54 1 0.2
0 
0.22 0.02 2.29 
HLQ 6 -0.71 1 0.68 0.49 0.02 13.92 -0.76 1 0.59 0.47 0.03 7.55 -0.14 1 0.9
1 
0.87 0.08 10.02 
HLQ 7 -0.08 1 0.97 0.93 0.02 42.41 -0.04 1 0.98 0.95 0.04 20.96 -0.95 1 0.5
0 
0.39 0.03 5.92 
HLQ 8 1.76 1 0.36 5.83 0.14 246.54 1.31 1 0.45 3.71 0.12 112.79 2.24 1 0.1
6 
9.38 0.41 214.23 
HLQ 9 -3.28 1 0.08 0.04 0.00 1.47 -3.12 1 0.07 0.04 <0.01 1.24 -2.59 1 0.0
9 
0.08 0.00 1.541 
Fatigue 
NRS 
-0.33 1 0.36 0.72 0.35 1.47 -0.15 1 0.58 0.86 0.50 1.48 -0.37 1 0.1
3 
0.69 0.43 1.12 
Pain 
NRS 
-0.41 1 0.19 0.66 0.36 1.23 -0.28 1 0.30 0.76 0.45 1.27 -0.35 1 0.1
3 
0.70 0.44 1.11 
Positive 
affect 
(PANAS
) 
0.05 1 0.60 1.05 0.88 1.25 0.04 1 0.63 1.04 0.89 1.21 0.02 1 0.8
1 
1.02 0.89 1.16 
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Negative 
affect 
(PANAS
) 
-0.22 1 0.02 0.80 0.67 0.97 -0.20 1 0.03 0.82 0.69 0.98 -0.12 1 0.1
5 
0.89 0.76 1.05 
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8.4 Timepoint two discussion 
A feature of the research is that there was not a statistically significant change in PAM 
scores between the samples but some participants experienced substantial changes 
on an individual level. Individuals have been identified to have substantial changes in 
other PAM survey research (Aung et al., 2015). The absence of significant differences 
in demographic factors between the groups that did have PAM score changes in both 
directions implies that there is no specific type of patient more likely to reduce or 
increase patient activation. The strong correlation between PAM scores at the first 
and second timepoint also reflect findings of other studies that collected PAM data 
at follow-up (Rask et al., 2009). 
 
In the comparisons across the two timepoints, most of the subscales on the HLQ did 
see significant changes for participants who completed both surveys. Longitudinal data 
on the HLQ is not available and the initial publication did not capture test-retest 
reliability (Osborne et al., 2013). This could reflect either changes in participants’ 
ability to gather, understand and apply health-related information, or could reflect 
the suggestion that the HLQ is particularly sensitive to fluctuations in participants’ 
abilities. 
 
While the data remain non-normally distributed at the second timepoint, they are 
less so. This was initially hypothesised to be because participants who had extreme 
scores at the lower end of the scale were the participants who did not complete the 
second round of data collection. However, there were no significant differences in 
initial PAM scores and levels between completers and non-completers.  
 
The major differences in findings of the multiple regression between the first and 
second round of data analysis are that there are more variables that contribute to 
variance in PAM scores in the second round. The inclusion of the HAQ, powerful 
others HLOC (while internal HLOC was no longer a factor), BIPQ scores, and 
negative affect contributed to a broader conceptualisation of patient activation. The 
consistent contributions of RASE and HLQ subscale 2 add weight to the roles of self-
efficacy and health literacy respectively in patient activation.  
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Yet again, the average PAM scores across the sample at follow-up were lower than 
in other studies with other health conditions (Rask et al., 2009). This contributes to 
the argument that patient activation is different between conditions, with 
rheumatology patients being lower in their patient activation than patients with other 
health conditions. Alternatively, the PAM may be less appropriate for IA patients and 
their patient activation. 
 
Negative affect did contribute to variance in PAM scores at the follow-up point. 
While the first round of data collection and analysis implied that affect did not 
contribute to patient activation to a statistically significant degree, this second round 
of analysis disagrees to a small extent with this finding. Given that the current model 
of patient activation is built around positive and negative affect (Hibbard and 
Mahoney, 2010) these findings do not provide clear support for this model. 
 
While there was also some consistency in variables that contributed to variance in 
PAM levels, HLQ subscales were more often significant contributors to PAM levels. 
Therefore, the variables that contribute to PAM levels may be broader than the 
variables that contribute to PAM scores. 
 
8.5 Study strengths and limitations 
8.5.1 Strengths 
One strength of the study was that approximately one third of the participants in the 
initial sample were male. As men are often under-represented in research of this 
kind, there is a benefit to understanding the impact of sex on PAM scores and levels. 
There was also good representation of different forms of IA beyond RA which is 
often the most represented in quantitative rheumatology research. 
 
Another strength of this study was that participants were recruited from multiple 
sites across England. This was intended to reduce the risk of bias if all participants 
received their care from the same rheumatology department.  
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8.5.2 Limitations 
One limitation is that the recruitment goal was not reached for the study. This was 
for pragmatic reasons owing to the timeline for recruitment that was possible in the 
remit of a PhD study. 
 
Another challenge for the study is that outcome measures used in health contexts 
are often also written in a way that makes them inaccessible to people with low 
health literacy, so their responses may not be valid (Adams et al., 2013). Outcome 
measures were selected to be as accessible as possible and the PRP was consulted in 
conjunction with this to select the contents of the pack. However, some of the 
outcome measures included more complex language, and this may have contributed 
to people with poor literacy or health literacy choosing not to participate. 
 
During the formatting of the survey pack, the PAM was deliberately placed first to 
gather naïve responses to this questionnaire. However, there were no alternative 
versions of the survey with outcome measures in different orders to reduce order 
effects. Therefore, patients may have become tired or fatigued the further into survey 
completion they got. Data were also not collected on how participants perceived 
their care, and neither was the type of self-management support provided in the 
recruiting sites. The opportunity was missed to understand the interaction between 
patient activation and service provision factors. Education levels were not captured 
in this survey. This was for multiple reasons. Firstly, there were substantial challenges 
with standardising and categorising the wide range of education levels and 
qualifications in the qualitative interview study. The range would have undoubtedly 
been wider with a much larger sample in the survey study and it is possible there may 
not have been a way to use the data. Therefore, it did not seem justifiable to collect 
it from participants. However, it is a limitation of this study. 
 
Another aspect of the data collection that was not comprehensive was that the HAQ 
was not collected in the second survey pack. This means that participants’ level of 
disability may have fluctuated between the two data collection points. However, 
HAQ scores have been found to be relatively stable over time with changes in 
longitudinal studies considered to be related to the natural aging process (Sokka et 
al., 2006). 
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Participants who completed a full data set for one or both time points in some 
circumstances needed to be excluded from the sample because of the way that they 
had completed the PAM. In line with the guidance provided by the licensers of the 
PAM, participants who respond to the measure with the same response for each item 
should be excluded from the analysis because of the assumption they have not 
meaningfully completed the measure. This means that the full range of PAM scores 
are not available as participants who respond ‘strongly agreed’ to all items would 
have a PAM score of 100 but consequently be removed from the analysis. The highest 
score across both data collection points possible for this study was approximately 
90. This means that 10% of scores available in the PAM were not applicable for the 
study. While trying to reduce automatic responses to the measure, it does risk 
excluding participants who have completed the PAM with accurate and considered 
responses to all items.  
 
Another limitation of this study was the high attrition rate between the first and 
second data collection point. As a result, the sample size at the second time point 
meant that the findings of the regression analysis were not generalisable.  
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Chapter 9: Patient Activation Framework  
Following the research findings presented in chapters 4, 6 and 8, this chapter synthesises 
the aspects of patient activation that might be amenable to intervention into a single 
framework to inform future interventions. The factors will each be discussed in turn. 
 
9.1 Framework overview 
The framework presented in this section is built upon the idea of patient activation 
as a crucial aspect of the self-management process, particularly around commencing 
self-management. Within this framework, patient activation is a broad, umbrella 
concept that encapsulates other concepts, knowledge and skills that may be amenable 
to intervention.  
 
The framework was developed by synthesising the findings from current literature, 
the systematic literature review, qualitative interview study, and quantitative survey 
study. The key factors were considered early in the process of the PhD during the 
systematic literature review. Potential factors were then considered at each stage of 
the PhD process with each new set of findings from the qualitative and quantitative 
studies. The findings would be discussed with the supervisory team as common 
themes across the studies were reviewed to identify potential factors. During this 
time the framework underwent several iterations of revision to reach its current 
form (see Appendix DD). On occasions where findings from one study suggested a 
framework factor that was not necessarily supported by another study (for example, 
the contribution of illness beliefs to PAM scores and levels was not consistent in the 
survey study), the factor was included and discussed with the wider supervisory team. 
The source of each factor in the framework and how it was identified during the 
course of the research is noted in the section dedicated to each factor. 
 
Pertinent findings from all these sources were discussed with the researcher’s 
supervisory team, including the PRP. This framework (see figure 9.1) has also been 
presented to an audience of rheumatologists at a local training day (see this in the list 
of outputs from the PhD in Appendix EE) to gather feedback and refine this in detail.  
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Figure 9.1: Framework of factors relevant to patient activation 
The factors noted here under the umbrella of patient activation can be used as targets 
to increase patient activation directly or indirectly in patients with IA. Based on the 
findings of this research, they are considered to be part of the process of actively 
managing a condition by experienced self-managers and are statistically significant 
contributors to variance in patient activation in a sample of rheumatology patients in 
England. The framework was developed to be rheumatology specific following 
research covering a review of patient activation interventions in long-term fluctuating 
physical health conditions, discussing patient activation with experienced 
rheumatology patients, and identifying what is statistically associated with patient 
activation in a rheumatology sample. However, there are aspects of this that may be 
appropriate for other long-term conditions largely managed in secondary care, 
particularly fluctuating ones where people may experience periods of remission and 
flares of disease activity. For example, self-efficacy is a common target in self-
management interventions across a range of long-term conditions. Given the lack of 
association between positive and negative affect in the survey study, this was not 
included in the framework.  While a sense of positivity and determination was 
mentioned by participants in the qualitative study, this was specifically related to their 
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perceptions of their health related to illness beliefs and did not necessarily reflect 
consistent positive affect beyond that.  
 
The framework factors are: 
• Health literacy (this is understood to contain three sub-types of health 
literacy: critical, communicative and functional health literacy); 
• Illness beliefs (i.e., how severe and limiting someone perceives their IA to be). 
• Self-efficacy (a common focus of most self-management interventions); 
• Internal HLOC (the sense that someone’s health is down to their own actions 
and behaviours); 
• Societal expectations of health and healthcare; 
• Social support; 
• Clinical provision; 
• Therapeutic alliance; 
• Demographic factors. 
 
Interventions targeting patient activation could be strengthened with a focus on these 
personal factors, provided that they are amenable to intervention in rheumatology 
patients. 
 
It is considered that mediating relationships (i.e., it explains the relationship between 
the dependent and independent variables) are bidirectional and individual factors that 
are related to patient activation. Additionally, increased patient activation contributes 
to greater skill and confidence in these individual factors.  
 
The impact of individual factors and how interventions may target them to improve 
patient activation will each be discussed. 
 
9.2 Personal factors 
9.2.1 Self-efficacy 
Self-efficacy is one of the most commonly targeted concepts in self-management 
research and has been demonstrated to be amenable to intervention in many of the 
studies both within rheumatology and in wider health research (Lorig et al., 2001). 
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The belief that there are things that somebody could do to improve their health 
contributes to their feeling of being able to take responsibility for actively managing 
their condition. The sense of being able to carry out specific self-care behaviours to 
take responsibility for one's condition can be a steppingstone to taking action to self-
manage.  
 
As discussed in section 2.7.2, self-efficacy is often increased following observing peers 
modelling positive behaviours and finding success. Mastering experiences, for instance 
through setting and achieving goals that are important to patients, can also contribute 
to increased self-efficacy and confidence. These activities may form meaningful and 
effective aspects of an intervention targeting patient activation. Self-efficacy is a key 
feature of self-management literature, was discussed by the skilled self-managers in 
the interview study, and was the most consistent significant contributor to variance 
in PAM scores and levels in the survey study. This stresses that self-efficacy is 
particularly valuable to patient activation across time and participants.  
 
9.2.2 Illness beliefs 
The sense of subjective severity that patients have of their condition and health 
contributes to them considering how to take responsibility for their health. Although 
illness beliefs as a term covers a wide range of potential beliefs, the beliefs particularly 
relevant from this research are those related to perceived condition severity. The 
qualitative interviews suggested that when the confident self-managers recruited felt 
their condition was less serious compared to others they saw and knew, they felt 
more able and inclined to manage their own health. This feeling of their condition 
being less severe contributed perspective and allowed them to feel more positive 
about activities they could still do. More precise research is needed about how best 
to target illness beliefs and subjective health status in long-term conditions and IA in 
particular (Coulter and Ellins, 2006).  
 
In the survey study described in chapter 8, there was a moderate correlation between 
perceived condition severity (i.e. illness beliefs) as captured by the BIPQ and levels of 
disability as a proxy for disease severity captured by the HAQ. However, it could be 
suggested that it is illness beliefs that should be a focus for intervention rather than 
levels of disability because illness beliefs predict disability and this could be a useful 
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mediator (Graves et al., 2009). As noted in the qualitative study, particular health 
beliefs could contribute to increased health literacy. These included perceptions of 
risks, expectations about the impact of symptoms on one’s life, and expectations 
about the nature and severity of one’s condition (McCormack et al., 2016). 
 
The role of illness beliefs in patient activation was identified through the review of 
the literature and the qualitative study. Participants referred to how they managed 
their health in a positive way by comparing their own experiences with those around 
them to make them more determined to take action. 
 
 
9.2.3 Internal HLOC 
The internal locus of control reflects somebody's willingness to take an active role in 
managing their health. The contributions of an internal HLOC were demonstrated in 
the survey study and reflect the determination to manage one’s health that 
experienced self-managers in the interview study described. The sense of internal 
HLOC was discussed by participants in the interview study, albeit without using this 
terminology. HLOC and the sense of responsibility that people felt for their condition 
was discussed in the interviews. HLOC can be underpinned by the broad foundations 
of patient activation and might be a state concept given that participants’ HLOC did 
experience some changes across the two timepoints.  
 
9.2.4 Health literacy 
Health literacy was very well represented in the findings of the thesis, appearing with 
skills training during interventions in the systematic review, the skills and abilities 
being reviewed as vital for self-management in the interviews, and aspects of health 
literacy were statistically significant predictors of PAM scores and levels in the survey 
study. 
 
Health literacy appears vitally important to how people can actively manage their 
health. Specifically, how people gather and apply knowledge to health-related 
challenges that occur over the course of living with IA. As discussed previously, the 
three different types of health literacy are (Nutbeam, McGill and Premkumar, 2017): 
• communicative health literacy (how people establish meaning from sources); 
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• critical health literacy (ability to manage health based on analysing health-
related information); 
• functional health literacy (how someone gathers information related to their 
health and applies it to their life). 
  
Health literacy overall includes many skills that are relevant to actively managing one's 
health. Skills-based training to increase peoples’ health literacy, particularly the ability 
to judge when to seek appropriate medical help and do so can contribute to someone 
actively managing their condition in a more effective, safe, and confident way. 
Healthcare professionals in the UK reported that there were barriers to 
incorporating routine health literacy strategies into their clinical practice (Brooks et 
al., 2019). They discussed a need for implementing health literacy assessment and 
interventions more widely into patient contact. This could be carried out by 
reviewing participants’ health literacy before determining what interventions would 
be most suitable and confirming understanding regularly during face-to-face and 
telephone contact (Brooks et al., 2019). 
 
Interventions that currently target health literacy within rheumatology are often 
informal and can take the form of resources provided in clinic such as leaflets. They 
have been demonstrated to have a small and short-term impact on health literacy 
knowledge, but there is a lack of evidence about how much patient education 
interventions more generally target health literacy (Lowe et al., 2013). Therefore, 
provision could be made to map this framework onto clinical interactions to 
understand how suitable they are for supporting patients with their activation. 
 
9.3 Contextual factors 
Contextual factors are not always amenable to intervention in routine clinical 
contact. As they do not contribute to the aim/objective of the thesis and could not 
easily be incorporated into an appropriate intervention, they are not discussed in 
detail here. However, they inform tailoring of support for patients and may 
contribute to additional risk of low patient activation. A knowledge of contextual 
factors can also determine appropriate examples of language, support, teaching 
examples (e.g. scenarios for problem solving practice), and finding patients peer 
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groups that would meet their needs. Wider societal factors such as the environment 
where a patient lives, the cultural expectations of healthcare systems and other wider 
systemic factors are also not being discussed in this section as they are not amenable 
to change on an individual behavioural or cognitive level. However, they are not the 
primary focus of the framework, as the intention of the framework is to provide a 
pragmatic overview of patient activation. This framework could be mapped onto 
existing interventions or used as a tool to design interventions in collaboration with 
healthcare professionals and patient partners.   
 
9.3.1 Social support 
As described in the qualitative interviews, the confident self-managers that were 
recruited relied on the support around them in order to effectively and actively 
manage their condition. In these circumstances the support was often practical and 
allowed for participants to focus on other aspects of the management of their 
condition. The benefit of social support in active self-management is reported in the 
literature (Koetsenruijter et al., 2016). In some circumstances, social support may be 
provided as an intervention e.g., individual community worker support (McEwen, 
2010). However, it does not necessarily lend itself to immediate intervention in a 
clinical setting and therefore is a wider contextual factor relevant to patient 
activation. There are also indirect sources of social support that can impact patients 
and their self-management that can constitute interventions. One such example is the 
provision of resources by employers for employees’ and their family or friends to 
make use of such as leisure and wellbeing facilities or signposting to peer groups for 
social support. 
 
In the discussion of the findings of the qualitative study, it was mentioned that 
rheumatology patients in a prior study had identified a gap between the need for 
additional social and emotional support and current service provision (Dures et al., 
2014). Consequently, there is a need for additional support for patients. Some of the 
studies covered in the systematic review provided forms of social support in the form 
of keyworkers, and the move towards social prescribing in the UK offers the 
opportunity for some of these gaps to be addressed (Drinkwater, Wildman and 
Moffatt, 2019). This may come in the form of third sector or more holistic clinically 
commissioned support that focuses on creating activated networks as much self-
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management support within the NHS does not consider social context and the 
environmental issues that contribute to and shape how people manage their health. 
Some steps have been taken to incorporate this into clinical practice and these should 
be expanded on and further implemented to create an environment which is more 
geared towards self-management (James et al., 2020; Band et al., 2019). The 
inequalities discussed in section 3.5 may persist and impact what enablers are present 
for someone to take on active self-management, and work to strengthen social 
networks and increase access to support will reduce some of these inequalities. 
Reducing the barriers to other determinants of health such as reliable public 
transport to resources and facilities can also contribute to social support 
interventions with a view to increasing patient activation. 
 
9.3.2 Demographic characteristics 
Demographic characteristics that are relevant to patient activation have been 
discussed in sections 3.3 and 7.3. The evidence suggests associations between specific 
demographic characteristics (i.e. age, race, sex, socio-economic status) and patient 
activation in a range of long-term conditions. While some participants mentioned that 
they felt there were certain demographics of people that may find it more challenging 
to self-manage (e.g. older adults), the survey study did not find that specific 
demographic characteristics were significant predictors of higher patient activation in 
a sample of rheumatology patients. Demographic characteristics are often not 
amenable to intervention but may help to understand people more likely to benefit 
from interventions or more likely to struggle to actively manage their conditions. 
Therefore, demographics have been included in a wider circle as these factors 
influence how interventions are tailored and targeted based on patients’ demographic 
characteristics. 
 
9.3.3 Therapeutic alliance 
The collaborative relationship between patient and healthcare professional was 
discussed in detail by participants in the interview study. The relationship between 
patient activation and therapeutic alliance has been discussed in some recent research 
(Alexander, 2018; Chew et al., 2017) and could contribute to patients feeling more 
able to take charge in appointments and carry out activities knowing they have the 
support and positive relationship with their healthcare team. Therapeutic alliance has 
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also been identified as an attribute of patient engagement in a concept analysis 
because of the collaborative working relationship between patients and healthcare 
professionals. Participants formed and maintained these working relationships by 
contributing in a positive and meaningful way in decision making and the structure of 
patient-centred care (Zambelli Pinto et al., 2012). Increased therapeutic alliance in 
one rheumatology study has been associated with increased belief from patients that 
they can follow their health regimens and prescribed treatments, greater agreement 
on action plans between patients and professionals, and more trust between the two 
parties (Fuertes et al., 2015). 
 
The movement towards collaborative care within the NHS sees patients taking on a 
collaborative role more commonly and becoming more skilled at doing so (NHS, 
2019). However, for those with expectations that healthcare professionals will stay 
in a more biomedical “problem-solver” role, this would potentially contribute to 
them being less willing to manage their own health. Therapeutic alliance and the 
relationship between patient and healthcare professionals have been identified as a 
factor that can support patients who are less activated, with healthcare professionals 
checking in for self-management support (Alexander, 2018). In a mental health 
service, patient activation was found to increase following an intervention targeted at 
patients (Allen et al., 2017). However, interventions that support both patients and 
healthcare professionals may be beneficial in order to support the development of 
effective collaboration between both parties. This was initially covered in the CCH 
and the courses were largely well received by healthcare professionals (Wallace et 
al., 2012; Sharma et al., 2011). Skills-based training for rheumatology professionals 
have begun to fill this gap (Halls et al., 2018). This suggests that further interventions 
would be beneficial in the future. 
 
9.3.4 Clinical provision 
Given the relationship between quality of care and patient activation, the resources 
and skills of rheumatology departments will contribute towards patient activation 
(Hibbard et al., 2004). 
 
Participants in the interview studies discussed how much they valued prompt access 
to specialist care from healthcare professionals who knew the participants’ 
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experiences and had resources to contribute towards solving problems related to 
their IA. Interview study participants also noted how they felt the availibility and 
consistency of their care contributed to them effectively managing their health. This 
was particularly evident given how much they valued the direct access system 
avaialble in their departments. Therefore, this is noted as an important contextual 
factor to patient activation. While the responsibility for managing their health 
generally falls to patients, they will likely have little to no control over the service 
provision of their rheumatology department and limited control over what peer-
support and third sector support is available locally.  
 
While the NHS is known to be stretched and long-term conditions take up a 
substantial portion of costs and resources and the availability of support to patients 
does impact their self-management (NHS England Care Quality Commission, Health 
Education England and Public Health England, 2014). While the availibility of clinical 
support is not easily adapted and is unlikely to be impacted by individual intervention, 
it is a vital factor that contributes to how much of the responsibility for self-
management falls to individuals and how supported they are in order to manage and 
deal with challenges that occur as a consequence of their conditions. This factor could 
also include the impact of institutions, hospital systems and management that 
contribute to how easily healthcare professionals and patients can engage in 
collaborative care together. 
 
9.3.5 Societal expectations of health and healthcare 
The expectations of what good health looks like and how healthcare systems support 
patients will likely contribute to how willing and able someone is to take an active 
role in managing their health. While a patient’s internal locus of control is discussed 
above, perceptions of health at a population level require broader public health 
campaigns to inform interventions, which will have limited effectiveness at an 
individual level in clinical settings. While rheumatology studies have reported that 
patients can feel a sense of shared responsibility for their health (Dures et al., 2016a), 
this is not always the case.  These expectations are likely shaped by locus of control, 
prior experiences, confidence to act, wider public perceptions of the NHS, and a host 
of other factors.  
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Chapter 10: Thesis discussion  
The previous chapters have reported the results of the studies included in the thesis as well 
as some preliminary discussion. This chapter will review the novel findings of the thesis with 
reference to the original aims and objectives before evaluating the strengths and limitations 
of the research. The implications for research, clinical application, and theory will be 
discussed and a summary of the thesis will précis the original contributions to knowledge. 
 
10.1 Thesis aim and objectives  
10.1.1 Aim  
To develop a framework to describe patient activation and factors which contribute 
to patient activation, in the context of inflammatory arthritis. 
 
10.1.2 Objectives 
• To identify the evidence surrounding patient activation interventions in long-
term physical health conditions. 
• To understand how skilled self-managers with IA conceptualise patient 
activation. 
• To understand how skilled self-managers at different levels of activation 
perceive and enact patient activation over time. 
• To explore longitudinal changes to patient activation (measured using the 
PAM), and its associations with related constructs in patients with IA. 
• To develop a framework to describe patient activation in patients with IA.  
• To identify factors that influence patient activation and may be amenable to 
intervention. 
 
10.2 Contributions to knowledge 
The three studies (systematic literature review, qualitative interviews, and survey) 
included in this thesis provided the following original contributions to knowledge: 
 
• Evidence to suggest that interventions targeting patient activation can be 
effective but that there is no specific format of intervention that is most likely 
to be effective. 
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• Evidence that skilled self-managers perceive patient activation to involve the 
ability to prioritise and enact small changes. They believe another important 
aspect of patient activation is to determine when and how to get health 
related information and support as well as a sense of determination that they 
are responsible for their own health. 
• Evidence that there are aspects of the PAM that are not applicable or relevant 
to patients with fluctuating long-term conditions.  
• Evidence that actively managing rheumatology patients feel that the PAM does 
not capture their experience of patient activation.  
• A description of the range and dispersion of PAM scores and levels across a 
sample of rheumatology patients, including evidence that these PAM scores 
and levels are lower than the scores in the samples of prior studies with 
different long-term conditions. 
• The association between patient activation scores (as captured using the 
PAM) and self-efficacy, health locus of control, and health literacy as significant 
predictors that explain variance in PAM scores in a sample formed of 
rheumatology patients.  
• The association between patient activation levels (as captured using the PAM) 
and self-efficacy, illness beliefs and aspects of health literacy. These factors are 
significant predictors that explain variance in PAM levels in a sample formed 
of rheumatology patients. 
• Evidence to demonstrate that in a sample of rheumatology patients, the 
average score of the sample as a whole may exhibit statistically significant 
changes but individual patient activation scores are not static. These 
fluctuations can be in either direction. 
 
The longitudinal design of two of the studies provided an opportunity to investigate 
the fluctuating nature of patient activation. This broadened the current understanding 
around the complex nature of patient activation within rheumatology patients. 
Discussing patient activation with experienced, perceptive self-managers provided 
value in reviewing how rheumatology patients understand and perform patient 
activation.   
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The development of a model of factors amenable to intervention to improve patient 
activation is an original contribution to knowledge and provides flexible guidance that 
can be easily implemented into tailored interventions clinically.  
  
The novel findings that contribute to current knowledge will now be discussed in 
detail with reference to wider literature. 
   
10.3 Interventions targeting patient activation  
The systematic review investigated the effectiveness of interventions targeting patient 
activation in long-term fluctuating physical health conditions. The number of studies 
identified when the search was re-run 18 months after the initial searches 
demonstrates the increasing interest in patient activation. The findings indicated that 
while there was a wide range of formats, lengths and types of intervention included 
in the review, no one style or type of intervention was most effective for increasing 
patient activation. Consequently, interventions introduced into the NHS that target 
patient activation could be designed to suit individual departments or services 
according to their needs, resource availability, and the circumstances of long-term 
condition patients in their area. This includes funds for intervention duration, 
availability of staff and space for face-to-face interventions versus telephone and 
remote based support, and the digital literacy of patients in order to access internet-
based support. Community-focussed interventions can focus on reducing health 
inequalities by increasing access to resources, widening patients’ access to meaningful 
activities and identifying and mapping their networks. 
  
10.4 Patient perceptions of patient activation  
This thesis presents the novel finding that participants with rheumatic conditions had 
a broad and holistic sense of patient activation and of how they actively managed their 
health condition. 
 
The wide range of skills, behaviours and knowledge that participants gathered in 
order to actively manage their condition was evident. Of interest was their ability to 
negotiate the NHS to gather the help, support and information that they required, as 
well as their ability to proactively seek out information themselves and evaluate what 
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they had identified before applying it to their lives. This reflects aspects of health 
literacy contained under the wider umbrella of patient activation. 
 
Other self-management techniques such as pacing, adaptation, and prioritising valued 
activities were incorporated into patients’ perceptions of patient activation. This 
broad understanding with clear applied skills and behaviours relevant to 
rheumatology patients specifically contributes to the literature in a way that previous 
studies have not. This knowledge can prepare healthcare professionals for supporting 
rheumatology patients to actively manage their health, particularly those who are 
already skilled and for whom it can be difficult to clearly identify ways in which they 
may require support. The study provided an understanding of how current campaigns 
in place in the UK (e.g. the Ask 3 questions programme (The Kings Fund, 2013), 
agenda-setting tools for appointments etc.) are relevant to patient activation as the 
participants in this study perceived it. The data provided by participants provided a 
clear sense of the kind of care they valued to be able to effectively manage their 
health collaboratively. The direct access care system matched their preference for 
time-efficient specialist care that meant they were more likely to have contact with a 
clinician who knew their personal history. This supports the quantitative findings of a 
RCT introducing the direct access care system (Kirwan et al., 2003) as well as findings 
of prior qualitative research into patient priorities for care (Ward et al., 2007). 
 
The relevance of health literacy to patient activation was identified in this thesis. 
Participants discussed being able and confident to do their own health related 
research and apply what they have learned to their own circumstances including 
making health-related decisions. When asked about how they had learnt to self-
manage their health, participants discussed trial and error and being able to evaluate 
information and knowledge about their condition by following cues in their body. 
Skills demonstrating health literacy were present across much of participants’ 
perceptions of patient activation and underpinned their sense of an active 
responsibility for their health.  
 
The role of positive illness beliefs was a protective factor for participants in actively 
managing their health. They regularly reported feeling more motivated or able to 
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make changes or carry out activities because they considered how they were 
healthier, with fewer symptoms than others they knew or had seen before. This 
research provides qualitative descriptions of participants’ experiences of the 
relationship between illness beliefs and patient activation (Rask et al., 2009). 
 
One novel design of this qualitative study was meeting participants at the second 
timepoint to discuss their year of actively managing their condition, along with aspects 
of patient activation they had identified during this time. This design aspect offered a 
greater sense of participants’ ongoing journey to actively manage their health, and in 
some ways the first interview had the potential to be a self-management intervention 
of its own accord. Discussing tactics to take responsibility for one’s health, barriers 
and facilitators to this, and the skills that participants made use of along the way may 
have brought to light ways that they may like to self-manage individually. Alternatively, 
it may have led to them reconsidering how they managed their health and the active 
role they played in this over the course of the year in the knowledge that they would 
be re-interviewed. Research interviews acting as informal interventions is an issue 
particularly relevant to this study. Within the interviews, participants noted that they 
reviewed and reconsidered aspects of their self-management. Participants 
implemented self-management skills to allow them to retain activities or life roles 
that they personally valued. 
 
Prior to this study, no research had been identified by the researcher into patient 
perceptions of the term “patient activation” in any condition. Neither has there been 
research into what factors, skills and behaviours patients believed were contained in 
this construct for rheumatology patients. Given that prior research has identified that 
skills and behaviours performed by patients captured in a behavioural taxonomy by 
clinicians did not necessarily correlate well with high scores on the PAM (Ledford, 
Ledford and Childress, 2013), a clearer understanding of how patients understood 
patient activation offers detail about how to describe the concept and skills involved 
to patients. Participants described that to them, the term “patient activation” was 
appropriate to describe the skills and behaviours they made use of to manage their 
condition. They did not report issues with the term and the balance of power and 
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responsibility the term implies that have been reported elsewhere where clinicians 
are responsible for “activating patients” (de Iongh, 2018).  
 
10.5 Patient perceptions of the PAM as a measure of patient 
activation 
As literature so far has not identified how closely patients feel the PAM captures their 
understanding of patient activation, this has a clear contribution with relevance to 
both theory and practice. While there were mixed opinions on how closely 
participants in this study felt the items in the PAM captured their experiences of 
actively managing their condition, participants raised clear criticisms about the 
measure. Of these, the common reflection that participants could not always 
anticipate or prevent problems and fluctuations in their health was particularly vital. 
Participants’ perceptions were that while they could sometimes anticipate when they 
were likely to experience a flare because of overactivity, there were unpredictable 
circumstances outside of their control. Given that fluctuations and flares are common 
in IA (Walsh and McWilliams, 2012), and being able to respond effectively to changes 
must be a part of self-management, and participants felt the PAM did not meaningfully 
capture this aspect of managing their condition. 
 
Similarly, the lack of clarity about the accuracy of health-related beliefs such as the 
nature of patients’ condition and what their medications do could also contribute to 
participants with inaccurate but strong health beliefs scoring more highly on the PAM 
than they ought to be. As the PAM does not offer the opportunity to clarify the 
source and accuracy of the health-related beliefs, this could contribute to patients 
becoming “dangerous self-managers” with high PAM scores but poor health-related 
knowledge acquired from unhelpful sources or retained from contact with healthcare 
professionals rather than proactive information seeking. This has implications for the 
relevance of the PAM in determining the patient activation and skills of patients with 
fluctuating health conditions of complex aetiology such as IA, and consequently the 
benefit of the PAM as a tailoring tool for self-management support in these 
circumstances. 
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Patient perceptions of the PAM are particularly valuable given the move towards 
stratifying services based on patient activation abilities (Coleman and Price, 2017; de 
Iongh, 2018). This approach to tailoring may initially appear to be beneficial and based 
on patients’ individual needs. However, issues around the ethics of stratifying using 
the outcome measure have been raised (de Iongh, 2018, Gibert et al., 2017). The risk 
of only considering patients’ PAM scores and missing out on the valuable additional 
contextual information that the interview study participants noted could lead to the 
person-centred and tailored approach to care being so in name only. Gibert et al. 
(2017) discuss the lack of clarity in the type of responsibility patients may be asked 
to take for their health, including the anticipated practical responsibility but also the 
moral responsibility that was raised by a participant in the interview study (Mark in 
section 6.2). Gibert et al. (2017) also note that causal responsibility may also become 
an expectation held of patients. Therefore, supporting people who are able and willing 
to take practical responsibility for their health should not also include encouragement 
for patients to do so out of a sense of duty or judgement.  
 
Another ethical challenge that may occur when considering the role of patient 
activation in clinical decisions is that of encouraging patients who are able and willing 
to manage their health to feel autonomous and supported to do so without 
downplaying the role of wider health inequalities that impact self-management. 
Gilbert et al. (2017) suggested that this focus on individuals had the potential to place 
the burden of positive self-management solely at patients’ feet and fail to recognise 
already present health disparities. If people are unable or unwilling to prioritise their 
health about other challenges or goals in their lives, this may be met with shame or 
stigma. This should be considered when using PROMs to determine and support 
patient activation or self-management.  
 
10.6 PAM scores across a rheumatology population 
The study identified the spread of PAM scores and levels across a sample of UK 
rheumatology patients. Additionally, data demonstrating how PAM scores and levels 
behave over time were collected during this study. This is a novel finding as this has 
not previously been investigated in a rheumatology population. Identifying personal 
and contextual factors that contribute to patient activation scores within the sample 
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has the potential to contribute towards identifying factors for intervention that are 
appropriate, associated with patient activation, and represent skills that patients find 
beneficial. Identifying the demographic characteristics that were associated with high 
or low patient activation could be used to identify patients who are likely to have low 
patient activation for targeted additional self-management support. 
 
10.7 Predictors of patient activation (as captured using the 
PAM) 
Another contribution to knowledge arising from this study were the variables 
associated with patient activation (captured using the PAM) in a sample of 
rheumatology patients. While the non-normal distribution of the sample prevents 
these findings from being generalised to the wider rheumatology population, they 
suggest that different aspects of self-management could be associated with patient 
activation in patients with different long-term conditions. Crijns et al. (2019) reported 
no statistically significant relationship between a pain NRS and patient activation in 
their study with a sample of osteoarthritis patients, but the relationship was 
recognised in the study reported in this thesis. Therefore, this study strengthens the 
position that patient activation appears and behaves differently in different long-term 
conditions and, therefore, interventions to increase patient activation should be 
specific to the condition in their targeting.  
 
A particularly notable finding within this study was that positive and negative affect 
(captured using the PANAS) rarely contributed to variance in PAM scores. Given that 
the current model of patient activation centres around positive and negative affect 
and the PAM is the dominant measure to capture patient activation, this presents 
findings that undermine the model. Health literacy, self-efficacy and illness beliefs 
appear to be much more relevant to variance in patient activation within this sample 
of rheumatology patients. This has not been identified in previous research into affect 
and patient activation. 
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10.8 PAM score/level behaviour over time in rheumatology 
patients 
Given the limited longitudinal research into patient activation and the lack of 
longitudinal patient activation research within rheumatology, the findings of this thesis 
are novel. The behaviour of PAM scores and levels over time was of interest in order 
to understand how patient activation may change in an opportunity sample without 
any planned interventions. This also has implications for the potential impact of a 
patient activation intervention and how (if at all) to offer top-up support for patients.  
 
The findings of this study identified that there was a significant change in PAM scores 
between the two data collection timepoints across participants. However, individuals 
had changes in PAM scores that contributed to average PAM scores for the sample 
remaining consistent. This appears to be representative of PAM scores in long-term 
conditions (Rijken et al., 2014) but does not explain the substantial changes 
experienced by individuals in both directions from their baseline scores that 
contributed to balance in the average scores. 
 
10.9 Research strengths  
10.9.1 Patient and public involvement in the research 
The key strength of the project was the way that the studies were designed, discussed 
and planned with substantial PRP involvement and with patients in mind. There was 
a clear sense of the potential patient benefit to the outcomes of the thesis and the 
researcher took time to review how acceptable the planned studies were throughout 
the process. Patients were consulted as key stakeholders in the project to reflect 
their voice. The clearest evidence of patient involvement was the presence and 
perspective of the PRP, whose contributions are described in detail throughout the 
thesis. He communicated often with the researcher, both face-to-face and by email 
to offer his perspective on the research. The PRP and the researcher also co-
presented together during the PhD (see Appendices FF-II), most notably delivering a 
symposium at a national conference about patient activation.  
 
The patient advisory group at the BRI were consulted with the research design at the 
beginning of the PhD, and the researcher regularly made efforts to discuss the design, 
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results and implications of the project with patients and the public in order to gather 
a variety of perspectives and responses to consider throughout the PhD process.  
 
10.9.2 The longitudinal nature of the research 
Another strength of the research was that two of the three studies reported in this 
thesis were longitudinal. This is uncommon in both patient activation and 
rheumatology literature and represents an important opportunity to review self-
management and associated skills and constructs in detail. 
 
The longitudinal nature of the studies provided several benefits. Within the qualitative 
study, the opportunity to develop a rapport with participants during the first 
interview that could be maintained and built upon in the second interview was useful. 
Participants had already met and spent time with the researcher, reducing some of 
the risks of stilted conversation and allowing a better flow for discussions. The 
researcher already knew the participant and had some understanding of the context 
of their lives (but without making assumptions because they had met already). There 
was consistency in the interview style across both interviews as the researcher 
collected both datasets as the interviewer. This rapport may have potentially 
increased retention as the participants had already met and become comfortable with 
the researcher. On a practical level, being able to pick up on details of interest in the 
second interview or review anything that had been forgotten or may have required 
expansion from the first meeting was beneficial. 
 
Meeting participants for a second time added context and observations for the 
researcher which provided increased insight into how participants responded to 
changes. It also provided retrospective context to details discussed in the first 
interview as during the individual review in the second interviews participants 
sometimes volunteered additional information or updates for ongoing aspects of their 
lives.  
 
From a rigour and research design point of view, the opportunity to return to 
participants for the second interviews and present the findings of the first offers a 
strength as a form of member checking (Hannes, Lockwood and Pearson, 2010). 
While participants may have felt a sense of social desirability to agree with the 
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findings, the risk of this was reduced by the way the topic was introduced and pre-
empted with the researcher’s introduction to that phase of the interview. Being able 
to discuss the findings of the study and the initial framework analysis in detail with 
participants, including aspects where it may not have appeared to be credible for 
them personally, was a strength.  
 
10.9.3 Planning and integrating the mixed-methods research 
The precise nature of what mixed-methods work entails has been debated but there 
is general agreement that working with mixed-methods typically involves 
(Denscombe, 2008): 
• both quantitative and qualitative work within one project; 
• determining the design of the project, including what order the quantitative 
and qualitative aspects of the project will be conducted in and how the findings 
will be prioritised; 
• determining how the quantitative and qualitative findings of the project will 
relate to each-other; 
• working within a pragmatic epistemology. 
  
This thesis was developed, and the studies conducted, with a mixed-methods 
methodology as it was determined to be the most appropriate approach for the thesis 
and the specific research questions.  
 
A strength of the research was the way that the studies built on the findings of each-
other and were designed with the intention to be mixed from the beginning. The 
forethought on how the research findings would be triangulated later allowed the 
research design to use mixed methods in order to develop the framework of factors 
amenable to intervention. The intentions of integrating the findings were to increase 
credibility of the findings and reduce the impact of some of the limitations of each 
aspect of the study (i.e. gathering a sense of the prevalence of relationships between 
aspects of patient activation identified in the qualitative study and the PAM without 
having the social desirability of collecting these data in a face to face format) (Bryman, 
2006).  
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Developing the strategy so that the data could be collected sequentially ensured that 
the initial findings of the first interview timepoint contributed to the selection of 
constructs and measures to be included in the survey, and the first round of survey 
data collection was complete prior to the second interviews. These second 
interviews could then also include discussion of participants’ skills and activation 
relative to other rheumatology patients, as well as their perspectives on constructs 
that were identified as being associated with patient activation during the first survey 
analysis. Beginning with the systematic review provided a sense of the current 
literature in the field as well as identifying ways patient activation is currently being 
approached for interventions and in clinics. Subsequently, beginning the qualitative 
work after this allowed the research to continue in an inductive and open way. Given 
the timing of the studies there was a slight lead from the qualitative aspect of the 
project. There was a phase of interpretation and integration at the end of the data 
collection processes to review the findings as a whole (Dures et al., 2011). 
 
To understand the quality of the integration of both the qualitative and quantitative 
aspects of the data collection, an additional evaluation is proposed above and beyond 
the traditional assessment of quality for the two separate methods of data collection. 
This provides a sense of “inference quality” (Tashakkori and Teddlie, 2008). This 
incorporates aspects of internal validity, credibility as well as the appropriateness and 
quality of the studies’ designs (Ihantola and Kihn, 2011).  
 
10.9.4 Consideration of implementation 
Another strength of the thesis was the ongoing focus on potential implementation 
and how the research is relevant to academic researchers, clinical staff, and patients. 
Given that patient activation is a construct that is receiving increasing focus and 
interest and there were several gaps in the knowledge identified at the beginning of 
the project, the need for research with a consideration for implementation strategy 
when designing the research project was necessary. Developing a theoretical 
understanding of patient activation could then be applied to evaluating and 
understanding how useful and acceptable the current provision for supporting self-
management is.  
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10.9.5 Research rigour 
Efforts were taken to conduct the research described in this thesis to the maximum 
rigour possible to increase the strength of the work. These attempts to conduct 
rigorous research are another strength of the research. Steps taken to ensure rigour 
included: 
• Regular reflection throughout, but most specifically during the planning, data 
collection and analysis of the qualitative data. A reflective journal maintained 
throughout the PhD process by the researcher offered the opportunity for 
contemplation and to consider varying perspectives on the research 
(Appendix J). 
• A selection of the full texts of the systematic review were reviewed by a 
second screener for clarity and a consensus exercise was conducted between 
the researcher and second screener to clarify agreement for inclusion. 
Additionally, the risk of bias exercise was conducted with a second screener. 
Again, a consensus exercise was conducted between the researcher and 
second screener to clarify agreement. 
• Triangulation efforts were incorporated into study protocols including the 
review of interview transcripts by members of the supervisory team, 
discussion of analysis categories and codes with the PRP, and a review of the 
completed analysis with members of the supervisory team. This regular 
independent review, as well as the member checking and suggestions made 
by the participants during member checking and independent colleagues 
throughout the PhD process reduced the risk of researcher bias.  
• Transparency was a priority throughout the process. Sharing the initial 
findings during the second interviews with interview participants provided a 
sense of how categories were developed and interpreted by the researcher.  
• Attempts were made to reduce the risk of socially desirable answers and 
conformity from the interview study participants, with the researcher 
introducing herself as such and reminding participants at appropriate intervals 
that she was separate from their healthcare team. It was anticipated that this 
may have helped participants to feel like they could be more open and honest 
about how they managed their health and the relationship they had with their 
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healthcare team without feeling the need to provide socially desirable 
responses. 
• For the quantitative research, an analysis protocol was developed prior to the 
collection of the data to ensure that the results were not shaped by 
researcher bias or reduced to data dredging (Ioannidis, 2005). The data 
analysis plan was developed following discussion with a statistician and 
reviewed in detail at a later date. 
  
10.10   Research limitations  
There were several limitations of the research. The majority of these were related 
to the studies’ methods. 
 
The qualitative study focused on participants who were good self-managers but 
consequently this contributed to a sample that was made up of participants who were 
already engaged and interested in managing their health. These participants were all 
white, many of them had prior experience as a research participant, they had largely 
been in professional work, and those who were in the circumstances to be able to 
access higher education had done so. This was beneficial for understanding how these 
experienced participants understood patient activation, but the qualitative findings 
were limited in their transferability as a result. Their experiences of proactive self-
management would have led to them having substantially different encounters with 
healthcare professionals and this should be considered when putting the findings of 
this study into context. This is particularly relevant given that increased therapeutic 
alliance is associated with improved self-management skills (Ehde et al., 2015).  
 
Including several participants who were passive self-managers with low patient 
activation would have offered an alternative perspective and strengthened the study. 
The decision had been taken not to recruit these participants because identifying 
these lower PAM level participants would have necessitated a screening process and 
this had the potential to be distressing or inconvenient for participants. Consequently, 
screening was not included in the study design. 
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While this was one of the few studies capturing patients’ perspectives on patient 
activation in rheumatology, including interviews with clinicians in the rheumatology 
field would have provided an additional, rich perspective on how they work 
collaboratively with activated rheumatology patients. 
 
Another limitation is that the retention rates for both the interview and the survey 
studies were moderate overall. While all the participants lost to follow-up for the 
interview study had been contacted and the reasons for their discontinued 
participation were established, ultimately not all participants could be contacted for 
a second interview. This likely had an impact on the findings of the follow-up 
interviews and had an impact on how the interviews progressed. Additionally, the 
sample of participants in this study who completed the PAM at both interviews was 
very low. This then provided limited information about how we can consider 
participants’ perspectives in light of their PAM scores. However, this limitation was 
mediated with the survey study capturing a much greater sample of rheumatology 
patients’ PAM scores and levels in order to understand their current skills and 
abilities. 
 
In some ways, the rapport and prior contact that had made the longitudinal interviews 
a strength did have drawbacks. For participants who felt as though little had changed 
in the year between interviews, they sometimes described having little to report as 
things were “business as usual”. In some ways, an additional strand of data collection 
in the research design, such as regular diary entries or reflections over the year may 
have offered additional structure and served as a reminder of how participants had 
managed their health during the intervening year at the second interview.  
 
The survey study also had several limitations. With hindsight, collecting data on co-
morbidity may have been beneficial in order to identify whether there were significant 
differences in either patient activation or predictors of patient activation in these 
participants compared to those with a single diagnosis. Given that there are 
associations between multimorbidity and patient activation and additional challenges 
involved in navigating healthcare with multiple diagnoses (Blakemore et al., 2016), it 
is possible that there were differences in patient activation that originated from 
managing multiple conditions in this sample.  
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The decision to use the Health Literacy Questionnaire as the outcome measure 
capturing health literacy was made because it was convenient for capturing without 
any sort of quiz or test for participants to increase the risk of shame, or checking of 
answers. However, consequently this led to capturing nine separate dimensions of 
health literacy in the form of the subscales. These nine separate variables may have 
weakened the strength of the findings because there were so many variables and a 
much larger sample size was needed. 
 
While the sample was intended to be as representative as possible of rheumatology 
patients in the UK, the skewness of the sample meant that the findings could not be 
generalised to a wider population. 
 
Finally, some aspects of interest identified in the qualitative study were not followed 
up during the survey for a variety of reasons (presented in Table 7.8). This may be 
considered a limitation of this research. 
 
 
10.11  Implications for research  
10.11.1 Methodology 
The use of longitudinal research methods to assess patient activation and overall self-
management constructs offered increased insight into how rheumatology patients 
actively manage their health. The two sets of interviews offered the opportunity for 
analysis to be approached between participants and within participants using 
framework analysis. Longitudinal qualitative self-management research is uncommon 
within the field of rheumatology but in these circumstances provided a detailed sense 
of patient activation within a temporal context.  
 
10.11.2 Knowledge implications 
• The findings of the thesis contribute to understanding the self-management of 
rheumatology patients and factors that could support them to feel more able 
to take responsibility for their own self-management. Illness beliefs have been 
demonstrated to contribute to increased ability to effectively self-manage, and 
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it is possible that patient activation is the mediating factor to improved self-
management because of its relationship with illness beliefs.  
• The systematic review identified that, while there are conceptual differences 
between patient activation, patient engagement, patient enablement and 
patient empowerment, the terms are often used inter-changeably within 
publications. 
• The model of factors amenable to intervention in patient activation provides 
a theoretical grounding on which self-management interventions can be 
mapped. 
  
10.11.3 Clinical implications 
• The PAM does not necessarily capture aspects of patient activation as 
rheumatology patients understand the concept. There are aspects of the 
measure that they feel are not appropriate for their needs. The source of 
patients’ knowledge and information is important to them and the PAM does 
not account for this. Additionally, the use of the PAM with fluctuating health 
conditions has some challenges as it does not account for the unpredictable 
fluctuations and flares that can occur with IA. The PAM should be considered 
as a tool that captures aspects of patient activation but is not a comprehensive 
measure. For this reason, when the measure is used in clinic, PAM scores and 
levels should be supplemented with clinical judgement and discussion with 
patients about how well they feel they are actively managing their health. This 
will contribute to ethical care planning based on the understanding that 
patients’ PAM scores and levels may change substantially between routine 
follow-up appointments in rheumatology. 
• These issues with the PAM may contribute to a “false positive” where 
someone completes the PAM with strong beliefs that they are aware of the 
nature and cause of their condition (with inaccurate information). 
Consequently, healthcare professionals should consider PAM responses in 
context to reduce the risk of this false positive where patients have a higher 
PAM level or score than may be appropriate. 
• Patients with a strong ability to actively manage their rheumatic condition 
generally value prompt access to their rheumatology units. This is because of 
both the specialist knowledge about rheumatic conditions these healthcare 
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professionals hold and the consistency of support from professionals who 
understand and can recall patients’ personal experiences. The direct access 
care system was particularly appreciated as a method of accessing the kind of 
care participants valued because they could make prompt use of secondary 
care support rather than negotiating the barriers of primary care through 
general practitioners. This adds to the evidence supporting this type of care 
and the benefits it has within a rheumatology setting. 
• Rheumatology healthcare professionals or units who intend to focus on 
increasing a patient’s activation would benefit from incorporating regular 
reviews and preparations for any increases or reductions in patient activation 
into the care planning process. As learning to actively manage a rheumatic 
condition appears to be an ongoing process that does not necessarily relate 
to disease duration, healthcare professionals should also consider the 
possibility of changes to patient activation as a factor when making clinical 
judgements and decisions with patients. The findings of the thesis also have 
implications for the NHS services that are currently designed to provide a 
stratified, stepped care service with the PAM as a method of determining the 
form of support their patients require. While average PAM scores across the 
survey study sample remained similar over time, some individuals saw 
substantial changes. This should be considered when implementing such a 
service design. 
• Patients tended to prioritise and make decisions around their daily life with 
their condition in order to preserve roles they valued and to be able to carry 
out activities that were important to them. This sense of participants’ making 
use of their values to self-manage their health suggests that there may be a 
role for Acceptance and Commitment Therapy (Hayes, Strosahl and Wilson, 
1999) in patient activation interventions. 
• Reviewing, assessing and supporting patients to develop health literacy skills 
is a key component of supporting them to actively manage a long-term 
condition. This health literacy ability contributes to a curriculum of learning 
to manage long-term conditions, including how to deal with flare-ups, setbacks 
and accessing appropriate support for these challenges. Patients need to learn 
how to seek out different types of support for long-term conditions (e.g. 
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physiotherapy access via primary or secondary care, or how to organise 
additional pharmacology treatments in the event of a flare-up), as well as when 
and how to get answers to questions. These are examples of health literacy 
skills that could be targeted during an intervention or resources to guide 
patients to actively manage their health more effectively. 
• The current emphasis of patient activation interventions within the NHS 
appears to be focused on developing methods to support people who are 
currently passive in the management of their health condition to take as much 
responsibility as they can. However, as identified in the survey study there are 
a broad range of skills and most of the rheumatology patients in the sample 
were at PAM level 3. Consideration should be given to how best to support 
patients with low patient activation without overburdening them or 
preventing other patients learning to manage their health receiving the 
support they need.  
• Given the difference between PAM levels 3 and 4 largely depends on people’s 
abilities to return to self-management and respond to setbacks, the way that 
patients are supported to prepare for fluctuations and flares (if support is 
provided) will differ based on their activation level and self-management skills.  
Stepped interventions to deal with flares and planning how to return to 
actively managing one’s condition can be developed prior to flares, if this is 
possible.  
• Supporting patients who have high levels of activation but lower levels of 
health literacy (the “dangerous self-managers” referred to by Yadav et al. 
(2018)) requires consideration. Health literacy assessments could identify 
these patients at risk. The value of health literacy in patient activation has been 
demonstrated and improving these skills can contribute to higher levels of 
patient activation overall. 
• Training healthcare professionals within rheumatology in understanding the 
nature of patient activation according to patients will help to clarify the 
concept, contribute to conversations being more collaborative where 
appropriate, and provide healthcare professionals with the skills to effectively 
assess levels of patient activation in a holistic way.  
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10.12   Directions for future research 
Given the substantial increase in interest in patient activation within the NHS 
currently, future research building on the findings of this thesis should take the form 
of implementing intervention support based on the needs of departments and 
services as well as the resources available. The priority should be that the support is 
easily implemented and grounded in theory, particularly as the systematic review 
identified no strong evidence about a single format that is most suitable. The 
interventions to increase patient activation would ideally focus on the factors 
identified within this thesis as being amenable to intervention. This might compromise 
group programmes or as training opportunities for healthcare professionals to 
incorporate support into routine care and clinical practice. Research to identify 
appropriate forms of intervention and determine the acceptability of these 
interventions to patients, healthcare professionals and commissioners should be the 
next step. 
 
A combination of the research findings and review of the literature in preparation for 
the thesis has also identified a need for increased health literacy skills both for people 
with rheumatic conditions and across the population more broadly. This requires 
further examination, and health literacy training at a broader, population level may 
be a direction for future research. 
 
There is also a need for further research about how to provide ongoing support and 
how to structure services to support people with high patient activation in order to 
understand what kind of ongoing support is appropriate for them. The introduction 
of sustainability and transformation plans in the NHS are built on the foundations of 
patient activation and increasing this in the patient population (NHS England Midlands 
and East, 2016; Bristol, North Somerset and South Gloucestershire Clinical 
Commissioning Group, 2016). Evaluating the effectiveness and implementation of 
these plans with a more holistic patient-centred sense of patient activation would be 
useful. This is particularly relevant given the financial benefits of increased patient 
activation identified in the literature.  
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Given some of the issues identified by interview participants, there is a need for future 
research into an appropriate alternative or alterations to the PAM for rheumatology 
patients. This could contribute towards a more holistic assessment of patient 
activation for patients with fluctuating conditions. 
 
10.13   Concluding thesis summary 
Patient activation is more than the PAM and has been under-represented in long-tern 
condition research, particularly in rheumatology. The findings presented in this thesis 
report the broad range of skills, beliefs and behaviours that are incorporated in 
patient activation in IA. This has implications for the use of the PAM in clinical 
practice, as it is a tool best used when incorporated with collaborative conversations 
with patients about how they prefer and are able to manage their health, as well as 
clinical judgement from healthcare professionals. 
 
Skilled self-managers reported that being determined and independent about 
managing their health, finding ways to make small, sustainable behaviour change, 
effectively navigating the NHS, knowing what techniques suited them individually, 
having positive perceptions about their health, and good social support were key to 
how they actively managed their conditions. They felt that while aspects of the PAM 
reflected how they performed patient activation it was not suitable for capturing the 
fluctuating nature of their IA. 
 
While there has been a substantial amount of research into identifying factors 
associated with patient activation, this has not been previously conducted with 
rheumatology patients. Self-efficacy, illness beliefs, health literacy and an internal 
HLOC were associated with variance in PAM scores. The first three factors were 
also predictive of variance in PAM levels. Positive and negative affect was not 
associated with PAM scores, despite being fundamental to the prior conceptualisation 
of patient activation. The framework of factors presented in the thesis suggests that 
self-efficacy, illness beliefs, health literacy, and internal HLOC are personal factors 
amenable to intervention for people with IA. 
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Appendices 
Appendix A: Systematic review inclusion and exclusion 
criteria 
 
Inclusion Criteria: 
Studies that relate to: 
• People with chronic physical conditions as participants. 
• An intervention with a measure of patient activation as a primary or 
secondary outcome measure. 
• Randomised control trials and pragmatic randomised control trials where 
there is an intervention. 
• The review will only include studies that are written in English, or translated 
to English. 
• Articles since 2004 (increase in patient activation lit at this time). 
• The participants will be adults (over 18 years old) There were no limitations 
on multi-morbidity, so people with more than one physical health condition 
will be considered. 
 
Exclusion: 
• Studies with mental health diagnoses as the primary chronic condition. 
• Studies with participants under 18. 
• Studies with no measure of patient activation (matching the definition). 
• Studies prior to 2004. 
• Studies with participants without a chronic physical health condition. 
• Studies not written in English or translated to English. 
• Studies that are not RCTs or a pragmatic RCT. 
• Studies without an intervention. 
• Protocols without data. 
• Duplicates. 
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Appendix B: Blank Cochrane risk of bias tool 
General Information 
Risk of Bias assessment 
(See Handbook Chapter 8. Additional domains may be added for non-randomised studies.) 
Domain Risk of bias Support for judgement 
(include direct quotes where available with 
explanatory comments) 
Location in text or 
source (pg & 
¶/fig/table/other) 
Low High  Unclear 
Random sequence 
generation  (selection bias) 
   
  
Allocation concealment 
(selection bias) 
   
  
Blinding of participants 
and personnel 
(performance bias) 
   
Outcome group: All/  
(if separate judgement by 
outcome(s) required) 
   
Outcome group:   
Blinding of outcome 
assessment (detection 
bias) 
   
Outcome group: All/  
(if separate judgement by 
outcome(s) required) 
   
Outcome group:   
Incomplete outcome data 
(attrition bias) 
   
Outcome group: All/  
(if separate judgement by 
outcome(s) required) 
   
Outcome group:   
Selective outcome 
reporting? (reporting bias) 
   
  
Other bias      
Notes: 
 
Date form completed (dd/mm/yyyy)  
Name/ID of person extracting data  
Reference citation  
Study author contact details  
Publication type (e.g. full report, abstract, letter)  
Notes: 
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Appendix C: Interview consent to contact form 
 
Dear  
 
Invitation to take part in an interview  
 
I am writing to tell you about a research project for which I am helping PhD student 
Bethan Jones and her research supervisors. Bethan would like to find out more 
about the ways that patients have learned to live with their arthritis, including what 
they have found helpful and whether this changes over time.  
 
This research is being run in rheumatology units in two hospitals across England. It 
is led by Bethan Jones and her research supervisors from the University of the West 
of England, who are based in the Bristol Royal Infirmary Rheumatology Unit. 
 
I am enclosing the patient information sheet about the study for you to read. Taking 
part in research is voluntary and if you would prefer not to do so nobody will be 
upset and your treatment will not be affected. 
 
If you would be interested in taking part, please complete the enclosed slip and 
return it to the researcher Bethan Jones in the prepaid envelope provided.  
 
Thank you for taking the time to read the enclosed information. 
 
Yours sincerely 
 
 
Consultant Rheumatologist 
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Understanding Patient Activation: an interview study 
Invitation to take part in an interview 
 
Reply slip 
 
 
 Yes I would be interested in hearing more (I understand this does not 
commit me) 
 No  Thank you, I would prefer not to be involved 
 
 
Name: 
Address: 
 
 
Tel Number (s): 
Email: 
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Appendix D: Information sheet for qualitative interviews 
 
How people with inflammatory arthritis understand Patient 
Activation: an interview study 
 
Patient Information Sheet 
 
You are being invited to take part in a research study. Before you decide it is important for 
you to understand why the study is being done and what it will involve. Please read the 
following information and discuss it with friends and relatives if you wish. If anything is not 
clear or if you would like more information, you are welcome to get in touch with Bethan 
Jones. Her contact details are at the end of the document.   
 
Who is asking you to take part? 
I am Bethan Jones, and I am a student at the University of the West of England. I am inviting 
you to take part in a research study that will contribute to my PhD. 
 
What is the purpose of the study? 
The purpose is to find out what you have learned about living with arthritis. I am interested 
in what has been helpful to manage your arthritis, how you have found this out and if this 
changes over time. 
 
Why have I been invited to take part? 
You have been invited to take part because you are living with a type of inflammatory 
arthritis. I am inviting patients to take part from two NHS hospitals in England. 
 
What will I be asked to do if I take part? 
I will ask you to take part in two interviews and to complete a questionnaire called the Patient 
Activation Measure. At each interview, I will ask you about your experiences of learning to 
live with arthritis. I will audio-record the interview and type it up. Everything that you say will 
be confidential. The interview will last for around one hour and will take place in a non-
clinical room in your local rheumatology department. I will offer you refreshments and I will 
pay your travel costs to attend. I will then contact you approximately one year after the first 
interview to see whether you are interested in taking part in a second interview with me.   
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Do I have to take part? 
No, taking part is voluntary. It is up to you to decide whether to take part. If you do decide 
to take part, I will ask you to sign a consent form at each interview, and I will give you a copy 
to keep. If you decide not to take part you do not have to give a reason, nobody will be upset 
and the care you receive will not be affected. If you do decide to take part, you are still free 
to withdraw at any time and without giving a reason.  A decision to withdraw at any time, or 
a decision not to take part, will not affect the standard of care you receive. You can withdraw 
from the study by contacting Bethan Jones on the details provided below. 
 
What are the possible risks of taking part? 
I hope there will not be any risk to your wellbeing from discussing your experiences of having 
arthritis. However, if the interview makes you feel worried or concerned about your arthritis, 
I will arrange for you to see your clinical nurse specialist or rheumatologist. 
 
What are the possible benefits of taking part? 
There is not likely to be any direct benefit of taking part to you, but some people may find it 
helpful to discuss how they manage arthritis. However, I think this study will benefit people 
with arthritis in the future as we understand more about how people learn to live life with 
arthritis over time. 
 
Will my taking part in this study be kept confidential? 
Yes. When the interview is typed up it I will take out all names of people and places. My 
reports will not contain the names of people or places from the interviews. The audio 
recordings will be deleted as soon as I have typed up each of the interviews.  
 
What will happen to the results of the research study? 
The findings will be reported in professional publications, journals and conferences. This will 
include direct quotes from the interviews, which will be anonymised. They will also be 
published in my doctoral thesis. In addition, I will send a summary of the results to everyone 
who takes part in the study. A copy of your anonymised questionnaire answers will also be 
sent to Insignia Health, a commercial company outside of the NHS who offer us the licence 
to use the Patient Activation Measure. They are not directly working on the study, but your 
name and any identifying information will be removed to keep this data anonymous. They 
use this information to improve, refine and understand how the questionnaire is completed.  
 
Will you keep my information and contact me again? 
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After the second interview is over, we may retain your contact details to get in touch with 
once more with information about future research going on in this project, but you do not 
have to read it or ask to take part. This information will be retained for one year following 
completion of your second interview, and then it will be destroyed.  
 
Who is funding the study? 
This research study is funded by Arthritis Research UK. 
 
Who has reviewed the research? 
It has been approved by the include West of Scotland REC 4 for the Health Research 
Authority. (REC  
project ID 219233) and the University of the West of England (UWE) ethics committee.   
 
What do I do now? 
If you are interested in taking part in an interview, please complete and return the slip in the 
reply-paid envelope.  I will then contact you with further information.   
 
 
Central study contact details:  Bethan Jones 
     Rheumatology Research 
     Level 5, Zone B 
Bristol Royal Infirmary 
Bristol  
BS2 8HW 
 
 
0117 342 7415 
Bethan8.jones@live.uwe.ac.uk 
 
Study Team: 
Bethan Jones, PhD Student (UWE Bristol) 
Emma Dures, Senior Research Fellow (UWE Bristol) 
Sarah Hewlett, Professor of Rheumatology Nursing (UWE Bristol) 
Diana Harcourt, Professor of Appearance & Health Psychology (UWE Bristol) 
Andrew Hunt, Patient Partner (Bristol Royal Infirmary) 
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If you have any concerns about participating in this study and would like to receive 
free independent advice please contact PALS (Patient Advice and Liaison Service) 
on: 
0117 342 1050 or via email on psct@uhbristol.nhs.uk. 
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Appendix E: Interview consent 
forms 
 
CONSENT FORM 
 
How people with inflammatory arthritis 
understand Patient Activation 
Please 
initial 
box 
 
 
1. I confirm that I have read and understand the information sheet dated  
15/05/2017 for the above study, and I have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at  
any time, without giving any reason. 
 
3. I agree to take part in a research interview.  
 
4. I agree to the interview being recorded and understand that names will be  
removed from the typed transcript.  
 
5. I agree that anonymised quotes from interviews will be used in academic 
journal publications, conference presentations, reports, and a doctoral thesis. 
 
6. I understand that relevant sections of my medical records and data collected during  
the study may be looked at by responsible individuals from the NHS Trust where I receive 
my care, or from regulatory authorities. I understand that this will only happen where it 
is relevant to my taking part in this research. I give permission for these individuals to  
have access to my medical records. 
 
7. I agree to be contacted about a second interview in approximately 12 months’ time.  
  
      
________________________ ________________ ______________ 
Name of Participant Date Signature 
 
 
_________________________ _____________ ______________ 
Name of Person taking consent Date Signature 
(if different from researcher) 
 
________________________ ________________ ______________ 
Name of Researcher Date Signature 
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CONSENT FORM 
 
Understand Patient Activation: An Interview 
Study (follow-up) 
Please 
initial 
box 
 
 
1. I understand that my participation is voluntary and that I am free to withdraw at  
any time, without giving any reason. 
 
2. I agree to take part in this second research interview.  
 
 
3. I agree to this interview being recorded and understand that names will be  
removed from the typed transcript.  
 
4. I agree that anonymised quotes from this interview will be used in academic 
journal publications, conference presentations, reports, and a doctoral thesis. 
 
5. I understand that relevant sections of my medical records and data collected during  
the study may be looked at by responsible individuals from the NHS Trust where I receive 
my care, or from regulatory authorities. I understand that this will only happen where it 
is relevant to my taking part in this research. I give permission for these individuals to  
have access to my medical records. 
 
6. I understand that an anonymised copy of my questionnaire data will be shared with  
a commercial company outside the NHS who licence the Patient Activation Measure.  
 
7. I agree to be contacted about similar research in the future.  
  
      
________________________ ________________ _______________ 
Name of Participant Date Signature 
 
_________________________ ________________ _______________ 
Name of Person taking consent Date Signature 
(if different from researcher) 
 
________________________ ________________ _______________ 
Name of Researcher Date Signature 
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Appendix F: Qualitative study protocol 
Understanding Patient Activation: a longitudinal interview study 
 
Protocol – 24th July 2017 (Version 2) 
 
Principal Investigator 
Bethan Jones PhD student, University of the West of England (UWE), Bristol  
 
 
Project team members 
Emma Dures   Senior Research Fellow, UWE, Bristol 
Sarah Hewlett   Professor of Rheumatology Nursing, UWE, Bristol  
Diana Harcourt  Professor of Appearance & Health Psychology, UWE, 
Bristol 
Andrew Hunt   Patient Research Partner, Bristol Royal Infirmary 
 
 
Contact details 
Bethan Jones 
Rheumatology Research 
Level 5, Zone B 
Bristol Royal Infirmary 
Bristol  
BS2 8HW 
 
Tel: 0117 342 7415 
Email: Bethan8.jones@live.uwe.ac.uk 
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Glossary: 
IA  Inflammatory arthritis 
PAM  Patient Activation Measure 
UWE  University of the West of England, Bristol 
UHB  University Hospitals Bristol 
 
Summary of the study: 
                                                                                         
Inflammatory arthritis (IA) describes several long-term conditions including 
rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, connective tissue 
disease and systemic lupus erythematosus (Arthritis Research UK, 2016). 
Inflammatory arthritis impacts people in a variety of ways, often requiring significant 
life adaptations to cope with the diagnosis. People can experience pain, fatigue, 
reduced mobility, low mood, increased anxiety, and unpredictable fluctuations or 
“flares” in symptoms (Homer, 2005). Because IA is often managed in specialist 
departments in secondary care, people are expected to develop skills to manage 
their condition (Hibbard, Stockard, Mahoney & Tusler, 2004). 
 
Research indicates that there are a variety of factors that can impact how someone 
manages their health, and one of these is a concept called patient activation (Hibbard 
et al., 2004). It is defined as how willing and able someone is to take an active role in 
dealing with their health (Hibbard and Greene, 2013). 
 
Higher levels of patient activation are associated with fewer emergency hospital 
admissions, fewer days as an inpatient and lower healthcare costs (Hibbard et al., 
2015). Therefore, there is a value in understanding activation to reduce strain on the 
NHS.  For individuals, people who are more activated are also more likely to stick to 
their treatment schedules, and have better outcomes overall (McCusker et al., 2016).  
 
In order to understand patient activation in people with inflammatory arthritis, 
interviews will be carried out with people living with arthritis to understand how they 
manage their health, what factors have an impact on the way they cope with arthritis, 
and what skills they have to reduce the impact of their condition on their life. The 
study will be longitudinal, and participants will be re-interviewed 12 months after 
their initial interview to understand how their perceptions of patient activation 
develop over time, and whether they have learned or recognised any additional ways 
of managing their health actively during this time. 
 
This study (funded with a PhD scholarship from Arthritis Research UK) will contribute 
to the development of a framework to describe patient activation in IA. 
Understanding people’s experiences of managing their health, and what has had an 
impact on this can contribute to the framework. Seeing the same people again a year 
later for a second interview can help understand whether actively managing their 
health has changed, and identify what they think has contributed to this. They will 
also have the opportunity to reflect on their last interview, to see if their 
understanding of patient activation has changed. This longer-term approach can help 
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us to understand changes over time, particularly as inflammatory arthritis is a long 
term condition (Lorig et al., 2001). 
The main aim of the study is to understand how people at different levels of patient 
activation perceive and understand this construct over time.  
 
The study objectives are: 
• To explore perceptions of the term, description, and concept of “patient 
activation” from the perspectives of people with IA. 
• To identify individual and contextual factors that people with IA believe 
contribute to patient activation. 
• To explore people’s experiences of actively managing their IA. 
• To gather opinions from people with IA on the PAM as a method of capturing 
patient activation. 
• To find out how these perceptions develop over a period of 12 months. 
 
Having a framework to describe patient activation in people with inflammatory 
arthritis offers the opportunity for a theory-driven intervention to support people in 
taking the next step to actively manage their health condition. This study will help to 
ensure that any future intervention is focused sufficiently on rheumatology related 
contextual factors to suit people living with inflammatory arthritis. 
 
Background: 
Models of illness have an impact on the way that care is delivered to people living 
with long term health conditions. The previously dominant biomedical model has 
been criticised for not considering the impact of other social, psychological and 
behavioural factors that can contribute to people’s experience of living with health 
conditions (Wade & Halligan, 2004). This can imply that people are passive in their 
experiences, and doesn’t consider how people can influence their health.  
 Because of these criticisms, the biopsychosocial model has encompassed these 
additional factors which can contribute to outcomes (Engel, 1977) and describe 
people’s experiences in a more holistic way. This shift gives people with long term 
conditions more of a position as experts in living with their health condition with 
more responsibility to self-manage their condition. People are expected to develop 
skills to manage their illness, become more involved in making decisions about their 
condition in collaboration with health care professionals, and develop knowledge 
about behaviours which help manage their health (Hibbard, Stockard, Mahoney & 
Tusler, 2004).  
 
 
Research indicates that there are a variety of factors that contribute to how engaged 
someone becomes in managing their health, and one of these is a concept called 
patient activation (Hibbard et al., 2004). It is defined as being how willing and able 
someone is to take an active role in dealing with their health (Hibbard and Greene, 
2013). It appears to be a multidimensional construct, incorporating associated 
concepts such as self-management behaviours, health literacy, and self-efficacy (the 
belief in one’s ability to achieve a desired outcome) (Hibbard et al., 2004; Do, Young, 
Barnason & Tran, 2015).  
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Higher levels of activation are associated with fewer emergency admissions, fewer 
days as an inpatient and lower healthcare costs (Hibbard et al., 2015). Therefore, 
there is a value in understanding activation to benefit a resource-scarse NHS.  On an 
individual level, increased activation is associated with greater adherence to 
treatment schedules and better outcomes overall (McCusker et al., 2016). In the 
context of inflammatory arthritis, activation might also involve behaviours such as 
regular stretching to reduce stiffness, having and acting on a plan for when their 
condition flares up, and managing stress levels by scheduling in time to practice 
relaxation techniques (Dixon, Hibbard and Tusler, 2009). 
The dominant model of explaining activation is captured in the extensively used 
“Patient Activation Measure” (PAM) (Hibbard et al., 2004), with the PAM described 
as identifying the beliefs that people have about themselves and the responsibility 
they hold for managing their health (Hibbard & Mahoney, 2010).  A licence is required 
to use the PAM in research, and this is being applied for using the funding in place 
for the research study.  
The PAM and the underpinning model describe activation as involving four stages, 
each building on the other in a hierarchy (Hibbard et al., 2004). Hibbard proposes 
that people become more able to develop through the stages and become more able 
to engage in more complex behaviours as they become more activated (Hibbard et 
al., 2015). While it is believed that providing information alone is not sufficient to 
activate patients (Rix and Martin, 2015), factors which do contribute to increasing 
people’s confidence and ability to actively manage their health are less understood.  
However, little is known about the dimensions and factors involved in patient 
activation in the context of people with IA. Therefore, gathering qualitative data on 
patients’ perceptions of activation, and how it changes over time, could contribute 
to an understanding of the concepts and contextual and psychosocial factors 
underpinning patient activation as a construct. 
 
Design and methods:  
 The study design is longitudinal and will include two phases, using qualitative 
methods of data collection and analysis. The two phases will require NHS Research 
Ethics (REC), university ethics, and local research governance approvals in a combined 
application before data collection can commence.  
 
Phase 1:  
Method: 
Rheumatology patients with a diagnosis of IA will be invited to take part in two face-
to-face interviews, approximately 12 months apart. The interviews will help develop 
an understanding of participants’ thoughts, feelings, beliefs and personal 
circumstances. By using a semi-structured format this will allow for all participants to 
be asked the same initial set of questions. However each interview will be able to 
progress based on the participants’ responses, in order to gather more information, 
ask for clarification and open up new lines of enquiry.  
 
These interviews will be facilitated by Bethan Jones, a PhD student with prior 
experience of conducting semi-structured interviews in a research context. The 
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interview schedule has been developed by the research team, and reviewed by a 
patient group associated with one of the research sites. 
 
The interview includes questions on personal and contextual factors which might 
have an impact on activation, and explores participants’ thoughts on the definition 
and dominant model of activation and use of the Patient Activation Measure (PAM) 
(Hibbard et al., 2005) to measure activation. Asking participants about their 
understanding of self-management, and strategies they use, including things which 
have challenged them will provide insight into their current activation, and how they 
engage with this (Dixon, Hibbard & Tusler, 2009). Asking implicitly about what skills 
they feel they have developed and what they found beneficial in this learning process 
will allow the opportunity to develop an understanding of the information and skills 
necessary. These interviews will also offer the opportunity to gather data from 
participants about how they believe their active role in managing their health is 
related to concepts such as self-efficacy and self management. 
 
Recruitment: 
As there is a great deal of variety in patient activation levels in people with long term 
conditions (Hibbard et al., 2005), there is a benefit to speaking with participants who 
have had more experience of managing their health to understand the factors 
involved that they have identified. People will be eligible to take part if they are over 
18 years old, with a diagnosis of IA, able to provide informed consent to participate 
and are able to communicate, read and write in English sufficiently to participate. 
 
To gather a sufficient range of experiences participants will be sampled from two 
rheumatology departments in the Southwest: the Bristol Royal Infirmary and Weston 
General Hospital.  Eligible patients will be given study information pack when they 
attend for an outpatient clinic appointment, or through the post.  The information 
pack will contain an invitation to participate from the local clinical lead, a Patient 
Information Sheet, a brief information slip about a related longitudinal survey study, 
a reply slip and reply-paid envelope. The reply slip will offer patients the options of 
hearing more about taking part in the longitudinal interview study, being contacted 
at a later date with information about the longitudinal survey study, or declining to 
be involved with the either research study. Patients who are interested in taking part 
in the interviews will contact Bethan Jones to arrange a mutually convenient time to 
meet.  
 
This protocol relates to the longitudinal interview study only. A separate protocol and 
ethics application will be made for the longitudinal survey study, which will start at a 
later date.   
 
Data Collection: 
A total of 20-25 interviews will be conducted across the two sites. Prior to the start 
of the interviews, Bethan will obtain written consent from the participant for the 
Phase 1 interview and to be contacted in 12 months’ time about a second interview. 
Participants will also be asked to provide brief demographic data about themselves 
and their conditions. The semi-structured interviews will be carried out in non-clinical 
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rooms with Bethan Jones at the hospital site, and are expected to last approximately 
one hour. With participants’ consent, the interview will be audio recorded. The 
interviews will be held in a non-clinical room on a hospital site during regular working 
hours. Bethan Jones is GCP trained, and has read the lone working policy information 
at the University of the West of England. As the interviews will take place within a 
busy department during working hours, it is anticipated that no additional lone 
working training will be required. 
 
Participants will also complete the PAM (Hibbard et al., 2005), and feedback their 
experiences of doing so. They will be informed that these scores will also be 
calculated as part of the data collection process.  
 
Data analysis: 
The interviews will be transcribed and all identifying information will be removed for 
the purpose of confidentiality. Participants will be given pseudonyms in order to 
ensure anonymity. The transcribed data will be analysed using framework analysis 
(Ritchie and Spencer, 1994). This will include becoming familiarised with the 
transcripts, coding each line in turn, and developing initial categories based on the 
initial transcripts. Further interview transcripts will be applied by comparison to 
these categories and codes, and a matrix will be created describing the framework 
with each transcript forming a row on the matrix. This will allow the opportunity to 
compare people’s perceptions within their interviews and between participants 
(Ritchie and Spencer, 1994). This will be carried out by Bethan Jones throughout the 
data collection process, with support and supervision from the rest of the research 
team.  
 
Study Two - Phase Two: Follow-up Interviews  
This phase involves interviews with the same group of participants 12 months after 
their initial interview.  
 
Method: 
As with phase one, the data collected will be via face-to-face interviews conducted 
by Bethan Jones. The structure and focus of the second set of interviews will be 
informed by the findings and reflections following the first phase, and following 
discussions with the study team. However it is anticipated that this interview will 
allow participants to discuss what they believe has contributed to any changes in 
patient activation, and how they view their experiences of being activated or doing 
things to actively manage their condition since their last interview.  
 
Sampling and recruitment: 
The sample will be formed of people who participated in phase one, and no 
additional recruitment will be carried out. Phase 1 participants will be contacted by 
telephone, letter or email approximately 12 months after their Phase 1 interview, 
and invited to participate in a second face-to-face interview.  
 
Data collection: 
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As in phase one, the interviews will take place in a non-clinical room at the 
participants’ usual rheumatology department and be audio recorded (with the 
participants consent). Participants will also complete the PAM once again, to 
understand if their patient activation level has changed over time and whether this 
is reflected in their interviews. 
 
Data analysis: 
The participants’ PAM scores will be analysed using paired t tests to identify change 
between the two points of data collection. This information will contribute to 
identifying if changes to participants’ perspectives on activation are reflected in the 
measures. The transcribed, anonymised data will be analysed using a qualitative 
approach called framework analysis, which will involve using the data from both 
phases one and two, as this data is collected (Ritchie and Spencer, 1994). The benefit 
of using this type of analysis is that it allows data to be compared both between 
participants, and within participants across both of their interviews.  
 
Project management and the research team  
This research will contribute to a PhD project at the University of the West of England 
(UWE), and is supervised by a team with significant experience in rheumatology, the 
impact of long term health conditions, qualitative methodology, and patient 
perspectives on living with IA.  
 
Bethan Jones, a PhD student with a background in health psychology in long term 
conditions, has designed this study and will conduct the data collection and analysis. 
Dr Emma Dures, a Senior Research Fellow at UWE and chartered psychologist, is 
Bethan’s Director of Studies. Dr Dures similarly has a background in health 
psychology and substantial experience of designing and conducting mixed methods 
and qualitative research. Professor Sarah Hewlett (Professor of Rheumatology 
Nursing, UWE) is Bethan’s second supervisor. Professor Hewlett is a clinical academic 
who is at the forefront of research into patient involvement, self management, and 
understanding the impact of IA on patients’ wellbeing. Further supervision is 
provided by Professor Diana Harcourt, who has substantial experience of the 
psychological impact of living with a long term condition; and Mr Andrew Hunt, a 
patient partner who brings lived experience of living with IA to the team.  
 
Throughout the study there will be regular whole team meetings as required, and 
fortnightly meetings between Bethan Jones and Dr Dures for ongoing day to day 
management of the study. 
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Appendix G: Interview schedule for first qualitative interviews 
 
This is a guide to the semi-structured interviews, and the researcher may ask additional 
questions for clarity, or for further information following participants’ responses. 
 
Before commencing the interview: 
The researcher will obtain signed consent, ask patients to complete the 
demographic/clinical questionnaire, and ask for permission to turn on the audio recorder. 
 
Part A: People’s experiences of actively managing their condition. 
1. Tell me a little about your experience of having arthritis. 
• What are your symptoms? 
• What sort of impact does this have on your life? 
 
2. I’m interested in how you manage the impact of arthritis on your life. What kind of 
things did you learn when you were beginning to manage your arthritis? 
• How did you find this out? 
• Did you try other things before then? What wasn’t helpful? 
• Are there aspects of your arthritis that you find particularly challenging to 
deal with?  
• How do you manage your health now? 
 
3. What kind of decisions do you make around your arthritis? These can be about 
broader things medications or treatments, or ways in which you’ve had to change 
your lifestyle. They can also be smaller ones, like how you manage your daily 
activities. 
• What prompts you to make these decisions? 
• How did the last time you did that go? 
 
Part B: Identifying individual and contextual factors that contribute to active 
management 
4. I’m interested in the kind of things you can do to help your arthritis, and the things 
that others also do to help your arthritis. What sort of things do you do to help 
your arthritis? 
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• What other people are involved in helping with your arthritis? What do 
they do? 
• How does that factor impact your health? How do you manage that? 
• What things are most important for you to manage your arthritis? 
 
5. What sort of relationship do you have with your health care team? How do they 
support you? 
• What is the most helpful thing they do to support you? 
• What changes, if any, would you make to your healthcare? 
 
6. How do you know if you need more support, or information about your arthritis? 
• What do you tend to do then? 
• If you were talking to a new patient, what would be your top tip for dealing 
with arthritis? 
 
Part C: Exploring perceptions of “Patient activation” 
7. If I used the term “patient activation”, what would that mean to you? You may not 
have heard it before, so what would you guess it means? 
• Opportunities for clarification on participants’ definitions here. 
 
8. Can I tell you what some researchers think it means? 
• Give definition “skills, ability and likelihood that someone will take an 
active role in managing their health”. What do you make of that? 
• How does that fit in with the experiences you described to me earlier? 
• Describe what active health management means to you, and what that 
would look like with your condition. How closely does what you do now fit 
that? 
• Do you think there is a better phrase? If so, what would it be? 
 
Part D: Gathering opinions on the Patient Activation Measure: 
9. Can I ask you to complete this questionnaire, and while you are doing this, let me 
know what you think of it? 
• Do the questions seem relevant for your experience of living with arthritis? 
• Does it make sense? 
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• How does that fit with what you think about actively looking after your 
arthritis – is everything you expect to see there? 
 
Part E: Close 
10. Are there any issues that we have not talked about that you would like to raise? 
• Thank you very much for your time and valuable contribution to the study. 
• Confirm consent to contact for interview in 12 months’ time.  
 
 
The second interview schedule will be informed by the findings of the first interview, and 
individuals’ responses to their interview. 
 
 
Appendix H: Interview schedule for second qualitative 
interviews 
 
• How have you managed your health since we last spoke? What has changed? 
• What has really worked for you in the way you’ve coped? 
• What has been a challenge? 
• Individual follow-up questions 
• Something that’s really struck me following my conversations with all these people 
is that … feed back – 
o How does this sit with you? 
o Do parts of that not apply to you? 
o Why do you think this is the case? 
o What would make this closer to your experiences? 
• Locus of control related question 
• Have you seen your GP/consultant/another healthcare professional in the last 
year? How often? What did that conversation look like? 
• Did you change anything about how you managed your health after our 
conversation? Has anything occurred to you since 
• What prompted you to take action? “penny dropping”? 
• Has your condition fluctuated much since we last spoke? How have you responded 
to this? 
• Giving in versus choosing not to take action? 
• Engaging social support 
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Appendix I: Demographic pack for qualitative interviews 
Understand Patient Activation: An Interview 
Study 
 
Pre-interview questionnaire 
 
Date: ________________                  Study ID: ______________                                                
 
Thank you for agreeing to take part in this study 
 
This questionnaire will help the researchers make sure that they talk to a wide 
range of people with types of inflammatory arthritis. Your answers are 
confidential to the researchers, and although other people will see the results 
of the overall study, they will not be able to link your name to the answers you 
give on this sheet. 
 
A) This section asks about your demographic details 
 
 
1. Gender:         Male / Female  (Please circle) 
 
 
2. Date of birth: __ __ / __ __ / __ __ __ __  (Day / Month / Year) 
 
3. What is your highest level of qualification? 
 
______________________________ 
 
 
 
 
B) This section asks about your inflammatory arthritis 
 
1. How long have you been diagnosed with inflammatory arthritis? 
 
 _______________ (Years, Months)  
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This section asks about your usual ABILITIES over the PAST WEEK  (Please 
tick) 
  
Without 
ANY  
difficulty 
 
 
With 
SOME 
difficulty 
 
With 
MUCH 
difficulty 
 
Unable  
to do 
1. DRESSING AND GROOMING 
    Are you able to: 
  - Dress yourself, including tying 
    shoelaces and doing buttons? 
 
  - Shampoo your hair? 
 
 
_________ 
 
 
_________ 
 
 
_________ 
 
 
_________ 
 
 
_________ 
 
 
_________ 
 
 
_________ 
 
 
_________ 
 
2. RISING 
    Are you able to: 
  - Stand up from an armless 
straight  
    chair?  
 
  -Get in and out of bed? 
 
 
 
 
_________ 
 
_________ 
 
 
 
 
_________ 
 
_________ 
 
 
 
 
_________ 
 
_________ 
 
 
 
 
_________ 
 
_________ 
 
3. EATING 
    Are you able to: 
  - Cut your meat? 
 
  - Lift a full cup or glass to your 
mouth? 
 
  - Open a new carton of milk (or 
soap 
     powder)? 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
4. WALKING 
    Are you able to: 
  - Walk outdoors on flat ground?  
 
  - Climb up five steps? 
 
 
 
_________ 
 
_________ 
 
 
 
 
_________ 
 
_________ 
 
 
 
_________ 
 
_________ 
 
 
 
_________ 
 
_________ 
Please tick any aids or devices that you usually use for any of these activities: 
 
 _____  Cane    _____  Devices used for dressing (button 
hook, zipper 
 _____  Walking frame   pull, long handled shoe horn etc) 
 _____  Crutches   _____  Built-up or special utensils 
 _____  Wheelchair   _____  Special or built-up chair 
   
Other: ____________________________________________________________ (Please 
specify) 
Please tick any categories for which you usually need help from another person: 
 _____  Dressing and grooming _____  Eating 
 _____  Rising    _____  Walking 
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5.  HYGIENE      
    Are you able to: 
  - Wash and dry your entire      
     body? 
 
  - Take a bath? 
 
  - Get on and off the toilet? 
 
Without 
ANY 
difficulty 
 
 
_________ 
 
_________ 
 
_________ 
 
 
With SOME 
difficulty 
 
 
 
_________ 
 
_________ 
 
_________ 
 
 
With MUCH 
difficulty 
 
 
 
_________ 
 
_________ 
 
_________ 
 
Unable  
to do 
 
 
 
 
_________ 
 
_________ 
 
_________ 
 
6. REACH      
    Are you able to: 
  - Reach and get down a 5lb    
    object (e.g. a bag of potatoes)    
    from just above your head? 
 
  - Bend down to pick up clothing  
    from the floor? 
 
 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
 
_________ 
7. GRIP      
    Are you able to: 
  - Open car doors? 
 
  - Open jars which have been  
    previously opened? 
 
  - Turn taps on and off? 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
_________ 
 
_________ 
8. ACTIVITIES      
    Are you able to: 
  - Run errands and shop? 
 
  - Get in and out of a car? 
 
  - Do chores such as 
vacuuming,  
     housework or light 
gardening? 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
Please tick any aids or devices that you usually use for any of these activities: 
 
 _____  Raised toilet seat _____  Bath rail  
 _____  Bath seat  _____  Long handled appliances for reach 
 _____  Jar opener (for jars   
   previously opened)  
Other: ____________________________________________________________ (Please 
specify) 
  
Please tick any categories for which you usually need help from another person:  
 
 _____  Hygiene  _____  Gripping and opening things 
 _____  Reach   _____  Errands and housework 
 
THANK YOU FOR COMPLETING THIS QUESTIONNAIRE 
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Below are some statements that people sometimes make when they talk about their 
health. Please indicate how much you agree or disagree with each statement as it applies 
to you personally by circling your answer. There are no right or wrong answers, just what is 
true for you. If the statement does not apply to you, circle N/A. 
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Appendix J: Reflective note example 
5/12/2017 
 
 
Lots of discussion on the challenges of parenting and balancing this 
responsibility with a rheumatic condition. Sometimes they report how 
their caring role (and the enjoyable aspects of spending time with their 
children) doesn’t go away regardless of how they feel. Is this something 
that I’m underplaying the value of because I am not a parent or is it more 
about the general life responsibilities that they are finding the balance of? 
Perhaps do some reading around the role of parenting and rheumatology 
and the impact of that – pay attention to it as I progress through the 
interviews. Noticing my own challenge of not validating any boom and 
bust type techniques to manage childcare, and not trying to challenge 
them either.  I also wonder if I’d be paying this amount of concern about 
my response if it was other responsibilities I could relate to more e.g. 
work, older adult care.
 328 
 
Appendix K: Example of analysis 
Perceived social support - often practical. 
 
Participants did receive some help to 
manage their condition, but what support 
they chose was often practical instead of 
emotional. 
“When [husband] is here is does help, he will drive if we are going out for the day. Or even the shopping he will do all 
the driving and push the trolley.” 
“They are all there and if I need anything I can say “can you do this. Like getting things down off the top of 
cupboards” 
“Probably the only person that has been involved is my husband” 
“I’ll do things like building computers for people, repairing them…. And in return they’ll help me” 
“I find if I help others they help me” 
"things like the garden, I get the bloke across the road to do it, he’ll come over and do it for me in return I look after 
his computer. " 
"Just does a lot of fetching and carrying for me.  If I can’t open something, she’ll open it for me.  If I can’t lift 
something, she’ll lift it for me.  So yes, it’s just helping out." 
"I think I would manage if I was on my own but it is nice to have someone there to help you" 
“I don’t lift things. Like I’ve got books for the shop to sell, so I only bring them in when my husband’s there to carry 
them, I wouldn’t carry them, because even like that, for just from the car in here, would, I’d, I’d be suffering tonight 
in my shoulders” 
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Appendix L: Charting following first interviews 
 
“You do it 
because you 
have to”: 
Determined 
independenc
e 
“You find 
ways to do 
different 
things”: 
Making small 
changes 
“If you have a problem just 
phone up”: Navigating the 
system  
“I think I've recognised what works for me, and 
what I need”: Knowing oneself 
“There are 
people far 
worse than 
me”: 
Positive 
perspective
s on health 
“Just does a 
lot of fetching 
and carrying”: 
Practical Social 
Support 
 
“If I have that 
knowledge 
then it helps”: 
How to seek 
and get help 
and 
information 
"If I feel 
there’s a 
concern, I 
will raise it “: 
Collaborating 
with 
healthcare 
professionals 
 “I know what 
each tablet is 
for”: Health-
related 
knowledge 
“I knew it 
was 
obviously 
something 
shook up in 
my body”: 
When to seek 
help and 
information 
"It just helps 
me”: Knowing 
what 
techniques 
work for 
individuals 
Mary 
"Get on and 
do it 
regardless" - 
sometimes 
it’s a struggle 
but you 
"have to do 
the things 
that need to 
"Now do two 
days from 
home." - "life 
might have 
been easier if 
I'd done 
something 
that way, 
Aware of 
resources but 
"I like the fact 
that I can" 
Personal 
service, and 
value of 
people 
"acknowledgi
ng that 
there's 
things that 
they can do 
Aware of 
three-monthly 
blood tests 
and review 
phases, along 
with having 
enough 
detailed 
knowledge to 
"Your body's 
actually 
telling you 
that's what 
you need to 
do" - internal. 
External - 
friend 
"I think I've 
recognized 
what works 
for me, and 
what I need, 
whether I get 
or can have 
what I need" 
"I am lucky 
in that 
respect" 
[support 
network] 
"It is more the 
practical stuff 
of opening 
things, that 
I've needed 
help with" 
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be done". 
Self-
described as 
independent  
rather than 
that way" 
to help 
manage" 
with HCPs  
know they 
have "changed 
the policy" 
advised 
getting seen 
Joanna 
"I am 
determined". 
"you are the 
only one that 
can" 
[manage 
condition] 
Shifted work 
pattern to 
remain in 
work and 
retain 
energy. "  
"I know they 
say you 
shouldn’t read 
everything, 
but there are 
good sites on 
there." 
Can trust 
doctor and 
will be taken 
seriously.  
Describes 
routine and 
aware of next 
appointment 
due       
Will ask for 
practical help 
and partner 
automatically 
drives, pushes 
trolleys 
Lindsay 
"independen
t that’s the 
word yeah" - 
but will ask 
for help and 
accept offers 
Swap to 
shopping 
basket, tries 
to reduce 
trips up-stairs 
to spare 
energy 
"not much 
point" in 
seeing GP as 
will be 
referred to 
rheum. 
"Screen" gets 
in way of 
solving 
problems 
"It's got to 
be 
consultant" 
leading 
rather than 
patient. Feels 
empowered 
in 
appointment
s. "Just want   
Assertive, 
happy to 
return and 
know when 
things can be 
resolved on 
the day 
Avoid reliance 
on 
medication. 
Rest 
"I'm not 
going to 
end up with 
fingers like 
that, that 
can't do all 
the things 
she wants 
to do. It 
helps" 
Bag carrying, 
lifting and DIY 
work from 
others 
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to try" and 
HCP 
mediates. 
"not going 
until 
something's 
done" 
Tony 
"I cope 
because I 
have to, I've 
got no 
choice". 
Being 
determined 
Practical 
problem 
solver - 
levers to 
keep cooking 
Direct access - 
peace of 
mind. Looks 
for support 
elsewhere too 
"finished 
waffling and 
ask him at 
the end" - 
will ensure 
queries are 
responded 
to. 
"I know the 
way the NHS 
works". 
Manages 
medication 
himself to 
avoid being 
disengaged   
Identified 
techniques, 
that doesn't 
work for him. 
"Modify life 
to suit 
regime"   
Exchange 
system with 
whole estate 
Jim 
  
Does own 
cooking to 
stay healthy, 
paces things 
to keep doing 
DIY and 
gardening 
Advises using 
rheumatology 
team. Reading 
scientific 
reports for 
info 
Aware of 
value of 
time, but 
likes 
reassurance 
and generally 
guided. 
Aware of daily 
fluctuations 
and the 
challenges 
involved 
Prolonged 
period of 
flare up 
Knows limits 
for alcohol for 
them 
personally 
"I'm very 
fortunate" - 
lifestyle 
comparison 
to help 
manage 
Cooking help 
from partner 
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Positive - will 
"do 
anything" 
Jackie 
Can't resolve 
everything 
with tablets, 
sometimes 
you have to 
do things 
yourself. "On 
my own…. 
I'm better 
and able to 
cope" 
Pacing to 
keep 
catering, trial 
and error, 
planning to 
stay warm 
and keep a 
going out. 
Make best of 
self. Shower, 
not bath 
Also seeks 
help for 
relatives using 
skills. 
Confident 
calling and 
asking for 
appointment - 
preference for 
rheum 
Guiding plan 
as doesn’t 
want tablets. 
Determines 
choices 
based on 
offers given 
Efficiency of 
NHS 
awareness - 
biosimilars   
Creams and 
techniques to 
complement 
the changes 
required 
"At this 
moment in 
time, I'm 
quite happy 
with what's 
going on.  
Because I 
feel I've 
taken 
control 
again.” 
Lifting support 
from family 
Avril 
Got to find 
ways to live 
with this - 
although 
feels upset 
by this 
Manages 
limits 
Preference for 
rheum but 
aware of 
options such 
as pharmacist 
Some 
confusion 
about who to 
approach 
with what 
challenges, 
but directed 
by HCPs 
Able to discuss 
and describe 
routine of 
monitoring. 
Aware of 
sense of own 
body and 
condition  
Routine of 
regular 
appointment 
to help Know limits  
Comparison 
of poor 
joins. "99% 
of people 
wouldn’t 
know 
there’s 
anything 
Carrying and 
lifting, but 
able to 
organise 
backup if not 
available 
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the matter 
with me" 
Mark 
"Carry on as 
normal" 
Exercise to 
prevent 
fractures and 
bigger 
degeneration 
Frustrated by 
delays in GP 
services, often 
uses internet 
"Health 
service have 
a degree of 
responsibility
"     
doesn’t find 
anything in 
particular 
necessary 
"[mum] has 
always had 
a far more 
significant 
problem 
with it than 
I have". 
Some 
people get 
"lucky"   
Jan 
"Carry on 
and see how 
you go" - 
cautious 
confidence   
Takes 
research and 
potential 
solutions to 
HCPs 
Joint 
decision 
making 
Risks and 
activity of 
biological 
medication 
Seeking 
solutions - 
e.g. injections 
Knows best 
time of day 
top get things 
done, 
medication 
preferences 
etc. 
"[daughter] 
has it in her 
legs as well, 
so she has 
it worse" 
"husband's 
there if I need 
him" 
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Richard 
Resigned to 
pain but 
"won't let it 
get in the 
way". 
Chooses not 
to involve 
others   
Often online, 
but prefers 
direct access 
to GP. Seeks 
help during 
flareups 
Sees HCPs as 
"guide". 
Plans 
discussions 
in advance   
Flare up not 
resolving in 
several days 
Still going 
through trial 
and erorr 
process but 
has sense of 
what works 
for them 
" I’m not a 
sicky 
person.  
I’ve had this 
for 12 years 
and never 
lost a day 
of work 
through it" 
"  If I can’t 
open 
something, 
she’ll open it 
for me.  If I 
can’t lift 
something, 
she’ll lift it for 
met." 
Cheryl 
Push through 
- sometimes 
to boom and 
bust. Gentle 
moving 
better than 
nothing. "If 
we can 
manage we 
will try and 
do it 
ourselves" 
Downstairs 
toilet to keep 
exercises 
Variety of 
sources - uses 
peers 
no "magic 
wand" for 
HCPs     
"You do what 
you feel 
comfortable 
with" 
"there’s an 
awful lot of 
people out 
there who 
are an 
awful lot 
worse off 
than I am " 
"He does, he 
does manual 
things like 
maintenance 
stuff if we 
need stuff 
doing. " 
 335 
 
Greta Aware 
imbalance of 
pacing vs 
"giving in". 
Fear 
vulnerability. 
"I'm capable 
of doing that 
myself"  
Only using 
chairs with 
arms to be 
able to get 
out, holding 
on stairs. 
Practical, 
adaptable 
change 
Looks for 
information 
first by self 
assuption of 
HCPs making 
decision for 
you - but 
frustration at 
expectations 
for HCP. 
Value of 
personal 
relationship 
Offers 
suggestions 
for healthcare 
monitoring - 
proactive   
"Still learning" 
- has tested 
and found 
routine 
"When you 
then speak 
to other 
people at 
the group 
you realise 
that it 
affects 
people in 
different 
ways. 
That’s been 
really 
helpful" - 
sought out 
peer 
contact 
"I probably I 
would say my 
family is 
probably more 
practical, 
emotion, 
doesn’t come 
into it " 
Patricia 
Getting 
through - 
looking back 
and amazed 
at coping 
Still learning 
small 
changes 
matter - 
Problem 
solving 
research using 
internet. 
Generally only 
Doesn't have 
conviction to 
disagree with 
HCPs, but 
sees     
Clear sense of 
health 
behaviours 
that help, as   
Domestic 
responsibility 
with husband 
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beginning 
with pacing 
seeks in-
person help 
for flare and 
rheum 
preference 
dialogue. 
Assumption 
HCP will pre-
warn of risky 
side effects 
well as 
activities 
Christin
e 
Plough on, 
then crash. 
Now can 
change 
things with 
pacing but 
it's not going 
away. Make 
life as good 
as possible. 
Reports 
wanting 
"Independen
ce, 
completely" 
Bite sized 
chunks, 
switch to 
automatic to 
keep driving 
Lots of own 
research in 
search of 
power and 
control. Seeks 
help from 
peers but 
aware of 
individual 
differences 
Struggled 
with 
inconsistency 
of care     
"mentally I’ve 
really 
struggled 
with having to 
give up 
everything. 
And also, the 
rounds of 
medication, 
I’ve still not 
found the 
right 
medication, 
the right 
immune 
suppressant" 
"life can be 
worse", try 
and see 
positive 
Husband 
support, 
parental 
support during 
a flare 
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Stuart 
Preparation, 
positive 
thinking, 
don’t "give 
up" 
Find balance 
between 
elimination 
diet and 
enjoyable 
food 
Charity help, 
but 
confidence to 
drop in to 
clinic in 
person if 
necessary. 
Ladder of 
severity to 
solution 
Gp focused 
previously, 
but less 
reliant on 
rheumatolog
y 
Limited 
understanding 
demonstrated 
Searching for 
tests, for 
answers 
"But I like to 
try things 
anyway and 
try for myself, 
see if it’s 
beneficial or 
not. If it’s not 
then it’s fine, 
you know, go 
on to 
something 
else" 
"I can do 
almost 
anything I 
want to do" 
- even if it 
isn’t the 
same 
Flexible 
workload with 
wife 
Anne 
"you just get 
on with it.. 
There's 
nothing you 
can 
do..""Pretty 
much 
independent
"           
Identified 
preference 
after setback 
"So when 
you’ve seen 
that, it’s 
just a case 
of like, and 
had she 
done 
exactly the 
same as 
me, she   
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wouldn’t 
have been 
as bad. " 
Meryl 
"Little bit of 
determinatio
n" - just 
getting on 
with it even 
if some days 
hard. Plans 
to retain 
independenc
e - doesn't 
have 
someone to 
ask for help 
Adapted way 
to sleep. 
Change 
trolley in 
supermarket 
to keep being 
able to. Lots 
of adaptation Google 
Appreciate 
balance and 
happy to 
discuss and 
suggest but 
not 
comfortable 
taking the 
lead 
Reports sense 
of feeling 
when a flare is 
coming     
"if he can 
do it, he is 
obviously 
been 
diagnosed 
years then I 
thought 
well I’m 
sure I can 
cope" 
Neighbours 
supporting 
and feels able 
to ask for help 
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Appendix M: Charting second interviews 
 
“You do it 
because you 
have to”: 
Determined 
independence 
“You find 
ways to 
do 
different 
things”: 
Making 
small 
changes 
“If you have a problem just 
phone up”: Navigating the 
system  
“I think I've recognised what works for 
me, and what I need”: Knowing oneself 
“There are 
people far 
worse than 
me”: 
Positive 
perspective 
on health 
“Just does 
a lot of 
fetching 
and 
carrying”: 
Practical 
Social 
Support 
 
“If I have that 
knowledge 
then it helps”: 
How to seek 
and get help 
and 
information 
"If I feel 
there’s a 
concern, I 
will raise it “: 
Collaborating 
with 
healthcare 
professionals 
 “I know 
what each 
tablet is for”: 
Health-
related 
knowledge 
“I knew it 
was 
obviously 
something 
shook up in 
my body”: 
When to 
seek help 
and 
information 
"It just 
helps me”: 
Knowing 
what 
techniques 
work for 
individuals 
Mary                   
Joanna                   
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Lindsay 
"You can't live 
life with your 
feet up"   
Seeks advice 
from HCPs 
and from own 
research. 
Reads all the 
leaflets for 
medications. 
Benefitted 
from online 
GP system 
and internet 
as a tool. 
Able to 
refuse new 
medication 
plan and 
discuss with 
HCP. Found 
seeing 
different 
HCPs 
challenging.  
Did on 
research 
about anti-
inflammatory 
to pas on to 
consultant. 
Created 
folder of 
health 
summary. 
"I don't go 
to the 
doctor for 
every silly 
little thing" 
Describes 
how side 
effects of 
steroids 
more 
challenging 
than the 
symtpoms 
Caring for 
parent with 
RA  
Partner did 
the dog 
walking. 
Tony                   
Jim 
"Work from 
the top. If you 
don’t you give 
up on life. 
That's the 
mentality of it, 
making small 
changes to 
manage" 
Found a 
balance 
to 
continue 
playing 
golf 
Does own 
research 
including 
academic 
research   
prepared for 
travel and 
practical 
problem 
solving based 
on 
medication 
needs - 
fridges etc.   
Still 
travelling 
abroad for 
heat. 
Dietary 
changes. 
Sense of 
illness being 
invisible 
when other 
people 
visibly 
suffer too - 
perspective. 
"mind 
Spouse 
provides a 
lot of 
practical 
support, 
particularly 
around 
house 
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works 
differently" 
Jackie Gotten 
through 
difficult year - 
"I'm on my 
own" 
sensible 
but 
enjoyable 
shoes, 
pacing 
doing the 
house 
Comfortable 
postponing 
appointment 
to manage 
independently 
for a while 
and review at 
a more crucial 
time 
Wish HCPs 
had been 
more open 
with her 
during last 
year   
Needed 
more help 
over last 
year, but 
lots of 
health 
changes 
walking for 
health. 
"lotions 
and 
potions" 
Sat in 
waiting 
rooms and 
"realises 
how lucky 
you are" 
Relatives 
doing jobs 
around 
house - 
"I've asked 
for 
practical 
help" 
Avril                   
Mark                   
Jan 
"You like to 
keep your 
independence 
as long as you 
can".  
"You take 
more 
time but 
you still 
do it"     
Tracks blood 
count 
numbers 
"Helps to 
figure it out 
by yourself, 
because 
you're   
Has friends 
with the 
condition 
and that 
helps.   
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doing 
something 
that suits 
you" 
Richard                   
Cheryl                   
Greta                   
Patricia                   
Christine 
"Independence 
is my most 
prioritised 
thing, and just 
getting on with 
it sometimes"   
"[GPs] just 
refer me. So I 
tend to go 
direct to the 
rheumatology 
nurse 
helpline"   
Has 
permission to 
manage 
steroids 
herself based 
on blood 
tests than 
risk delay 
awaiting 
confirmation. 
"My body 
won’t let 
me do 
those 
things". 
Trying to 
unpick the 
impact of 
different 
health 
conditions.  
"My use of 
oramorph 
goes up in 
August, I 
have kids 
at home. 
My family" 
Previously 
would 
have 
pushed 
through, 
now   
Family 
helps, 
partner 
has flexible 
working 
and 
supportive 
parent to 
add help.  
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learned 
balance 
Stuart                   
Anne                   
Meryl                   
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Appendix N: Summary of framework categories 
“You find ways to 
do different things”: 
Making small 
changes 
This category recognises the ways that participants have 
chosen or recognised smaller decisions they make in order 
to manage their health or stay focused with activities they 
value. These smaller changes often have been determined 
through trial and error and focus on common self-
management behaviours such as adaptations, pacing, goal-
setting and tweaking routines. 
“If you have a 
problem just phone 
up”: Navigating the 
system  
This recognises a specific skill participants have of navigating 
the NHS in order to work with healthcare professionals in all 
forms in order to get the support, tests and medications 
required. Sometimes this refers to decision making in 
collaboration with healthcare professionals or knowing how 
best to get the support they need. 
“If I have that 
knowledge then it 
helps”: How to seek 
and get help and 
information 
This subcategory refers to participants knowing appropriate 
ways to get help and information about their condition - 
whether by doing so themselves and evaluating the 
information or by choosing a suitable and efficient route to 
speaking to a healthcare professional. 
“If I feel there’s a 
concern, I will raise it”: 
Collaborating with 
healthcare 
professionals 
This specifically refers to in-consultation working with 
healthcare professionals to play a part in decision making, 
determining the aim and direction or care or to be an active 
participant in appointments. 
“I think I've 
recognised what 
works for me, and 
what I need”: 
Knowing oneself 
This category describes the participants experience and 
sense of their own body that they used to determine what 
techniques for self-care were useful for them, when they may 
need additional help or information (separately to how they 
went about doing this). This also included knowing the 
routines around managing their health and what was 
required in order to maintain their health. 
“I know what each 
tablet is for”: Health-
related knowledge 
This sub-category covered both participants' understanding 
of their own condition and the biological aspects involved in 
it and the practical aspects of managing as well as a sense of 
how they were currently coping. 
“I knew it was 
obviously something 
shook up in my body”: 
When to seek help and 
information 
Participants were generally aware of when they needed more 
help and information to manage a flare-up or their condition. 
“It just helps me”: 
Knowing what 
techniques work for 
individuals 
Participants closely connected actively managing their 
condition with having a sense of what was useful for them to 
manage the physical aspects of their condition. 
“There are people 
far worse than me”: 
Positive 
perspectives on 
health 
This category refers to the comparisons participants used to 
recognise that their health was often better than others they 
knew. These comparisons were not always conscious or 
explicit but formed a part of how participants viewed life 
with their condition. 
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“Just does a lot of 
fetching and 
carrying”: Practical 
Social Support 
Participants did receive some help to manage their condition, 
but what support they chose was often practical instead of 
emotional. 
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Appendix O: Summary of findings for participants 
I interviewed people who were skilled at managing their health to find out what they 
thought this looked like and what things were important to them to manage their 
health. 
I met 17 people overall at various stages of learning to manage their condition. We 
talked about various things that contributed to them feeling like they were actively 
managing their condition. Not everyone agreed on everything, but the major factors 
that came up in these conversations were: 
· Being determined and “just getting on with it” sometimes. The idea of “doing it 
because you have to”, and trying not to let your health condition rule your life. This 
sometimes meant doing what you can even if you’re feeling poorly, or sometimes 
asking for help to make sure things get done. This recognises that people had 
responsibilities (jobs, family, children, housework, social responsibilities) that couldn’t 
be rescheduled even if they were having a bad day. Sometimes flares meant that 
people did need to rest and take things easy, and people figured out when this was 
the case through trial and error. 
· Making small changes to manage big life goals. This means that sometimes to do an 
overall big life change (e.g. getting more exercise) this had to me done through smaller 
steps (like using stairs more, or a short walk with a dog). People were organised and 
often very good at planning, things in advance to reduce the risk of upsetting their 
symptoms. Sometimes these changes were to keep doing an activity people enjoyed, 
or practical changes. 
· What works for me. Everyone I spoke to had a clear sense of the things (whether it 
is rest, heat, diet, hydrotherapy etc.) that made a difference to their condition and 
made it easier. They described how they had to learn this, and that knowing this made 
a difference to their flare-ups was useful (knowledge is power!). 
· Independence where possible. People were very independent and tried to do as 
much for themselves as possible rather than asking other people. When they did get 
help it was often practical – opening jars, carrying things down from high shelves, 
driving etc. 
· Learning to navigate the NHS. People had found out how best to organise the system 
so that they could see their rheumatology team when needed (and often preferred to 
see their rheumatologist rather than their GP). They knew when to seek help and 
when they could manage their flareups themselves, and how to do this, sometimes 
knowing how to chase health professionals for the tests or reviews they need. 
· Positive sense of their own health. People generally felt quite positive about their 
own health compared to other people. A lot of participants I spoke to have or had 
older relatives with rheumatic conditions, and this seemed to be a factor in them 
feeling lucky compared to other people they knew. 
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Appendix P: Survey pack for quantitative study 
 
How people manage their health conditions: A 
survey study 
 
Thank you for agreeing to take part in this study. Your answers are confidential to the 
researchers, and we are interested in everybody’s views. If you have been diagnosed with 
more than one health condition, we ask that you answer these questionnaires thinking 
about your rheumatology condition.  
 
Some of the questions in this survey  may seem repetitive. This is because I am using a 
number of established questionnaires that cannot be changed. Please answer all the 
questions in the survey.  
 
 
 
Bristol research team contact: 
Bethan Jones 
Bethan8.jones@live.uwe.ac.uk 
0117 342 7415 
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HAQ         Date: 
________________ 
 
 
1. About you 
Are you  [  ] male          
   [  ] female  
       [  ] other 
    [  ] prefer not to say 
 
How old are you?  
           …………….………………………years 
 
What is your ethnic group? 
 [  ] white British 
 [  ] black British 
 [  ] other white 
 [  ] other black 
 [  ] Asian 
 [  ] Chinese 
 [  ] other ethnic group   ……………………………………………. 
 [  ] prefer not to say 
 
 
What rheumatic condition(s) do you attend the rheumatology clinic for? 
Please circle: 
Rheumatoid arthritis Scleroderma 
Adult with juvenile 
idiopathic arthritis 
SLE / lupus 
Ankylosing 
spondylitis 
Psoriatic arthritis 
Inflammatory 
polyarthritis 
Don’t know 
Other (please specify) 
…………………………………... 
 
 
How old were you when you were diagnosed with this condition? 
 
 …………………………….……………………………………. 
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This section asks about your usual ABILITIES over the PAST WEEK  (Please 
tick) 
  
Without 
ANY  
difficulty 
 
 
With 
SOME 
difficulty 
 
With 
MUCH 
difficulty 
 
Unable  
to do 
1. DRESSING AND GROOMING 
    Are you able to: 
  - Dress yourself, including tying 
    shoelaces and doing buttons? 
 
  - Shampoo your hair? 
 
 
_________ 
 
 
_________ 
 
 
_________ 
 
 
_________ 
 
 
_________ 
 
 
_________ 
 
 
_________ 
 
 
_________ 
 
2. RISING 
    Are you able to: 
  - Stand up from an armless 
straight  
    chair?  
 
  -Get in and out of bed? 
 
 
 
 
_________ 
 
_________ 
 
 
 
 
_________ 
 
_________ 
 
 
 
 
_________ 
 
_________ 
 
 
 
 
_________ 
 
_________ 
 
3. EATING 
    Are you able to: 
  - Cut your meat? 
 
  - Lift a full cup or glass to your 
mouth? 
 
  - Open a new carton of milk (or 
soap 
     powder)? 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
4. WALKING 
    Are you able to: 
  - Walk outdoors on flat ground?  
 
  - Climb up five steps? 
 
 
 
_________ 
 
_________ 
 
 
 
 
_________ 
 
_________ 
 
 
 
_________ 
 
_________ 
 
 
 
_________ 
 
_________ 
Please tick any aids or devices that you usually use for any of these activities: 
 
 _____  Cane    _____  Devices used for dressing (button 
hook, zipper 
 _____  Walking frame   pull, long handled shoe horn etc) 
 _____  Crutches   _____  Built-up or special utensils 
 _____  Wheelchair   _____  Special or built-up chair 
   
Other: ____________________________________________________________ (Please 
specify) 
Please tick any categories for which you usually need help from another person: 
 _____  Dressing and grooming _____  Eating 
 _____  Rising    _____  Walking 
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5.  HYGIENE      
    Are you able to: 
  - Wash and dry your entire      
     body? 
 
  - Take a bath? 
 
  - Get on and off the toilet? 
 
Without 
ANY 
difficulty 
 
 
_________ 
 
_________ 
 
_________ 
 
 
With SOME 
difficulty 
 
 
 
_________ 
 
_________ 
 
_________ 
 
 
With MUCH 
difficulty 
 
 
 
_________ 
 
_________ 
 
_________ 
 
Unable  
to do 
 
 
 
 
_________ 
 
_________ 
 
_________ 
 
6. REACH      
    Are you able to: 
  - Reach and get down a 5lb    
    object (e.g. a bag of potatoes)    
    from just above your head? 
 
  - Bend down to pick up clothing  
    from the floor? 
 
 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
 
_________ 
7. GRIP      
    Are you able to: 
  - Open car doors? 
 
  - Open jars which have been  
    previously opened? 
 
  - Turn taps on and off? 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
_________ 
 
_________ 
8. ACTIVITIES      
    Are you able to: 
  - Run errands and shop? 
 
  - Get in and out of a car? 
 
  - Do chores such as 
vacuuming,  
     housework or light 
gardening? 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
Please tick any aids or devices that you usually use for any of these activities: 
 
 _____  Raised toilet seat _____  Bath rail  
 _____  Bath seat  _____  Long handled appliances for reach 
 _____  Jar opener (for jars   
   previously opened)  
Other: ____________________________________________________________ (Please 
specify) 
  
Please tick any categories for which you usually need help from another person:  
 
 _____  Hygiene  _____  Gripping and opening things 
 _____  Reach   _____  Errands and housework 
 
THANK YOU FOR COMPLETING THIS QUESTIONNAIRE 
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Below are some statements that people sometimes make when they talk about their 
health. Please indicate how much you agree or disagree with each statement as it 
applies to you personally by circling your answer. There are no right or wrong 
answers, just what is true for you. If the statement does not apply to you, circle N/A. 
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Rheumatoid Arthritis Self Efficacy Scale (RASE) 
We are interested in finding out what things you believe you could do to help you with your arthritis.  
We want to know what you think you could do, even if you are not actually doing it at the moment.  
Please tick one column for each question. 
 
Do you believe you could do these things to help you with your arthritis? 
 Strongly 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Strongly 
agree 
I believe I could use 
relaxation techniques to 
help with pain 
     
I believe I could think about 
something else to help with 
pain 
     
I believe I could use my 
joints carefully (joint 
protection) to help with pain 
     
I believe I could think 
positively to help with pain 
     
I believe I could avoid doing 
things that cause pain 
     
I believe I could wind down 
and relax before going to 
bed, to improve my sleep 
     
I believe I could have a hot 
drink before bed, to 
improve my sleep 
     
I believe I could use 
relaxation before bed, to 
improve my sleep 
     
I believe I could pace myself 
and take my arthritis into 
account to help deal with 
tiredness 
     
I believe I could accept 
fatigue as part of my 
arthritis 
     
I believe I could use gadgets 
to help with mobility, 
household tasks or personal 
care 
     
I believe I could ask for help 
to deal with the difficulties 
of doing everyday tasks 
     
I believe I could do exercises 
to deal with the difficulties 
of doing everyday tasks 
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 Strongly 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Strongly 
agree 
I believe I could plan or 
prioritise my day to deal 
with difficulties of doing 
everyday tasks 
     
I believe I could educate my 
family and friends about my 
arthritis to help with the 
strains that arthritis can 
make on relationships 
     
I believe I could explain to 
friends and family when I do 
or don’t need help 
     
I believe I could discuss any 
problems with my partner 
or family 
     
I believe I could make time 
for leisure activities, hobbies 
or socializing 
     
I believe I could save energy 
for leisure activities, hobbies 
or socializing 
     
I believe I could focus on the 
positive when I’m feeling 
down 
     
I believe I could use 
relaxation to deal with 
worries 
     
I believe I could allocate 
time for relaxation 
     
I believe I could use a 
relaxation tape or 
instructions to help me relax 
     
I believe I could use regular 
exercise 
     
I believe I could be aware of 
my limits in exercise 
     
I believe I could manage my 
medication, knowing how 
and when to take it 
     
I believe I could look out for 
and avoid side-effects of my 
medication 
     
I believe I could seek help 
with persistent side-effects 
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Instructions: Each item below is a belief statement about your inflammatory arthritis with 
which you may agree or disagree. Beside each statement is a scale which ranges from 
strongly disagree (1) to strongly agree (6).  
Multidimensional HLOC scale 
For each item we would like you to circle the number that represents the extent to which 
you agree or disagree with that statement. The more you agree with a statement, the 
higher the number you circle. The more you disagree with a statement, the lower the 
number you circle. Please make sure that you answer EVERY ITEM and that you circle ONLY 
ONE number per item. This is a measure of your personal beliefs; obviously, there are no 
right or wrong answers. 
 Strongly 
disagree 
Moderately 
disagree 
Slightly 
disagree 
Slightly 
agree 
Moderately 
agree 
Strongly 
agree 
If my arthritis worsens, it is 
my own behaviour which 
determines how soon I will 
feel better again. 
1 2 3 4 5 6 
As to my arthritis, what will 
be will be. 
1 2 3 4 5 6 
If I see my doctor regularly, 
I am less likely to have 
problems with my arthritis. 
1 2 3 4 5 6 
Most things that affect my 
arthritis happen to me by 
chance. 
1 2 3 4 5 6 
Whenever my arthritis 
worsens, I should consult a 
medically trained 
professional. 
1 2 3 4 5 6 
I am directly responsible for 
my arthritis getting better 
or worse. 
1 2 3 4 5 6 
Other people play a big role 
in whether my arthritis 
1 2 3 4 5 6 
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improves, stays the same, 
or gets worse. 
Whatever goes wrong with 
my arthritis is my own 
fault. 
1 2 3 4 5 6 
Luck plays a big part in 
determining how my 
arthritis improves. 
1 2 3 4 5 6 
In order for my arthritis to 
improve, it is up to other 
people to see that the right 
things happen. 
1 2 3 4 5 6 
Whatever improvement 
occurs with my arthritis is 
largely a matter of good 
fortune. 
1 2 3 4 5 6 
The main thing which 
affects my arthritis is what I 
myself do. 
1 2 3 4 5 6 
I deserve the credit when 
my arthritis improves and 
the blame when it gets 
worse. 
1 2 3 4 5 6 
Following doctor's orders 
to the letter is the best way 
to keep my arthritis from 
getting any worse. 
1 2 3 4 5 6 
If my arthritis worsens, it's 
a matter of fate. 
1 2 3 4 5 6 
If I am lucky, my arthritis 
will get better. 
1 2 3 4 5 6 
If my arthritis takes a turn 
for the worse, it is because 
1 2 3 4 5 6 
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I have not been taking 
proper care of myself. 
The type of help I receive 
from other people 
determines how soon my 
arthritis improves. 
1 2 3 4 5 6 
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Brief Illness Perception Questionnaire (BIPQ) 
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Health Literacy Questionnaire (HLQ) 
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The Health Literacy Questionnaire (HLQ). © Copyright 2014 Swinburne University of 
Technology. Authors: Richard H Osborne, Rachelle Buchbinder, Roy Batterham, Gerald R 
Elsworth. No part of the HLQ can be reproduced, copied, altered or translated without 
the permission of the authors. Further information: ghe-licences@swin.edu.au 
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Bristol Rheumatoid Arthritis Fatigue scale (BRAF) NRS 
 
 
Fatigue Rating Scale 
 
1.  Please circle the number which shows your average level of fatigue 
during the past 7 days 
 
No fatigue  0     1     2     3     4     5     6     7    8     9     10 Totally 
exhausted 
 
2.  Please circle the number which shows the effect fatigue has had on your 
life during the past 7 days  
 
No effect 0     1     2     3    4     5     6     7    8     9     10 A great deal of 
effect 
 
3.   Please circle the number which shows how well you have coped with 
fatigue over the past 7 days 
 
Not at  0     1     2     3     4     5     6     7    8     9     10 Very well 
all well 
 
Pain Rating Scale 
 
1. Please rate your pain by circling the one number that best describes 
your pain at its worst in the last week 
 
        0   1     2     3     4     5     6     7    8     9     10                                                                                                                                                                                                            
 
 
2. Please rate your pain by circling the one number that best 
describes your pain on the average in the last week 
 
          0     1     2     3     4     5     6     7    8     9     10 
                                                                                                                    
No pain 
No pain 
Pain as bad as you  
can imagine 
Pain as bad as you 
 can imagine 
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Positive and Negative Affect Scale (PANAS) 
 
This scale consists of a number of words that describe different feelings and emotions. 
Read each item and then enter the appropriate number in the space next to that word. 
Indicate to what extent you feel this way on average: 
 
 
   
1 2 3 4 5 
Very slightly or 
not at all 
A little Moderately Quite a bit Extremely 
 
   
 
 
 
 
 
 
 
 
  
_____ interested _____ irritable 
_____ distressed _____ alert 
_____ excited _____ ashamed 
_____ upset _____ inspired 
_____ strong _____ nervous 
_____ guilty _____ determined 
_____ scared _____ attentive 
_____ hostile _____ jittery 
_____ enthusiastic _____ active 
_____ proud _____ afraid 
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There will be another survey to complete in 9 months’ time. If 
you are happy to receive this, please tick this box and we will 
organise to send the survey out to you. This means that you 
give permission for the research team to access your address 
via your rheumatology team. We will only send you the second 
survey if you tick the box to confirm that you are happy to 
receive it:  
 
 
 
 
Thank you for taking the time to complete the survey. Please 
return it to the research team in Bristol using the prepaid 
envelope. 
If you have any questions please feel free to contact the 
research team at any time using the details on the front page 
of this survey. 
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Appendix Q: Follow-up survey pack for quantitative study 
 
 
How people manage their health conditions: A 
survey study 
 
Follow-up Survey 
Thank you for agreeing to take part in this study, and for completing the first survey last 
year. Your answers are confidential to the researchers, and we are interested in 
everybody’s views. If you have been diagnosed with more than one health condition, we 
ask that you answer these questionnaires thinking about your rheumatology condition.  
 
Some of the questions in this survey  may seem repetitive. This is because I am using a 
number of established questionnaires that cannot be changed. Please answer all the 
questions in the survey.  
 
Bristol research team contact: 
Bethan Jones 
Bethan8.jones@live.uwe.ac.uk 
0117 342 7415 
 
 
 
 
 
 
 366 
 
A) This section asks about your usual ABILITIES over the PAST WEEK 
 (Please tick) 
  
Without 
ANY  
difficulty 
 
 
With 
SOME 
difficulty 
 
With 
MUCH 
difficulty 
 
Unable  
to do 
1. DRESSING AND GROOMING 
    Are you able to: 
  - Dress yourself, including tying 
    shoelaces and doing buttons? 
 
  - Shampoo your hair? 
 
 
_________ 
 
 
_________ 
 
 
_________ 
 
 
_________ 
 
 
_________ 
 
 
_________ 
 
 
_________ 
 
 
_________ 
 
2. RISING 
    Are you able to: 
  - Stand up from an armless 
straight  
    chair?  
 
  -Get in and out of bed? 
 
 
 
 
_________ 
 
_________ 
 
 
 
 
_________ 
 
_________ 
 
 
 
 
_________ 
 
_________ 
 
 
 
 
_________ 
 
_________ 
 
3. EATING 
    Are you able to: 
  - Cut your meat? 
 
  - Lift a full cup or glass to your 
mouth? 
 
  - Open a new carton of milk (or 
soap 
     powder)? 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
4. WALKING 
    Are you able to: 
  - Walk outdoors on flat ground?  
 
  - Climb up five steps? 
 
 
_________ 
 
_________ 
 
 
 
_________ 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
 
_________ 
 
Please tick any aids or devices that you usually use for any of these activities: 
 _____  Cane  _____  Devices used for dressing (button hook, zipper 
 _____  Walking frame   pull, long handled shoe horn etc) 
 _____  Crutches   _____  Built-up or special utensils 
 _____  Wheelchair   _____  Special or built-up chair 
   
Other: ____________________________________________________________ (Please 
specify) 
Please tick any categories for which you usually need help from another person:  
 _____  Dressing and grooming _____  Eating _____  Rising   
 _____  Walking 
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5.  HYGIENE      
    Are you able to: 
  - Wash and dry your entire      
     body? 
 
  - Take a bath? 
 
  - Get on and off the toilet? 
Without 
ANY 
difficulty 
 
________ 
 
_________ 
 
_________ 
 
With SOME 
difficulty 
 
 
_________ 
 
_________ 
 
_________ 
 
With 
MUCH 
difficulty 
 
_________ 
 
_________ 
 
_________ 
 
Unable  
to do 
 
 
_________ 
 
_________ 
 
_________ 
 
 
6. REACH      
    Are you able to: 
  - Reach and get down a 5lb    
    object (e.g. a bag of 
potatoes)    
    from just above your head? 
 
  - Bend down to pick up 
clothing  from the floor? 
 
 
 
 
_________ 
 
 
_________ 
 
 
 
 
_________ 
 
 
_________ 
 
 
 
 
_________ 
 
 
_________ 
 
 
 
 
_________ 
 
 
_________ 
 
7. GRIP      
    Are you able to: 
  - Open car doors? 
 
  - Open jars which have been  
    previously opened? 
 
  - Turn taps on and off? 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
_________ 
 
_________ 
 
8. ACTIVITIES      
    Are you able to: 
  - Run errands and shop? 
 
  - Get in and out of a car? 
 
  - Do chores such as 
vacuuming,      housework or 
light gardening? 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
 
 
_________ 
 
_________ 
 
 
_________ 
 
Please tick any aids or devices that you usually use for any of these activities: 
 _____  Raised toilet seat _____  Bath rail  
 _____  Bath seat  _____  Long handled appliances for reach 
 _____  Jar opener (for jars   
  previously opened) Other: 
____________________________________________________________ (Please specify) 
  
Please tick any categories for which you usually need help from another person:  
 _____  Hygiene  _____  Gripping and opening things 
 _____  Reach   _____  Errands and housework  
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Below are some statements that people sometimes make when they talk about their 
health. Please indicate how much you agree or disagree with each statement as it 
applies to you personally by circling your answer. There are no right or wrong 
answers, just what is true for you. If the statement does not apply to you, circle N/A. 
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We are interested in finding out what things you believe you could do to help you with your 
arthritis. We want to know what you think you could do, even if you are not actually doing 
it at the moment.  Please tick one column for each question. 
Do you believe you could do these things to help you with your arthritis? 
 Strongly 
disagree 
Disagree Neither 
disagree nor 
agree 
Agree Strongly 
agree 
I believe I could use 
relaxation techniques 
to help with pain 
     
I believe I could think 
about something else 
to help with pain 
     
I believe I could use my 
joints carefully (joint 
protection) to help 
with pain 
     
I believe I could think 
positively to help with 
pain 
     
I believe I could avoid 
doing things that cause 
pain 
     
I believe I could wind 
down and relax before 
going to bed, to 
improve my sleep 
     
I believe I could have a 
hot drink before bed, 
to improve my sleep 
     
I believe I could use 
relaxation before bed, 
to improve my sleep 
     
I believe I could pace 
myself and take my 
arthritis into account 
to help deal with 
tiredness 
     
I believe I could accept 
fatigue as part of my 
arthritis 
     
I believe I could use 
gadgets to help with 
mobility, household 
tasks or personal care 
     
I believe I could ask for 
help to deal with the 
difficulties of doing 
everyday tasks 
     
I believe I could do 
exercises to deal with 
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the difficulties of doing 
everyday tasks 
 Strongly 
disagree 
Disagree Neither 
disagree 
nor agree 
Agree Strongly 
agree 
I believe I could plan or 
prioritise my day to 
deal with difficulties of 
doing everyday tasks 
     
I believe I could 
educate my family and 
friends about my 
arthritis to help with 
the strains that 
arthritis can make on 
relationships 
     
I believe I could explain 
to friends and family 
when I do or don’t 
need help 
     
I believe I could discuss 
any problems with my 
partner or family 
     
I believe I could make 
time for leisure 
activities, hobbies or 
socializing 
     
I believe I could save 
energy for leisure 
activities, hobbies or 
socializing 
     
I believe I could focus 
on the positive when 
I’m feeling down 
     
I believe I could use 
relaxation to deal with 
worries 
     
I believe I could 
allocate time for 
relaxation 
     
I believe I could use a 
relaxation tape or 
instructions to help me 
relax 
     
I believe I could use 
regular exercise 
     
I believe I could be 
aware of my limits in 
exercise 
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I believe I could 
manage my 
medication, knowing 
how and when to take 
it 
     
I believe I could look 
out for and avoid side-
effects of my 
medication 
     
I believe I could seek 
help with persistent 
side-effects 
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Instructions: Each item below is a belief statement about your inflammatory arthritis with 
which you may agree or disagree. Beside each statement is a scale which ranges from 
strongly disagree (1) to strongly agree (6).  
For each item we would like you to circle the number that represents the extent to which 
you agree or disagree with that statement. The more you agree with a statement, the 
higher the number you circle. The more you disagree with a statement, the lower the 
number you circle. Please make sure that you answer EVERY ITEM and that you circle ONLY 
ONE number per item. This is a measure of your personal beliefs; obviously, there are no 
right or wrong answers. 
 Strongly 
disagree 
Moderately 
disagree 
Slightly 
disagree 
Slightly 
agree 
Moderately 
agree 
Strongly 
agree 
If my arthritis worsens, it is my 
own behaviour which determines 
how soon I will feel better again. 
1 2 3 4 5 6 
As to my arthritis, what will be 
will be. 
1 2 3 4 5 6 
If I see my doctor regularly, I am 
less likely to have problems with 
my arthritis. 
1 2 3 4 5 6 
Most things that affect my 
arthritis happen to me by chance. 
1 2 3 4 5 6 
Whenever my arthritis worsens, I 
should consult a medically trained 
professional. 
1 2 3 4 5 6 
I am directly responsible for my 
arthritis getting better or worse. 
1 2 3 4 5 6 
Other people play a big role in 
whether my arthritis improves, 
stays the same, or gets worse. 
1 2 3 4 5 6 
Whatever goes wrong with my 
arthritis is my own fault. 
1 2 3 4 5 6 
Luck plays a big part in 
determining how my arthritis 
improves. 
1 2 3 4 5 6 
In order for my arthritis to 
improve, it is up to other people 
to see that the right things 
happen. 
1 2 3 4 5 6 
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Whatever improvement occurs 
with my arthritis is largely a 
matter of good fortune. 
1 2 3 4 5 6 
The main thing which affects my 
arthritis is what I myself do. 
1 2 3 4 5 6 
I deserve the credit when my 
arthritis improves and the blame 
when it gets worse. 
1 2 3 4 5 6 
Following doctor's orders to the 
letter is the best way to keep my 
arthritis from getting any worse. 
1 2 3 4 5 6 
If my arthritis worsens, it's a 
matter of fate. 
1 2 3 4 5 6 
If I am lucky, my arthritis will get 
better. 
1 2 3 4 5 6 
If my arthritis takes a turn for the 
worse, it is because I have not 
been taking proper care of 
myself. 
1 2 3 4 5 6 
The type of help I receive from 
other people determines how 
soon my arthritis improves. 
1 2 3 4 5 6 
 374 
 
 
 
 
 
  
 375 
 
 
 
 376 
 
 
 
 377 
 
 
 
 378 
 
 
 
 
 
 
The Health Literacy Questionnaire (HLQ). © Copyright 2014 Swinburne University of 
Technology. Authors: Richard H Osborne, Rachelle Buchbinder, Roy Batterham, Gerald R 
Elsworth. No part of the HLQ can be reproduced, copied, altered or translated without 
the permission of the authors. Further information: ghe-licences@swin.edu.au 
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Fatigue Rating Scale 
1.  Please circle the number which shows your average level of fatigue 
during the past 7 days 
No fatigue  0     1     2     3     4     5     6     7    8     9     10 Totally 
exhausted 
 
2.  Please circle the number which shows the effect fatigue has had on your 
life during the past 7 days  
 
No effect 0     1     2     3    4     5     6     7    8     9     10 A great deal of 
effect 
 
3.   Please circle the number which shows how well you have coped with 
fatigue over the past 7 days 
 
Not at  0     1     2     3     4     5     6     7    8     9     10 Very well 
all well 
 
Pain Rating Scale 
 
3. Please rate your pain by circling the one number that best describes 
your pain at its worst in the last week 
 
        0   1     2     3     4     5     6     7    8     9     10                                                                                                                                                                                                            
 
4. Please rate your pain by circling the one number that best 
describes your pain on the average in the last week 
 
          0     1     2     3     4     5     6     7    8     9     10 
No pain 
No pain 
Pain as bad as you can 
imagine 
Pain as bad as  
you can imagine 
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This scale consists of a number of words that describe different feelings and emotions. 
Read each item and then enter the appropriate number in the space next to that word. 
Indicate to what extent you feel this way on average: 
 
1 2 3 4 5 
Very slightly or 
not at all 
A little Moderately Quite a bit Extremely 
 
   
   
 
 
 
 
 
 
 
 
  
_____ interested _____ irritable 
_____ distressed _____ alert 
_____ excited _____ ashamed 
_____ upset _____ inspired 
_____ strong _____ nervous 
_____ guilty _____ determined 
_____ scared _____ attentive 
_____ hostile _____ jittery 
_____ enthusiastic _____ active 
_____ proud _____ afraid 
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If you would like to receive a summary of the study results, 
please tick this box and we will organise to send one to you. 
We will only send this if you tick the box to confirm that you 
are happy with this:  
 
 
 
 
Thank you for taking the time to complete these 
questionnaires. Please return these to the research team in 
Bristol using the prepaid envelope in the question. 
If you have any questions please feel free to contact the 
research team at any time using the details on your 
information sheet. 
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Appendix R: Quantitative study protocol 
 
How people manage their health conditions: A survey study 
Protocol – 5th April 2018 (Version 1) 
 
 
Principal Investigator 
Bethan Jones PhD student, University of the West of England (UWE), Bristol  
 
 
Project team members 
Emma Dures Associate Professor in Rheumatology and Self-Management, UWE, 
Bristol 
Sarah Hewlett   Professor of Rheumatology Nursing, UWE, Bristol  
Diana Harcourt  Professor of Appearance & Health Psychology, UWE, 
Bristol 
Andrew Hunt   Patient Research Partner, Bristol Royal Infirmary 
 
 
Contact details 
Bethan Jones 
Rheumatology Research 
Level 5, Zone B 
Bristol Royal Infirmary 
Bristol  
BS2 8HW 
 
Tel: 0117 342 7415 
Email: Bethan8.jones@live.uwe.ac.uk 
 
 
Funded by a PhD Scholarship by Arthritis Research UK. 
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Glossary: 
IA  Inflammatory arthritis 
PAM  Patient Activation Measure 
UWE  University of the West of England, Bristol 
UHB  University Hospitals Bristol 
 
 
Summary of the study: 
                                                                                  
Inflammatory arthritis (IA) describes several long term conditions including 
rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, connective tissue 
disease and systemic lupus erythematosus (Arthritis Research UK, 2016). These 
conditions impact people in a variety of physical and psychosocial ways, commonly 
requiring significant life adaptations to cope with the diagnosis. Some of the 
consequences of IA include pain and fatigue, reduced mobility, low mood, increased 
anxiety, and unpredictable fluctuations or “flares” in disease activity and symptoms 
(Homer, 2005). IA is generally managed in secondary care settings with specialist 
rheumatology teams, with an overall focus on managing the physical symptoms and 
reducing joint damage and disease activity (Gettings, 2010; National Audit Office, 
2009).  
 
Research indicates that there are a variety of factors that contribute to how engaged 
someone becomes in managing their health, and one of these is a concept called 
patient activation (Hibbard et al., 2004). It is defined as how willing and able someone 
is to take an active role in dealing with their health (Hibbard and Greene, 2013). 
Higher levels of patient activation are associated with fewer emergency hospital 
admissions, fewer days as an inpatient and lower healthcare costs (Hibbard et al., 
2015). Therefore, there is a value in understanding activation to reduce strain on the 
NHS.  For individuals, people who are more activated are also more likely to adhere 
to their treatment schedules, and have better outcomes overall (McCusker et al., 
2016).  
 
However, little is known about the dimensions and factors involved in patient 
activation in the context of people with arthritis, and ways in which they might 
change over time. Consequently, activation is considered to be one of the lesser-
understood concepts in self-management research (Roberts et al., 2016). The PI has 
previously conducted a qualitative study to identify potential variables associated 
with activation. The PI would now like to look at these associations in a large sample, 
over time. 
 
The study will provide an opportunity to look at patient activation scores (captured 
using the Patient Activation Measure) plus a range of demographic, clinical and 
psychosocial factors in a large sample of people with IA. These data will be collected 
with the same sample, at two timepoints, enabling analysis of changes over time.   
Data analysis will examine the relationship between these psychosocial factors, as 
well as other demographic factors to understand what may have an impact on 
patient activation. The purpose of repeating the questionnaires later are to identify 
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whether patient activation changes over time in this population, and to explore 
whether constructs that were related at phase one continue to be related at phase 
two.         
 
 
This study (funded as part of a PhD scholarship from Arthritis Research UK) will 
contribute to the development of a framework to describe patient activation in IA. 
Having a framework to describe patient activation in people with IA offers the 
opportunity for a theory-driven intervention to support people in taking the next step 
to actively manage their health condition. This study will help to ensure that any 
future intervention is focused sufficiently on rheumatology related contextual factors 
to suit people living with IA. 
 
The main aim of the study is to describe associations between patient activation 
(measured using the PAM) and a range of clinical, demographic and psychosocial 
variables. 
 
The study objectives are: 
 
To examine the relationship between PAM scores and other related constructs and 
demographic characteristics 
To identify levels of activation in a cross-section of people with IA 
To examine changes in PAM scores in a cross-section of people with IA 
To explore and map changes to these scores over time. 
 
Background: 
Models of illness have an impact on the way that care is delivered to people living 
with long term health conditions. The previously dominant biomedical model has 
been criticised for not considering the impact of other social, psychological and 
behavioural factors that can contribute to people’s experience of living with health 
conditions (Wade & Halligan, 2004). This can imply that people are passive in their 
experiences, and doesn’t consider how people can influence their health.  
 
Because of these criticisms, the biopsychosocial model has encompassed these 
additional factors which can contribute to outcomes (Engel, 1977) and describe 
people’s experiences in a more holistic way. This shift gives people with long term 
conditions more of a position as experts in living with their health condition with 
more responsibility to self-manage their condition. People are expected to develop 
skills to manage their illness, become more involved in making decisions about their 
condition in collaboration with health care professionals, and develop knowledge 
about behaviours which help manage their health (Hibbard, Stockard, Mahoney & 
Tusler, 2004).  
 
Research indicates that there are a variety of factors that contribute to how engaged 
someone becomes in managing their health, and one of these is a concept called 
patient activation (Hibbard et al., 2004). It is defined as being how willing and able 
someone is to take an active role in dealing with their health (Hibbard and Greene, 
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2013). It appears to be a multidimensional construct, incorporating associated 
concepts such as self-management behaviours, health literacy, and self-efficacy (the 
belief in one’s ability to achieve a desired outcome) (Hibbard et al., 2004; Do, Young, 
Barnason & Tran, 2015).  
 
Higher levels of activation are associated with fewer emergency admissions, fewer 
days as an inpatient and lower healthcare costs (Hibbard et al., 2015). Therefore, 
there is a value in understanding activation to benefit a resource-scarse NHS.  On an 
individual level, increased activation is associated with greater adherence to 
treatment schedules and better outcomes overall (McCusker et al., 2016). In the 
context of IA, activation might also involve behaviours such as regular stretching to 
reduce stiffness, having and acting on a plan for when their condition flares up, and 
managing stress levels by scheduling in time to practice relaxation techniques (Dixon, 
Hibbard and Tusler, 2009). 
 
The dominant model of explaining activation is captured in the extensively used 
“Patient Activation Measure” (PAM) (Hibbard et al., 2004), with the PAM described 
as identifying the beliefs that people have about themselves and the responsibility 
they hold for managing their health (Hibbard & Mahoney, 2010).  A licence is required 
to use the PAM in research, and this has already been obtained for the research 
study.  
 
The PAM and the underpinning model describe activation as involving four stages, 
each building on the other in a hierarchy (Hibbard et al., 2004). Hibbard proposes 
that people become more able to develop through the stages and become more able 
to engage in more complex behaviours as they become more activated (Hibbard et 
al., 2015). While it is believed that providing information alone is not sufficient to 
activate patients (Rix and Martin, 2015), factors which do contribute to increasing 
people’s confidence and ability to actively manage their health are less understood.  
 
However, little is known about the dimensions and factors involved in patient 
activation in the context of people with arthritis. There has also been limited 
longitudinal research focused on patient activation in a rheumatology context and it 
is considered to be one of the lesser-understood concepts in self-management 
research (Roberts et al., 2016). A survey to understand and map patient activation 
scores, therefore, can complement the qualitative research study to contribute to 
the understanding of patient activation and its progression, or otherwise, over time, 
 
The study will provide an opportunity to look at patient activation scores (captured 
using the Patient Activation Measure) plus a range of demographic, clinical and 
psychosocial factors in a large sample of people with IA. These data will be collected 
with the same sample, at two timepoints, enabling analysis of changes over time.   
Data analysis will examine the relationship between these psychosocial factors, as 
well as other demographic factors in order to understand what may have an impact 
on patient activation. The purpose of repeating the questionnaires at a later date are 
to identify whether patient activation changes over time in this population, and to 
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explore whether constructs that were related at phase one continue to be related at 
phase two.         
 
Design and methods:  
The study design is longitudinal and will include two phases, using quantitative 
methods of data collection and analysis. The study requires NHS Research Ethics 
(REC), Health Research Authority and university ethics, and local research governance 
approvals in a combined application before data collection can commence. The 
research has been designed following consultation with patient research partners, a 
statistician, and the chief investigator's supervisory team to ensure scientific rigour 
and potential benefit to the patient population.  
 
 
 
Phase 1:  
Recruitment and Sampling: 
People will be eligible to take part if they are: 
Over 18 years old 
Living with a diagnosis of IA 
A patient at one of the collaborating units 
Able to provide informed consent to participate  
Able to communicate, read and write in English 
 
The intention is to ensure a range of patients (i.e. age, gender and disease duration) 
are represented in this study. However there is the potential for this diversity to not 
be reflected in the participant characteristics. In order to access as broad a range of 
people as possible, recruitment will take place at six rheumatology units throughout 
England. The units have been selected to cover diverse geographical locations, urban 
and rural communities, ethnically and socioeconomically diverse areas, and the size 
and scope of the rheumatology department. The inclusion criteria are also 
deliberately broad to ensure as many interested patients as possible can participate. 
 
The collaborating rheumatology units across hospitals in England are: 
Bristol Royal Infirmary, Bristol  
Haywood Hospital, Stoke-On-Trent  
Weston General Hospital, Weston-Super-Mare  
Torbay Hospital, Torquay  
Northumbria  
St Peter’s Hospital, Chertsey  
 
Eligible patients will be given a study information pack when they attend for an 
outpatient clinic appointment, or sent the pack through the post. This information 
pack will contain an invitation to participate from the local clinical lead, a Patient 
Information Sheet, a consent form, the questionnaires, a reply slip and a reply-paid 
envelope. Approximately 700 survey packs will be provided across all sites (i.e. 100-
120 per site), assuming an estimated return rate of 50%. This estimation is based on 
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similar postal surveys following these methods that have been used previously in 
rheumatology (Sanderson et al., 2010).  
 
 
Data Collection: 
An estimated total of 350 datasets will be collected across the six sites. This target 
sample size is based on the Draper & Smith (1998) guidance that there should be at 
least 10 participants for each independent variable being measured, and to gather a 
sufficient number of participants for a thorough analysis. Potential participants will 
be asked to read the information sheet, which will have information about how to 
contact the research team to ask any questions they may have, or to request further 
information. Providing they would like to participate, they will be asked on the 
information sheet to sign the consent form and complete the questionnaires. 
Participants will have the option of completing these in clinic or at home, then 
posting them back to the central study team in Bristol using the reply-paid envelope.  
 
The survey packs will all be labelled with unique pack numbers. Each local unit will 
keep a record of which patients have been handed which survey pack number. The 
Bristol team will inform each collaborating centre of which surveys have not been 
returned.  
 
The measures in the survey pack have been chosen for a variety of reasons, including 
their psychometric properties, prior use with people with rheumatic conditions, and 
the briefest version has been selected where possible to reduce participant burden. 
 
 
The measures in the survey pack will include: 
Demographic information about participants – sex, age, ethnicity, rheumatic 
condition and disease duration. 
Health Assessment Questionnaire (HAQ) (Fries et al., 1980): 
The disability component of the HAQ will capture participants’ level of disability, and 
the impact that the rheumatic condition has on participants’ level of function. 
Patient Activation Measure: Short form (PAM) (Hibbard et al., 2005): 
The PAM is a commercially-licenced questionnaire designed to capture patient 
activation over 13 items and categorise patients into one of four activation levels 
ranging from 1 (passive) to 4 (actively managing their health). It is the most widely 
used measure to capture patient activation, having been used internationally and 
translated into a wide range of languages (Hibbard, Greene and Tusler, 2009). The 
PAM will be the dependent variable for the data analysis. 
Rheumatoid Arthritis Self Efficacy Scale (RASE) (Hewlett et al., 2001): 
Self-efficacy is the belief someone has that they will be able to carry out a task, 
instead of their actual ability to do so (Hewlett et al., 2001). The RASE is a 28-item 
measure, developed to capture self-efficacy in British people living with rheumatoid 
arthritis. 
Brief Illness Perceptions Questionnaire (BIPQ) (Broadbent et al., 2006): 
This 9-item measure captures participants’ understanding of the timeline and nature 
of this condition, the emotional impact of their health changes and the impact to 
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their sense of identity, and an open-ended question focused around the causes they 
attribute to their illness.  
Pain Numerical Rating Scale (NRS) & Fatigue NRS: 
This is a clear and brief measure of pain and fatigue levels, asking participants about 
their pain/fatigue levels over the last 24 hours.  
Multidimensional Health Locus of Control Scale – Form C (Wallston, Stein & Smith, 
1995): 
The use of this questionnaire will offer the opportunity to confirm whether locus of 
control is related to patient activation in a sample of rheumatology. This 18-item 
measure captures participants’ beliefs about how much of their health is related to 
their own personal control or because of chance.  
Health Literacy Questionnaire (Osborne et al., 2013) 
This 44 item measure captures participants’ abilities to navigate the healthcare 
system confidently, to gather and apply health-related information and to work with 
healthcare providers. 
Positive and Negative Affect Scale (Watson et al., 1988): 
This 10 item measure, selected for its use in prior patient activation research 
(Hibbard & Mahoney, 2010) has been demonstrated to reliably capture participants’ 
positive and negative affect. It has been validated for use with people with rheumatic 
conditions (Zautra et al., 1995). 
 
This will also be the case for follow-up questionnaires to optimise the response rate.  
 
Data analysis: 
The analysis will be carried out by Bethan Jones, a PhD researcher with prior 
experience in quantitative data analysis, with support and supervision from the rest 
of the research team. Study participants will be allocated a unique ID number. The 
database which notes participants' names and their allocated ID number will be 
password protected, and only accessible to the study team. Data collected for the 
study will be entered directly on a computer which is password protected in a locked 
office, according to local hospital policy. Hard copies of the signed consent forms will 
be stored in a locked filing cabinet within the same office.  
 
Phase one data will be analysed using SPSS for Windows, and will involve multivariate 
analysis to investigate the relationship between multiple factors and participant 
scores on the PAM. As the PAM is a continuous measure, this analysis is likely to be 
in the form of multiple regression analysis. Descriptive statistics will describe the 
spread of PAM scores across the sample, and multivariate analysis will investigate 
the relationships between PAM scores and other variables. 
 
 
Phase 2: Timepoint two Questionnaires  
This phase involves collecting questionnaire data from the same group of participants 
9 months after their initial participation. It will be noted on the initial questionnaire 
that participants can tick to agree to receive the second questionnaire. If participants 
do not tick agreeing to the second questionnaire being sent out, they will not receive 
the next set of questionnaires. 
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Method: 
The PI will make a visit to each site before timepoint two, and will liaise with the 
research team at the site to get the postal addresses of all the patients who took part 
from that site. This will be based on the comparison of ID codes from returned 
questionnaires and the records held by the sites that notes which participant has 
been given each questionnaire. Participants will be asked to complete the 
questionnaires and return them in a reply paid envelope to the research team at 
UWE.  
 
Recruitment and Sampling: 
The sample will be formed of people who participated in phase one, and no 
additional recruitment will be carried out.   
 
Data collection: 
Data collection for phase two will be carried out the same way as phase one. The 
questionnaires included will not differ from the original questionnaire pack. Sites will 
note which people have received which questionnaire number, in order to track 
participants who returned the questionnaires for follow-up. A reminder 
questionnaire may be sent if the follow-up survey is not returned within 6 weeks, in 
order to increase retention rates. The research team will collaborate with sites in the 
same way as previously noted to establish who requires a reminder pack sent out.  
 
There will also be a checkbox asking if participants would like a summary of the 
results posted to the home address using the same method as the second 
questionnaires (i.e. comparing ticked boxes on uniquely numbered questionnaires 
and working with sites retaining the addresses of participants). 
 
Data analysis: 
Phase two data will be analysed using multivariate analysis to understand the 
relationships between the variables, and to understand what contributes to 
variations in PAM scores reported by participants. Data analysis will also investigate 
whether there has been a significant change within participants’ PAM scores over 
time, and to describe the sample at the follow-up point. 
 
Dissemination: 
The research method and findings will be presented in the Principal Investigator’s 
PhD thesis. It is intended that the research findings will also be presented at 
appropriate academic conferences in rheumatology or psychology, and submitted 
for publication to an appropriate academic peer reviewed journal. The results will be 
fed back to the teams at the sites that participated in the research. 
 
 
Project management and the research team  
This research will contribute to a PhD project at the University of the West of England 
(UWE), and is supervised by a team with significant experience in rheumatology, the 
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impact of long term health conditions, mixed-methods data collection and analysis, 
and patient perspectives on living with IA.  
 
Bethan Jones, a PhD student with a background in health psychology in long term 
conditions, has designed this study and will conduct the data collection and analysis. 
She has also completed Good Clinical Practice training. 
 
Dr Emma Dures, Associate Professor and chartered psychologist, is Bethan’s Director 
of Studies. Dr Dures similarly has a background in health psychology and substantial 
experience of designing and conducting mixed methods research. Professor Sarah 
Hewlett (Professor of Rheumatology Nursing, UWE) is Bethan’s second supervisor. 
Professor Hewlett is a clinical academic who is at the forefront of research into 
patient involvement, self management, and understanding the impact of IA on 
patients’ wellbeing. Further supervision is provided by Professor Diana Harcourt, who 
has substantial experience of the psychological impact of living with a long term 
condition; and Mr Andrew Hunt, a patient partner who brings lived experience of 
living with IA to the team.  
 
Throughout the study there will be regular whole team meetings as required, and 
fortnightly meetings between Bethan Jones and Dr Dures for ongoing day to day 
management of the study. 
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Appendix S: Patient Information Sheet for survey study 
 
 
 
 
 
 
How people manage their health conditions: A survey study 
Patient Information Sheet 
 
You are being invited to take part in a research study. Before you decide it is important for 
you to understand why the study is being done and what it will involve. Please read the 
following information and discuss it with friends and relatives if you wish. If anything is not 
clear or if you would like more information, you are welcome to get in touch with Bethan 
Jones. Her contact details are at the end of the document.   
 
Who is asking you to take part? 
I am Bethan Jones, and I am a student at the University of the West of England. I am inviting 
you to take part in a research study that will be part of my PhD. 
 
What is the purpose of the study? 
I am interested in finding out how people with rheumatic conditions manage their health, 
and how confident and able they feel to do this. I am also interested in how peoples’ opinions 
of how they self-manage change over time, which is why this study involves completing 2 
sets of questionnaires. 
 
Why have I been invited to take part? 
You have been invited to take part because you are living with a type of inflammatory 
arthritis. I am inviting around 350 people to take part from six NHS hospitals in England. We 
are interested in everyone’s answers to understand people’s experiences. 
 
What will I be asked to do if I take part? 
If you decide to participate, it will involve the following: 
 393 
 
• Completing the questionnaires and about you, and your health and returning them 
to us in the next 2 months. You will also be asked for some brief details regarding 
your age, gender and the length of time since you were diagnosed with your 
rheumatic condition. We think that this will take around 30 minutes to fill in. 
• Agreeing to be contacted 9 months after your first questionnaire to be sent a second 
set of questionnaires. 
• Completing this second set of questionnaires and return them to us. 
• We may send you a reminder about the study a little while after the second 
questionnaire. We think it is important that you decide whether you take part in 
private, so we may not know who has already responded in that time and who has 
decided not to take part in the research. Please accept our apologies in advance if 
you have already replied, or already decided you don't want to take part, when you 
receive the reminder. You do not have to take part in either questionnaire, can ignore 
the reminder. 
 
Do I have to take part? 
No, taking part is voluntary. It is up to you to decide whether to take part. If you do decide 
to take part, you will be asked to complete and return the first set of questionnaires within 
two months. If you decide not to take part you do not have to give a reason, nobody will be 
upset and the care you receive will not be affected. If you do decide to take part, you are 
still free to withdraw at any time and without giving a reason, we will retain any data you 
have already completed as part of this study unless you specifically ask us to delete this 
information. If you do ask us to remove your information we will destroy hard copy 
documents you have completed and will delete any electronic data.  A decision to withdraw 
at any time, or a decision not to take part, will not affect the standard of care you receive. 
You can withdraw from the study by contacting Bethan Jones on the details provided below 
or the department that provided you with this information pack. 
 
 
What are the possible risks of taking part? 
It is not expected that this study has disadvantages to you personally, but completing the 
questionnaires will take up to 30 minutes of your time. If you find that completing the survey 
that you are feeling low or anxious about your condition then we suggest contacting your 
GP or rheumatology team to talk about this. Alternatively, if you would like support from 
other sources you may find it useful to contact: 
• NRAS (National Rheumatoid Arthritis Society) https://www.nras.org.uk 
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Freephone Helpline: 0800 298 7650 helpline@nras.org.uk 
 
• Arthritis Research UK https://www.arthritisresearchuk.org 
1 Helpline 0800 5200 520 
 
What are the possible benefits of taking part? 
There is not likely to be any direct benefit to you from taking part in this study. However, I 
think this study will benefit people with arthritis in the future as we understand more about 
how people learn to live life with arthritis over time. 
 
Will my taking part in this study be kept confidential? 
Information collected about you will be kept confidential. We will lock the forms you return 
to us in the project office, and any information we store about you on the secure University 
of Bristol computer will be password protected. No-one else outside the research team will 
have access to any identifying information and all identifiable information will be kept 
securely. A researcher may look at your medical notes to check that the study is being 
carried out correctly. The department in your local NHS trust that recruited you will keep a 
copy of your name attached to your ID number so that we know who has responded to the 
questionnaires, and this link will not leave the NHS trust.  
 
What will you do with my data? 
UWE is the sponsor for this study based in the United Kingdom. We will be using information 
from you in order to undertake this study and will act as the data controller for this study. 
This means that we are responsible for looking after your information and using it properly. 
UWE will keep identifiable information about you for up to 12 months after the study has 
ended, and your responses to the questionnaires for 5 years. 
 
Your rights to access, change or move your information are limited, as we need to manage 
your information in specific ways in order for the research to be reliable and accurate. If you 
withdraw from the study, we will keep the information about you that we have already 
obtained. To safeguard your rights, we will use the minimum personally-identifiable 
information possible. 
 
The NHS site will keep your name and contact confidential and will not pass this information 
to UWE. The NHS site will use this information as needed, to contact you about the research 
study, and make sure that relevant information about the study is recorded for your care, 
and to oversee the quality of the study. Certain individuals from UWE and regulatory 
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organisations may look at your medical and research records to check the accuracy of the 
research study. UWE will only receive information without any identifying information. The 
people who analyse the information will not be able to identify you and will not be able to 
find out your name or contact details. 
 
You can find out more about how we use your information by contacting Bethan Jones or 
another member of the study team. 
 
What will happen to the results of the research study? 
The findings will be reported in professional publications, journals and conferences. They 
will also be published in my doctoral thesis. A copy of your anonymised questionnaire 
answers will also be sent to Insignia Health, a commercial company outside of the NHS who 
offer us the licence to use the Patient Activation Measure. They are not directly working on 
the study, but your name and any identifying information will be removed to keep this data 
anonymous. They use this information to improve, refine and understand how the 
questionnaire is completed.  
 
Who is funding the study? 
This research study is funded by Arthritis Research UK. 
 
Who has reviewed the research? 
It has been approved by the Health Research Authority, a Research Ethics Committee (REC 
Project ID 235922) and the University of the West of England (UWE) ethics committee.   
 
What do I do now? 
If you are interested in taking part, please complete and return the questionnaires in the 
reply-paid envelope. If you have any questions or would like more information before you 
decide whether to participate, you can contact the study team on the details below. 
 
 
Central study contact details:  Bethan Jones 
     Rheumatology Research 
     Level 5, Zone B 
Bristol Royal Infirmary 
Bristol  
BS2 8HW 
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0117 342 7415 
Bethan8.jones@live.uwe.ac.uk 
 
Study Team: 
Bethan Jones, PhD Student (UWE Bristol) 
Emma Dures, Associate Professor in Rheumatology and Self-Management (UWE Bristol) 
Sarah Hewlett, Professor of Rheumatology Nursing (UWE Bristol) 
Diana Harcourt, Professor of Appearance & Health Psychology (UWE Bristol) 
Andrew Hunt, Patient Partner (Bristol Royal Infirmary) 
 
If you have any concerns about participating in this study and would like to receive 
free independent advice please contact PALS (Patient Advice and Liaison Service) 
on: 
0117 342 1050 or via email on psct@uhbristol.nhs.uk 
 
If you wish to talk to my academic supervisor about any concerns relating to this 
study, please contact Dr Emma Dures on: 0117 342 7418 or via email on 
emma2.dures@uwe.ac.uk  
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Appendix T: Invitation letter to participate 
 
 
Dear  
 
Invitation to take part in an interview  
 
I am writing to tell you about a research project for which I am 
helping PhD student Bethan Jones and her research 
supervisors. Bethan would like to find out more about how 
people with rheumatic conditions manage their health, and 
how confident and able they feel to do this 
 
This research is being run in rheumatology units in six hospitals 
across England. It is led by Bethan Jones and her research 
supervisors from the University of the West of England, who 
are based in the Bristol Royal Infirmary Rheumatology Unit. 
 
I am enclosing the patient information sheet about the study 
for you to read. Taking part in research is voluntary and if you 
would prefer not to do so nobody will be upset and your 
treatment will not be affected. 
 
If you would be interested in taking part, please complete the 
survey pack and return it to the researcher Bethan Jones in the 
prepaid envelope provided.  
 
Thank you for taking the time to read the enclosed 
information. 
 
Yours sincerely 
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Consultant Rheumatologist 
 
Appendix U: Chase letter for second survey pack 
 
 
Local site logo 
 
Dear Sir/Madam, 
 
Reminder of an invitation to take part in a follow-up survey 
study 
 
A few weeks ago, we sent you an invitation to take part in a 
follow-up survey study. This is a reminder of our invitation and 
a copy of the follow-up survey.  
 
Please accept our apologies if you have already completed and 
returned the follow-up survey, or if you have already decided 
that you do not wish to take part. 
 
Yours sincerely  
 
Bethan Jones 
PhD Student 
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Appendix V: Summary of BIPQ data 
First data collection round categories of responses to the item “Please list in rank-
order the three most important factors that you believe caused your illness. The most 
important causes for me:” 
Category (first set of data) Number of responses 
Stress 60 
Age 18 
Heredity/Genetics 101 
Bad Luck 18 
Don't Know 32 
Overactivity 25 
Underactivity 7 
Other autoimmune condition or pre-existing health issue 26 
Diet 16 
Immune system problem/infection 34 
Occupation/Work 42 
Lifestyle-related factors (including sleep) 18 
Fall/accident 18 
Depression/Anxiety/Worry 7 
Wear and tear/impact on joints 9 
Don't think there is a specific cause 3 
Trauma 9 
Significant life events 10 
Medication / other health treatment 7 
Inflammation 1 
Hormones/menopause/pregnancy 6 
Weather/climate 5 
Other (listed separately) 22 
Neglect (self or NHS) 12 
Chemicals/pollutants/smoking 7 
Total 494 
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Category (Follow-up data) Number of responses 
Stress 40 
Age 11 
Heredity/Genetics 81 
Bad Luck 19 
Don't Know 8 
Overactivity 12 
Underactivity 3 
Other autoimmune condition or pre-existing health issue 29 
Diet 9 
Immune system problem/infection 20 
Occupation/Work 33 
late intervention 3 
Lifestyle-related factors (including sleep) 13 
Fall/accident 16 
Depression/Anxiety/Worry 4 
Wear and tear/impact on joints 5 
Don't think there is a specific cause 2 
Trauma 3 
Significant life events 4 
Medication / other health treatment 6 
Inflammation 4 
Hormones/menopause/pregnancy 12 
Weather/climate 1 
Other (listed separately) 24 
Neglect (self or NHS) 12 
Chemicals/pollutants 1 
Total 375 
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Appendix W: Probability plot, scatterplot and Shapiro-Wilk 
results for first timepoint multiple regression 
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 Statistic Df p Value 
PAM 0.969 251 0.000 
HAQ 0.910 251 0.000 
RASE 0.980 251 .001 
Locus of Control: Internal 0.980 251 .002 
Locus of Control: Chance 0.976 251 .000 
Locus of Control: Doctors 0.982 251 .003 
Locus of Control: Powerful Others 0.971 251 .000 
BIPQ 0.993 251 .296 
Health Literacy Questionnaire Subscale 1 0.846 251 <.001 
Health Literacy Questionnaire Subscale 2 0.724 251 <.001 
Health Literacy Questionnaire Subscale 3 0.942 251 <.001 
Health Literacy Questionnaire Subscale 4 0.977 251 <.001 
Health Literacy Questionnaire Subscale 5 0.978 251 <.001 
Health Literacy Questionnaire Subscale 6 0.937 251 <.001 
Health Literacy Questionnaire Subscale 7 0.949 251 <.001 
Health Literacy Questionnaire Subscale 8 0.938 251 <.001 
Health Literacy Questionnaire Subscale 9 0.936 251 <.001 
PANAS Positive Affect 0.985 251 <.001 
PANAS Negative Affect 0.933 251 <.001 
Fatigue NRS Average level 0.912 251 <.001 
Pain NRS Average level 0.965 251 <.001 
 
Appendix X: Cronbach’s alpha coefficients 
 
Measure:  Cronbach’s Alpha Coefficient:  
PAM  .87  
RASE  .93  
Locus of Control  .78  
BIPQ  .75  
Health Literacy Questionnaire  
(total measure)  
.95  
PANAS  .70  
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Appendix Y: Trimmed mean information for first survey 
dataset 
 
Outcome Measure Mean 
(Standard 
deviation) 
5% Trimmed Mean 
PAM 58.31 (11.46) 57.86 
HAQ 0.75  0.70 
RASE 101.61 (15.24) 101.8 
Locus of Control: Internal 16.98 (6.14) 16.81 
Locus of Control: Chance 11.32 (3.23) 11.32 
Locus of Control: Doctors 16.33 (6.47) 16.13 
Locus of Control: Powerful Others 8.71 (3.57) 8.58 
BIPQ 45.55 45.64 
Health Literacy Questionnaire Subscale 
1 
2.99 (.83) 3.01 
Health Literacy Questionnaire Subscale 
2 
2.94 (.65) 2.91 
Health Literacy Questionnaire Subscale 
3 
2.89 (.47) 2.89 
Health Literacy Questionnaire Subscale 
4 
2.92 (.57) 2.92 
Health Literacy Questionnaire Subscale 
5 
2.68 (.53) 2.69 
Health Literacy Questionnaire Subscale 
6 
3.78 (73) 3.81 
Health Literacy Questionnaire Subscale 
7 
3.59 (.66) 3.62 
Health Literacy Questionnaire Subscale 
8 
3.93 (.63) 3.86 
Health Literacy Questionnaire Subscale 
9 
4.08 (.55) 4.10 
PANAS Positive Affect 30.03 (8.85) 30.11 
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PANAS Negative Affect 19.88 (.7.72) 19.37 
Fatigue NRS Average level 6.43 (2.27) 6.54 
Pain NRS Average level 5.42 (2.51) 5.46 
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Appendix Z: Transformed confirmatory multiple regression 
 
Variables Preliminary multiple regression Final multiple regression 
Standardised β 95% CI P value Standardised β 95% CI P value 
Sex 0.04 -1.70 to 3.83 0.45    
Age -0.08 -0.17 to 0.04 0.21    
Disease duration -0.01 -0.11 to 0.09 0.88    
Ethnicity -0.02 -1.39 to 0.97 0.73    
Condition 0.06 -0.22 to 0.71 0.29    
Square root HAQ -0.10 -11.73 to 
1.78 
0.15    
Square root RASE 0.20 1.01 to 4.89 <0.01 0.31 2.91 to 6.27 <0.01 
Square root Int HLOC 0.09 -0.32 to 3.04 0.11    
Square root Docs 
HLOC 
0.05 -1.28 to 3.71 0.34    
BIPQ -0.12 -0.33 to 0.05 0.15    
Square root HLQ 1 -0.01 -7.88 to 7.38 0.95    
Square root HLQ 2 0.21 4.61 to 28.12 <0.01 0.30 13.75 to 34.08 <0.01 
Square root HLQ 3 0.05 -6.69 to 
14.80 
0.46    
Square root HLQ 4 0.01 -8.44 to 9.71 0.89    
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Square root HLQ 5 0.07 -4.24 to 
13.48 
0.31    
Square root HLQ 6 0.03 -9.15 to 
12.92 
0.74    
Square root HLQ 7 -0.19 -24.24 to 
1.21 
0.08 -0.12 -16.12 to 1.05 0.09 
Square root HLQ 8 0.05 -8.82 to 
15.68 
0.58    
Square root HLQ 9 0.23 5.83 to 30.39 <0.01 0.28 12.64 to 32.71 <0.01 
Square root Pain NRS 0.09 -1.41 to 5.35 0.25    
Square root Fatigue 
NRS 
-0.09 -5.49 to 1.35 0.23    
Square root Positive 
affect (PANAS) 
0.03 -1.49 to 2.21 0.70    
Square root Negative 
affect (PANAS) 
-0.04 -2.27 to 1.31 0.60    
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Appendix AA: Trimmed mean information for second set of 
survey data 
Outcome Measure Mean (Standard deviation) 5% Trimmed Mean 
PAM 58.43 (13.13) 57.68 
RASE 103.23 (14.69) 103.46 
Locus of Control: Internal 17.03 (5.40) 16.86 
Locus of Control: Chance 15.99 (6.07) 15.85 
Locus of Control: Doctors 10.90 (2.91) 10.91 
Locus of Control: Powerful 
Others 
8.54 (3.19) 8.47 
BIPQ 44.34 (11.63) 44.27 
HLQ Subscale 1 2.93 (.66) 2.96 
HLQ Subscale 2 2.92 (.51) 2.93 
HLQ Subscale 3 2.89 (.48) 2.89 
HLQ Subscale 4 2.85 (.60) 2.85 
HLQ Subscale 5 2.66 (.51) 2.66 
HLQ Subscale 6 3.65 (.84) 3.69 
HLQ Subscale 7 3.54 (.72) 3.58 
HLQ Subscale 8 3.8 (.65) 3.83 
HLQ Subscale 9 4.05 (.63) 4.09 
PANAS Positive Affect 30.83 (8.27) 31.06 
PANAS Negative Affect 20.1 (8.38) 19.55 
Fatigue NRS 6.44 (2.33) 6.53 
Pain NRS 5.01 (2.53) 5.02 
 410 
 
Appendix BB: Probability plot, scatterplot and Shapiro-Wilk 
results for second timepoint multiple regression 
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Variable Statistic Df p Value 
PAM  154  
HAQ 0.90 154 <0.01 
RASE 0.97 154 <0.01 
Locus of Control: Internal 0.98 154 0.01 
Locus of Control: Chance 0.98 154 0.01 
Locus of Control: Doctors 0.99 154 0.11 
Locus of Control: Powerful Others 0.98 154 0.01 
BIPQ 0.99 154 0.18 
Health Literacy Questionnaire Subscale 1 0.94 154 <0.01 
Health Literacy Questionnaire Subscale 2 0.92 154 <0.01 
Health Literacy Questionnaire Subscale 3 0.97 154 <0.01 
Health Literacy Questionnaire Subscale 4 0.97 154 <0.01 
Health Literacy Questionnaire Subscale 5 0.97 154 0.01 
Health Literacy Questionnaire Subscale 6 0.95 154 <0.01 
Health Literacy Questionnaire Subscale 7 0.95 154 <0.01 
Health Literacy Questionnaire Subscale 8 0.90 154 <0.01 
Health Literacy Questionnaire Subscale 9 0.92 154 <0.01 
PANAS Positive Affect 0.92 154 <0.01 
PANAS Negative Affect 0.97 154 <0.01 
Fatigue NRS Average level 0.97 154 <0.01 
Pain NRS Average level 0.92 154 <0.01 
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Appendix CC: Transformed confirmatory multiple regression on second round of multiple 
regressions 
Variables Preliminary multiple regression Final multiple regression 
Standardised β 95% CI P value Standardised β 95% CI P value 
HAQ -0.25 -32.03 to -
6.26 
<0.01 -0.22 -27.51 to -4.91 <0.01 
RASE 0.25 14.45 to 
76.70 
<0.01 0.29 25.11 to 78.98 0.01 
Powerful others HLOC -0.18 -20.01 to -
3.54 
<0.01 -0.14 -16.84 to -1.41 <0.01 
BIPQ -0.28 -0.51 to -0.06 0.01 -0.11 -0.29 to 0.06 0.19 
HLQ 1 -0.18 -38.10 to 2.04 0.07 -0.08 -23.19 to 6.63 0.27 
HLQ 2 0.27 4.73 to 64.95 0.02 0.32 18.54 to 63.65 <0.01 
HLQ 3 0.08 -11.25 to 
35.96 
0.30    
HLQ 4 0.11 -14.42 to 
30.63 
0.48    
HLQ 5 0.20 -6.02 to 34.53 0.17    
HLQ 6 -0.13 -9.99 to 47.28 0.20    
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HLQ 7 -0.13 -48.39 to 
19.55 
0.40    
HLQ 8 -0.03 -36.29 to 
29.19 
0.83    
HLQ 9 -0.02 -35.87 to 
31.53 
0.90    
Pain NRS 0.09 -4.22 to 14.42 0.28    
Fatigue NRS 0.06 -7.70 to 15.59 0.50    
Positive affect (PANAS) -0.06 -18.83 to 8.64 0.47    
Negative affect 
(PANAS) 
0.11 -3.79 to 18.44 0.20    
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Appendix DD: Example of framework development 
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Appendix EE: List of Invited talks, workshops and 
presentations disseminating findings of the PhD  
 
Poster Presentations 
Jones, B., Dures, E., Hewlett, S., Harcourt, A. & Hunt, A. (2017) Patient Activation in 
inflammatory arthritis: Developing a framework to inform interventions.  
Presented at:  
• Centre for Health and Clinical Research Conference, Bristol. 17th January 
2017. 
• Health and Applied Sciences Postgraduate Conference, Bristol. 19th June 
2017 
 
Jones, B., Hewlett, S., Harcourt, D., Hunt, A. & Dures, E. (2018) How effective are 
interventions targeting patient activation in people with long-term physical conditions? A 
systematic review. 
Presented at: 
• Versus Arthritis Fellows meeting, Loughborough. 15th March 2018 
• British Society for Rheumatology Annual Conference, Liverpool. 3rd May 
2018. (included on poster tour) 
• European League Against Rheumatism (EULAR) Annual Congress, 
Amsterdam. 15th June 2018. 
 
Jones, B., Hunt A., Harcourt, D., Hewlett, S. & Dures, E. (2019) The Patient 
Activation Measure (PAM): what do patients with rheumatic conditions think about it? 
Presented at: 
• British Society for Rheumatology Annual Conference, Birmingham. 1st May 
2018.  
• European League Against Rheumatism (EULAR) Annual Congress, Madrid. 
13th June 2018. 
 
Conference Abstracts 
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Jones, B., Hewlett, S., Harcourt, D., Hunt, A. & Dures, E. (2018). How effective are 
interventions targeting patient activation in people with long-term physical 
conditions? a systematic review. Ann Rheum Dis. volume 77, (Supp). p A829 
 
Jones, B., Hewlett, S., Harcourt, D., Hunt, A. & Dures, E. (2018) How effective are 
interventions targeting patient activation in people with long-term physical conditions? A 
systematic review. Rheumatology, Volume 57, Issue suppl_3, 1 April 2018, key075.502. 
 
Jones, B. (2018). i040 Patient activation: what is it? Rheumatology. Volume 57, Issue 
suppl_3, 1 April 2018, key075.040 
 
Jones, B., Hunt A., Harcourt, D., Hewlett, S. & Dures, E. (2019) The Patient Activation 
Measure (PAM): what do patients with rheumatic conditions think about it? Rheumatology, 
Volume 58, Issue suppl_3, kez108.056. 
 
Jones, B., Hunt A., Harcourt, D., Hewlett, S. & Dures, E. (2019) The Patient Activation 
Measure (PAM): what do patients with rheumatic conditions think about it? Ann Rheum 
Dis. volume 78, (Supp 2). p 656 
 
 
 
Invited talks/workshops 
• Jones, B. (2017) Patient Activation - what is it, and why should it matter to me? 
[BRI Rheumatology Patient Advisory Group meeting], Bristol Royal Infirmary. 
13th September 2017. 
• Jones, B. (2018) Patient Activation – what is it? British Society for Rheumatology 
Annual Conference, Liverpool. 2nd May 2018. 
• Jones, B. (2018) Patient activation: A survival guide for clinicians. Vitality 360 Away 
Day, Bristol. 10th November 2018. 
• Jones, B. (2019) Patient activation in rheumatic conditions: what does it mean to 
patients? Versus Arthritis Fellows Meeting, Loughborough. 14th February 2019. 
• Jones, B. (2019) Patient activation: A summary of the evidence. South West 
Rheumatology fellows away day, Bristol. 29th June 2019. 
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• Jones, B. (2019) Patient activation: what does it mean for me? Arthritis Action 
Eastbourne Group, Web-based presentation. 15th August 2019. 
• Jones, B. (2019) What is patient activation and why does it matter? British Pain 
Society (Pain Management Special Interest Group), Bristol. 12th September 
2019. 
• Jones, B. (2019) What is patient activation and why does it matter? Manchester 
Royal Infirmary Rheumatology team, Manchester. 15th November 2019. 
• Jones, B. (2019) An introduction to patient activation. British Society of 
Rheumatology Core Skills Course, Bristol. 25th November 2019. 
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Appendix FF: Abstract for Centre for Health and Clinical 
Research conference 2017  
Background: 
Self-management is an increasingly referenced concept in healthcare policies in the 
UK, following a shift to view people with chronic illness to be experts in their own 
condition (Dures et al., 2014). People are expected to be more involved in making 
decisions in collaboration with health care professionals, and to develop knowledge 
about managing their health (Hibbard, et al. 2004). Patient activation is how willing 
and able someone is to take an active role in dealing with their health (Hibbard and 
Greene, 2013). It appears to be a multidimensional construct, associated with self-
management behaviours such as treatment adherence, health literacy, and self-
efficacy (Hibbard et al., 2004; Do et al., 2015). Evidence suggests that patient 
activation is associated with fewer days in hospital and fewer emergency admissions 
(Hibbard & Greene, 2013). The Patient Activation Measure (PAM) stratifies patient 
activation scores into four developmental stages, with people developing their active 
role further over time (Hibbard et al., 2004). 
 
However, little is known about the dimensions involved in patient activation in 
context of inflammatory arthritis. There has also been limited qualitative research 
focused on patient perspectives on the concept of activation. Therefore, research 
to understand PAM scores and perceptions of activation over time can contribute 
to a model to describe patient activation within Rheumatology. 
 
Aims and Objectives: 
The project will be split into three studies: 
• Study one is a systematic review on the effectiveness of prior interventions 
targeting patient activation in long-term conditions. Understanding how 
research has captured changes in patient activation in other populations, the 
duration of interventions, and outcome measures used will inform the next two 
studies.  
• Study two will carry out semi-structured interviews, repeated 12 months later, 
with a purposive sample of people diagnosed with inflammatory arthritis. This 
will focus on their perspectives of the concept of activation. The interview 
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schedule will cover personal and contextual factors which participants believe 
impact activation, and their thoughts on the PAM (Hibbard et al., 2005). The 
interviews will aim to map developments in their understanding of activation 
over time. 
• Study three will investigate changes to participants’ PAM scores over time, to 
identify whether patient activation fluctuates, and describe the relationships 
between patient activation and related constructs. Participants will be surveyed 
across several sites, providing data at two separate points in time over 12 
months. They will complete the PAM and other outcome measures, to be 
determined following study one. 
 
Outcomes: 
The final aspect of the project will involve compiling all the data, and determining 
core components for a framework to describe patient activation in this context. 
The framework could form the foundation for developing a theory-led, 
rheumatology specific intervention targeting activation in the future to facilitate 
people taking greater responsibility for their own self-management. 
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Appendix GG: Summary of session for British Society for 
Rheumatology (BSR) conference 2018  
 
Patient activation is a concept related to self-management and refers to how willing 
and able somebody is to take active responsibility for their health. There is growing 
interest in patient activation, particularly around the Patient Activation Measure 
(PAM). This validated measure stratifies patient activation scores into four 
developmental stages, with people developing their active role further over time, and 
is increasingly used within health contexts to evaluate interventions and to tailor self-
management support to individuals. 
 
There is some evidence to suggest that high levels of patient activation are associated 
with better individual outcomes, a greater sense of control over their condition and 
increased confidence to manage their health. Activated patients are less likely to 
require emergency admission to hospital, and have fewer nights of inpatient 
hospitalisation overall, so there is considerable benefit to the NHS to support people 
to manage their health. 
 
The session covers an introduction to the evidence supporting patient activation, and 
how patient activation has been targeted in interventions. Initial findings from a 
qualitative study of people living with rheumatic conditions about personal and 
contextual factors that impact how they manage their health will be presented, along 
with participants perceptions of the PAM. The session will detail about how patient 
activation is becoming a useful construct to measure within the NHS, and review the 
evidence about how the PAM is currently being used in these contexts. The 
experience of a patient living with a rheumatic condition will provide an 
understanding of the process of becoming activated, and some of the challenges and 
benefits for them will be reviewed, as well as their perspectives on patient activation 
overall. 
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Appendix HH: Abstract BSR conference 2018 and European 
League Against Rheumatism (EULAR) 2018 
Background: 
Patient activation is an increasingly referenced concept in the self-management of 
long-term physical conditions. It refers to someone’s ability to take an active role in 
self-managing their health. There has been a substantial increase in the number of 
studies trailing interventions targeting patient activation in a variety of formats. This 
study aimed to identify the effectiveness of interventions targeting patient activation 
in people with long-term conditions. The findings from this review will contribute to 
maximising the impact of current rheumatology interventions, and to increase the 
understanding of patient activation to develop a framework to describe its core 
components within a rheumatology context.   
 
 
Methods: 
Studies that were randomised control trials of interventions targeting patient 
activation in adults with long-term physical conditions were included in the review. 
PsycINFO, Medline, AMED, CINAHL, and ProQuest were searched during January 
2017, as well as a variety of grey literature locations, snowballing and hand-searching 
to identify potential studies for inclusion. The Cochrane Collaboration’s Risk of Bias 
Tool was used to determine the methodological quality of included studies, and any 
differences were resolved by the two reviewers. Authors were contacted if any 
additional information was required to extract data or to clarify risk of bias. 
 
Results: 
17 papers were included in the review. There was a great deal of heterogeneity in 
the types of interventions available targeting patient activation in a variety of 
populations, and a meta-analysis was not possible as a result. Interventions were 
delivered via face to face, telephone, internet and resource-based approaches. The 
studies also included a mix of group and individually delivered interventions. 
Outcome measures used also varied, including both direct and proxy measures for 
patient activation. 
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The findings suggest that in studies with interventions that are more structured, there 
appear to be a trend towards differences in patient activation scores between groups 
in favour of the intervention. It is possible that these increases in patient activation 
may occur with an increase in health literacy, as the literature suggests an association 
between the two constructs. This is discussed in terms of a proposed model for 
patient activation for rheumatology. 
 
Conclusions: 
There is moderate evidence for the benefit of increasing structure in interventions 
targeting patient activation. There is no evidence for a medium of delivery that is 
most effective in people with long-term conditions. There is a need for increased 
research into patient activation within Rheumatology. 
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Appendix II: Abstract BSR conference 2019 and EULAR 2019 
Background: 
Patient activation describes the skills, abilities and confidence someone has to actively 
manage their health. The most common way of capturing patient activation is by using 
the Patient Activation Measure (PAM), and the NHS has begun to integrate use of 
the measure into services as an outcome measure or as a tool to tailor care. The 
PAM has been widely adopted and used in a variety of populations both within the 
NHS and internationally, but case studies have reported that some patients found 
that the PAM was too broad to capture the skills they used to manage their health. 
There has been limited research gathering patients’ perceptions of the suitability and 
acceptability of the PAM, particularly within a rheumatology context.  
 
Objectives: 
To gather participants’ opinions on the PAM as a method of capturing patient 
activation. 
 
Methods: 
Seventeen participants living with a rheumatic condition in the South West of England 
participated in semi-structured interviews as part of a wider qualitative study 
investigating perceptions of patient activation. Participants completed the PAM at the 
beginning of the interview. In the last phase of the interview, they were asked to 
review and reflect on the PAM, including individual survey items and how closely they 
matched their experiences. Relevant sections of the interviews were analysed 
iteratively and participants’ perspectives were grouped into themes.  
 
Results: 
Participants’ feedback on the PAM ranged, and some participants reported that the 
PAM entirely captured how they perceived patient activation and the way that they 
managed their conditions. However, this was not the case for all participants. Aspects 
of the PAM that participants felt were not sufficiently recognised included how they 
managed the psychological impact of their condition, and how they discussed their 
condition with loved ones. Participants commonly reported that they thought the 
phrasing of certain PAM items did not match the lived experience of their conditions. 
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For example, PAM items capturing how well patients could prevent further problems 
was identified as a challenge for participants living with a fluctuating condition, and 
participants commented that the PAM does not check from where participants 
received or sought this information. The distinction between whether patients 
independently researched information about diagnoses and medications or received 
this passively from healthcare professionals also appeared important to some 
participants, as well as whether this information was accurate.  
 
Conclusion: 
The PAM survey is generally considered a reliable and valid measure of patient 
activation, but there may be aspects of it that do not capture the realities of living 
with a long-term fluctuating condition. Rather than a stand-alone measure, the PAM 
would be best used in conjunction with healthcare professionals’ clinical judgement 
to capture peoples’ understanding of their conditions and how well they are able to 
recognise and respond to flare-ups and fluctuations.
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